Dopamine	HMDB_SMPDB	Samples:	62	Pathways:	96	Tyrosinemia Type I	Levomethadyl Acetate Action Action Pathway	Ethylmorphine Action Pathway	3-Methylthiofentanyl Action Pathway	Levorphanol Action Pathway	Heroin Pathway	Dibucaine Action Pathway	Prilocaine Pathway	Proparacaine Pathway	Oxycodone Pathway	Carfentanil Pathway	Disulfiram Pathway	Bupivacaine Action Pathway	Fentanyl Pathway	Ropivacaine Action Pathway	Procaine Action Pathway	Procaine Pathway	Benzocaine Action Pathway	Buprenorphine Action Pathway	Nicotine Action Pathway	Tyrosine hydroxylase deficiency	Heroin Action Pathway	Mepivacaine Action Pathway	Cocaine Pathway	Dihydromorphine Action Pathway	Sufentanil Pathway	Alvimopan Action Pathway	Alfentanil Action Pathway	Fentanyl Action Pathway	Dezocine Action Pathway	Levobupivacaine Pathway	Naloxone Action Pathway	Levallorphan Action Pathway	Methadone Action Pathway	Ropivacaine Pathway	Prilocaine Action Pathway	Citalopram Pathway	Hawkinsinuria	Tyrosine Metabolism	Oxybuprocaine Pathway	Nalbuphine Action Pathway	Fluoxetine Action Pathway	Monoamine oxidase-a deficiency (MAO-A)	Benzocaine Pathway	Hydrocodone Action Pathway	Hydromorphone Action Pathway	Propoxyphene Action Pathway	Aromatic L-Aminoacid Decarboxylase Deficiency	Imipramine Action Pathway	Citalopram Action Pathway	Disulfiram Action Pathway	Dibucaine Pathway	Methadyl Acetate Action Pathway	Anileridine Action Pathway	Proparacaine Action Pathway	Desipramine Pathway	Alkaptonuria	Lidocaine (Local Anaesthetic) Pathway	Sufentanil Action Pathway	Oxycodone Action Pathway	Escitalopram Action Pathway	Mepivacaine Pathway	Nicotine Pathway	Codeine Pathway	Dopamine beta-hydroxylase deficiency	Chloroprocaine Action Pathway	Pentazocine Action Pathway	Catecholamine Biosynthesis	Oxymorphone Pathway	Dimethylthiambutene Action Pathway	Oxybuprocaine Action Pathway	Remifentanil Pathway	Desipramine Action Pathway	Codeine Action Pathway	Imipramine Pathway	Remifentanil Action Pathway	Tyrosinemia, transient, of the newborn	Ketobemidone  Action Pathway	Naltrexone Action Pathway	Tramadol Action Action Pathway	Morphine Action Pathway	Hydromorphone Pathway	Chloroprocaine Pathway	Hydrocodone Pathway	Levobupivacaine Action Pathway	Bupivacaine Pathway	Morphine Pathway	Escitalopram Pathway	Oxymorphone Action Pathway	Fluoxetine Pathway	Alfentanil Pathway	Methadone Pathway	Carfentanil Action Pathway	Diphenoxylate Action Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Cocaine Action Pathway
Norepinephrine	HMDB_SMPDB	Samples:	61	Pathways:	63	Nalbuphine Action Pathway	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Levomethadyl Acetate Action Action Pathway	Ethylmorphine Action Pathway	Benzocaine Pathway	Aromatic L-Aminoacid Decarboxylase Deficiency	Propoxyphene Action Pathway	3-Methylthiofentanyl Action Pathway	Methadone Pathway	Levorphanol Action Pathway	Dibucaine Pathway	Methadyl Acetate Action Pathway	Anileridine Action Pathway	Heroin Pathway	Desipramine Pathway	Alkaptonuria	Prilocaine Pathway	Lidocaine (Local Anaesthetic) Pathway	Proparacaine Pathway	Mepivacaine Pathway	Oxycodone Pathway	Nicotine Pathway	Carfentanil Pathway	Dopamine beta-hydroxylase deficiency	Codeine Pathway	Disulfiram Pathway	Pentazocine Action Pathway	Fentanyl Pathway	Catecholamine Biosynthesis	Procaine Pathway	Buprenorphine Action Pathway	Dimethylthiambutene Action Pathway	Oxymorphone Pathway	Remifentanil Pathway	Tyrosine hydroxylase deficiency	Imipramine Pathway	Tyrosinemia, transient, of the newborn	Cocaine Pathway	Ketobemidone  Action Pathway	Naltrexone Action Pathway	Dihydromorphine Action Pathway	Tramadol Action Action Pathway	Sufentanil Pathway	Alvimopan Action Pathway	Dezocine Action Pathway	Levobupivacaine Pathway	Naloxone Action Pathway	Levallorphan Action Pathway	Chloroprocaine Pathway	Hydromorphone Pathway	Hydrocodone Pathway	Ropivacaine Pathway	Citalopram Pathway	Bupivacaine Pathway	Morphine Pathway	Escitalopram Pathway	Fluoxetine Pathway	Hawkinsinuria	Alfentanil Pathway	Tyrosine Metabolism	Diphenoxylate Action Pathway	Oxybuprocaine Pathway
Serotonin	HMDB_SMPDB	Samples:	55	Pathways:	85	Levomethadyl Acetate Action Action Pathway	Ethylmorphine Action Pathway	3-Methylthiofentanyl Action Pathway	Levorphanol Action Pathway	Heroin Pathway	Dibucaine Action Pathway	Prilocaine Pathway	Proparacaine Pathway	Oxycodone Pathway	Carfentanil Pathway	Bupivacaine Action Pathway	Fentanyl Pathway	Ropivacaine Action Pathway	Procaine Action Pathway	Procaine Pathway	Benzocaine Action Pathway	Buprenorphine Action Pathway	Nicotine Action Pathway	Heroin Action Pathway	Mepivacaine Action Pathway	Cocaine Pathway	Dihydromorphine Action Pathway	Sufentanil Pathway	Alvimopan Action Pathway	Naloxone Action Pathway	Fentanyl Action Pathway	Alfentanil Action Pathway	Dezocine Action Pathway	Levobupivacaine Pathway	Levallorphan Action Pathway	Methadone Action Pathway	Ropivacaine Pathway	Prilocaine Action Pathway	Citalopram Pathway	Oxybuprocaine Pathway	Nalbuphine Action Pathway	Fluoxetine Action Pathway	Benzocaine Pathway	Hydrocodone Action Pathway	Hydromorphone Action Pathway	Propoxyphene Action Pathway	Imipramine Action Pathway	Citalopram Action Pathway	Dibucaine Pathway	Methadyl Acetate Action Pathway	Anileridine Action Pathway	Proparacaine Action Pathway	Desipramine Pathway	Lidocaine (Local Anaesthetic) Pathway	Sufentanil Action Pathway	Oxycodone Action Pathway	Escitalopram Action Pathway	Mepivacaine Pathway	Nicotine Pathway	Codeine Pathway	Chloroprocaine Action Pathway	Pentazocine Action Pathway	Oxymorphone Pathway	Dimethylthiambutene Action Pathway	Oxybuprocaine Action Pathway	Remifentanil Pathway	Desipramine Action Pathway	Codeine Action Pathway	Imipramine Pathway	Remifentanil Action Pathway	Ketobemidone  Action Pathway	Naltrexone Action Pathway	Tramadol Action Action Pathway	Morphine Action Pathway	Tryptophan Metabolism	Hydromorphone Pathway	Chloroprocaine Pathway	Hydrocodone Pathway	Levobupivacaine Action Pathway	Bupivacaine Pathway	Morphine Pathway	Escitalopram Pathway	Oxymorphone Action Pathway	Fluoxetine Pathway	Alfentanil Pathway	Methadone Pathway	Carfentanil Action Pathway	Diphenoxylate Action Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Cocaine Action Pathway
Calcium	HMDB_SMPDB	Samples:	95	Pathways:	216	Ureidopropionase deficiency	Levomethadyl Acetate Action Action Pathway	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Lidocaine (Antiarrhythmic) Pathway	Phenindione Action Pathway	Phospholipid Biosynthesis	Ardeparin Pathway	Dicumarol Pathway	Ketoprofen Pathway	Levorphanol Action Pathway	Clopidogrel Pathway	Proparacaine Pathway	Nisoldipine Pathway	Phenylalanine and Tyrosine Metabolism	Oxycodone Pathway	Teniposide Pathway	Fentanyl Pathway	Pindolol Pathway	Antrafenine Action Pathway	Buprenorphine Action Pathway	Citrullinemia Type I	Mucopolysaccharidosis VI. Sly syndrome	Diclofenac Pathway	Ibuprofen Pathway	Aminocaproic Acid Pathway	Arbutamine Action Pathway	Esmolol Pathway	Anistreplase Pathway	Dihydromorphine Action Pathway	Bromfenac Pathway	Sufentanil Pathway	Alvimopan Action Pathway	Etodolac Pathway	Coagulation 	Pantothenate and CoA Biosynthesis	Ropivacaine Pathway	Citalopram Pathway	Naproxen Pathway	Alprenolol Pathway	Hawkinsinuria	Oxybuprocaine Pathway	Nalbuphine Action Pathway	Atenolol Pathway	Carvedilol Pathway	Starch and Sucrose Metabolism	Teniposide Metabolism Pathway	Benzocaine Pathway	Felodipine Pathway	Aprotinin Pathway	Glycogenosis, Type VI. Hers disease	Ketorolac Pathway	Tranexamic Acid Pathway	Bopindolol Action Pathway	Sotalol Action Pathway	Methadyl Acetate Action Pathway	Anileridine Action Pathway	Methotrexate Pathway	Salicylate-sodium Action Pathway	Desipramine Pathway	Tolmetin Action Pathway	Lidocaine (Local Anaesthetic) Pathway	Etoposide Metabolism Pathway	Nicotine Pathway	Codeine Pathway	Dopamine beta-hydroxylase deficiency	Androgen and Estrogen Metabolism	Quinidine Pathway	Practolol Action Pathway	Dicoumarol Action Pathway	Propranolol Pathway	Phenprocoumon Pathway	Pentazocine Action Pathway	Epinephrine Action Pathway	Lepirudin Pathway	Glycogen synthetase deficiency	Mefanamic Acid Pathway	Meloxicam Pathway	Oxymorphone Pathway	Dimethylthiambutene Action Pathway	Oxaprozin Pathway	Suprofen Pathway	Alpha Linolenic Acid and Linoleic Acid Metabolism	Timolol Action Pathway	Streptokinase Pathway	Trisalicylate-choline Action Pathway	Nadolol Pathway	Imipramine Pathway	Penbutolol Pathway	Heparin Pathway	Phenytoin (Antiarrhythmic) Pathway	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Isoprenaline Action Pathway	Ketobemidone  Action Pathway	Argininosuccinic Aciduria	Procainamide (Antiarrhythmic) Pathway	Enoxaparin Pathway	Hydromorphone Pathway	Clopidogrel Metabolism Pathway	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Flecainide Pathway	Glibenclamide Pathway	Hydrocodone Pathway	Leukotriene C4 Synthesis Deficiency	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	Carprofen Action Pathway	Escitalopram Pathway	Alfentanil Pathway	Methadone Pathway	Rofecoxib Pathway	Diphenoxylate Action Pathway	Labetalol Pathway	Nabumetone Pathway	Tyrosinemia Type I	Warfarin Pathway	Beta-Alanine Metabolism	Ethylmorphine Action Pathway	Etoricoxib Action Pathway	Verapamil Pathway	Disopyramide Pathway	Tiaprofenic Acid Action Pathway	Folate Metabolism	3-Methylthiofentanyl Action Pathway	Aromatase deficiency	Ibutilide Pathway	Nitrendipine Pathway	Heroin Pathway	Prilocaine Pathway	Alteplase Pathway	Nebivolol Pathway	Levobunolol Action Pathway	Carfentanil Pathway	Muscle/Heart Contraction	Disulfiram Pathway	Antipyrine Action Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Betaxolol Pathway	Procaine Pathway	Bupranolol Action Pathway	Nepafenac Action Pathway	Urokinase Pathway	Amlodipine Pathway	Nateglinide Pathway	Carteolol Action Pathway	Carnosinuria, carnosinemia	Flurbiprofen Action Pathway	Nifedipine Pathway	Acetaminophen  Action Pathway	Cocaine Pathway	Urea Cycle	Phenylketonuria	Dezocine Action Pathway	Levobupivacaine Pathway	Naloxone Action Pathway	Phenylbutazone Action Pathway	Levallorphan Action Pathway	Pancreas Function	Isradipine Pathway	Ximelagatran Pathway	Metoprolol Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Nimodipine Pathway	Diltiazem Pathway	Argatroban Pathway	Tyrosine Metabolism	Magnesium salicylate Action Pathway	Thyroid hormone synthesis	Monoamine oxidase-a deficiency (MAO-A)	Tenecteplase Pathway	Carbamoyl Phosphate Synthetase Deficiency	Reteplase Pathway	Propoxyphene Action Pathway	Histidinemia	Oxprenolol Pathway	Salicylic Acid Action Pathway	Dibucaine Pathway	Piroxicam Pathway	Acenocoumarol Pathway	Alkaptonuria	Bivalirudin Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Mepivacaine Pathway	Argininemia	Amiodarone Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Gliclazide Pathway	Salsalate Action Pathway	Remifentanil Pathway	Repaglinide Pathway	Tenoxicam Action Pathway	Mexiletine Pathway	Acebutolol Pathway	Sucrase-isomaltase deficiency	Malate-Aspartate Shuttle	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Bevantolol Action Pathway	Naltrexone Action Pathway	Acetylsalicylic Acid Pathway	Tramadol Action Action Pathway	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Chloroprocaine Pathway	Diflunisal Pathway	Bupivacaine Pathway	Morphine Pathway	Fluoxetine Pathway	Fosphenytoin (Antiarrhythmic) Pathway	Tocainide Pathway	Fondaparinux Pathway	Bisoprolol Pathway	Lornoxicam Action Pathway	Dobutamine Action Pathway	Folate malabsorption, hereditary	Metipranolol Action Pathway
Adenosine triphosphate	HMDB_SMPDB	Samples:	88	Pathways:	300	Lidocaine (Antiarrhythmic) Pathway	Levomethadyl Acetate Action Action Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Butyrate Metabolism	Vinorelbine Pathway	Beta-Ketothiolase Deficiency	Proparacaine Pathway	Nisoldipine Pathway	Oxycodone Pathway	Mitochondrial Electron Transport Chain	Carnitine-acylcarnitine translocase deficiency	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	Fentanyl Pathway	Gastric Acid Production	Carnitine palmitoyl transferase deficiency (I)	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Citrullinemia Type I	Mucopolysaccharidosis VI. Sly syndrome	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Ethylmalonic Encephalopathy	Arbutamine Action Pathway	Glycogenosis, Type IB	Malonic Aciduria	Dihydromorphine Action Pathway	Adrenoleukodystrophy, X-linked	Alvimopan Action Pathway	Sufentanil Pathway	Doxorubicin Metabolism Pathway	Transfer of Acetyl Groups into Mitochondria	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Sarcosinemia	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E2)	Pantothenate and CoA Biosynthesis	Ropivacaine Pathway	Citalopram Pathway	Succinic semialdehyde dehydrogenase deficiency	Alprenolol Pathway	Sulfite oxidase deficiency	Pyruvate dehydrogenase deficiency (E3)	Nalbuphine Action Pathway	Starch and Sucrose Metabolism	Congenital Bile Acid Synthesis Defect Type III	Benzocaine Pathway	Arginine and Proline Metabolism	The oncogenic action of Succinate	Felodipine Pathway	Gluconeogenesis	Bopindolol Action Pathway	Sotalol Action Pathway	Methadyl Acetate Action Pathway	Desipramine Pathway	Lidocaine (Local Anaesthetic) Pathway	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Etoposide Metabolism Pathway	Codeine Pathway	Quinidine Pathway	sarcosine oncometabolite pathway 	Practolol Action Pathway	Threonine and 2-Oxobutanoate Degradation	Vinblastine Pathway	Pentazocine Action Pathway	Epinephrine Action Pathway	Glycogen synthetase deficiency	Oxymorphone Pathway	Timolol Action Pathway	Nadolol Pathway	Phenytoin (Antiarrhythmic) Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Isobutyryl-coa dehydrogenase deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Erlotinib Pathway	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Acetaminophen Metabolism Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Flecainide Pathway	Glibenclamide Pathway	Hydrocodone Pathway	Cholesteryl ester storage disease	Alfentanil Pathway	Nevirapine Metabolism Pathway	Ranitidine Pathway	Selenoamino Acid Metabolism	Hyperprolinemia Type I	Disopyramide Pathway	Trifunctional protein deficiency	Folate Metabolism	Ibutilide Pathway	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Nitrendipine Pathway	Prilocaine Pathway	Nebivolol Pathway	Trehalose Degradation	Muscle/Heart Contraction	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Disulfiram Pathway	Carfentanil Pathway	Vindesine Pathway	Dimethylglycine Dehydrogenase Deficiency	The oncogenic action of 2-hydroxyglutarate	Beta Oxidation of Very Long Chain Fatty Acids	Betaxolol Pathway	Irinotecan Metabolism Pathway	Hyperglycinemia, non-ketotic	Nateglinide Pathway	Gemcitabine Metabolism Pathway	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Nifedipine Pathway	Steroid Biosynthesis	Cocaine Pathway	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Dezocine Action Pathway	Omeprazole Pathway	Levallorphan Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Metoprolol Pathway	Nimodipine Pathway	Pirenzepine Pathway	Phenylacetate Metabolism	Diltiazem Pathway	Leigh Syndrome	Cerebrotendinous Xanthomatosis (CTX)	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Citric Acid Cycle	Histidinemia	27-Hydroxylase Deficiency	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Hypercholesterolemia	Amiodarone Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Vincristine Pathway	Remifentanil Pathway	Hyper-IgD syndrome	Repaglinide Pathway	Congenital Bile Acid Synthesis Defect Type II	Mexiletine Pathway	Acebutolol Pathway	Prolinemia Type II	Wolman disease	Nizatidine Pathway	Glutaminolysis and Cancer	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Famotidine Pathway	Chloroprocaine Pathway	Morphine Pathway	Esomeprazole Pathway	Fosphenytoin (Antiarrhythmic) Pathway	Tocainide Pathway	Glycine and Serine Metabolism	Folate malabsorption, hereditary	Metipranolol Action Pathway	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Valproic Acid Metabolism Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Levorphanol Action Pathway	Oxidation of Branched Chain Fatty Acids	Homocarnosinosis	Clopidogrel Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	3-Methylglutaconic Aciduria Type I	Pindolol Pathway	Buprenorphine Action Pathway	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Lansoprazole Pathway	Esmolol Pathway	Metiamide Action Pathway	3-Methylglutaconic Aciduria Type III	CHILD Syndrome	Propanoate Metabolism	Propionic Acidemia	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Valine, Leucine and Isoleucine Degradation	Pyruvate Metabolism	Oxybuprocaine Pathway	Atenolol Pathway	Lactose Intolerance	Carvedilol Pathway	Primary hyperoxaluria II, PH2	Pantoprazole Pathway	Tramadol Metabolism Pathway	Glycogenosis, Type VI. Hers disease	Anileridine Action Pathway	Methotrexate Pathway	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Zellweger Syndrome	Nicotine Pathway	Propranolol Pathway	Betaine Metabolism	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Dimethylthiambutene Action Pathway	Carnitine palmitoyl transferase deficiency (II)	Primary Hyperoxaluria Type I	Simvastatin Action Pathway	Imipramine Pathway	Penbutolol Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	The oncogenic action of Fumarate	Isoprenaline Action Pathway	3-Methylglutaconic Aciduria Type IV	Triosephosphate isomerase	Ketobemidone  Action Pathway	Argininosuccinic Aciduria	Tryptophan Metabolism	Procainamide (Antiarrhythmic) Pathway	Hydromorphone Pathway	Clopidogrel Metabolism Pathway	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	Maple Syrup Urine Disease	Tyrosinemia Type 3 (TYRO3)	Escitalopram Pathway	Methadone Pathway	Diphenoxylate Action Pathway	Labetalol Pathway	Rabeprazole Pathway	Lactic Acidemia	Congenital lactic acidosis	Ethylmorphine Action Pathway	Glycogenosis, Type IC	Verapamil Pathway	3-Methylthiofentanyl Action Pathway	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Heroin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Levobunolol Action Pathway	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Gemcitabine Pathway	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Procaine Pathway	Non Ketotic Hyperglycinemia	Bupranolol Action Pathway	Amlodipine Pathway	Carteolol Action Pathway	Desmosterolosis	Sulfate/Sulfite Metabolism	Fatty acid Metabolism	Fumarase deficiency	Phenylketonuria	Lactose Degradation	Levobupivacaine Pathway	Naloxone Action Pathway	Pancreas Function	Betazole Action Pathway	Prolidase Deficiency (PD)	Roxatidine acetate Action Pathway	Isradipine Pathway	Mevalonic aciduria	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Warburg Effect	Glutamate Metabolism	Glycolysis	Alanine Metabolism	Familial Hypercholanemia (FHCA)	Carbamoyl Phosphate Synthetase Deficiency	Propoxyphene Action Pathway	Oxprenolol Pathway	Dibucaine Pathway	Fructose-1,6-diphosphatase deficiency	Cimetidine Pathway	Bile Acid Biosynthesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Mepivacaine Pathway	Argininemia	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Gliclazide Pathway	3-hydroxyisobutyric acid dehydrogenase deficiency	Sucrase-isomaltase deficiency	Histidine Metabolism	Thiamine Metabolism	Bevantolol Action Pathway	Naltrexone Action Pathway	Tramadol Action Action Pathway	Ammonia Recycling	Bupivacaine Pathway	L-arginine:glycine amidinotransferase deficiency	Fluoxetine Pathway	Bisoprolol Pathway	Dobutamine Action Pathway
Potassium	HMDB_SMPDB	Samples:	72	Pathways:	164	Lidocaine (Antiarrhythmic) Pathway	Levomethadyl Acetate Action Action Pathway	Indapamide Pathway	Levorphanol Action Pathway	Lysinuric Protein Intolerance	Proparacaine Pathway	Nisoldipine Pathway	Oxycodone Pathway	Fentanyl Pathway	Gastric Acid Production	Pindolol Pathway	Buprenorphine Action Pathway	Arbutamine Action Pathway	Lansoprazole Pathway	Esmolol Pathway	Chlorthalidone Pathway	Dihydromorphine Action Pathway	Metiamide Action Pathway	Sufentanil Pathway	Alvimopan Action Pathway	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Methyclothiazide Pathway	Ropivacaine Pathway	Citalopram Pathway	Blue diaper syndrome	Iminoglycinuria	Alprenolol Pathway	Amiloride Pathway	Pyruvate Metabolism	Bendroflumethiazide Pathway	Oxybuprocaine Pathway	Nalbuphine Action Pathway	Atenolol Pathway	Lactose Intolerance	Carvedilol Pathway	Primary hyperoxaluria II, PH2	Benzocaine Pathway	Felodipine Pathway	Pantoprazole Pathway	Spironolactone Pathway	Bopindolol Action Pathway	Sotalol Action Pathway	Methadyl Acetate Action Pathway	Anileridine Action Pathway	Desipramine Pathway	Lidocaine (Local Anaesthetic) Pathway	Nicotine Pathway	Polythiazide Pathway	Codeine Pathway	Quinidine Pathway	sarcosine oncometabolite pathway 	Practolol Action Pathway	Propranolol Pathway	Pentazocine Action Pathway	Betaine Metabolism	Epinephrine Action Pathway	Oxymorphone Pathway	Dimethylthiambutene Action Pathway	Chlorothiazide Pathway	Furosemide Pathway	Timolol Action Pathway	Nadolol Pathway	Eplerenone Pathway	Imipramine Pathway	Penbutolol Pathway	Phenytoin (Antiarrhythmic) Pathway	Isoprenaline Action Pathway	Triamterene Pathway	Ketobemidone  Action Pathway	Procainamide (Antiarrhythmic) Pathway	Hydromorphone Pathway	Flecainide Pathway	Glibenclamide Pathway	Hydrocodone Pathway	Escitalopram Pathway	Quinethazone Pathway	Alfentanil Pathway	Methadone Pathway	Ranitidine Pathway	Diphenoxylate Action Pathway	Labetalol Pathway	Rabeprazole Pathway	Kidney Function	Ethylmorphine Action Pathway	Verapamil Pathway	Disopyramide Pathway	3-Methylthiofentanyl Action Pathway	Ibutilide Pathway	Nitrendipine Pathway	Heroin Pathway	Cyclothiazide Pathway	Prilocaine Pathway	Nebivolol Pathway	Levobunolol Action Pathway	Trehalose Degradation	Carfentanil Pathway	Muscle/Heart Contraction	Betaxolol Pathway	Procaine Pathway	Bupranolol Action Pathway	Glucose Transporter Defect (SGLT2)	Amlodipine Pathway	Nateglinide Pathway	Carteolol Action Pathway	Ethacrynic Acid pathway	Nifedipine Pathway	Cocaine Pathway	Cystinuria	Lactose Degradation	Dezocine Action Pathway	Levobupivacaine Pathway	Naloxone Action Pathway	Omeprazole Pathway	Levallorphan Action Pathway	Pancreas Function	Betazole Action Pathway	Roxatidine acetate Action Pathway	Isradipine Pathway	Hydrochlorothiazide Pathway	Metoprolol Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Nimodipine Pathway	Pirenzepine Pathway	Diltiazem Pathway	Warburg Effect	Glycolysis	Leigh Syndrome	Lysinuric protein intolerance (LPI)	Propoxyphene Action Pathway	Oxprenolol Pathway	Trichlormethiazide Pathway	Hydroflumethiazide Pathway	Dibucaine Pathway	Pyruvate kinase deficiency	Cimetidine Pathway	Mepivacaine Pathway	Amiodarone Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	Bumetanide Pathway	Gliclazide Pathway	Remifentanil Pathway	Repaglinide Pathway	Torsemide Pathway	Mexiletine Pathway	Acebutolol Pathway	Bevantolol Action Pathway	Hartnup Disorder	Naltrexone Action Pathway	Nizatidine Pathway	Tramadol Action Action Pathway	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Famotidine Pathway	Chloroprocaine Pathway	Bupivacaine Pathway	Morphine Pathway	Fluoxetine Pathway	Esomeprazole Pathway	Fosphenytoin (Antiarrhythmic) Pathway	Tocainide Pathway	Bisoprolol Pathway	Metolazone Pathway	Dobutamine Action Pathway	Metipranolol Action Pathway
Sodium	HMDB_SMPDB	Samples:	65	Pathways:	135	Lidocaine (Antiarrhythmic) Pathway	Levomethadyl Acetate Action Action Pathway	Indapamide Pathway	Levorphanol Action Pathway	Lysinuric Protein Intolerance	Proparacaine Pathway	Nisoldipine Pathway	Oxycodone Pathway	Fentanyl Pathway	Pindolol Pathway	Buprenorphine Action Pathway	Capecitabine Pathway	Arbutamine Action Pathway	Esmolol Pathway	Chlorthalidone Pathway	Dihydromorphine Action Pathway	Sufentanil Pathway	Alvimopan Action Pathway	Methyclothiazide Pathway	Ropivacaine Pathway	Citalopram Pathway	Blue diaper syndrome	Iminoglycinuria	Alprenolol Pathway	Amiloride Pathway	Bendroflumethiazide Pathway	Oxybuprocaine Pathway	Nalbuphine Action Pathway	Atenolol Pathway	Lactose Intolerance	Carvedilol Pathway	Benzocaine Pathway	Felodipine Pathway	Spironolactone Pathway	Bopindolol Action Pathway	Sotalol Action Pathway	Methadyl Acetate Action Pathway	Anileridine Action Pathway	Desipramine Pathway	Lidocaine (Local Anaesthetic) Pathway	Nicotine Pathway	Polythiazide Pathway	Codeine Pathway	Quinidine Pathway	Practolol Action Pathway	Propranolol Pathway	Pentazocine Action Pathway	Epinephrine Action Pathway	Oxymorphone Pathway	Dimethylthiambutene Action Pathway	Chlorothiazide Pathway	Furosemide Pathway	Timolol Action Pathway	Nadolol Pathway	Eplerenone Pathway	Imipramine Pathway	Penbutolol Pathway	Phenytoin (Antiarrhythmic) Pathway	Isoprenaline Action Pathway	Triamterene Pathway	Ketobemidone  Action Pathway	Procainamide (Antiarrhythmic) Pathway	Hydromorphone Pathway	Flecainide Pathway	Hydrocodone Pathway	Escitalopram Pathway	Quinethazone Pathway	Capecitabine Metabolism Pathway	Alfentanil Pathway	Methadone Pathway	Diphenoxylate Action Pathway	Labetalol Pathway	Kidney Function	Ethylmorphine Action Pathway	Verapamil Pathway	Disopyramide Pathway	3-Methylthiofentanyl Action Pathway	Ibutilide Pathway	Nitrendipine Pathway	Heroin Pathway	Cyclothiazide Pathway	Prilocaine Pathway	Nebivolol Pathway	Levobunolol Action Pathway	Trehalose Degradation	Carfentanil Pathway	Muscle/Heart Contraction	Betaxolol Pathway	Procaine Pathway	Bupranolol Action Pathway	Glucose Transporter Defect (SGLT2)	Amlodipine Pathway	Carteolol Action Pathway	Ethacrynic Acid pathway	Nifedipine Pathway	Cocaine Pathway	Cystinuria	Lactose Degradation	Dezocine Action Pathway	Levobupivacaine Pathway	Naloxone Action Pathway	Levallorphan Action Pathway	Isradipine Pathway	Hydrochlorothiazide Pathway	Metoprolol Pathway	Nimodipine Pathway	Diltiazem Pathway	Lysinuric protein intolerance (LPI)	Thyroid hormone synthesis	Propoxyphene Action Pathway	Oxprenolol Pathway	Trichlormethiazide Pathway	Hydroflumethiazide Pathway	Dibucaine Pathway	Mepivacaine Pathway	Amiodarone Action Pathway	Bumetanide Pathway	Remifentanil Pathway	Torsemide Pathway	Mexiletine Pathway	Acebutolol Pathway	Bevantolol Action Pathway	Hartnup Disorder	Naltrexone Action Pathway	Tramadol Action Action Pathway	Chloroprocaine Pathway	Bupivacaine Pathway	Morphine Pathway	Fluoxetine Pathway	Fosphenytoin (Antiarrhythmic) Pathway	Tocainide Pathway	Bisoprolol Pathway	Metolazone Pathway	Dobutamine Action Pathway	Metipranolol Action Pathway
ADP	HMDB_SMPDB	Samples:	87	Pathways:	353	Alprenolol Action Pathway	Levomethadyl Acetate Action Action Pathway	Lidocaine (Antiarrhythmic) Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Bisoprolol Action Pathway	Vinorelbine Pathway	Beta-Ketothiolase Deficiency	Proparacaine Pathway	Nisoldipine Pathway	Oxycodone Pathway	Mitochondrial Electron Transport Chain	Carnitine-acylcarnitine translocase deficiency	Bupivacaine Action Pathway	Malonyl-coa decarboxylase deficiency	Fentanyl Pathway	Gastric Acid Production	Vindesine Action Pathway	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Mucopolysaccharidosis VI. Sly syndrome	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Citrullinemia Type I	Arbutamine Action Pathway	Heroin Action Pathway	Glycogenosis, Type IB	Malonic Aciduria	Dihydromorphine Action Pathway	Mexiletine Action Pathway	Doxorubicin Metabolism Pathway	Adrenoleukodystrophy, X-linked	Alvimopan Action Pathway	Sufentanil Pathway	Fentanyl Action Pathway	Transfer of Acetyl Groups into Mitochondria	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Sarcosinemia	Methadone Action Pathway	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Phenytoin (Antiarrhythmic) Action Pathway	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E2)	Pantothenate and CoA Biosynthesis	Ropivacaine Pathway	Lidocaine (Antiarrhythmic) Action Pathway	Labetalol Action Pathway	Citalopram Pathway	Succinic semialdehyde dehydrogenase deficiency	Alprenolol Pathway	Sulfite oxidase deficiency	Pyruvate dehydrogenase deficiency (E3)	Disopyramide Action Pathway	Nalbuphine Action Pathway	Fluoxetine Action Pathway	Starch and Sucrose Metabolism	Congenital Bile Acid Synthesis Defect Type III	Felodipine Pathway	Arginine and Proline Metabolism	Tocainide Action Pathway	Benzocaine Pathway	The oncogenic action of Succinate	Hydrocodone Action Pathway	Procainamide (Antiarrhythmic) Action Pathway	Gluconeogenesis	Bopindolol Action Pathway	Sotalol Action Pathway	Methadyl Acetate Action Pathway	Proparacaine Action Pathway	Desipramine Pathway	Lidocaine (Local Anaesthetic) Pathway	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Sufentanil Action Pathway	Etoposide Metabolism Pathway	Codeine Pathway	Quinidine Pathway	Practolol Action Pathway	Chloroprocaine Action Pathway	Threonine and 2-Oxobutanoate Degradation	Vinblastine Pathway	Pentazocine Action Pathway	Epinephrine Action Pathway	Glycogen synthetase deficiency	Oxymorphone Pathway	Timolol Action Pathway	Oxprenolol Action Pathway	Nadolol Pathway	Phenytoin (Antiarrhythmic) Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Remifentanil Action Pathway	Mitochondrial complex II deficiency	Isobutyryl-coa dehydrogenase deficiency	Erlotinib Pathway	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Esmolol Action Pathway	Acetaminophen Metabolism Pathway	Morphine Action Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Acebutolol Action Pathway	Flecainide Pathway	Hydrocodone Pathway	Vincristine Action Pathway	Cholesteryl ester storage disease	Omeprazole Action Pathway	Selenoamino Acid Metabolism	Alfentanil Pathway	Nevirapine Metabolism Pathway	Ranitidine Pathway	Cocaine Action Pathway	Ibutilide Action Pathway	Hyperprolinemia Type I	Disopyramide Pathway	Folate Metabolism	Ibutilide Pathway	Nitrendipine Pathway	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Dibucaine Action Pathway	Prilocaine Pathway	Nebivolol Pathway	Trehalose Degradation	Carfentanil Pathway	Muscle/Heart Contraction	Vindesine Pathway	Dimethylglycine Dehydrogenase Deficiency	The oncogenic action of 2-hydroxyglutarate	Beta Oxidation of Very Long Chain Fatty Acids	Betaxolol Pathway	Irinotecan Metabolism Pathway	Hyperglycinemia, non-ketotic	Ranitidine Action Pathway	Nicotine Action Pathway	Gemcitabine Metabolism Pathway	Etoposide Action Pathway	Propranolol Action Pathway	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Nifedipine Pathway	Steroid Biosynthesis	Cocaine Pathway	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Alfentanil Action Pathway	Dezocine Action Pathway	Omeprazole Pathway	Levallorphan Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Fosphenytoin (Antiarrhythmic) Action Pathway	Metoprolol Pathway	Nimodipine Pathway	Famotidine Action Pathway	Pirenzepine Pathway	Diltiazem Pathway	Leigh Syndrome	Atenolol Action Pathway	Cerebrotendinous Xanthomatosis (CTX)	Diltiazem Action Pathway	Citric Acid Cycle	Histidinemia	Imipramine Action Pathway	27-Hydroxylase Deficiency	Betaxolol Action Pathway	Pyruvate kinase deficiency	Hypercholesterolemia	Phytanic Acid Peroxisomal Oxidation	Oxycodone Action Pathway	Amiodarone Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	Methotrexate Action Pathway	Nebivolol Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	Vincristine Pathway	Clopidogrel Action Pathway	Oxybuprocaine Action Pathway	Codeine Action Pathway	Hyper-IgD syndrome	Remifentanil Pathway	Congenital Bile Acid Synthesis Defect Type II	Mexiletine Pathway	Acebutolol Pathway	Prolinemia Type II	Wolman disease	Nizatidine Pathway	Glutaminolysis and Cancer	Quinidine Action Pathway	Amlodipine Action Pathway	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Pirenzepine Action Pathway	Famotidine Pathway	Chloroprocaine Pathway	Morphine Pathway	Esomeprazole Pathway	Tocainide Pathway	Fosphenytoin (Antiarrhythmic) Pathway	Glycine and Serine Metabolism	Carfentanil Action Pathway	Folate malabsorption, hereditary	Metipranolol Action Pathway	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Levorphanol Action Pathway	Oxidation of Branched Chain Fatty Acids	Clopidogrel Pathway	Homocarnosinosis	Felodipine Action Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	3-Methylglutaconic Aciduria Type I	Isradipine Action Pathway	Nizatidine Action Pathway	Pindolol Pathway	Ropivacaine Action Pathway	Buprenorphine Action Pathway	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Lansoprazole Pathway	Esmolol Pathway	Nisoldipine Action Pathway	Verapamil Action Pathway	Metiamide Action Pathway	3-Methylglutaconic Aciduria Type III	Irinotecan Action Pathway	CHILD Syndrome	Propanoate Metabolism	Propionic Acidemia	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Valine, Leucine and Isoleucine Degradation	Pyruvate Metabolism	Oxybuprocaine Pathway	Atenolol Pathway	Lactose Intolerance	Carvedilol Pathway	Primary hyperoxaluria II, PH2	Lansoprazole Action Pathway	Pantoprazole Pathway	Tramadol Metabolism Pathway	Glycogenosis, Type VI. Hers disease	Anileridine Action Pathway	Methotrexate Pathway	Gemcitabine Action Pathway	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Vinorelbine Action Pathway	Escitalopram Action Pathway	Zellweger Syndrome	Nicotine Pathway	Propranolol Pathway	Dimethylthiambutene Action Pathway	Primary Hyperoxaluria Type I	Desipramine Action Pathway	Simvastatin Action Pathway	Pantoprazole Action Pathway	Cimetidine Action Pathway	Imipramine Pathway	Penbutolol Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	The oncogenic action of Fumarate	Isoprenaline Action Pathway	3-Methylglutaconic Aciduria Type IV	Triosephosphate isomerase	Ketobemidone  Action Pathway	Argininosuccinic Aciduria	Penbutolol Action Pathway	Procainamide (Antiarrhythmic) Pathway	Hydromorphone Pathway	Clopidogrel Metabolism Pathway	Nitrendipine Action Pathway	Hyperinsulinism-Hyperammonemia Syndrome	Maple Syrup Urine Disease	Levobupivacaine Action Pathway	Escitalopram Pathway	Methadone Pathway	Diphenoxylate Action Pathway	Labetalol Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Rabeprazole Action Pathway	Rabeprazole Pathway	Lactic Acidemia	Congenital lactic acidosis	Ethylmorphine Action Pathway	Glycogenosis, Type IC	Verapamil Pathway	3-Methylthiofentanyl Action Pathway	Heroin Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Levobunolol Action Pathway	Hyperprolinemia Type II	Gemcitabine Pathway	Erlotinib Action Pathway	Procaine Action Pathway	Procaine Pathway	Non Ketotic Hyperglycinemia	Benzocaine Action Pathway	Bupranolol Action Pathway	Vinblastine Action Pathway	Amlodipine Pathway	Carteolol Action Pathway	Mepivacaine Action Pathway	Desmosterolosis	Nifedipine Action Pathway	Sulfate/Sulfite Metabolism	Metoprolol Action Pathway	Fumarase deficiency	Naloxone Action Pathway	Lactose Degradation	Levobupivacaine Pathway	Betazole Action Pathway	Prolidase Deficiency (PD)	Roxatidine acetate Action Pathway	Isradipine Pathway	Mevalonic aciduria	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Prilocaine Action Pathway	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Warburg Effect	Glutamate Metabolism	Glycolysis	Alanine Metabolism	Familial Hypercholanemia (FHCA)	Carbamoyl Phosphate Synthetase Deficiency	Hydromorphone Action Pathway	Propoxyphene Action Pathway	Oxprenolol Pathway	Citalopram Action Pathway	Dibucaine Pathway	Fructose-1,6-diphosphatase deficiency	Cimetidine Pathway	Bile Acid Biosynthesis	Mepivacaine Pathway	Argininemia	Carvedilol Action Pathway	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-hydroxyisobutyric acid dehydrogenase deficiency	Sucrase-isomaltase deficiency	Histidine Metabolism	Thiamine Metabolism	Bevantolol Action Pathway	Flecainide Action Pathway	Naltrexone Action Pathway	Nimodipine Action Pathway	Nadolol Action Pathway	Tramadol Action Action Pathway	Esomeprazole Action Pathway	Ammonia Recycling	Bupivacaine Pathway	L-arginine:glycine amidinotransferase deficiency	Oxymorphone Action Pathway	Fluoxetine Pathway	Pindolol Action Pathway	Bisoprolol Pathway	Dobutamine Action Pathway
Phosphate	HMDB_SMPDB	Samples:	87	Pathways:	250	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Levomethadyl Acetate Action Action Pathway	Lidocaine (Antiarrhythmic) Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Levorphanol Action Pathway	Homocarnosinosis	Beta-Ketothiolase Deficiency	Clopidogrel Pathway	Vinorelbine Pathway	Proparacaine Pathway	Nisoldipine Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Oxycodone Pathway	Mitochondrial Electron Transport Chain	3-Methylglutaconic Aciduria Type I	Fentanyl Pathway	Gastric Acid Production	Pindolol Pathway	Buprenorphine Action Pathway	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Citrullinemia Type I	Mucopolysaccharidosis VI. Sly syndrome	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Capecitabine Pathway	Arbutamine Action Pathway	Lansoprazole Pathway	Esmolol Pathway	Glycogenosis, Type IB	Dihydromorphine Action Pathway	Metiamide Action Pathway	Sufentanil Pathway	Alvimopan Action Pathway	3-Methylglutaconic Aciduria Type III	Doxorubicin Metabolism Pathway	Transfer of Acetyl Groups into Mitochondria	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Sarcosinemia	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	CHILD Syndrome	Pyruvate dehydrogenase deficiency (E2)	Glycogenosis, Type VII. Tarui disease	Propionic Acidemia	Ropivacaine Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Citalopram Pathway	Valine, Leucine and Isoleucine Degradation	Succinic semialdehyde dehydrogenase deficiency	Alprenolol Pathway	Sulfite oxidase deficiency	Pyruvate dehydrogenase deficiency (E3)	Pyruvate Metabolism	Oxybuprocaine Pathway	Nalbuphine Action Pathway	Atenolol Pathway	Lactose Intolerance	Carvedilol Pathway	Starch and Sucrose Metabolism	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Benzocaine Pathway	Pantoprazole Pathway	Felodipine Pathway	Gluconeogenesis	Glycogenosis, Type VI. Hers disease	Bopindolol Action Pathway	Sotalol Action Pathway	Methadyl Acetate Action Pathway	Anileridine Action Pathway	Methotrexate Pathway	Desipramine Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Lidocaine (Local Anaesthetic) Pathway	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Etoposide Metabolism Pathway	Nicotine Pathway	Codeine Pathway	Quinidine Pathway	sarcosine oncometabolite pathway 	Practolol Action Pathway	Propranolol Pathway	Vinblastine Pathway	Pentazocine Action Pathway	Betaine Metabolism	Epinephrine Action Pathway	Glycogen synthetase deficiency	Oxymorphone Pathway	Dimethylthiambutene Action Pathway	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Primary Hyperoxaluria Type I	Timolol Action Pathway	Simvastatin Action Pathway	Nadolol Pathway	Imipramine Pathway	Penbutolol Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Phenytoin (Antiarrhythmic) Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	The oncogenic action of Fumarate	Isoprenaline Action Pathway	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Erlotinib Pathway	Ketobemidone  Action Pathway	Triosephosphate isomerase	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Argininosuccinic Aciduria	Acetaminophen Metabolism Pathway	Procainamide (Antiarrhythmic) Pathway	Hydromorphone Pathway	Clopidogrel Metabolism Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Flecainide Pathway	Maple Syrup Urine Disease	Hydrocodone Pathway	Cholesteryl ester storage disease	Escitalopram Pathway	Capecitabine Metabolism Pathway	Alfentanil Pathway	Methadone Pathway	Nevirapine Metabolism Pathway	Diphenoxylate Action Pathway	Ranitidine Pathway	Labetalol Pathway	Rabeprazole Pathway	Hyperprolinemia Type I	Lactic Acidemia	Congenital lactic acidosis	Ethylmorphine Action Pathway	Glycogenosis, Type IC	Verapamil Pathway	Disopyramide Pathway	Folate Metabolism	3-Methylthiofentanyl Action Pathway	Ibutilide Pathway	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Heroin Pathway	Nitrendipine Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Prilocaine Pathway	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Nebivolol Pathway	Levobunolol Action Pathway	Trehalose Degradation	Hyperprolinemia Type II	Carfentanil Pathway	Muscle/Heart Contraction	Vindesine Pathway	Dimethylglycine Dehydrogenase Deficiency	The oncogenic action of 2-hydroxyglutarate	Betaxolol Pathway	Procaine Pathway	Non Ketotic Hyperglycinemia	Irinotecan Metabolism Pathway	Hyperglycinemia, non-ketotic	Bupranolol Action Pathway	Amlodipine Pathway	Carteolol Action Pathway	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Nifedipine Pathway	Steroid Biosynthesis	Desmosterolosis	Cocaine Pathway	Sulfate/Sulfite Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Fumarase deficiency	Lactose Degradation	Dezocine Action Pathway	Levobupivacaine Pathway	Naloxone Action Pathway	Omeprazole Pathway	Levallorphan Action Pathway	Betazole Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Roxatidine acetate Action Pathway	Isradipine Pathway	Mevalonic aciduria	Metoprolol Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Nimodipine Pathway	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Pirenzepine Pathway	Diltiazem Pathway	Warburg Effect	Glutamate Metabolism	Glycolysis	Leigh Syndrome	Alanine Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Citric Acid Cycle	Propoxyphene Action Pathway	Histidinemia	Oxprenolol Pathway	Dibucaine Pathway	Fructose-1,6-diphosphatase deficiency	Pyruvate kinase deficiency	Cimetidine Pathway	Hypercholesterolemia	Mepivacaine Pathway	Argininemia	Amiodarone Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	Vincristine Pathway	Remifentanil Pathway	Hyper-IgD syndrome	Mexiletine Pathway	3-hydroxyisobutyric acid dehydrogenase deficiency	Prolinemia Type II	Acebutolol Pathway	Histidine Metabolism	Sucrase-isomaltase deficiency	Thiamine Metabolism	Wolman disease	Bevantolol Action Pathway	Naltrexone Action Pathway	Nizatidine Pathway	Glutaminolysis and Cancer	Tramadol Action Action Pathway	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Famotidine Pathway	Chloroprocaine Pathway	Ammonia Recycling	Bupivacaine Pathway	L-arginine:glycine amidinotransferase deficiency	Morphine Pathway	Fluoxetine Pathway	Esomeprazole Pathway	Fosphenytoin (Antiarrhythmic) Pathway	Bisoprolol Pathway	Tocainide Pathway	Glycine and Serine Metabolism	Dobutamine Action Pathway	Folate malabsorption, hereditary	Metipranolol Action Pathway
Water	HMDB_SMPDB	Samples:	92	Pathways:	426	Ureidopropionase deficiency	Levomethadyl Acetate Action Action Pathway	Lidocaine (Antiarrhythmic) Pathway	Indapamide Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Butyrate Metabolism	Ketoprofen Pathway	Vinorelbine Pathway	Beta-Ketothiolase Deficiency	Lysinuric Protein Intolerance	Proparacaine Pathway	Nisoldipine Pathway	Nicotine Metabolism Pathway	Oxycodone Pathway	Mitochondrial Electron Transport Chain	Felbamate Metabolism Pathway	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	Homocysteine Degradation	Teniposide Pathway	Fentanyl Pathway	Gastric Acid Production	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Antrafenine Action Pathway	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Mucopolysaccharidosis VI. Sly syndrome	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Citrullinemia Type I	Pyridoxine dependency with seizures	Ethylmalonic Encephalopathy	Tyrosine hydroxylase deficiency	Arbutamine Action Pathway	Glycogenosis, Type IB	Malonic Aciduria	Dihydromorphine Action Pathway	Bromfenac Pathway	Doxorubicin Metabolism Pathway	Sufentanil Pathway	Alvimopan Action Pathway	Transfer of Acetyl Groups into Mitochondria	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Sarcosinemia	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Methyclothiazide Pathway	Pyruvate dehydrogenase deficiency (E2)	Ropivacaine Pathway	Pantothenate and CoA Biosynthesis	Acute Intermittent Porphyria	Citalopram Pathway	Blue diaper syndrome	Succinic semialdehyde dehydrogenase deficiency	Alprenolol Pathway	Amiloride Pathway	Sulfite oxidase deficiency	Pyruvate dehydrogenase deficiency (E3)	Segawa syndrome	Hawkinsinuria	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Nalbuphine Action Pathway	Starch and Sucrose Metabolism	Congenital Bile Acid Synthesis Defect Type III	2-aminoadipic 2-oxoadipic aciduria	Fatty Acid Elongation In Mitochondria	Felodipine Pathway	Arginine and Proline Metabolism	Benzocaine Pathway	The oncogenic action of Succinate	Gluconeogenesis	Ketorolac Pathway	Bopindolol Action Pathway	Sotalol Action Pathway	Methadyl Acetate Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Desipramine Pathway	Lidocaine (Local Anaesthetic) Pathway	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Etoposide Metabolism Pathway	Polythiazide Pathway	Codeine Pathway	Quinidine Pathway	sarcosine oncometabolite pathway 	Practolol Action Pathway	Vinblastine Pathway	Pentazocine Action Pathway	Epinephrine Action Pathway	Catecholamine Biosynthesis	Glycogen synthetase deficiency	Meloxicam Pathway	Mefanamic Acid Pathway	Oxymorphone Pathway	Suprofen Pathway	Chlorothiazide Pathway	Timolol Action Pathway	Furosemide Pathway	Hereditary Coproporphyria (HCP)	Nadolol Pathway	Eplerenone Pathway	11-beta-hydroxylase deficiency (CYP11B1)	Phenytoin (Antiarrhythmic) Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Mitochondrial complex II deficiency	Isobutyryl-coa dehydrogenase deficiency	Erlotinib Pathway	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Acetaminophen Metabolism Pathway	Gamma-cystathionase deficiency (CTH)	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Leukotriene C4 Synthesis Deficiency	Flecainide Pathway	Hydrocodone Pathway	Cholesteryl ester storage disease	GABA-Transaminase Deficiency	Quinethazone Pathway	Alfentanil Pathway	Selenoamino Acid Metabolism	Nevirapine Metabolism Pathway	Nabumetone Pathway	Rofecoxib Pathway	Ranitidine Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	Venlafaxine Metabolism Pathway	Disopyramide Pathway	Trifunctional protein deficiency	Folate Metabolism	Ibutilide Pathway	Nitrendipine Pathway	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria, cystathionine beta-synthase deficiency	Cyclothiazide Pathway	Prilocaine Pathway	Nebivolol Pathway	Trehalose Degradation	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Muscle/Heart Contraction	Disulfiram Pathway	Carfentanil Pathway	Sorafenib Metabolism Pathway	Antipyrine Action Pathway	Dimethylglycine Dehydrogenase Deficiency	The oncogenic action of 2-hydroxyglutarate	Vindesine Pathway	Betaxolol Pathway	Celecoxib Metabolism Pathway	Irinotecan Metabolism Pathway	Hyperglycinemia, non-ketotic	Nepafenac Action Pathway	Corticosterone methyl oxidase I deficiency (CMO I)	Glucose Transporter Defect (SGLT2)	Gemcitabine Metabolism Pathway	Ethacrynic Acid pathway	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Flurbiprofen Action Pathway	Nifedipine Pathway	Steroid Biosynthesis	Acetaminophen  Action Pathway	Cocaine Pathway	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Cystinuria	Dezocine Action Pathway	Omeprazole Pathway	Levallorphan Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Hydrochlorothiazide Pathway	Metoprolol Pathway	Nimodipine Pathway	Pirenzepine Pathway	Diltiazem Pathway	Tyrosine Metabolism	Magnesium salicylate Action Pathway	Leigh Syndrome	Lysinuric protein intolerance (LPI)	Cerebrotendinous Xanthomatosis (CTX)	Thyroid hormone synthesis	Carnitine Synthesis	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Citric Acid Cycle	Histidinemia	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Artemether Metabolism Pathway	27-Hydroxylase Deficiency	Pyruvate kinase deficiency	Hypercholesterolemia	Alkaptonuria	Steroidogenesis	Phytanic Acid Peroxisomal Oxidation	Ibuprofen Metabolism Pathway	Lumiracoxib Action Pathway	Amiodarone Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	Fenoprofen Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Bumetanide Pathway	Methylmalonic Aciduria	Isovaleric acidemia	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Salsalate Action Pathway	Vincristine Pathway	Remifentanil Pathway	Hyper-IgD syndrome	Ubiquinone Biosynthesis	Torsemide Pathway	Congenital Bile Acid Synthesis Defect Type II	Acebutolol Pathway	Prolinemia Type II	Mexiletine Pathway	Wolman disease	Nizatidine Pathway	Glutaminolysis and Cancer	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Famotidine Pathway	Chloroprocaine Pathway	Diflunisal Pathway	Morphine Pathway	Esomeprazole Pathway	Tocainide Pathway	Fosphenytoin (Antiarrhythmic) Pathway	Pterine Biosynthesis	Glycine and Serine Metabolism	Lornoxicam Action Pathway	Folate malabsorption, hereditary	Metipranolol Action Pathway	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Valproic Acid Metabolism Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Levorphanol Action Pathway	Clopidogrel Pathway	Homocarnosinosis	Porphyria Variegata (PV)	Phenylalanine and Tyrosine Metabolism	Creatine deficiency, guanidinoacetate methyltransferase deficiency	3-Methylglutaconic Aciduria Type I	Pindolol Pathway	Buprenorphine Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Capecitabine Pathway	Lansoprazole Pathway	Esmolol Pathway	21-hydroxylase deficiency (CYP21)	Chlorthalidone Pathway	Glucose-Alanine Cycle	Metiamide Action Pathway	Etodolac Pathway	3-Methylglutaconic Aciduria Type III	CHILD Syndrome	Tamoxifen Pathway	Propanoate Metabolism	Propionic Acidemia	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Iminoglycinuria	Valine, Leucine and Isoleucine Degradation	Naproxen Pathway	Pyruvate Metabolism	Bendroflumethiazide Pathway	Oxybuprocaine Pathway	Atenolol Pathway	Lactose Intolerance	Carvedilol Pathway	Teniposide Metabolism Pathway	Primary hyperoxaluria II, PH2	Pantoprazole Pathway	Spironolactone Pathway	Tramadol Metabolism Pathway	Glycogenosis, Type VI. Hers disease	Anileridine Action Pathway	Methotrexate Pathway	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Zellweger Syndrome	Nicotine Pathway	Dopamine beta-hydroxylase deficiency	Androgen and Estrogen Metabolism	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Propranolol Pathway	Betaine Metabolism	Oxaprozin Pathway	17-alpha-hydroxylase deficiency (CYP17)	Dimethylthiambutene Action Pathway	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	Simvastatin Action Pathway	Trisalicylate-choline Action Pathway	Imipramine Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Penbutolol Pathway	The oncogenic action of Fumarate	Isoprenaline Action Pathway	3-Methylglutaconic Aciduria Type IV	Triosephosphate isomerase	Triamterene Pathway	Ketobemidone  Action Pathway	Argininosuccinic Aciduria	Procainamide (Antiarrhythmic) Pathway	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	Tryptophan Metabolism	Hydromorphone Pathway	D-Arginine and D-Ornithine Metabolism	Clopidogrel Metabolism Pathway	Hyperinsulinism-Hyperammonemia Syndrome	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Ethanol Degradation	Maple Syrup Urine Disease	Tyrosinemia Type 3 (TYRO3)	Carprofen Action Pathway	Escitalopram Pathway	Capecitabine Metabolism Pathway	Methadone Pathway	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Diphenoxylate Action Pathway	Labetalol Pathway	Carbamazepine Metabolism Pathway	Rabeprazole Pathway	Kidney Function	Congenital lactic acidosis	Degradation of Superoxides	Glycogenosis, Type IC	Beta-Alanine Metabolism	Ethylmorphine Action Pathway	Ketone Body Metabolism	Verapamil Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	3-Methylthiofentanyl Action Pathway	Aromatase deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Heroin Pathway	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Smith-Lemli-Opitz Syndrome (SLOS)	Fluoxetine Metabolism Pathway	Levobunolol Action Pathway	Sepiapterin reductase deficiency	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dopa-responsive dystonia	Gemcitabine Pathway	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Procaine Pathway	Non Ketotic Hyperglycinemia	Corticosterone methyl oxidase II deficiency - CMO II	Bupranolol Action Pathway	Amlodipine Pathway	Carteolol Action Pathway	Carnosinuria, carnosinemia	Desmosterolosis	Sulfate/Sulfite Metabolism	Fatty acid Metabolism	Hyperphenylalaninemia due to dhpr-deficiency	Phenylketonuria	Fumarase deficiency	Naloxone Action Pathway	Lactose Degradation	Levobupivacaine Pathway	Betazole Action Pathway	Prolidase Deficiency (PD)	Roxatidine acetate Action Pathway	Isradipine Pathway	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Mevalonic aciduria	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Vitamin K Metabolism	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Warburg Effect	Glutamate Metabolism	Glycolysis	Citalopram Metabolism Pathway	Monoamine oxidase-a deficiency (MAO-A)	Familial Hypercholanemia (FHCA)	Carbamoyl Phosphate Synthetase Deficiency	Aromatic L-Aminoacid Decarboxylase Deficiency	Propoxyphene Action Pathway	Salicylic Acid Action Pathway	Porphyrin Metabolism	Oxprenolol Pathway	Trichlormethiazide Pathway	Hydroflumethiazide Pathway	Dibucaine Pathway	Piroxicam Pathway	Fructose-1,6-diphosphatase deficiency	Cimetidine Pathway	Sulindac Pathway	Bile Acid Biosynthesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Mepivacaine Pathway	Argininemia	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Valdecoxib Pathway	Codeine Metabolism Pathway	Tenoxicam Action Pathway	3-hydroxyisobutyric acid dehydrogenase deficiency	Sucrase-isomaltase deficiency	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Thiamine Metabolism	Apparent mineralocorticoid excess syndrome	Bevantolol Action Pathway	Hyperlysinemia I, Familial	Hartnup Disorder	Naltrexone Action Pathway	Acetylsalicylic Acid Pathway	Tramadol Action Action Pathway	Tamoxifen Metabolism Pathway	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Ammonia Recycling	Bupivacaine Pathway	L-arginine:glycine amidinotransferase deficiency	Fluoxetine Pathway	Bisoprolol Pathway	Metolazone Pathway	Dobutamine Action Pathway	Phenylbutazone Action Pathway
Levobupivacaine	HMDB_SMPDB	Samples:	20	Pathways:	1	Levobupivacaine Pathway
Alpha-ketoisovaleric acid	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
(S)-3-Hydroxyisobutyric acid	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Biotin	HMDB_SMPDB	Samples:	64	Pathways:	62	Alanine Metabolism	Congenital lactic acidosis	Lactic Acidemia	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Glycogenosis, Type IC	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Citric Acid Cycle	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Gluconeogenesis	Homocarnosinosis	Beta-Ketothiolase Deficiency	Fructose-1,6-diphosphatase deficiency	Pyruvate kinase deficiency	2-Hydroxyglutric Aciduria (D And L Form)	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Malonyl-coa decarboxylase deficiency	The oncogenic action of 2-hydroxyglutarate	3-Methylglutaconic Aciduria Type I	Threonine and 2-Oxobutanoate Degradation	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Primary Hyperoxaluria Type I	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	3-hydroxyisobutyric acid dehydrogenase deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Triosephosphate isomerase	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Glycogenosis, Type IB	Malonic Aciduria	Fumarase deficiency	Glutaminolysis and Cancer	3-Methylglutaconic Aciduria Type III	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Transfer of Acetyl Groups into Mitochondria	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Glycogenosis, Type IA. Von gierke disease	Hyperinsulinism-Hyperammonemia Syndrome	Maple Syrup Urine Disease	Pyruvate dehydrogenase deficiency (E2)	Propanoate Metabolism	Propionic Acidemia	Ammonia Recycling	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Succinic semialdehyde dehydrogenase deficiency	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Glutamate Metabolism	Pyruvate Metabolism	Leigh Syndrome
Acetoacetic acid	HMDB_SMPDB	Samples:	61	Pathways:	32	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Ketone Body Metabolism	Butyrate Metabolism	Beta-Ketothiolase Deficiency	Alkaptonuria	Phenylalanine and Tyrosine Metabolism	Dopamine beta-hydroxylase deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Disulfiram Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	3-Methylglutaconic Aciduria Type I	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria	3-hydroxyisobutyric acid dehydrogenase deficiency	Tyrosinemia, transient, of the newborn	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Phenylketonuria	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Maple Syrup Urine Disease	Propionic Acidemia	Tyrosinemia Type 3 (TYRO3)	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Hawkinsinuria	Tyrosine Metabolism	Succinyl CoA: 3-ketoacid CoA transferase deficiency
L-Glutamic acid	HMDB_SMPDB	Samples:	66	Pathways:	132	Ureidopropionase deficiency	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Ketoprofen Pathway	Homocarnosinosis	Beta-Ketothiolase Deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Antrafenine Action Pathway	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Citrullinemia Type I	Diclofenac Pathway	Ibuprofen Pathway	Pyridoxine dependency with seizures	Isovaleric Aciduria	Glucose-Alanine Cycle	Malonic Aciduria	Bromfenac Pathway	Etodolac Pathway	3-Methylglutaconic Aciduria Type III	Sarcosinemia	Propanoate Metabolism	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	Succinic semialdehyde dehydrogenase deficiency	Naproxen Pathway	Hawkinsinuria	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	2-aminoadipic 2-oxoadipic aciduria	Arginine and Proline Metabolism	Ketorolac Pathway	Tolmetin Action Pathway	Methotrexate Pathway	Salicylate-sodium Action Pathway	2-Hydroxyglutric Aciduria (D And L Form)	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Dopamine beta-hydroxylase deficiency	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Saccharopinuria/Hyperlysinemia II	Primary Hyperoxaluria Type I	Trisalicylate-choline Action Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Argininosuccinic Aciduria	Tryptophan Metabolism	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Leukotriene C4 Synthesis Deficiency	Maple Syrup Urine Disease	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	Carprofen Action Pathway	Rofecoxib Pathway	Nabumetone Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	Lactic Acidemia	Beta-Alanine Metabolism	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Folate Metabolism	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Hyperprolinemia Type II	Disulfiram Pathway	Antipyrine Action Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	The oncogenic action of 2-hydroxyglutarate	Non Ketotic Hyperglycinemia	Hyperglycinemia, non-ketotic	Nepafenac Action Pathway	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Phenylketonuria	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Warburg Effect	Glutamate Metabolism	Tyrosine Metabolism	Magnesium salicylate Action Pathway	Monoamine oxidase-a deficiency (MAO-A)	Alanine Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Histidinemia	Salicylic Acid Action Pathway	Piroxicam Pathway	Alkaptonuria	Sulindac Pathway	Lumiracoxib Action Pathway	Argininemia	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Fenoprofen Action Pathway	Valdecoxib Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	Salsalate Action Pathway	Tenoxicam Action Pathway	3-hydroxyisobutyric acid dehydrogenase deficiency	Prolinemia Type II	Malate-Aspartate Shuttle	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Hyperlysinemia I, Familial	Acetylsalicylic Acid Pathway	Glutaminolysis and Cancer	Diflunisal Pathway	Ammonia Recycling	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Lornoxicam Action Pathway	Folate malabsorption, hereditary	Phenylbutazone Action Pathway
L-Isoleucine	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Methylmalonic acid	HMDB_SMPDB	Samples:	61	Pathways:	22	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Isobutyryl-coa dehydrogenase deficiency	Malonic Aciduria	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Malonyl-coa decarboxylase deficiency	Vitamin K Metabolism	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Oxoglutaric acid	HMDB_SMPDB	Samples:	65	Pathways:	109	Ureidopropionase deficiency	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Tyrosinemia Type I	Hyperprolinemia Type I	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Lactic Acidemia	Congenital lactic acidosis	Beta-Alanine Metabolism	Glycogenosis, Type IC	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Oxidation of Branched Chain Fatty Acids	Beta-Ketothiolase Deficiency	Homocarnosinosis	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Hyperprolinemia Type II	Disulfiram Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	The oncogenic action of 2-hydroxyglutarate	Non Ketotic Hyperglycinemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Citrullinemia Type I	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Hyperglycinemia, non-ketotic	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Pyridoxine dependency with seizures	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Glycogenosis, Type IB	3-Phosphoglycerate dehydrogenase deficiency	Glucose-Alanine Cycle	Malonic Aciduria	Urea Cycle	Fumarase deficiency	Phenylketonuria	3-Methylglutaconic Aciduria Type III	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Glycogenosis, Type IA. Von gierke disease	Prolidase Deficiency (PD)	Pyruvate dehydrogenase deficiency (E2)	Propanoate Metabolism	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Glutamate Metabolism	Tyrosine Metabolism	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Monoamine oxidase-a deficiency (MAO-A)	2-aminoadipic 2-oxoadipic aciduria	Alanine Metabolism	Carnitine Synthesis	Arginine and Proline Metabolism	The oncogenic action of Succinate	Carbamoyl Phosphate Synthetase Deficiency	Citric Acid Cycle	Gluconeogenesis	Fructose-1,6-diphosphatase deficiency	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Argininemia	Dopamine beta-hydroxylase deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	Saccharopinuria/Hyperlysinemia II	Primary Hyperoxaluria Type I	3-hydroxyisobutyric acid dehydrogenase deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	The oncogenic action of Fumarate	Prolinemia Type II	Malate-Aspartate Shuttle	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Triosephosphate isomerase	Tyrosinemia, transient, of the newborn	Hyperlysinemia I, Familial	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Argininosuccinic Aciduria	Glutaminolysis and Cancer	Tryptophan Metabolism	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Maple Syrup Urine Disease	Ammonia Recycling	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism
Succinic acid	HMDB_SMPDB	Samples:	64	Pathways:	57	Hyperprolinemia Type I	Congenital lactic acidosis	Ketone Body Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Arginine and Proline Metabolism	The oncogenic action of Succinate	Carnitine Synthesis	Citric Acid Cycle	Butyrate Metabolism	Oxidation of Branched Chain Fatty Acids	Beta-Ketothiolase Deficiency	Homocarnosinosis	Phytanic Acid Peroxisomal Oxidation	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Mitochondrial Electron Transport Chain	Hyperprolinemia Type II	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	The oncogenic action of 2-hydroxyglutarate	3-Methylglutaconic Aciduria Type I	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	3-hydroxyisobutyric acid dehydrogenase deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	The oncogenic action of Fumarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Fumarase deficiency	Glutaminolysis and Cancer	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperinsulinism-Hyperammonemia Syndrome	Maple Syrup Urine Disease	Pyruvate dehydrogenase deficiency (E2)	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	L-arginine:glycine amidinotransferase deficiency	3-hydroxyisobutyric aciduria	Succinic semialdehyde dehydrogenase deficiency	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Glutamate Metabolism	Succinyl CoA: 3-ketoacid CoA transferase deficiency
3-Methyl-2-oxovaleric acid	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Hydrogen carbonate	HMDB_SMPDB	Samples:	68	Pathways:	98	Rabeprazole Pathway	Kidney Function	Lactic Acidemia	Indapamide Pathway	Congenital lactic acidosis	Glycogenosis, Type IC	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Beta-Ketothiolase Deficiency	Lysinuric Protein Intolerance	Cyclothiazide Pathway	Malonyl-coa decarboxylase deficiency	The oncogenic action of 2-hydroxyglutarate	3-Methylglutaconic Aciduria Type I	Gastric Acid Production	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Glucose Transporter Defect (SGLT2)	Ethacrynic Acid pathway	Lansoprazole Pathway	Chlorthalidone Pathway	Glycogenosis, Type IB	Urea Cycle	Malonic Aciduria	Cystinuria	Metiamide Action Pathway	Fumarase deficiency	3-Methylglutaconic Aciduria Type III	Transfer of Acetyl Groups into Mitochondria	Omeprazole Pathway	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Betazole Action Pathway	Roxatidine acetate Action Pathway	Glycogenosis, Type IA. Von gierke disease	Methyclothiazide Pathway	Pyruvate dehydrogenase deficiency (E2)	Propanoate Metabolism	Propionic Acidemia	Hydrochlorothiazide Pathway	Iminoglycinuria	Blue diaper syndrome	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Amiloride Pathway	Pirenzepine Pathway	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Pyruvate Metabolism	Bendroflumethiazide Pathway	Leigh Syndrome	Lysinuric protein intolerance (LPI)	Alanine Metabolism	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Pantoprazole Pathway	Citric Acid Cycle	Spironolactone Pathway	Gluconeogenesis	Trichlormethiazide Pathway	Hydroflumethiazide Pathway	Fructose-1,6-diphosphatase deficiency	Pyruvate kinase deficiency	Cimetidine Pathway	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Polythiazide Pathway	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Threonine and 2-Oxobutanoate Degradation	Bumetanide Pathway	Methylmalonic Aciduria	Isovaleric acidemia	Chlorothiazide Pathway	Primary Hyperoxaluria Type I	Furosemide Pathway	Eplerenone Pathway	Torsemide Pathway	3-hydroxyisobutyric acid dehydrogenase deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Triamterene Pathway	Triosephosphate isomerase	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Hartnup Disorder	Nizatidine Pathway	Glutaminolysis and Cancer	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Famotidine Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Maple Syrup Urine Disease	Esomeprazole Pathway	Quinethazone Pathway	Metolazone Pathway	Ranitidine Pathway
L-Leucine	HMDB_SMPDB	Samples:	62	Pathways:	18	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	Glutaminolysis and Cancer	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Ketoleucine	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
L-Valine	HMDB_SMPDB	Samples:	59	Pathways:	21	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Isobutyryl-coa dehydrogenase deficiency	Malonic Aciduria	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Malonyl-coa decarboxylase deficiency	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
NAD	HMDB_SMPDB	Samples:	83	Pathways:	204	Ureidopropionase deficiency	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Lidocaine (Antiarrhythmic) Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Butyrate Metabolism	Phospholipid Biosynthesis	Homocarnosinosis	Beta-Ketothiolase Deficiency	Porphyria Variegata (PV)	Nicotine Metabolism Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Mitochondrial Electron Transport Chain	Felbamate Metabolism Pathway	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Teniposide Pathway	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Citrullinemia Type I	Mucopolysaccharidosis VI. Sly syndrome	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	2-ketoglutarate dehydrogenase complex deficiency	Ethylmalonic Encephalopathy	Isovaleric Aciduria	Pyridoxine dependency with seizures	21-hydroxylase deficiency (CYP21)	Glycogenosis, Type IB	Glucose-Alanine Cycle	Malonic Aciduria	Doxorubicin Metabolism Pathway	3-Methylglutaconic Aciduria Type III	Transfer of Acetyl Groups into Mitochondria	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Sarcosinemia	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E2)	Propanoate Metabolism	Propionic Acidemia	Acute Intermittent Porphyria	Citalopram Pathway	Valine, Leucine and Isoleucine Degradation	Succinic semialdehyde dehydrogenase deficiency	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Segawa syndrome	Pyruvate Metabolism	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Starch and Sucrose Metabolism	Congenital Bile Acid Synthesis Defect Type III	2-aminoadipic 2-oxoadipic aciduria	Fatty Acid Elongation In Mitochondria	Teniposide Metabolism Pathway	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Gluconeogenesis	Tramadol Metabolism Pathway	Glycogenosis, Type VI. Hers disease	Methotrexate Pathway	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Lidocaine (Local Anaesthetic) Pathway	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Etoposide Metabolism Pathway	Zellweger Syndrome	Nicotine Pathway	Codeine Pathway	Dopamine beta-hydroxylase deficiency	Androgen and Estrogen Metabolism	sarcosine oncometabolite pathway 	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Threonine and 2-Oxobutanoate Degradation	Betaine Metabolism	Glycogen synthetase deficiency	17-alpha-hydroxylase deficiency (CYP17)	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	Hereditary Coproporphyria (HCP)	11-beta-hydroxylase deficiency (CYP11B1)	Imipramine Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	The oncogenic action of Fumarate	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Triosephosphate isomerase	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Argininosuccinic Aciduria	Acetaminophen Metabolism Pathway	Tryptophan Metabolism	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Ethanol Degradation	Maple Syrup Urine Disease	GABA-Transaminase Deficiency	Selenoamino Acid Metabolism	Methadone Pathway	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Carbamazepine Metabolism Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	Venlafaxine Metabolism Pathway	Congenital lactic acidosis	Beta-Alanine Metabolism	Ketone Body Metabolism	Glycogenosis, Type IC	Trifunctional protein deficiency	Folate Metabolism	Aromatase deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Fluoxetine Metabolism Pathway	Sepiapterin reductase deficiency	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Disulfiram Pathway	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Dimethylglycine Dehydrogenase Deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	The oncogenic action of 2-hydroxyglutarate	Dopa-responsive dystonia	Non Ketotic Hyperglycinemia	Corticosterone methyl oxidase II deficiency - CMO II	Hyperglycinemia, non-ketotic	Corticosterone methyl oxidase I deficiency (CMO I)	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Hyperphenylalaninemia due to dhpr-deficiency	Urea Cycle	Fumarase deficiency	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Warburg Effect	Glutamate Metabolism	Tyrosine Metabolism	Glycolysis	Leigh Syndrome	Citalopram Metabolism Pathway	Cerebrotendinous Xanthomatosis (CTX)	Monoamine oxidase-a deficiency (MAO-A)	Familial Hypercholanemia (FHCA)	Carnitine Synthesis	Carbamoyl Phosphate Synthetase Deficiency	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Citric Acid Cycle	Histidinemia	Porphyrin Metabolism	Artemether Metabolism Pathway	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	27-Hydroxylase Deficiency	Fructose-1,6-diphosphatase deficiency	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Bile Acid Biosynthesis	Steroidogenesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Argininemia	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Codeine Metabolism Pathway	Congenital Bile Acid Synthesis Defect Type II	3-hydroxyisobutyric acid dehydrogenase deficiency	Prolinemia Type II	Sucrase-isomaltase deficiency	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Malate-Aspartate Shuttle	Apparent mineralocorticoid excess syndrome	Hyperlysinemia I, Familial	Glutaminolysis and Cancer	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Ammonia Recycling	Fluoxetine Pathway	L-arginine:glycine amidinotransferase deficiency	Pterine Biosynthesis	Glycine and Serine Metabolism	Folate malabsorption, hereditary
Lipoamide	HMDB_SMPDB	Samples:	65	Pathways:	44	2-aminoadipic 2-oxoadipic aciduria	Congenital lactic acidosis	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Citric Acid Cycle	Beta-Ketothiolase Deficiency	Pyruvate kinase deficiency	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	The oncogenic action of 2-hydroxyglutarate	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Lysine Degradation	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Saccharopinuria/Hyperlysinemia II	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Pyridoxine dependency with seizures	3-hydroxyisobutyric acid dehydrogenase deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Hyperlysinemia I, Familial	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Fumarase deficiency	Glutaminolysis and Cancer	3-Methylglutaconic Aciduria Type III	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Maple Syrup Urine Disease	Pyruvate dehydrogenase deficiency (E2)	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Pyruvate Metabolism	Leigh Syndrome	Hyperlysinemia II or Saccharopinuria
Dihydrolipoamide	HMDB_SMPDB	Samples:	59	Pathways:	23	3-hydroxyisobutyric acid dehydrogenase deficiency	Primary hyperoxaluria II, PH2	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	Pyruvate kinase deficiency	3-Methylglutaconic Aciduria Type III	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Pyruvate Metabolism	Leigh Syndrome	Isovaleric Aciduria
Methacrylyl-CoA	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Succinyl-CoA	HMDB_SMPDB	Samples:	65	Pathways:	51	Congenital lactic acidosis	Ketone Body Metabolism	The oncogenic action of Succinate	Citric Acid Cycle	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Butyrate Metabolism	Porphyrin Metabolism	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Beta-Ketothiolase Deficiency	Porphyria Variegata (PV)	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Dimethylglycine Dehydrogenase Deficiency	Malonyl-coa decarboxylase deficiency	The oncogenic action of 2-hydroxyglutarate	3-Methylglutaconic Aciduria Type I	Threonine and 2-Oxobutanoate Degradation	Non Ketotic Hyperglycinemia	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Hyperglycinemia, non-ketotic	Hereditary Coproporphyria (HCP)	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	3-hydroxyisobutyric acid dehydrogenase deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	3-Phosphoglycerate dehydrogenase deficiency	Malonic Aciduria	Fumarase deficiency	Glutaminolysis and Cancer	3-Methylglutaconic Aciduria Type III	Sarcosinemia	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Maple Syrup Urine Disease	Pyruvate dehydrogenase deficiency (E2)	Propanoate Metabolism	Propionic Acidemia	Acute Intermittent Porphyria	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Glycine and Serine Metabolism	Succinyl CoA: 3-ketoacid CoA transferase deficiency
2-Methylbutyryl-CoA	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
(S)-3-Hydroxyisobutyryl-CoA	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
3-Methylglutaconyl-CoA	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Isovaleryl-CoA	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
2-Methylacetoacetyl-CoA	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Acetyl-CoA	HMDB_SMPDB	Samples:	65	Pathways:	106	Ureidopropionase deficiency	Congenital lactic acidosis	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Beta-Alanine Metabolism	Ketone Body Metabolism	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Butyrate Metabolism	Trifunctional protein deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Oxidation of Branched Chain Fatty Acids	Beta-Ketothiolase Deficiency	Homocarnosinosis	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Smith-Lemli-Opitz Syndrome (SLOS)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Carnitine-acylcarnitine translocase deficiency	Disulfiram Pathway	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Dimethylglycine Dehydrogenase Deficiency	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Beta Oxidation of Very Long Chain Fatty Acids	The oncogenic action of 2-hydroxyglutarate	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Non Ketotic Hyperglycinemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Hyperglycinemia, non-ketotic	2-ketoglutarate dehydrogenase complex deficiency	Ethylmalonic Encephalopathy	Isovaleric Aciduria	Pyridoxine dependency with seizures	Carnosinuria, carnosinemia	Steroid Biosynthesis	Desmosterolosis	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Malonic Aciduria	Fumarase deficiency	Adrenoleukodystrophy, X-linked	3-Methylglutaconic Aciduria Type III	Transfer of Acetyl Groups into Mitochondria	Sarcosinemia	CHILD Syndrome	Pyruvate dehydrogenase deficiency (E2)	Mevalonic aciduria	Propanoate Metabolism	Propionic Acidemia	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Succinic semialdehyde dehydrogenase deficiency	3-hydroxyisobutyric aciduria	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Glutamate Metabolism	Pyruvate Metabolism	Lysine Degradation	Leigh Syndrome	Hyperlysinemia II or Saccharopinuria	2-aminoadipic 2-oxoadipic aciduria	Fatty Acid Elongation In Mitochondria	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Citric Acid Cycle	Disulfiram Action Pathway	Pyruvate kinase deficiency	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Phytanic Acid Peroxisomal Oxidation	Hypercholesterolemia	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Methylmalonic Aciduria	Isovaleric acidemia	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Simvastatin Action Pathway	Hyper-IgD syndrome	Lysosomal Acid Lipase Deficiency (Wolman Disease)	3-hydroxyisobutyric acid dehydrogenase deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Wolman disease	Hyperlysinemia I, Familial	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Glutaminolysis and Cancer	Tryptophan Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	Maple Syrup Urine Disease	Cholesteryl ester storage disease	GABA-Transaminase Deficiency	Glycine and Serine Metabolism	Succinyl CoA: 3-ketoacid CoA transferase deficiency
Isobutyryl-CoA	HMDB_SMPDB	Samples:	59	Pathways:	19	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	Refsum Disease	Phytanic Acid Peroxisomal Oxidation	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
FAD	HMDB_SMPDB	Samples:	72	Pathways:	161	Ureidopropionase deficiency	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Capecitabine Action Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Butyrate Metabolism	Phospholipid Biosynthesis	Homocarnosinosis	Beta-Ketothiolase Deficiency	Porphyria Variegata (PV)	Nicotine Metabolism Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Mitochondrial Electron Transport Chain	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Carnitine palmitoyl transferase deficiency (I)	Methylmalonate Semialdehyde Dehydrogenase Deficiency	2-ketoglutarate dehydrogenase complex deficiency	Ethylmalonic Encephalopathy	Isovaleric Aciduria	Pyridoxine dependency with seizures	Capecitabine Pathway	Malonic Aciduria	Doxorubicin Metabolism Pathway	3-Methylglutaconic Aciduria Type III	Sarcosinemia	Phenytoin (Antiarrhythmic) Action Pathway	CHILD Syndrome	Pyruvate dehydrogenase deficiency (E2)	Tamoxifen Pathway	Propanoate Metabolism	Propionic Acidemia	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Citalopram Pathway	Valine, Leucine and Isoleucine Degradation	Acute Intermittent Porphyria	Succinic semialdehyde dehydrogenase deficiency	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Pyruvate Metabolism	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Congenital Bile Acid Synthesis Defect Type III	2-aminoadipic 2-oxoadipic aciduria	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Methotrexate Pathway	2-Hydroxyglutric Aciduria (D And L Form)	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Zellweger Syndrome	Nicotine Pathway	Dopamine beta-hydroxylase deficiency	sarcosine oncometabolite pathway 	Threonine and 2-Oxobutanoate Degradation	Betaine Metabolism	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	Hereditary Coproporphyria (HCP)	Simvastatin Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Phenytoin (Antiarrhythmic) Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	The oncogenic action of Fumarate	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Tryptophan Metabolism	D-Arginine and D-Ornithine Metabolism	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Maple Syrup Urine Disease	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	Cholesteryl ester storage disease	Capecitabine Metabolism Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	Congenital lactic acidosis	Beta-Alanine Metabolism	Trifunctional protein deficiency	Folate Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Smith-Lemli-Opitz Syndrome (SLOS)	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Disulfiram Pathway	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	The oncogenic action of 2-hydroxyglutarate	Non Ketotic Hyperglycinemia	Hyperglycinemia, non-ketotic	Nicotine Action Pathway	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Steroid Biosynthesis	Desmosterolosis	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Fumarase deficiency	Phenylketonuria	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Mevalonic aciduria	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Tamoxifen Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Vitamin K Metabolism	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Warburg Effect	Glutamate Metabolism	Tyrosine Metabolism	Leigh Syndrome	Citalopram Metabolism Pathway	Cerebrotendinous Xanthomatosis (CTX)	Thyroid hormone synthesis	Monoamine oxidase-a deficiency (MAO-A)	Familial Hypercholanemia (FHCA)	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Citric Acid Cycle	Histidinemia	Porphyrin Metabolism	Citalopram Action Pathway	Disulfiram Action Pathway	27-Hydroxylase Deficiency	Pyruvate kinase deficiency	Hypercholesterolemia	Alkaptonuria	Bile Acid Biosynthesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Methotrexate Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Hyper-IgD syndrome	Congenital Bile Acid Synthesis Defect Type II	3-hydroxyisobutyric acid dehydrogenase deficiency	Prolinemia Type II	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Wolman disease	Hyperlysinemia I, Familial	Glutaminolysis and Cancer	Tamoxifen Metabolism Pathway	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Ammonia Recycling	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Folate malabsorption, hereditary
Propionyl-CoA	HMDB_SMPDB	Samples:	61	Pathways:	33	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type III	Familial Hypercholanemia (FHCA)	Valproic Acid Metabolism Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	27-Hydroxylase Deficiency	Oxidation of Branched Chain Fatty Acids	Beta-Ketothiolase Deficiency	Phytanic Acid Peroxisomal Oxidation	Refsum Disease	Bile Acid Biosynthesis	Zellweger Syndrome	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Malonyl-coa decarboxylase deficiency	Threonine and 2-Oxobutanoate Degradation	3-Methylglutaconic Aciduria Type I	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria	Congenital Bile Acid Synthesis Defect Type II	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Malonic Aciduria	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria
2-Methyl-3-hydroxybutyryl-CoA	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Thiamine pyrophosphate	HMDB_SMPDB	Samples:	66	Pathways:	50	2-aminoadipic 2-oxoadipic aciduria	Congenital lactic acidosis	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Citric Acid Cycle	Oxidation of Branched Chain Fatty Acids	Beta-Ketothiolase Deficiency	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Refsum Disease	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	The oncogenic action of 2-hydroxyglutarate	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Threonine and 2-Oxobutanoate Degradation	Lysine Degradation	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Saccharopinuria/Hyperlysinemia II	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Pyridoxine dependency with seizures	3-hydroxyisobutyric acid dehydrogenase deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Thiamine Metabolism	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Hyperlysinemia I, Familial	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Fumarase deficiency	Glutaminolysis and Cancer	3-Methylglutaconic Aciduria Type III	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Transfer of Acetyl Groups into Mitochondria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Maple Syrup Urine Disease	Pyruvate dehydrogenase deficiency (E2)	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Pyruvate Metabolism	Leigh Syndrome	Hyperlysinemia II or Saccharopinuria
3-Hydroxy-3-methylglutaryl-CoA	HMDB_SMPDB	Samples:	59	Pathways:	32	Ketone Body Metabolism	Butyrate Metabolism	Beta-Ketothiolase Deficiency	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Simvastatin Action Pathway	Hyper-IgD syndrome	Isovaleric Aciduria	Lysosomal Acid Lipase Deficiency (Wolman Disease)	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Desmosterolosis	Steroid Biosynthesis	Wolman disease	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	CHILD Syndrome	Maple Syrup Urine Disease	Mevalonic aciduria	Propionic Acidemia	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Succinyl CoA: 3-ketoacid CoA transferase deficiency
Oxygen	HMDB_SMPDB	Samples:	80	Pathways:	221	Diclofenac Action Pathway	Ureidopropionase deficiency	Lidocaine (Antiarrhythmic) Pathway	Valproic Acid Metabolism Pathway	Ketoprofen Pathway	Oxidation of Branched Chain Fatty Acids	Beta-Ketothiolase Deficiency	Ketorolac Action Pathway	Clopidogrel Pathway	Porphyria Variegata (PV)	Nicotine Metabolism Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Mitochondrial Electron Transport Chain	Felbamate Metabolism Pathway	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Teniposide Pathway	Antrafenine Action Pathway	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Diclofenac Pathway	Ibuprofen Pathway	Pyridoxine dependency with seizures	Isovaleric Aciduria	Tyrosine hydroxylase deficiency	21-hydroxylase deficiency (CYP21)	Bromfenac Pathway	Etodolac Pathway	Ketoprofen Action Pathway	3-Methylglutaconic Aciduria Type III	Sarcosinemia	Methadone Action Pathway	Phenytoin (Antiarrhythmic) Action Pathway	CHILD Syndrome	Tamoxifen Pathway	Suprofen Action Pathway	Propionic Acidemia	Lidocaine (Antiarrhythmic) Action Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Citalopram Pathway	Valine, Leucine and Isoleucine Degradation	Acute Intermittent Porphyria	Naproxen Pathway	Sulfite oxidase deficiency	Hawkinsinuria	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Fluoxetine Action Pathway	Congenital Bile Acid Synthesis Defect Type III	2-aminoadipic 2-oxoadipic aciduria	Teniposide Metabolism Pathway	Arginine and Proline Metabolism	The oncogenic action of Succinate	Tramadol Metabolism Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Desipramine Pathway	Refsum Disease	Lidocaine (Local Anaesthetic) Pathway	Etoposide Metabolism Pathway	Zellweger Syndrome	Nicotine Pathway	Codeine Pathway	Dopamine beta-hydroxylase deficiency	Androgen and Estrogen Metabolism	Piroxicam Action Pathway	Meloxicam Pathway	Catecholamine Biosynthesis	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	17-alpha-hydroxylase deficiency (CYP17)	Valdecoxib Action Pathway	Saccharopinuria/Hyperlysinemia II	Hereditary Coproporphyria (HCP)	Desipramine Action Pathway	Simvastatin Action Pathway	Trisalicylate-choline Action Pathway	11-beta-hydroxylase deficiency (CYP11B1)	Imipramine Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Phenytoin (Antiarrhythmic) Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	The oncogenic action of Fumarate	Oxaprozin Action Pathway	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Ibuprofen Action Pathway	Tryptophan Metabolism	Clopidogrel Metabolism Pathway	D-Arginine and D-Ornithine Metabolism	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Leukotriene C4 Synthesis Deficiency	Ethanol Degradation	Maple Syrup Urine Disease	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	Cholesteryl ester storage disease	Carprofen Action Pathway	Rofecoxib Action Pathway	Nevirapine Metabolism Pathway	Methadone Pathway	Rofecoxib Pathway	Nabumetone Pathway	Etodolac Action Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Carbamazepine Metabolism Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	Venlafaxine Metabolism Pathway	Beta-Alanine Metabolism	Degradation of Superoxides	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Aromatase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Smith-Lemli-Opitz Syndrome (SLOS)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Fluoxetine Metabolism Pathway	Meloxicam Action Pathway	Hyperprolinemia Type II	Disulfiram Pathway	Sorafenib Metabolism Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Antipyrine Action Pathway	Dimethylglycine Dehydrogenase Deficiency	Mefenamic Acid Action Pathway	Teniposide Action Pathway	Celecoxib Metabolism Pathway	Non Ketotic Hyperglycinemia	Corticosterone methyl oxidase II deficiency - CMO II	Hyperglycinemia, non-ketotic	Nicotine Action Pathway	Nepafenac Action Pathway	Corticosterone methyl oxidase I deficiency (CMO I)	Etoposide Action Pathway	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Flurbiprofen Action Pathway	Steroid Biosynthesis	Desmosterolosis	Sulfate/Sulfite Metabolism	Acetaminophen  Action Pathway	3-Phosphoglycerate dehydrogenase deficiency	Phenylketonuria	Diflunisal Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Mevalonic aciduria	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Tamoxifen Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Vitamin K Metabolism	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Tyrosine Metabolism	Magnesium salicylate Action Pathway	Citalopram Metabolism Pathway	Cerebrotendinous Xanthomatosis (CTX)	Monoamine oxidase-a deficiency (MAO-A)	Familial Hypercholanemia (FHCA)	Carnitine Synthesis	Aromatic L-Aminoacid Decarboxylase Deficiency	Histidinemia	Porphyrin Metabolism	Imipramine Action Pathway	Citalopram Action Pathway	Artemether Metabolism Pathway	Disulfiram Action Pathway	27-Hydroxylase Deficiency	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Salicylic Acid Action Pathway	Piroxicam Pathway	Hypercholesterolemia	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Bile Acid Biosynthesis	Steroidogenesis	Sulindac Pathway	Ibuprofen Metabolism Pathway	Lumiracoxib Action Pathway	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Bromfenac Action Pathway	Fenoprofen Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Valdecoxib Pathway	Methylmalonic Aciduria	Isovaleric acidemia	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Clopidogrel Action Pathway	Codeine Metabolism Pathway	Codeine Action Pathway	Hyper-IgD syndrome	Tenoxicam Action Pathway	Ubiquinone Biosynthesis	Congenital Bile Acid Synthesis Defect Type II	3-hydroxyisobutyric acid dehydrogenase deficiency	Prolinemia Type II	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Naproxen Action Pathway	Apparent mineralocorticoid excess syndrome	Wolman disease	Hyperlysinemia I, Familial	Acetylsalicylic Acid Pathway	Glutaminolysis and Cancer	Tamoxifen Metabolism Pathway	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Diflunisal Pathway	Sulindac Action Pathway	Fluoxetine Pathway	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Lornoxicam Action Pathway	Phenylbutazone Action Pathway
Coenzyme A	HMDB_SMPDB	Samples:	65	Pathways:	116	Ureidopropionase deficiency	Congenital lactic acidosis	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Beta-Alanine Metabolism	Valproic Acid Metabolism Pathway	Ketone Body Metabolism	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Butyrate Metabolism	Trifunctional protein deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Oxidation of Branched Chain Fatty Acids	Beta-Ketothiolase Deficiency	Homocarnosinosis	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Smith-Lemli-Opitz Syndrome (SLOS)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Carnitine-acylcarnitine translocase deficiency	Disulfiram Pathway	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Dimethylglycine Dehydrogenase Deficiency	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Beta Oxidation of Very Long Chain Fatty Acids	The oncogenic action of 2-hydroxyglutarate	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Non Ketotic Hyperglycinemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Hyperglycinemia, non-ketotic	2-ketoglutarate dehydrogenase complex deficiency	Ethylmalonic Encephalopathy	Isovaleric Aciduria	Pyridoxine dependency with seizures	Carnosinuria, carnosinemia	Steroid Biosynthesis	Desmosterolosis	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Malonic Aciduria	Fumarase deficiency	Adrenoleukodystrophy, X-linked	3-Methylglutaconic Aciduria Type III	Transfer of Acetyl Groups into Mitochondria	Sarcosinemia	CHILD Syndrome	Pyruvate dehydrogenase deficiency (E2)	Pantothenate and CoA Biosynthesis	Propanoate Metabolism	Propionic Acidemia	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Mevalonic aciduria	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Succinic semialdehyde dehydrogenase deficiency	3-hydroxyisobutyric aciduria	Phenylacetate Metabolism	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Glutamate Metabolism	Pyruvate Metabolism	Lysine Degradation	Leigh Syndrome	Hyperlysinemia II or Saccharopinuria	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type III	2-aminoadipic 2-oxoadipic aciduria	Fatty Acid Elongation In Mitochondria	Familial Hypercholanemia (FHCA)	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Citric Acid Cycle	27-Hydroxylase Deficiency	Pyruvate kinase deficiency	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Phytanic Acid Peroxisomal Oxidation	Hypercholesterolemia	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Bile Acid Biosynthesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Zellweger Syndrome	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Threonine and 2-Oxobutanoate Degradation	Methylmalonic Aciduria	Isovaleric acidemia	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Simvastatin Action Pathway	Hyper-IgD syndrome	Congenital Bile Acid Synthesis Defect Type II	Lysosomal Acid Lipase Deficiency (Wolman Disease)	3-hydroxyisobutyric acid dehydrogenase deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Wolman disease	Hyperlysinemia I, Familial	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Glutaminolysis and Cancer	Tryptophan Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	Maple Syrup Urine Disease	Cholesteryl ester storage disease	GABA-Transaminase Deficiency	Glycine and Serine Metabolism	Succinyl CoA: 3-ketoacid CoA transferase deficiency
Acetoacetyl-CoA	HMDB_SMPDB	Samples:	61	Pathways:	60	2-aminoadipic 2-oxoadipic aciduria	Ketone Body Metabolism	Primary hyperoxaluria II, PH2	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Trifunctional protein deficiency	Butyrate Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Beta-Ketothiolase Deficiency	Smith-Lemli-Opitz Syndrome (SLOS)	Pyruvate kinase deficiency	Hypercholesterolemia	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Malonyl-coa decarboxylase deficiency	Lysine Degradation	Carnitine palmitoyl transferase deficiency (I)	Methylmalonic Aciduria	Isovaleric acidemia	Carnitine palmitoyl transferase deficiency (II)	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Saccharopinuria/Hyperlysinemia II	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Simvastatin Action Pathway	Pyridoxine dependency with seizures	Isovaleric Aciduria	Ethylmalonic Encephalopathy	Hyper-IgD syndrome	Lysosomal Acid Lipase Deficiency (Wolman Disease)	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Desmosterolosis	Hyperlysinemia I, Familial	Fatty acid Metabolism	Steroid Biosynthesis	Wolman disease	Malonic Aciduria	3-Methylglutaconic Aciduria Type III	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	CHILD Syndrome	Maple Syrup Urine Disease	Mevalonic aciduria	Propanoate Metabolism	Propionic Acidemia	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Pyruvate Metabolism	Leigh Syndrome	Hyperlysinemia II or Saccharopinuria
NADH	HMDB_SMPDB	Samples:	83	Pathways:	215	Ureidopropionase deficiency	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Lidocaine (Antiarrhythmic) Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Butyrate Metabolism	Phospholipid Biosynthesis	Homocarnosinosis	Beta-Ketothiolase Deficiency	Porphyria Variegata (PV)	Nicotine Metabolism Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Mitochondrial Electron Transport Chain	Felbamate Metabolism Pathway	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Teniposide Pathway	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Citrullinemia Type I	Mucopolysaccharidosis VI. Sly syndrome	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	2-ketoglutarate dehydrogenase complex deficiency	Ethylmalonic Encephalopathy	Isovaleric Aciduria	Pyridoxine dependency with seizures	21-hydroxylase deficiency (CYP21)	Glycogenosis, Type IB	Glucose-Alanine Cycle	Malonic Aciduria	Doxorubicin Metabolism Pathway	3-Methylglutaconic Aciduria Type III	Transfer of Acetyl Groups into Mitochondria	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Sarcosinemia	Methadone Action Pathway	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E2)	Propanoate Metabolism	Propionic Acidemia	Lidocaine (Antiarrhythmic) Action Pathway	Citalopram Pathway	Valine, Leucine and Isoleucine Degradation	Acute Intermittent Porphyria	Succinic semialdehyde dehydrogenase deficiency	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Segawa syndrome	Pyruvate Metabolism	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Fluoxetine Action Pathway	Congenital Bile Acid Synthesis Defect Type III	2-aminoadipic 2-oxoadipic aciduria	Fatty Acid Elongation In Mitochondria	Teniposide Metabolism Pathway	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Starch and Sucrose Metabolism	Gluconeogenesis	Tramadol Metabolism Pathway	Glycogenosis, Type VI. Hers disease	Methotrexate Pathway	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Lidocaine (Local Anaesthetic) Pathway	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Etoposide Metabolism Pathway	Zellweger Syndrome	Nicotine Pathway	Codeine Pathway	Dopamine beta-hydroxylase deficiency	Androgen and Estrogen Metabolism	sarcosine oncometabolite pathway 	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Threonine and 2-Oxobutanoate Degradation	Betaine Metabolism	Glycogen synthetase deficiency	17-alpha-hydroxylase deficiency (CYP17)	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	Hereditary Coproporphyria (HCP)	11-beta-hydroxylase deficiency (CYP11B1)	Imipramine Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	The oncogenic action of Fumarate	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Triosephosphate isomerase	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Argininosuccinic Aciduria	Acetaminophen Metabolism Pathway	Tryptophan Metabolism	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Ethanol Degradation	Maple Syrup Urine Disease	GABA-Transaminase Deficiency	Methadone Pathway	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Lidocaine (Local Anaesthetic) Action Pathway	Carbamazepine Metabolism Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	Venlafaxine Metabolism Pathway	Congenital lactic acidosis	Beta-Alanine Metabolism	Ketone Body Metabolism	Glycogenosis, Type IC	Trifunctional protein deficiency	Folate Metabolism	Aromatase deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Fluoxetine Metabolism Pathway	Sepiapterin reductase deficiency	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Disulfiram Pathway	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Dimethylglycine Dehydrogenase Deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	The oncogenic action of 2-hydroxyglutarate	Dopa-responsive dystonia	Teniposide Action Pathway	Non Ketotic Hyperglycinemia	Corticosterone methyl oxidase II deficiency - CMO II	Hyperglycinemia, non-ketotic	Nicotine Action Pathway	Corticosterone methyl oxidase I deficiency (CMO I)	Etoposide Action Pathway	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Hyperphenylalaninemia due to dhpr-deficiency	Urea Cycle	Fumarase deficiency	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Warburg Effect	Glutamate Metabolism	Tyrosine Metabolism	Glycolysis	Leigh Syndrome	Citalopram Metabolism Pathway	Cerebrotendinous Xanthomatosis (CTX)	Monoamine oxidase-a deficiency (MAO-A)	Familial Hypercholanemia (FHCA)	Carnitine Synthesis	Carbamoyl Phosphate Synthetase Deficiency	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Citric Acid Cycle	Histidinemia	Imipramine Action Pathway	Citalopram Action Pathway	Artemether Metabolism Pathway	Disulfiram Action Pathway	27-Hydroxylase Deficiency	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Porphyrin Metabolism	Fructose-1,6-diphosphatase deficiency	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Bile Acid Biosynthesis	Steroidogenesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Argininemia	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Methotrexate Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Codeine Metabolism Pathway	Codeine Action Pathway	Congenital Bile Acid Synthesis Defect Type II	3-hydroxyisobutyric acid dehydrogenase deficiency	Prolinemia Type II	Sucrase-isomaltase deficiency	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Malate-Aspartate Shuttle	Apparent mineralocorticoid excess syndrome	Hyperlysinemia I, Familial	Glutaminolysis and Cancer	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Ammonia Recycling	Fluoxetine Pathway	L-arginine:glycine amidinotransferase deficiency	Pterine Biosynthesis	Glycine and Serine Metabolism	Folate malabsorption, hereditary
Pyridoxal 5'-phosphate	HMDB_SMPDB	Samples:	71	Pathways:	112	Ureidopropionase deficiency	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Tyrosinemia Type I	Hyperprolinemia Type I	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Lactic Acidemia	Beta-Alanine Metabolism	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Folate Metabolism	Homocarnosinosis	Beta-Ketothiolase Deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria, cystathionine beta-synthase deficiency	Porphyria Variegata (PV)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Hyperprolinemia Type II	Disulfiram Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Homocysteine Degradation	Non Ketotic Hyperglycinemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Citrullinemia Type I	Mucopolysaccharidosis VI. Sly syndrome	Hyperglycinemia, non-ketotic	Pyridoxine dependency with seizures	Isovaleric Aciduria	Tyrosine hydroxylase deficiency	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	3-Phosphoglycerate dehydrogenase deficiency	Glucose-Alanine Cycle	Malonic Aciduria	Urea Cycle	Phenylketonuria	3-Methylglutaconic Aciduria Type III	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Propanoate Metabolism	Propionic Acidemia	Acute Intermittent Porphyria	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Hawkinsinuria	Glutamate Metabolism	Tyrosine Metabolism	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Starch and Sucrose Metabolism	Monoamine oxidase-a deficiency (MAO-A)	2-aminoadipic 2-oxoadipic aciduria	Alanine Metabolism	Carnitine Synthesis	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Aromatic L-Aminoacid Decarboxylase Deficiency	Histidinemia	Porphyrin Metabolism	Glycogenosis, Type VI. Hers disease	Methotrexate Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Alkaptonuria	Argininemia	Dopamine beta-hydroxylase deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	sarcosine oncometabolite pathway 	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Threonine and 2-Oxobutanoate Degradation	Glycogen synthetase deficiency	Catecholamine Biosynthesis	Methylmalonic Aciduria	Isovaleric acidemia	Saccharopinuria/Hyperlysinemia II	Primary Hyperoxaluria Type I	Hereditary Coproporphyria (HCP)	3-hydroxyisobutyric acid dehydrogenase deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Prolinemia Type II	Sucrase-isomaltase deficiency	Histidine Metabolism	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Tyrosinemia, transient, of the newborn	Malate-Aspartate Shuttle	Hyperlysinemia I, Familial	Argininosuccinic Aciduria	Glutaminolysis and Cancer	Gamma-cystathionase deficiency (CTH)	Tryptophan Metabolism	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Maple Syrup Urine Disease	Ammonia Recycling	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Selenoamino Acid Metabolism	Folate malabsorption, hereditary
3-Methylcrotonyl-CoA	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Pyridoxal	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Carbon dioxide	HMDB_SMPDB	Samples:	71	Pathways:	164	Ureidopropionase deficiency	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Oxidation of Branched Chain Fatty Acids	Beta-Ketothiolase Deficiency	Homocarnosinosis	Porphyria Variegata (PV)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Gastric Acid Production	Carnitine palmitoyl transferase deficiency (I)	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Citrullinemia Type I	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	2-ketoglutarate dehydrogenase complex deficiency	Ethylmalonic Encephalopathy	Isovaleric Aciduria	Pyridoxine dependency with seizures	Tyrosine hydroxylase deficiency	Lansoprazole Pathway	Glycogenosis, Type IB	Malonic Aciduria	Metiamide Action Pathway	3-Methylglutaconic Aciduria Type III	Transfer of Acetyl Groups into Mitochondria	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Sarcosinemia	Glycogenosis, Type IA. Von gierke disease	CHILD Syndrome	Pyruvate dehydrogenase deficiency (E2)	Pantothenate and CoA Biosynthesis	Propanoate Metabolism	Propionic Acidemia	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Acute Intermittent Porphyria	Valine, Leucine and Isoleucine Degradation	Succinic semialdehyde dehydrogenase deficiency	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Pyruvate Metabolism	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	2-aminoadipic 2-oxoadipic aciduria	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Pantoprazole Pathway	Gluconeogenesis	Methotrexate Pathway	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Dopamine beta-hydroxylase deficiency	Threonine and 2-Oxobutanoate Degradation	Catecholamine Biosynthesis	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	Hereditary Coproporphyria (HCP)	Simvastatin Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	The oncogenic action of Fumarate	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Triosephosphate isomerase	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Argininosuccinic Aciduria	Tryptophan Metabolism	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Maple Syrup Urine Disease	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	Cholesteryl ester storage disease	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Ranitidine Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	Rabeprazole Pathway	Congenital lactic acidosis	Beta-Alanine Metabolism	Ketone Body Metabolism	Glycogenosis, Type IC	Trifunctional protein deficiency	Folate Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Smith-Lemli-Opitz Syndrome (SLOS)	Hyperprolinemia Type II	Disulfiram Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	The oncogenic action of 2-hydroxyglutarate	Non Ketotic Hyperglycinemia	Hyperglycinemia, non-ketotic	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Steroid Biosynthesis	Desmosterolosis	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Fumarase deficiency	Phenylketonuria	Omeprazole Pathway	Betazole Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Roxatidine acetate Action Pathway	Mevalonic aciduria	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Vitamin K Metabolism	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Pirenzepine Pathway	Warburg Effect	Glutamate Metabolism	Tyrosine Metabolism	Leigh Syndrome	Monoamine oxidase-a deficiency (MAO-A)	Carnitine Synthesis	Carbamoyl Phosphate Synthetase Deficiency	Aromatic L-Aminoacid Decarboxylase Deficiency	Citric Acid Cycle	Histidinemia	Porphyrin Metabolism	Fructose-1,6-diphosphatase deficiency	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Cimetidine Pathway	Hypercholesterolemia	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Argininemia	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	Hyper-IgD syndrome	3-hydroxyisobutyric acid dehydrogenase deficiency	Prolinemia Type II	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Wolman disease	Hyperlysinemia I, Familial	Nizatidine Pathway	Glutaminolysis and Cancer	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Famotidine Pathway	Ammonia Recycling	Esomeprazole Pathway	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Folate malabsorption, hereditary
Tiglyl-CoA	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Adenosylcobalamin	HMDB_SMPDB	Samples:	60	Pathways:	22	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Isobutyryl-coa dehydrogenase deficiency	Malonic Aciduria	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Malonyl-coa decarboxylase deficiency	Threonine and 2-Oxobutanoate Degradation	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
(S)-b-aminoisobutyric acid	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Molybdopterin	HMDB_SMPDB	Samples:	60	Pathways:	26	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Citalopram Action Pathway	Beta-Ketothiolase Deficiency	Doxorubicin Metabolism Pathway	3-Methylglutaconic Aciduria Type III	Tryptophan Metabolism	Nicotine Metabolism Pathway	Nicotine Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Citalopram Metabolism Pathway	Propionic Acidemia	Citalopram Pathway	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Pterine Biosynthesis	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Nicotine Action Pathway	Isovaleric Aciduria
(S)-Methylmalonic acid semialdehyde	HMDB_SMPDB	Samples:	59	Pathways:	21	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Isobutyryl-coa dehydrogenase deficiency	Malonic Aciduria	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Malonyl-coa decarboxylase deficiency	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
R-Methylmalonyl-CoA	HMDB_SMPDB	Samples:	60	Pathways:	22	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Isobutyryl-coa dehydrogenase deficiency	Malonic Aciduria	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Malonyl-coa decarboxylase deficiency	Threonine and 2-Oxobutanoate Degradation	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
S-Methylmalonyl-CoA	HMDB_SMPDB	Samples:	60	Pathways:	22	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Isobutyryl-coa dehydrogenase deficiency	Malonic Aciduria	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Malonyl-coa decarboxylase deficiency	Threonine and 2-Oxobutanoate Degradation	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Hydrogen peroxide	HMDB_SMPDB	Samples:	74	Pathways:	89	Ureidopropionase deficiency	Tyrosinemia Type I	Hyperprolinemia Type I	Beta-Alanine Metabolism	Degradation of Superoxides	Clopidogrel Pathway	Beta-Ketothiolase Deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Porphyria Variegata (PV)	Nicotine Metabolism Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Hyperprolinemia Type II	Disulfiram Pathway	Sorafenib Metabolism Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Non Ketotic Hyperglycinemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Hyperglycinemia, non-ketotic	Ibuprofen Pathway	Nicotine Action Pathway	Pyridoxine dependency with seizures	Isovaleric Aciduria	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Sulfate/Sulfite Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Phenylketonuria	3-Methylglutaconic Aciduria Type III	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Propionic Acidemia	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Acute Intermittent Porphyria	Citalopram Pathway	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Sulfite oxidase deficiency	Hawkinsinuria	Tyrosine Metabolism	Lysine Degradation	Citalopram Metabolism Pathway	Hyperlysinemia II or Saccharopinuria	Thyroid hormone synthesis	Monoamine oxidase-a deficiency (MAO-A)	2-aminoadipic 2-oxoadipic aciduria	Arginine and Proline Metabolism	Histidinemia	Porphyrin Metabolism	Citalopram Action Pathway	Disulfiram Action Pathway	Alkaptonuria	Ibuprofen Metabolism Pathway	Nicotine Pathway	Dopamine beta-hydroxylase deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	Saccharopinuria/Hyperlysinemia II	Clopidogrel Action Pathway	Hereditary Coproporphyria (HCP)	3-hydroxyisobutyric acid dehydrogenase deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Histidine Metabolism	Tyrosinemia, transient, of the newborn	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Hyperlysinemia I, Familial	Ibuprofen Action Pathway	Tryptophan Metabolism	Clopidogrel Metabolism Pathway	D-Arginine and D-Ornithine Metabolism	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Ethanol Degradation	Maple Syrup Urine Disease	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Nevirapine Metabolism Pathway
3-Methyl-1-hydroxybutyl-ThPP	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
2-Methyl-1-hydroxypropyl-ThPP 	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
S-(3-Methylbutanoyl)-dihydrolipoamide-E	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
S-(2-Methylpropionyl)-dihydrolipoamide-E	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
S-(2-Methylbutanoyl)-dihydrolipoamide	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
3-Hydroxyisovaleryl-CoA	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Lipoyl-GMP	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Hydrogen Ion	HMDB_SMPDB	Samples:	75	Pathways:	150	Ureidopropionase deficiency	Lidocaine (Antiarrhythmic) Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Homocarnosinosis	Beta-Ketothiolase Deficiency	Nicotine Metabolism Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Mitochondrial Electron Transport Chain	Felbamate Metabolism Pathway	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Gastric Acid Production	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Ibuprofen Pathway	2-ketoglutarate dehydrogenase complex deficiency	Ethylmalonic Encephalopathy	Isovaleric Aciduria	Lansoprazole Pathway	21-hydroxylase deficiency (CYP21)	Glycogenosis, Type IB	Glucose-Alanine Cycle	Metiamide Action Pathway	3-Methylglutaconic Aciduria Type III	Transfer of Acetyl Groups into Mitochondria	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycogenosis, Type IA. Von gierke disease	Pyruvate dehydrogenase deficiency (E2)	Tamoxifen Pathway	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	Succinic semialdehyde dehydrogenase deficiency	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Pyruvate Metabolism	Fatty Acid Elongation In Mitochondria	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Pantoprazole Pathway	Gluconeogenesis	Tramadol Metabolism Pathway	Methotrexate Pathway	Desipramine Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Lidocaine (Local Anaesthetic) Pathway	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Nicotine Pathway	Dopamine beta-hydroxylase deficiency	Androgen and Estrogen Metabolism	17-alpha-hydroxylase deficiency (CYP17)	Carnitine palmitoyl transferase deficiency (II)	11-beta-hydroxylase deficiency (CYP11B1)	Imipramine Pathway	Phenytoin (Antiarrhythmic) Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	The oncogenic action of Fumarate	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Triosephosphate isomerase	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Ethanol Degradation	Maple Syrup Urine Disease	GABA-Transaminase Deficiency	Nevirapine Metabolism Pathway	Ranitidine Pathway	Carbamazepine Metabolism Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	Rabeprazole Pathway	Congenital lactic acidosis	Beta-Alanine Metabolism	Glycogenosis, Type IC	Degradation of Superoxides	Trifunctional protein deficiency	Folate Metabolism	Aromatase deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Disulfiram Pathway	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	The oncogenic action of 2-hydroxyglutarate	Celecoxib Metabolism Pathway	Corticosterone methyl oxidase II deficiency - CMO II	Corticosterone methyl oxidase I deficiency (CMO I)	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Fatty acid Metabolism	Fumarase deficiency	Omeprazole Pathway	Betazole Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Roxatidine acetate Action Pathway	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Pirenzepine Pathway	Warburg Effect	Glutamate Metabolism	Tyrosine Metabolism	Leigh Syndrome	Monoamine oxidase-a deficiency (MAO-A)	Carnitine Synthesis	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Citric Acid Cycle	Histidinemia	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Fructose-1,6-diphosphatase deficiency	Pyruvate kinase deficiency	Cimetidine Pathway	Alkaptonuria	Steroidogenesis	Ibuprofen Metabolism Pathway	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Ubiquinone Biosynthesis	3-hydroxyisobutyric acid dehydrogenase deficiency	Prolinemia Type II	Malate-Aspartate Shuttle	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Apparent mineralocorticoid excess syndrome	Nizatidine Pathway	Glutaminolysis and Cancer	Tamoxifen Metabolism Pathway	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Famotidine Pathway	Esomeprazole Pathway	L-arginine:glycine amidinotransferase deficiency	Folate malabsorption, hereditary
(2S,3S)-3-Hydroxy-2-methylbutanoyl-CoA	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
(R)-Methylmalonyl-CoA	HMDB_SMPDB	Samples:	60	Pathways:	22	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Isobutyryl-coa dehydrogenase deficiency	Malonic Aciduria	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Malonyl-coa decarboxylase deficiency	Threonine and 2-Oxobutanoate Degradation	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
(S)-3-Hydroxy-3-methylglutaryl-CoA	HMDB_SMPDB	Samples:	59	Pathways:	32	Ketone Body Metabolism	Butyrate Metabolism	Beta-Ketothiolase Deficiency	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-Methylglutaconic Aciduria Type I	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Simvastatin Action Pathway	Hyper-IgD syndrome	Isovaleric Aciduria	Lysosomal Acid Lipase Deficiency (Wolman Disease)	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Desmosterolosis	Steroid Biosynthesis	Wolman disease	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	CHILD Syndrome	Maple Syrup Urine Disease	Mevalonic aciduria	Propionic Acidemia	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Succinyl CoA: 3-ketoacid CoA transferase deficiency
(S)-3-Hydroxyisobutyrate	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
(S)-Methylmalonate semialdehyde	HMDB_SMPDB	Samples:	59	Pathways:	21	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Isobutyryl-coa dehydrogenase deficiency	Malonic Aciduria	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Malonyl-coa decarboxylase deficiency	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
(S)-Methylmalonyl-CoA	HMDB_SMPDB	Samples:	60	Pathways:	22	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Isobutyryl-coa dehydrogenase deficiency	Malonic Aciduria	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Malonyl-coa decarboxylase deficiency	Threonine and 2-Oxobutanoate Degradation	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
2-Methyl-1-hydroxypropyl-ThPP	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
2-Methylbut-2-enoyl-CoA	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
2-Methylbutanoyl-CoA	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
2-Methylprop-2-enoyl-CoA	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
2-Methylpropanoyl-CoA	HMDB_SMPDB	Samples:	59	Pathways:	19	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	Refsum Disease	Phytanic Acid Peroxisomal Oxidation	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
2-Oxoglutarate	HMDB_SMPDB	Samples:	65	Pathways:	107	Ureidopropionase deficiency	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Tyrosinemia Type I	Hyperprolinemia Type I	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Lactic Acidemia	Congenital lactic acidosis	Beta-Alanine Metabolism	Glycogenosis, Type IC	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Oxidation of Branched Chain Fatty Acids	Beta-Ketothiolase Deficiency	Homocarnosinosis	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Hyperprolinemia Type II	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Malonyl-coa decarboxylase deficiency	The oncogenic action of 2-hydroxyglutarate	3-Methylglutaconic Aciduria Type I	Non Ketotic Hyperglycinemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Citrullinemia Type I	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Hyperglycinemia, non-ketotic	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Pyridoxine dependency with seizures	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Glycogenosis, Type IB	3-Phosphoglycerate dehydrogenase deficiency	Glucose-Alanine Cycle	Malonic Aciduria	Urea Cycle	Fumarase deficiency	Phenylketonuria	3-Methylglutaconic Aciduria Type III	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Glycogenosis, Type IA. Von gierke disease	Prolidase Deficiency (PD)	Pyruvate dehydrogenase deficiency (E2)	Propanoate Metabolism	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Glutamate Metabolism	Tyrosine Metabolism	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Monoamine oxidase-a deficiency (MAO-A)	2-aminoadipic 2-oxoadipic aciduria	Alanine Metabolism	Carnitine Synthesis	Arginine and Proline Metabolism	The oncogenic action of Succinate	Carbamoyl Phosphate Synthetase Deficiency	Citric Acid Cycle	Gluconeogenesis	Disulfiram Action Pathway	Fructose-1,6-diphosphatase deficiency	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Argininemia	Dopamine beta-hydroxylase deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	Saccharopinuria/Hyperlysinemia II	Primary Hyperoxaluria Type I	3-hydroxyisobutyric acid dehydrogenase deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	The oncogenic action of Fumarate	Prolinemia Type II	Malate-Aspartate Shuttle	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Triosephosphate isomerase	Tyrosinemia, transient, of the newborn	Hyperlysinemia I, Familial	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Argininosuccinic Aciduria	Glutaminolysis and Cancer	Tryptophan Metabolism	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Maple Syrup Urine Disease	Ammonia Recycling	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism
3-Methyl-2-oxobutanoic acid	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
3-Methyl-2-oxopentanoate	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
3-Methylbutanoyl-CoA	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
4-Methyl-2-oxopentanoate	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Acetoacetate	HMDB_SMPDB	Samples:	61	Pathways:	32	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Ketone Body Metabolism	Butyrate Metabolism	Disulfiram Action Pathway	Beta-Ketothiolase Deficiency	Alkaptonuria	Phenylalanine and Tyrosine Metabolism	Dopamine beta-hydroxylase deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	3-Methylglutaconic Aciduria Type I	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria	3-hydroxyisobutyric acid dehydrogenase deficiency	Tyrosinemia, transient, of the newborn	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Phenylketonuria	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Maple Syrup Urine Disease	Propionic Acidemia	Tyrosinemia Type 3 (TYRO3)	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Hawkinsinuria	Tyrosine Metabolism	Succinyl CoA: 3-ketoacid CoA transferase deficiency
ATP	HMDB_SMPDB	Samples:	88	Pathways:	295	Alprenolol Action Pathway	Levomethadyl Acetate Action Action Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Butyrate Metabolism	Bisoprolol Action Pathway	Beta-Ketothiolase Deficiency	Mitochondrial Electron Transport Chain	Carnitine-acylcarnitine translocase deficiency	Bupivacaine Action Pathway	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	Vindesine Action Pathway	Gastric Acid Production	Carnitine palmitoyl transferase deficiency (I)	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Citrullinemia Type I	Mucopolysaccharidosis VI. Sly syndrome	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Ethylmalonic Encephalopathy	Arbutamine Action Pathway	Heroin Action Pathway	Glycogenosis, Type IB	Malonic Aciduria	Dihydromorphine Action Pathway	Mexiletine Action Pathway	Adrenoleukodystrophy, X-linked	Alvimopan Action Pathway	Doxorubicin Metabolism Pathway	Fentanyl Action Pathway	Transfer of Acetyl Groups into Mitochondria	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Sarcosinemia	Methadone Action Pathway	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Phenytoin (Antiarrhythmic) Action Pathway	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E2)	Pantothenate and CoA Biosynthesis	Labetalol Action Pathway	Lidocaine (Antiarrhythmic) Action Pathway	Succinic semialdehyde dehydrogenase deficiency	Sulfite oxidase deficiency	Pyruvate dehydrogenase deficiency (E3)	Disopyramide Action Pathway	Nalbuphine Action Pathway	Glibenclamide Action Pathway	Congenital Bile Acid Synthesis Defect Type III	Repaglinide Action Pathway	Fluoxetine Action Pathway	Starch and Sucrose Metabolism	Hydrocodone Action Pathway	Arginine and Proline Metabolism	The oncogenic action of Succinate	Procainamide (Antiarrhythmic) Action Pathway	Tocainide Action Pathway	Gluconeogenesis	Bopindolol Action Pathway	Sotalol Action Pathway	Methadyl Acetate Action Pathway	Proparacaine Action Pathway	Sufentanil Action Pathway	Practolol Action Pathway	Chloroprocaine Action Pathway	Threonine and 2-Oxobutanoate Degradation	Pentazocine Action Pathway	Epinephrine Action Pathway	Glycogen synthetase deficiency	Timolol Action Pathway	Oxprenolol Action Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	Remifentanil Action Pathway	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Isobutyryl-coa dehydrogenase deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Esmolol Action Pathway	Nateglinide Action Pathway	Acetaminophen Metabolism Pathway	Morphine Action Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Acebutolol Action Pathway	Vincristine Action Pathway	Cholesteryl ester storage disease	Omeprazole Action Pathway	Nevirapine Metabolism Pathway	Selenoamino Acid Metabolism	Cocaine Action Pathway	Ibutilide Action Pathway	Hyperprolinemia Type I	Trifunctional protein deficiency	Folate Metabolism	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Dibucaine Action Pathway	Trehalose Degradation	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Muscle/Heart Contraction	Dimethylglycine Dehydrogenase Deficiency	The oncogenic action of 2-hydroxyglutarate	Beta Oxidation of Very Long Chain Fatty Acids	Hyperglycinemia, non-ketotic	Ranitidine Action Pathway	Nicotine Action Pathway	Etoposide Action Pathway	Propranolol Action Pathway	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Steroid Biosynthesis	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Alfentanil Action Pathway	Dezocine Action Pathway	Levallorphan Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Fosphenytoin (Antiarrhythmic) Action Pathway	Famotidine Action Pathway	Phenylacetate Metabolism	Leigh Syndrome	Atenolol Action Pathway	Cerebrotendinous Xanthomatosis (CTX)	Diltiazem Action Pathway	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Citric Acid Cycle	Histidinemia	Imipramine Action Pathway	Disulfiram Action Pathway	27-Hydroxylase Deficiency	Betaxolol Action Pathway	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Hypercholesterolemia	Oxycodone Action Pathway	Amiodarone Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	Methotrexate Action Pathway	Nebivolol Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	Oxybuprocaine Action Pathway	Clopidogrel Action Pathway	Codeine Action Pathway	Hyper-IgD syndrome	Congenital Bile Acid Synthesis Defect Type II	Prolinemia Type II	Wolman disease	Glutaminolysis and Cancer	Quinidine Action Pathway	Amlodipine Action Pathway	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Pirenzepine Action Pathway	Glycine and Serine Metabolism	Carfentanil Action Pathway	Folate malabsorption, hereditary	Metipranolol Action Pathway	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Valproic Acid Metabolism Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Gliclazide Action Pathway	Levorphanol Action Pathway	Oxidation of Branched Chain Fatty Acids	Homocarnosinosis	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Felodipine Action Pathway	3-Methylglutaconic Aciduria Type I	Isradipine Action Pathway	Nizatidine Action Pathway	Ropivacaine Action Pathway	Buprenorphine Action Pathway	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Nisoldipine Action Pathway	Verapamil Action Pathway	Metiamide Action Pathway	3-Methylglutaconic Aciduria Type III	Irinotecan Action Pathway	CHILD Syndrome	Propanoate Metabolism	Propionic Acidemia	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Valine, Leucine and Isoleucine Degradation	Pyruvate Metabolism	Lactose Intolerance	Primary hyperoxaluria II, PH2	Lansoprazole Action Pathway	Tramadol Metabolism Pathway	Glycogenosis, Type VI. Hers disease	Anileridine Action Pathway	Gemcitabine Action Pathway	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Vinorelbine Action Pathway	Escitalopram Action Pathway	Zellweger Syndrome	Betaine Metabolism	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Dimethylthiambutene Action Pathway	Carnitine palmitoyl transferase deficiency (II)	Primary Hyperoxaluria Type I	Desipramine Action Pathway	Simvastatin Action Pathway	Pantoprazole Action Pathway	Cimetidine Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	The oncogenic action of Fumarate	Isoprenaline Action Pathway	3-Methylglutaconic Aciduria Type IV	Triosephosphate isomerase	Ketobemidone  Action Pathway	Argininosuccinic Aciduria	Penbutolol Action Pathway	Tryptophan Metabolism	Nitrendipine Action Pathway	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	Maple Syrup Urine Disease	Tyrosinemia Type 3 (TYRO3)	Levobupivacaine Action Pathway	Diphenoxylate Action Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Rabeprazole Action Pathway	Lactic Acidemia	Congenital lactic acidosis	Ethylmorphine Action Pathway	Glycogenosis, Type IC	3-Methylthiofentanyl Action Pathway	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Smith-Lemli-Opitz Syndrome (SLOS)	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Levobunolol Action Pathway	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Erlotinib Action Pathway	Procaine Action Pathway	Non Ketotic Hyperglycinemia	Benzocaine Action Pathway	Bupranolol Action Pathway	Vinblastine Action Pathway	Carteolol Action Pathway	Mepivacaine Action Pathway	Nifedipine Action Pathway	Desmosterolosis	Fatty acid Metabolism	Sulfate/Sulfite Metabolism	Fumarase deficiency	Phenylketonuria	Metoprolol Action Pathway	Lactose Degradation	Naloxone Action Pathway	Pancreas Function	Betazole Action Pathway	Prolidase Deficiency (PD)	Roxatidine acetate Action Pathway	Mevalonic aciduria	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Prilocaine Action Pathway	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Warburg Effect	Glutamate Metabolism	Glycolysis	Alanine Metabolism	Familial Hypercholanemia (FHCA)	Carbamoyl Phosphate Synthetase Deficiency	Hydromorphone Action Pathway	Propoxyphene Action Pathway	Citalopram Action Pathway	Fructose-1,6-diphosphatase deficiency	Bile Acid Biosynthesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Argininemia	Carvedilol Action Pathway	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	3-hydroxyisobutyric acid dehydrogenase deficiency	Sucrase-isomaltase deficiency	Histidine Metabolism	Thiamine Metabolism	Bevantolol Action Pathway	Flecainide Action Pathway	Naltrexone Action Pathway	Nimodipine Action Pathway	Tramadol Action Action Pathway	Nadolol Action Pathway	Esomeprazole Action Pathway	Ammonia Recycling	L-arginine:glycine amidinotransferase deficiency	Oxymorphone Action Pathway	Pindolol Action Pathway	Dobutamine Action Pathway
CO2	HMDB_SMPDB	Samples:	71	Pathways:	162	Ureidopropionase deficiency	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Oxidation of Branched Chain Fatty Acids	Beta-Ketothiolase Deficiency	Homocarnosinosis	Porphyria Variegata (PV)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Nizatidine Action Pathway	Gastric Acid Production	Carnitine palmitoyl transferase deficiency (I)	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Citrullinemia Type I	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	2-ketoglutarate dehydrogenase complex deficiency	Ethylmalonic Encephalopathy	Isovaleric Aciduria	Pyridoxine dependency with seizures	Tyrosine hydroxylase deficiency	Glycogenosis, Type IB	Malonic Aciduria	Metiamide Action Pathway	3-Methylglutaconic Aciduria Type III	Transfer of Acetyl Groups into Mitochondria	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Sarcosinemia	Glycogenosis, Type IA. Von gierke disease	CHILD Syndrome	Pyruvate dehydrogenase deficiency (E2)	Pantothenate and CoA Biosynthesis	Propanoate Metabolism	Propionic Acidemia	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Acute Intermittent Porphyria	Valine, Leucine and Isoleucine Degradation	Succinic semialdehyde dehydrogenase deficiency	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Pyruvate Metabolism	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	2-aminoadipic 2-oxoadipic aciduria	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Lansoprazole Action Pathway	Gluconeogenesis	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Dopamine beta-hydroxylase deficiency	Catecholamine Biosynthesis	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	Hereditary Coproporphyria (HCP)	Simvastatin Action Pathway	Pantoprazole Action Pathway	Cimetidine Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	The oncogenic action of Fumarate	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Triosephosphate isomerase	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Argininosuccinic Aciduria	Tryptophan Metabolism	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Maple Syrup Urine Disease	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	Omeprazole Action Pathway	Cholesteryl ester storage disease	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Rabeprazole Action Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	Congenital lactic acidosis	Beta-Alanine Metabolism	Ketone Body Metabolism	Glycogenosis, Type IC	Trifunctional protein deficiency	Folate Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Smith-Lemli-Opitz Syndrome (SLOS)	Hyperprolinemia Type II	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	The oncogenic action of 2-hydroxyglutarate	Non Ketotic Hyperglycinemia	Hyperglycinemia, non-ketotic	Ranitidine Action Pathway	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Steroid Biosynthesis	Desmosterolosis	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Fumarase deficiency	Phenylketonuria	Betazole Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Roxatidine acetate Action Pathway	Mevalonic aciduria	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Vitamin K Metabolism	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Famotidine Action Pathway	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Warburg Effect	Glutamate Metabolism	Tyrosine Metabolism	Leigh Syndrome	Monoamine oxidase-a deficiency (MAO-A)	Carnitine Synthesis	Carbamoyl Phosphate Synthetase Deficiency	Aromatic L-Aminoacid Decarboxylase Deficiency	Citric Acid Cycle	Histidinemia	Porphyrin Metabolism	Disulfiram Action Pathway	Fructose-1,6-diphosphatase deficiency	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Hypercholesterolemia	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Argininemia	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Methotrexate Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	Hyper-IgD syndrome	3-hydroxyisobutyric acid dehydrogenase deficiency	Prolinemia Type II	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Wolman disease	Hyperlysinemia I, Familial	Glutaminolysis and Cancer	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Pirenzepine Action Pathway	Esomeprazole Action Pathway	Ammonia Recycling	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Folate malabsorption, hereditary
CoA	HMDB_SMPDB	Samples:	65	Pathways:	114	Ureidopropionase deficiency	Congenital lactic acidosis	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Beta-Alanine Metabolism	Valproic Acid Metabolism Pathway	Ketone Body Metabolism	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Butyrate Metabolism	Trifunctional protein deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Oxidation of Branched Chain Fatty Acids	Beta-Ketothiolase Deficiency	Homocarnosinosis	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Smith-Lemli-Opitz Syndrome (SLOS)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Carnitine-acylcarnitine translocase deficiency	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Dimethylglycine Dehydrogenase Deficiency	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Beta Oxidation of Very Long Chain Fatty Acids	The oncogenic action of 2-hydroxyglutarate	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Non Ketotic Hyperglycinemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Hyperglycinemia, non-ketotic	2-ketoglutarate dehydrogenase complex deficiency	Ethylmalonic Encephalopathy	Isovaleric Aciduria	Pyridoxine dependency with seizures	Carnosinuria, carnosinemia	Steroid Biosynthesis	Desmosterolosis	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Malonic Aciduria	Fumarase deficiency	Adrenoleukodystrophy, X-linked	3-Methylglutaconic Aciduria Type III	Transfer of Acetyl Groups into Mitochondria	Sarcosinemia	CHILD Syndrome	Pyruvate dehydrogenase deficiency (E2)	Pantothenate and CoA Biosynthesis	Propanoate Metabolism	Propionic Acidemia	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Mevalonic aciduria	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Succinic semialdehyde dehydrogenase deficiency	3-hydroxyisobutyric aciduria	Phenylacetate Metabolism	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Glutamate Metabolism	Pyruvate Metabolism	Lysine Degradation	Leigh Syndrome	Hyperlysinemia II or Saccharopinuria	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type III	2-aminoadipic 2-oxoadipic aciduria	Fatty Acid Elongation In Mitochondria	Familial Hypercholanemia (FHCA)	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Citric Acid Cycle	Disulfiram Action Pathway	27-Hydroxylase Deficiency	Pyruvate kinase deficiency	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Phytanic Acid Peroxisomal Oxidation	Hypercholesterolemia	Bile Acid Biosynthesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Zellweger Syndrome	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Threonine and 2-Oxobutanoate Degradation	Methylmalonic Aciduria	Isovaleric acidemia	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	Simvastatin Action Pathway	Hyper-IgD syndrome	Congenital Bile Acid Synthesis Defect Type II	Lysosomal Acid Lipase Deficiency (Wolman Disease)	3-hydroxyisobutyric acid dehydrogenase deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Wolman disease	Hyperlysinemia I, Familial	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Glutaminolysis and Cancer	Tryptophan Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	Maple Syrup Urine Disease	Cholesteryl ester storage disease	GABA-Transaminase Deficiency	Glycine and Serine Metabolism	Succinyl CoA: 3-ketoacid CoA transferase deficiency
Cobamide coenzyme	HMDB_SMPDB	Samples:	60	Pathways:	22	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Isobutyryl-coa dehydrogenase deficiency	Malonic Aciduria	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Malonyl-coa decarboxylase deficiency	Threonine and 2-Oxobutanoate Degradation	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
H+	HMDB_SMPDB	Samples:	75	Pathways:	149	Ureidopropionase deficiency	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Homocarnosinosis	Beta-Ketothiolase Deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Mitochondrial Electron Transport Chain	Felbamate Metabolism Pathway	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Nizatidine Action Pathway	Gastric Acid Production	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	2-ketoglutarate dehydrogenase complex deficiency	Ethylmalonic Encephalopathy	Isovaleric Aciduria	21-hydroxylase deficiency (CYP21)	Glycogenosis, Type IB	Glucose-Alanine Cycle	Malonic Aciduria	Metiamide Action Pathway	3-Methylglutaconic Aciduria Type III	Transfer of Acetyl Groups into Mitochondria	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycogenosis, Type IA. Von gierke disease	Phenytoin (Antiarrhythmic) Action Pathway	Pyruvate dehydrogenase deficiency (E2)	Propanoate Metabolism	Propionic Acidemia	Lidocaine (Antiarrhythmic) Action Pathway	Valine, Leucine and Isoleucine Degradation	Succinic semialdehyde dehydrogenase deficiency	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Pyruvate Metabolism	Fatty Acid Elongation In Mitochondria	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Lansoprazole Action Pathway	Gluconeogenesis	Tramadol Metabolism Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Dopamine beta-hydroxylase deficiency	Androgen and Estrogen Metabolism	17-alpha-hydroxylase deficiency (CYP17)	Carnitine palmitoyl transferase deficiency (II)	Desipramine Action Pathway	Pantoprazole Action Pathway	Cimetidine Action Pathway	11-beta-hydroxylase deficiency (CYP11B1)	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	The oncogenic action of Fumarate	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Triosephosphate isomerase	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Ibuprofen Action Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Ethanol Degradation	Maple Syrup Urine Disease	GABA-Transaminase Deficiency	Omeprazole Action Pathway	Nevirapine Metabolism Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Rabeprazole Action Pathway	Carbamazepine Metabolism Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	Congenital lactic acidosis	Beta-Alanine Metabolism	Glycogenosis, Type IC	Degradation of Superoxides	Trifunctional protein deficiency	Folate Metabolism	Aromatase deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	The oncogenic action of 2-hydroxyglutarate	Corticosterone methyl oxidase II deficiency - CMO II	Ranitidine Action Pathway	Nicotine Action Pathway	Corticosterone methyl oxidase I deficiency (CMO I)	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Fatty acid Metabolism	Fumarase deficiency	Betazole Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Roxatidine acetate Action Pathway	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Tamoxifen Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Famotidine Action Pathway	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Warburg Effect	Glutamate Metabolism	Tyrosine Metabolism	Leigh Syndrome	Monoamine oxidase-a deficiency (MAO-A)	Carnitine Synthesis	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Citric Acid Cycle	Histidinemia	Imipramine Action Pathway	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Disulfiram Action Pathway	Fructose-1,6-diphosphatase deficiency	Pyruvate kinase deficiency	Alkaptonuria	Steroidogenesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Methotrexate Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	Ubiquinone Biosynthesis	3-hydroxyisobutyric acid dehydrogenase deficiency	Prolinemia Type II	Malate-Aspartate Shuttle	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Apparent mineralocorticoid excess syndrome	Glutaminolysis and Cancer	Tamoxifen Metabolism Pathway	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Pirenzepine Action Pathway	Esomeprazole Action Pathway	L-arginine:glycine amidinotransferase deficiency	Folate malabsorption, hereditary
H2O	HMDB_SMPDB	Samples:	90	Pathways:	415	Ureidopropionase deficiency	Levomethadyl Acetate Action Action Pathway	Alprenolol Action Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Butyrate Metabolism	Bisoprolol Action Pathway	Beta-Ketothiolase Deficiency	Lysinuric Protein Intolerance	Mitochondrial Electron Transport Chain	Felbamate Metabolism Pathway	Bupivacaine Action Pathway	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	Homocysteine Degradation	Vindesine Action Pathway	Gastric Acid Production	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Antrafenine Action Pathway	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Mucopolysaccharidosis VI. Sly syndrome	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Citrullinemia Type I	Eplerenone Action Pathway	Pyridoxine dependency with seizures	Ethylmalonic Encephalopathy	Tyrosine hydroxylase deficiency	Arbutamine Action Pathway	Heroin Action Pathway	Glycogenosis, Type IB	Malonic Aciduria	Dihydromorphine Action Pathway	Mexiletine Action Pathway	Doxorubicin Metabolism Pathway	Alvimopan Action Pathway	Fentanyl Action Pathway	Transfer of Acetyl Groups into Mitochondria	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Sarcosinemia	Methadone Action Pathway	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Phenytoin (Antiarrhythmic) Action Pathway	Glycogenosis, Type VII. Tarui disease	Suprofen Action Pathway	Pyruvate dehydrogenase deficiency (E2)	Lidocaine (Antiarrhythmic) Action Pathway	Pantothenate and CoA Biosynthesis	Labetalol Action Pathway	Acute Intermittent Porphyria	Blue diaper syndrome	Ethacrynic Acid Action Pathway	Succinic semialdehyde dehydrogenase deficiency	Sulfite oxidase deficiency	Pyruvate dehydrogenase deficiency (E3)	Segawa syndrome	Hawkinsinuria	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Disopyramide Action Pathway	Nalbuphine Action Pathway	Fluoxetine Action Pathway	Starch and Sucrose Metabolism	Congenital Bile Acid Synthesis Defect Type III	Fatty Acid Elongation In Mitochondria	2-aminoadipic 2-oxoadipic aciduria	Hydrocodone Action Pathway	Arginine and Proline Metabolism	Tocainide Action Pathway	The oncogenic action of Succinate	Procainamide (Antiarrhythmic) Action Pathway	Spironolactone Action Pathway	Gluconeogenesis	Bopindolol Action Pathway	Sotalol Action Pathway	Methadyl Acetate Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Proparacaine Action Pathway	Sufentanil Action Pathway	Practolol Action Pathway	Chloroprocaine Action Pathway	Pentazocine Action Pathway	Epinephrine Action Pathway	Catecholamine Biosynthesis	Glycogen synthetase deficiency	Trichlormethiazide Action Pathway	Timolol Action Pathway	Hereditary Coproporphyria (HCP)	Oxprenolol Action Pathway	11-beta-hydroxylase deficiency (CYP11B1)	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Oxaprozin Action Pathway	Remifentanil Action Pathway	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Mitochondrial complex II deficiency	Isobutyryl-coa dehydrogenase deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Chlorthalidone Action Pathway	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Esmolol Action Pathway	Acetaminophen Metabolism Pathway	Morphine Action Pathway	Gamma-cystathionase deficiency (CTH)	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Leukotriene C4 Synthesis Deficiency	Acebutolol Action Pathway	Vincristine Action Pathway	Cholesteryl ester storage disease	GABA-Transaminase Deficiency	Omeprazole Action Pathway	Selenoamino Acid Metabolism	Nevirapine Metabolism Pathway	Cocaine Action Pathway	Ibutilide Action Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	Venlafaxine Metabolism Pathway	Trifunctional protein deficiency	Folate Metabolism	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Dibucaine Action Pathway	Homocystinuria, cystathionine beta-synthase deficiency	Trehalose Degradation	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Muscle/Heart Contraction	Sorafenib Metabolism Pathway	Antipyrine Action Pathway	Dimethylglycine Dehydrogenase Deficiency	The oncogenic action of 2-hydroxyglutarate	Quinethazone Action Pathway	Hyperglycinemia, non-ketotic	Ranitidine Action Pathway	Nicotine Action Pathway	Nepafenac Action Pathway	Corticosterone methyl oxidase I deficiency (CMO I)	Glucose Transporter Defect (SGLT2)	Etoposide Action Pathway	Propranolol Action Pathway	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Flurbiprofen Action Pathway	Steroid Biosynthesis	Acetaminophen  Action Pathway	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Cystinuria	Diflunisal Action Pathway	Alfentanil Action Pathway	Dezocine Action Pathway	Levallorphan Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Fosphenytoin (Antiarrhythmic) Action Pathway	Hydroflumethiazide Action Pathway	Tamoxifen Action Pathway	Famotidine Action Pathway	Tyrosine Metabolism	Magnesium salicylate Action Pathway	Leigh Syndrome	Atenolol Action Pathway	Lysinuric protein intolerance (LPI)	Cerebrotendinous Xanthomatosis (CTX)	Cyclothiazide Action Pathway	Thyroid hormone synthesis	Diltiazem Action Pathway	Carnitine Synthesis	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Citric Acid Cycle	Histidinemia	Imipramine Action Pathway	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Artemether Metabolism Pathway	27-Hydroxylase Deficiency	Betaxolol Action Pathway	Disulfiram Action Pathway	Pyruvate kinase deficiency	Hypercholesterolemia	Alkaptonuria	Steroidogenesis	Phytanic Acid Peroxisomal Oxidation	Lumiracoxib Action Pathway	Oxycodone Action Pathway	Amiodarone Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	Methotrexate Action Pathway	Nebivolol Action Pathway	Fenoprofen Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Chlorothiazide Action Pathway	Methylmalonic Aciduria	Isovaleric acidemia	Salsalate Action Pathway	Oxybuprocaine Action Pathway	Clopidogrel Action Pathway	Codeine Action Pathway	Hyper-IgD syndrome	Ubiquinone Biosynthesis	Congenital Bile Acid Synthesis Defect Type II	Prolinemia Type II	Naproxen Action Pathway	Wolman disease	Glutaminolysis and Cancer	Quinidine Action Pathway	Amlodipine Action Pathway	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Pirenzepine Action Pathway	Pterine Biosynthesis	Glycine and Serine Metabolism	Carfentanil Action Pathway	Lornoxicam Action Pathway	Folate malabsorption, hereditary	Metipranolol Action Pathway	Diclofenac Action Pathway	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Valproic Acid Metabolism Pathway	Capecitabine Action Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Levorphanol Action Pathway	Ketorolac Action Pathway	Homocarnosinosis	Porphyria Variegata (PV)	Phenylalanine and Tyrosine Metabolism	Felodipine Action Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Triamterene Action Pathway	Furosemide Action Pathway	3-Methylglutaconic Aciduria Type I	Isradipine Action Pathway	Nizatidine Action Pathway	Ropivacaine Action Pathway	Buprenorphine Action Pathway	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	21-hydroxylase deficiency (CYP21)	Nisoldipine Action Pathway	Polythiazide Action Pathway	Glucose-Alanine Cycle	Verapamil Action Pathway	Metiamide Action Pathway	Ketoprofen Action Pathway	3-Methylglutaconic Aciduria Type III	Irinotecan Action Pathway	CHILD Syndrome	Methyclothiazide Action Pathway	Propanoate Metabolism	Propionic Acidemia	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Iminoglycinuria	Valine, Leucine and Isoleucine Degradation	Pyruvate Metabolism	Lactose Intolerance	Teniposide Metabolism Pathway	Primary hyperoxaluria II, PH2	Bendroflumethiazide Action Pathway	Lansoprazole Action Pathway	Tramadol Metabolism Pathway	Glycogenosis, Type VI. Hers disease	Nabumetone Action Pathway	Anileridine Action Pathway	Gemcitabine Action Pathway	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Vinorelbine Action Pathway	Hydrochlorothiazide Action Pathway	Escitalopram Action Pathway	Zellweger Syndrome	Dopamine beta-hydroxylase deficiency	Androgen and Estrogen Metabolism	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Piroxicam Action Pathway	Betaine Metabolism	Valdecoxib Action Pathway	17-alpha-hydroxylase deficiency (CYP17)	Carnitine palmitoyl transferase deficiency (II)	Dimethylthiambutene Action Pathway	Saccharopinuria/Hyperlysinemia II	Desipramine Action Pathway	Simvastatin Action Pathway	Pantoprazole Action Pathway	Trisalicylate-choline Action Pathway	Cimetidine Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	The oncogenic action of Fumarate	Isoprenaline Action Pathway	3-Methylglutaconic Aciduria Type IV	Triosephosphate isomerase	Ketobemidone  Action Pathway	Argininosuccinic Aciduria	Ibuprofen Action Pathway	Penbutolol Action Pathway	Tryptophan Metabolism	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	D-Arginine and D-Ornithine Metabolism	Nitrendipine Action Pathway	Hyperinsulinism-Hyperammonemia Syndrome	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Ethanol Degradation	Amiloride Action Pathway	Maple Syrup Urine Disease	Tyrosinemia Type 3 (TYRO3)	Levobupivacaine Action Pathway	Carprofen Action Pathway	Capecitabine Metabolism Pathway	Rofecoxib Action Pathway	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Diphenoxylate Action Pathway	Etodolac Action Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Rabeprazole Action Pathway	Carbamazepine Metabolism Pathway	Kidney Function	Congenital lactic acidosis	Degradation of Superoxides	Glycogenosis, Type IC	Beta-Alanine Metabolism	Ethylmorphine Action Pathway	Ketone Body Metabolism	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Aromatase deficiency	3-Methylthiofentanyl Action Pathway	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Smith-Lemli-Opitz Syndrome (SLOS)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Bumetanide Action Pathway	Meloxicam Action Pathway	Levobunolol Action Pathway	Sepiapterin reductase deficiency	Hyperprolinemia Type II	Mefenamic Acid Action Pathway	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dopa-responsive dystonia	Erlotinib Action Pathway	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Teniposide Action Pathway	Procaine Action Pathway	Non Ketotic Hyperglycinemia	Benzocaine Action Pathway	Corticosterone methyl oxidase II deficiency - CMO II	Bupranolol Action Pathway	Vinblastine Action Pathway	Torsemide Action Pathway	Carteolol Action Pathway	Carnosinuria, carnosinemia	Mepivacaine Action Pathway	Desmosterolosis	Nifedipine Action Pathway	Fatty acid Metabolism	Hyperphenylalaninemia due to dhpr-deficiency	Sulfate/Sulfite Metabolism	Phenylketonuria	Metoprolol Action Pathway	Fumarase deficiency	Naloxone Action Pathway	Lactose Degradation	Betazole Action Pathway	Prolidase Deficiency (PD)	Roxatidine acetate Action Pathway	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Mevalonic aciduria	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Vitamin K Metabolism	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Prilocaine Action Pathway	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Warburg Effect	Glutamate Metabolism	Glycolysis	Monoamine oxidase-a deficiency (MAO-A)	Familial Hypercholanemia (FHCA)	Carbamoyl Phosphate Synthetase Deficiency	Aromatic L-Aminoacid Decarboxylase Deficiency	Propoxyphene Action Pathway	Hydromorphone Action Pathway	Salicylic Acid Action Pathway	Citalopram Action Pathway	Porphyrin Metabolism	Fructose-1,6-diphosphatase deficiency	Metolazone Action Pathway	Bile Acid Biosynthesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Argininemia	Carvedilol Action Pathway	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Bromfenac Action Pathway	Acetylsalicylic Acid Action Pathway	Tenoxicam Action Pathway	3-hydroxyisobutyric acid dehydrogenase deficiency	Sucrase-isomaltase deficiency	Indapamide Action Pathway	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Thiamine Metabolism	Apparent mineralocorticoid excess syndrome	Bevantolol Action Pathway	Hyperlysinemia I, Familial	Flecainide Action Pathway	Hartnup Disorder	Naltrexone Action Pathway	Nimodipine Action Pathway	Nadolol Action Pathway	Tramadol Action Action Pathway	Tamoxifen Metabolism Pathway	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Esomeprazole Action Pathway	Sulindac Action Pathway	Ammonia Recycling	L-arginine:glycine amidinotransferase deficiency	Oxymorphone Action Pathway	Pindolol Action Pathway	Dobutamine Action Pathway	Phenylbutazone Action Pathway
HCO3-	HMDB_SMPDB	Samples:	68	Pathways:	96	Kidney Function	Lactic Acidemia	Congenital lactic acidosis	Glycogenosis, Type IC	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Beta-Ketothiolase Deficiency	Bumetanide Action Pathway	Lysinuric Protein Intolerance	Triamterene Action Pathway	Furosemide Action Pathway	Malonyl-coa decarboxylase deficiency	The oncogenic action of 2-hydroxyglutarate	3-Methylglutaconic Aciduria Type I	Nizatidine Action Pathway	Gastric Acid Production	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Quinethazone Action Pathway	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Ranitidine Action Pathway	Eplerenone Action Pathway	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Glucose Transporter Defect (SGLT2)	Torsemide Action Pathway	Glycogenosis, Type IB	Polythiazide Action Pathway	Malonic Aciduria	Cystinuria	Metiamide Action Pathway	Fumarase deficiency	3-Methylglutaconic Aciduria Type III	Transfer of Acetyl Groups into Mitochondria	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Betazole Action Pathway	Roxatidine acetate Action Pathway	Glycogenosis, Type IA. Von gierke disease	Methyclothiazide Action Pathway	Pyruvate dehydrogenase deficiency (E2)	Propanoate Metabolism	Propionic Acidemia	Hydroflumethiazide Action Pathway	Iminoglycinuria	Blue diaper syndrome	Valine, Leucine and Isoleucine Degradation	Famotidine Action Pathway	Ethacrynic Acid Action Pathway	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Pyruvate Metabolism	Leigh Syndrome	Lysinuric protein intolerance (LPI)	Cyclothiazide Action Pathway	Alanine Metabolism	Primary hyperoxaluria II, PH2	Bendroflumethiazide Action Pathway	The oncogenic action of Succinate	Lansoprazole Action Pathway	Citric Acid Cycle	Spironolactone Action Pathway	Gluconeogenesis	Fructose-1,6-diphosphatase deficiency	Pyruvate kinase deficiency	Metolazone Action Pathway	Hydrochlorothiazide Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Threonine and 2-Oxobutanoate Degradation	Trichlormethiazide Action Pathway	Chlorothiazide Action Pathway	Methylmalonic Aciduria	Isovaleric acidemia	Primary Hyperoxaluria Type I	Pantoprazole Action Pathway	Cimetidine Action Pathway	3-hydroxyisobutyric acid dehydrogenase deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Indapamide Action Pathway	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Chlorthalidone Action Pathway	Triosephosphate isomerase	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Hartnup Disorder	Glutaminolysis and Cancer	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Pirenzepine Action Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Esomeprazole Action Pathway	Amiloride Action Pathway	Maple Syrup Urine Disease	Omeprazole Action Pathway	Rabeprazole Action Pathway
L-3-Aminoisobutanoate	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
L-Glutamate	HMDB_SMPDB	Samples:	71	Pathways:	131	Diclofenac Action Pathway	Ureidopropionase deficiency	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Homocarnosinosis	Beta-Ketothiolase Deficiency	Ketorolac Action Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Malonyl-coa decarboxylase deficiency	3-Methylglutaconic Aciduria Type I	Antrafenine Action Pathway	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Citrullinemia Type I	Pyridoxine dependency with seizures	Isovaleric Aciduria	Glucose-Alanine Cycle	Malonic Aciduria	Ketoprofen Action Pathway	3-Methylglutaconic Aciduria Type III	Sarcosinemia	Suprofen Action Pathway	Propanoate Metabolism	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	Succinic semialdehyde dehydrogenase deficiency	Hawkinsinuria	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	2-aminoadipic 2-oxoadipic aciduria	Arginine and Proline Metabolism	Nabumetone Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Dopamine beta-hydroxylase deficiency	Piroxicam Action Pathway	Valdecoxib Action Pathway	Saccharopinuria/Hyperlysinemia II	Primary Hyperoxaluria Type I	Trisalicylate-choline Action Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Oxaprozin Action Pathway	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Argininosuccinic Aciduria	Ibuprofen Action Pathway	Tryptophan Metabolism	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Leukotriene C4 Synthesis Deficiency	Maple Syrup Urine Disease	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	Carprofen Action Pathway	Rofecoxib Action Pathway	Etodolac Action Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	Lactic Acidemia	Beta-Alanine Metabolism	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Folate Metabolism	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Meloxicam Action Pathway	Hyperprolinemia Type II	Antipyrine Action Pathway	Mefenamic Acid Action Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	The oncogenic action of 2-hydroxyglutarate	Non Ketotic Hyperglycinemia	Hyperglycinemia, non-ketotic	Nepafenac Action Pathway	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Phenylketonuria	Diflunisal Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Famotidine Action Pathway	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Warburg Effect	Glutamate Metabolism	Tyrosine Metabolism	Magnesium salicylate Action Pathway	Monoamine oxidase-a deficiency (MAO-A)	Alanine Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Histidinemia	Salicylic Acid Action Pathway	Disulfiram Action Pathway	Alkaptonuria	Lumiracoxib Action Pathway	Argininemia	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Methotrexate Action Pathway	Bromfenac Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Fenoprofen Action Pathway	Methylmalonic Aciduria	Isovaleric acidemia	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Tenoxicam Action Pathway	3-hydroxyisobutyric acid dehydrogenase deficiency	Prolinemia Type II	Malate-Aspartate Shuttle	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Naproxen Action Pathway	Hyperlysinemia I, Familial	Glutaminolysis and Cancer	Sulindac Action Pathway	Ammonia Recycling	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Lornoxicam Action Pathway	Folate malabsorption, hereditary	Phenylbutazone Action Pathway
Methylmalonate	HMDB_SMPDB	Samples:	61	Pathways:	22	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Isobutyryl-coa dehydrogenase deficiency	Malonic Aciduria	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Malonyl-coa decarboxylase deficiency	Vitamin K Metabolism	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
NAD+	HMDB_SMPDB	Samples:	81	Pathways:	197	Ureidopropionase deficiency	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Butyrate Metabolism	Phospholipid Biosynthesis	Homocarnosinosis	Beta-Ketothiolase Deficiency	Porphyria Variegata (PV)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Mitochondrial Electron Transport Chain	Felbamate Metabolism Pathway	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	3-Methylglutaconic Aciduria Type I	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Citrullinemia Type I	Mucopolysaccharidosis VI. Sly syndrome	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	2-ketoglutarate dehydrogenase complex deficiency	Ethylmalonic Encephalopathy	Isovaleric Aciduria	Pyridoxine dependency with seizures	21-hydroxylase deficiency (CYP21)	Glycogenosis, Type IB	Glucose-Alanine Cycle	Malonic Aciduria	Doxorubicin Metabolism Pathway	3-Methylglutaconic Aciduria Type III	Transfer of Acetyl Groups into Mitochondria	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Sarcosinemia	Methadone Action Pathway	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E2)	Propanoate Metabolism	Propionic Acidemia	Lidocaine (Antiarrhythmic) Action Pathway	Acute Intermittent Porphyria	Valine, Leucine and Isoleucine Degradation	Succinic semialdehyde dehydrogenase deficiency	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Segawa syndrome	Pyruvate Metabolism	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Fluoxetine Action Pathway	Congenital Bile Acid Synthesis Defect Type III	2-aminoadipic 2-oxoadipic aciduria	Fatty Acid Elongation In Mitochondria	Teniposide Metabolism Pathway	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Starch and Sucrose Metabolism	Gluconeogenesis	Tramadol Metabolism Pathway	Glycogenosis, Type VI. Hers disease	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Zellweger Syndrome	Dopamine beta-hydroxylase deficiency	Androgen and Estrogen Metabolism	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Threonine and 2-Oxobutanoate Degradation	Betaine Metabolism	Glycogen synthetase deficiency	17-alpha-hydroxylase deficiency (CYP17)	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	Hereditary Coproporphyria (HCP)	11-beta-hydroxylase deficiency (CYP11B1)	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	The oncogenic action of Fumarate	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Triosephosphate isomerase	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Argininosuccinic Aciduria	Acetaminophen Metabolism Pathway	Tryptophan Metabolism	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Ethanol Degradation	Maple Syrup Urine Disease	GABA-Transaminase Deficiency	Selenoamino Acid Metabolism	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Lidocaine (Local Anaesthetic) Action Pathway	Carbamazepine Metabolism Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	Venlafaxine Metabolism Pathway	Congenital lactic acidosis	Beta-Alanine Metabolism	Ketone Body Metabolism	Glycogenosis, Type IC	Trifunctional protein deficiency	Folate Metabolism	Aromatase deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Sepiapterin reductase deficiency	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Dimethylglycine Dehydrogenase Deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	The oncogenic action of 2-hydroxyglutarate	Dopa-responsive dystonia	Teniposide Action Pathway	Non Ketotic Hyperglycinemia	Corticosterone methyl oxidase II deficiency - CMO II	Hyperglycinemia, non-ketotic	Nicotine Action Pathway	Corticosterone methyl oxidase I deficiency (CMO I)	Etoposide Action Pathway	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Hyperphenylalaninemia due to dhpr-deficiency	Urea Cycle	Fumarase deficiency	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Warburg Effect	Glutamate Metabolism	Tyrosine Metabolism	Glycolysis	Leigh Syndrome	Cerebrotendinous Xanthomatosis (CTX)	Monoamine oxidase-a deficiency (MAO-A)	Familial Hypercholanemia (FHCA)	Carnitine Synthesis	Carbamoyl Phosphate Synthetase Deficiency	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Citric Acid Cycle	Histidinemia	Imipramine Action Pathway	Citalopram Action Pathway	Artemether Metabolism Pathway	Disulfiram Action Pathway	27-Hydroxylase Deficiency	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Porphyrin Metabolism	Fructose-1,6-diphosphatase deficiency	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Bile Acid Biosynthesis	Steroidogenesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Argininemia	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Methotrexate Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	Codeine Action Pathway	Congenital Bile Acid Synthesis Defect Type II	3-hydroxyisobutyric acid dehydrogenase deficiency	Prolinemia Type II	Sucrase-isomaltase deficiency	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Malate-Aspartate Shuttle	Apparent mineralocorticoid excess syndrome	Hyperlysinemia I, Familial	Glutaminolysis and Cancer	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Ammonia Recycling	L-arginine:glycine amidinotransferase deficiency	Pterine Biosynthesis	Glycine and Serine Metabolism	Folate malabsorption, hereditary
Orthophosphate	HMDB_SMPDB	Samples:	87	Pathways:	252	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Levomethadyl Acetate Action Action Pathway	Alprenolol Action Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Capecitabine Action Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Bisoprolol Action Pathway	Levorphanol Action Pathway	Homocarnosinosis	Beta-Ketothiolase Deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Felodipine Action Pathway	Mitochondrial Electron Transport Chain	Bupivacaine Action Pathway	Malonyl-coa decarboxylase deficiency	3-Methylglutaconic Aciduria Type I	Isradipine Action Pathway	Nizatidine Action Pathway	Vindesine Action Pathway	Ropivacaine Action Pathway	Gastric Acid Production	Buprenorphine Action Pathway	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Citrullinemia Type I	Mucopolysaccharidosis VI. Sly syndrome	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Arbutamine Action Pathway	Heroin Action Pathway	Nisoldipine Action Pathway	Glycogenosis, Type IB	Verapamil Action Pathway	Malonic Aciduria	Dihydromorphine Action Pathway	Metiamide Action Pathway	Mexiletine Action Pathway	Doxorubicin Metabolism Pathway	Alvimopan Action Pathway	3-Methylglutaconic Aciduria Type III	Fentanyl Action Pathway	Transfer of Acetyl Groups into Mitochondria	Irinotecan Action Pathway	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Sarcosinemia	Methadone Action Pathway	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Phenytoin (Antiarrhythmic) Action Pathway	CHILD Syndrome	Pyruvate dehydrogenase deficiency (E2)	Labetalol Action Pathway	Propanoate Metabolism	Propionic Acidemia	Lidocaine (Antiarrhythmic) Action Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Valine, Leucine and Isoleucine Degradation	Glycogenosis, Type VII. Tarui disease	Succinic semialdehyde dehydrogenase deficiency	Sulfite oxidase deficiency	Pyruvate dehydrogenase deficiency (E3)	Pyruvate Metabolism	Disopyramide Action Pathway	Nalbuphine Action Pathway	Fluoxetine Action Pathway	Lactose Intolerance	Starch and Sucrose Metabolism	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Hydrocodone Action Pathway	Lansoprazole Action Pathway	Procainamide (Antiarrhythmic) Action Pathway	Tocainide Action Pathway	Gluconeogenesis	Glycogenosis, Type VI. Hers disease	Bopindolol Action Pathway	Sotalol Action Pathway	Methadyl Acetate Action Pathway	Anileridine Action Pathway	Proparacaine Action Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Sufentanil Action Pathway	Vinorelbine Action Pathway	Escitalopram Action Pathway	Practolol Action Pathway	Chloroprocaine Action Pathway	Pentazocine Action Pathway	Betaine Metabolism	Epinephrine Action Pathway	Glycogen synthetase deficiency	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Dimethylthiambutene Action Pathway	Primary Hyperoxaluria Type I	Timolol Action Pathway	Desipramine Action Pathway	Simvastatin Action Pathway	Pantoprazole Action Pathway	Oxprenolol Action Pathway	Cimetidine Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	The oncogenic action of Fumarate	Remifentanil Action Pathway	Isoprenaline Action Pathway	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Ketobemidone  Action Pathway	Triosephosphate isomerase	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Argininosuccinic Aciduria	Esmolol Action Pathway	Acetaminophen Metabolism Pathway	Penbutolol Action Pathway	Morphine Action Pathway	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Nitrendipine Action Pathway	Hyperinsulinism-Hyperammonemia Syndrome	Acebutolol Action Pathway	Maple Syrup Urine Disease	Vincristine Action Pathway	Levobupivacaine Action Pathway	Omeprazole Action Pathway	Cholesteryl ester storage disease	Capecitabine Metabolism Pathway	Nevirapine Metabolism Pathway	Selenoamino Acid Metabolism	Diphenoxylate Action Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Cocaine Action Pathway	Rabeprazole Action Pathway	Ibutilide Action Pathway	Hyperprolinemia Type I	Lactic Acidemia	Congenital lactic acidosis	Ethylmorphine Action Pathway	Glycogenosis, Type IC	Folate Metabolism	3-Methylthiofentanyl Action Pathway	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Smith-Lemli-Opitz Syndrome (SLOS)	Dibucaine Action Pathway	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Levobunolol Action Pathway	Trehalose Degradation	Hyperprolinemia Type II	Muscle/Heart Contraction	Dimethylglycine Dehydrogenase Deficiency	The oncogenic action of 2-hydroxyglutarate	Erlotinib Action Pathway	Procaine Action Pathway	Non Ketotic Hyperglycinemia	Benzocaine Action Pathway	Hyperglycinemia, non-ketotic	Ranitidine Action Pathway	Nicotine Action Pathway	Bupranolol Action Pathway	Vinblastine Action Pathway	Etoposide Action Pathway	Carteolol Action Pathway	Propranolol Action Pathway	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Steroid Biosynthesis	Mepivacaine Action Pathway	Nifedipine Action Pathway	Desmosterolosis	Sulfate/Sulfite Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Fumarase deficiency	Metoprolol Action Pathway	Lactose Degradation	Alfentanil Action Pathway	Dezocine Action Pathway	Naloxone Action Pathway	Levallorphan Action Pathway	Betazole Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Roxatidine acetate Action Pathway	Fosphenytoin (Antiarrhythmic) Action Pathway	Mevalonic aciduria	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Prilocaine Action Pathway	Famotidine Action Pathway	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Warburg Effect	Glutamate Metabolism	Glycolysis	Leigh Syndrome	Atenolol Action Pathway	Alanine Metabolism	Diltiazem Action Pathway	Carbamoyl Phosphate Synthetase Deficiency	Hydromorphone Action Pathway	Citric Acid Cycle	Propoxyphene Action Pathway	Imipramine Action Pathway	Citalopram Action Pathway	Histidinemia	Betaxolol Action Pathway	Fructose-1,6-diphosphatase deficiency	Pyruvate kinase deficiency	Hypercholesterolemia	Oxycodone Action Pathway	Amiodarone Action Pathway	Argininemia	Carvedilol Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Methotrexate Action Pathway	Nebivolol Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Methylmalonic Aciduria	Isovaleric acidemia	Oxybuprocaine Action Pathway	Clopidogrel Action Pathway	Codeine Action Pathway	Hyper-IgD syndrome	3-hydroxyisobutyric acid dehydrogenase deficiency	Prolinemia Type II	Sucrase-isomaltase deficiency	Histidine Metabolism	Thiamine Metabolism	Wolman disease	Bevantolol Action Pathway	Flecainide Action Pathway	Naltrexone Action Pathway	Nimodipine Action Pathway	Glutaminolysis and Cancer	Tramadol Action Action Pathway	Amlodipine Action Pathway	Nadolol Action Pathway	Quinidine Action Pathway	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Pirenzepine Action Pathway	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Esomeprazole Action Pathway	Ammonia Recycling	L-arginine:glycine amidinotransferase deficiency	Oxymorphone Action Pathway	Pindolol Action Pathway	Glycine and Serine Metabolism	Carfentanil Action Pathway	Dobutamine Action Pathway	Folate malabsorption, hereditary	Metipranolol Action Pathway
Propanoyl-CoA	HMDB_SMPDB	Samples:	61	Pathways:	33	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type III	Familial Hypercholanemia (FHCA)	Valproic Acid Metabolism Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	27-Hydroxylase Deficiency	Oxidation of Branched Chain Fatty Acids	Beta-Ketothiolase Deficiency	Phytanic Acid Peroxisomal Oxidation	Refsum Disease	Bile Acid Biosynthesis	Zellweger Syndrome	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Malonyl-coa decarboxylase deficiency	Threonine and 2-Oxobutanoate Degradation	3-Methylglutaconic Aciduria Type I	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria	Congenital Bile Acid Synthesis Defect Type II	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Malonic Aciduria	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Maple Syrup Urine Disease	Propanoate Metabolism	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria
Pyridoxal phosphate	HMDB_SMPDB	Samples:	71	Pathways:	110	Ureidopropionase deficiency	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Tyrosinemia Type I	Hyperprolinemia Type I	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Lactic Acidemia	Beta-Alanine Metabolism	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Folate Metabolism	Homocarnosinosis	Beta-Ketothiolase Deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocystinuria, cystathionine beta-synthase deficiency	Porphyria Variegata (PV)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Hyperprolinemia Type II	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Malonyl-coa decarboxylase deficiency	3-Methylglutaconic Aciduria Type I	Homocysteine Degradation	Non Ketotic Hyperglycinemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Citrullinemia Type I	Mucopolysaccharidosis VI. Sly syndrome	Hyperglycinemia, non-ketotic	Pyridoxine dependency with seizures	Isovaleric Aciduria	Tyrosine hydroxylase deficiency	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	3-Phosphoglycerate dehydrogenase deficiency	Glucose-Alanine Cycle	Malonic Aciduria	Urea Cycle	Phenylketonuria	3-Methylglutaconic Aciduria Type III	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Propanoate Metabolism	Propionic Acidemia	Acute Intermittent Porphyria	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Pyruvate Carboxylase Deficiency	3-hydroxyisobutyric aciduria	Hawkinsinuria	Glutamate Metabolism	Tyrosine Metabolism	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Starch and Sucrose Metabolism	Monoamine oxidase-a deficiency (MAO-A)	2-aminoadipic 2-oxoadipic aciduria	Alanine Metabolism	Carnitine Synthesis	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Aromatic L-Aminoacid Decarboxylase Deficiency	Histidinemia	Porphyrin Metabolism	Glycogenosis, Type VI. Hers disease	Disulfiram Action Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Alkaptonuria	Argininemia	Dopamine beta-hydroxylase deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Methotrexate Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Threonine and 2-Oxobutanoate Degradation	Glycogen synthetase deficiency	Catecholamine Biosynthesis	Methylmalonic Aciduria	Isovaleric acidemia	Saccharopinuria/Hyperlysinemia II	Primary Hyperoxaluria Type I	Hereditary Coproporphyria (HCP)	3-hydroxyisobutyric acid dehydrogenase deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Prolinemia Type II	Sucrase-isomaltase deficiency	Histidine Metabolism	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Tyrosinemia, transient, of the newborn	Malate-Aspartate Shuttle	Hyperlysinemia I, Familial	Argininosuccinic Aciduria	Glutaminolysis and Cancer	Gamma-cystathionase deficiency (CTH)	Tryptophan Metabolism	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Maple Syrup Urine Disease	Ammonia Recycling	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Selenoamino Acid Metabolism	Folate malabsorption, hereditary
S-(2-Methylpropanoyl)-dihydrolipoamide	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
S-(3-Methylbutanoyl)-dihydrolipoamide	HMDB_SMPDB	Samples:	59	Pathways:	17	3-hydroxyisobutyric acid dehydrogenase deficiency	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Beta-Ketothiolase Deficiency	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Maple Syrup Urine Disease	Propionic Acidemia	3-Methylglutaconic Aciduria Type I	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Isovaleric Aciduria
Succinate	HMDB_SMPDB	Samples:	64	Pathways:	56	Hyperprolinemia Type I	Congenital lactic acidosis	Ketone Body Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Arginine and Proline Metabolism	The oncogenic action of Succinate	Carnitine Synthesis	Citric Acid Cycle	Butyrate Metabolism	Oxidation of Branched Chain Fatty Acids	Beta-Ketothiolase Deficiency	Homocarnosinosis	Phytanic Acid Peroxisomal Oxidation	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Mitochondrial Electron Transport Chain	Hyperprolinemia Type II	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	The oncogenic action of 2-hydroxyglutarate	3-Methylglutaconic Aciduria Type I	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	3-hydroxyisobutyric acid dehydrogenase deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	The oncogenic action of Fumarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Fumarase deficiency	Glutaminolysis and Cancer	3-Methylglutaconic Aciduria Type III	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperinsulinism-Hyperammonemia Syndrome	Maple Syrup Urine Disease	Pyruvate dehydrogenase deficiency (E2)	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	L-arginine:glycine amidinotransferase deficiency	3-hydroxyisobutyric aciduria	Succinic semialdehyde dehydrogenase deficiency	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Glutamate Metabolism	Succinyl CoA: 3-ketoacid CoA transferase deficiency
Thiamin diphosphate	HMDB_SMPDB	Samples:	66	Pathways:	52	2-aminoadipic 2-oxoadipic aciduria	Congenital lactic acidosis	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Citric Acid Cycle	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Oxidation of Branched Chain Fatty Acids	Beta-Ketothiolase Deficiency	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Refsum Disease	Pyruvate Dehydrogenase Complex Deficiency	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	Malonyl-coa decarboxylase deficiency	The oncogenic action of 2-hydroxyglutarate	3-Methylglutaconic Aciduria Type I	Threonine and 2-Oxobutanoate Degradation	Lysine Degradation	Methylmalonic Aciduria	Isovaleric acidemia	Methylmalonate Semialdehyde Dehydrogenase Deficiency	Saccharopinuria/Hyperlysinemia II	2-ketoglutarate dehydrogenase complex deficiency	Isovaleric Aciduria	Pyridoxine dependency with seizures	3-hydroxyisobutyric acid dehydrogenase deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Thiamine Metabolism	3-Methylglutaconic Aciduria Type IV	Isobutyryl-coa dehydrogenase deficiency	Hyperlysinemia I, Familial	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Malonic Aciduria	Fumarase deficiency	Glutaminolysis and Cancer	3-Methylglutaconic Aciduria Type III	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Transfer of Acetyl Groups into Mitochondria	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	Maple Syrup Urine Disease	Pyruvate dehydrogenase deficiency (E2)	Propanoate Metabolism	Propionic Acidemia	Valine, Leucine and Isoleucine Degradation	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	3-hydroxyisobutyric aciduria	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Pyruvate Metabolism	Leigh Syndrome	Hyperlysinemia II or Saccharopinuria
Acetic acid	HMDB_SMPDB	Samples:	60	Pathways:	9	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Disulfiram Pathway	Ethanol Degradation	Heroin Pathway	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
Morphine	HMDB_SMPDB	Samples:	44	Pathways:	8	Codeine Pathway	Morphine Metabolism Pathway	Heroin Action Pathway	Morphine Pathway	Heroin Pathway	Morphine Action Pathway	Codeine Metabolism Pathway	Codeine Action Pathway
6-Acetylmorphine	HMDB_SMPDB	Samples:	6	Pathways:	2	Heroin Action Pathway	Heroin Pathway
D-Glucose	HMDB_SMPDB	Samples:	62	Pathways:	25	Glibenclamide Action Pathway	Lactose Intolerance	Repaglinide Action Pathway	Nateglinide Pathway	Glycogenosis, Type IC	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type IB	Gliclazide Action Pathway	Glucose-Alanine Cycle	Nateglinide Action Pathway	Fructose-1,6-diphosphatase deficiency	Lactose Degradation	Transfer of Acetyl Groups into Mitochondria	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Pancreas Function	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glibenclamide Pathway	Glycogenosis, Type VII. Tarui disease	Gliclazide Pathway	Warburg Effect	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycolysis	Repaglinide Pathway
Alpha-Lactose	HMDB_SMPDB	Samples:	33	Pathways:	2	Lactose Degradation	Lactose Intolerance
Pyrophosphate	HMDB_SMPDB	Samples:	68	Pathways:	111	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Lactic Acidemia	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Butyrate Metabolism	Trifunctional protein deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Oxidation of Branched Chain Fatty Acids	Homocarnosinosis	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Smith-Lemli-Opitz Syndrome (SLOS)	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Disulfiram Pathway	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Carnitine palmitoyl transferase deficiency (I)	Non Ketotic Hyperglycinemia	Citrullinemia Type I	Mucopolysaccharidosis VI. Sly syndrome	Hyperglycinemia, non-ketotic	Ethylmalonic Encephalopathy	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Steroid Biosynthesis	Desmosterolosis	Sulfate/Sulfite Metabolism	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Malonic Aciduria	Phenylketonuria	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	CHILD Syndrome	Mevalonic aciduria	Pantothenate and CoA Biosynthesis	Propanoate Metabolism	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Succinic semialdehyde dehydrogenase deficiency	Pyruvate Carboxylase Deficiency	Sulfite oxidase deficiency	Phenylacetate Metabolism	Glutamate Metabolism	Pyruvate Metabolism	Leigh Syndrome	Cerebrotendinous Xanthomatosis (CTX)	Starch and Sucrose Metabolism	Congenital Bile Acid Synthesis Defect Type III	Alanine Metabolism	Familial Hypercholanemia (FHCA)	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Histidinemia	Glycogenosis, Type VI. Hers disease	27-Hydroxylase Deficiency	Pyruvate kinase deficiency	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Phytanic Acid Peroxisomal Oxidation	Hypercholesterolemia	Bile Acid Biosynthesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Zellweger Syndrome	Argininemia	Pyruvate Dehydrogenase Complex Deficiency	sarcosine oncometabolite pathway 	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Betaine Metabolism	Glycogen synthetase deficiency	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Primary Hyperoxaluria Type I	Simvastatin Action Pathway	Hyper-IgD syndrome	Ubiquinone Biosynthesis	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Congenital Bile Acid Synthesis Defect Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Prolinemia Type II	Sucrase-isomaltase deficiency	Histidine Metabolism	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Wolman disease	Argininosuccinic Aciduria	Tryptophan Metabolism	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	Ammonia Recycling	Tyrosinemia Type 3 (TYRO3)	Cholesteryl ester storage disease	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Selenoamino Acid Metabolism
Uridine triphosphate	HMDB_SMPDB	Samples:	6	Pathways:	7	Glycogen synthetase deficiency	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Mucopolysaccharidosis VI. Sly syndrome	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Glycogenosis, Type VI. Hers disease
Uridine diphosphate glucose	HMDB_SMPDB	Samples:	6	Pathways:	7	Glycogen synthetase deficiency	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Mucopolysaccharidosis VI. Sly syndrome	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Glycogenosis, Type VI. Hers disease
Uridine 5'-diphosphate	HMDB_SMPDB	Samples:	76	Pathways:	35	Starch and Sucrose Metabolism	Morphine Metabolism Pathway	Valproic Acid Metabolism Pathway	Aromatase deficiency	Porphyrin Metabolism	Tramadol Metabolism Pathway	Artemether Metabolism Pathway	Glycogenosis, Type VI. Hers disease	Porphyria Variegata (PV)	Etoposide Metabolism Pathway	Nicotine Metabolism Pathway	Ibuprofen Metabolism Pathway	Nicotine Pathway	Codeine Pathway	Androgen and Estrogen Metabolism	Sorafenib Metabolism Pathway	Glycogen synthetase deficiency	Celecoxib Metabolism Pathway	Irinotecan Metabolism Pathway	Mucopolysaccharidosis VI. Sly syndrome	Codeine Metabolism Pathway	Ibuprofen Pathway	Hereditary Coproporphyria (HCP)	Phenytoin (Antiarrhythmic) Pathway	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Acetaminophen Metabolism Pathway	Tamoxifen Metabolism Pathway	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Tamoxifen Pathway	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Acute Intermittent Porphyria	Morphine Pathway	Nevirapine Metabolism Pathway
Magnesium	HMDB_SMPDB	Samples:	82	Pathways:	200	Lidocaine (Antiarrhythmic) Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Butyrate Metabolism	Phospholipid Biosynthesis	Ketoprofen Pathway	Oxidation of Branched Chain Fatty Acids	Homocarnosinosis	Nisoldipine Pathway	Phenylalanine and Tyrosine Metabolism	Carnitine-acylcarnitine translocase deficiency	Glutaric Aciduria Type I	Teniposide Pathway	Pindolol Pathway	Carnitine palmitoyl transferase deficiency (I)	Antrafenine Action Pathway	Mucopolysaccharidosis VI. Sly syndrome	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Diclofenac Pathway	Ibuprofen Pathway	2-ketoglutarate dehydrogenase complex deficiency	Ethylmalonic Encephalopathy	Arbutamine Action Pathway	Esmolol Pathway	Glycogenosis, Type IB	Bromfenac Pathway	Adrenoleukodystrophy, X-linked	Etodolac Pathway	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Sarcosinemia	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	CHILD Syndrome	Pyruvate dehydrogenase deficiency (E2)	Glycogenosis, Type VII. Tarui disease	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Succinic semialdehyde dehydrogenase deficiency	Alprenolol Pathway	Naproxen Pathway	Sulfite oxidase deficiency	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Pyruvate Metabolism	Atenolol Pathway	Starch and Sucrose Metabolism	Carvedilol Pathway	Teniposide Metabolism Pathway	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Felodipine Pathway	Gluconeogenesis	Glycogenosis, Type VI. Hers disease	Ketorolac Pathway	Bopindolol Action Pathway	Sotalol Action Pathway	Tolmetin Action Pathway	Methotrexate Pathway	Salicylate-sodium Action Pathway	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Etoposide Metabolism Pathway	Dopamine beta-hydroxylase deficiency	Quinidine Pathway	sarcosine oncometabolite pathway 	Practolol Action Pathway	Propranolol Pathway	Betaine Metabolism	Epinephrine Action Pathway	Glycogen synthetase deficiency	Mefanamic Acid Pathway	Meloxicam Pathway	Oxaprozin Pathway	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Suprofen Pathway	Carnitine palmitoyl transferase deficiency (II)	Timolol Action Pathway	Simvastatin Action Pathway	Trisalicylate-choline Action Pathway	Nadolol Pathway	Penbutolol Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Phenytoin (Antiarrhythmic) Pathway	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Isoprenaline Action Pathway	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Triosephosphate isomerase	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Procainamide (Antiarrhythmic) Pathway	Hyperinsulinism-Hyperammonemia Syndrome	Leukotriene C4 Synthesis Deficiency	Flecainide Pathway	Tyrosinemia Type 3 (TYRO3)	Cholesteryl ester storage disease	Carprofen Action Pathway	Rofecoxib Pathway	Labetalol Pathway	Nabumetone Pathway	Tyrosinemia Type I	Congenital lactic acidosis	Etoricoxib Action Pathway	Glycogenosis, Type IC	Verapamil Pathway	Disopyramide Pathway	Tiaprofenic Acid Action Pathway	Trifunctional protein deficiency	Folate Metabolism	Ibutilide Pathway	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Nitrendipine Pathway	Smith-Lemli-Opitz Syndrome (SLOS)	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Nebivolol Pathway	Levobunolol Action Pathway	Muscle/Heart Contraction	Disulfiram Pathway	Antipyrine Action Pathway	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Beta Oxidation of Very Long Chain Fatty Acids	The oncogenic action of 2-hydroxyglutarate	Gemcitabine Pathway	Betaxolol Pathway	Non Ketotic Hyperglycinemia	Hyperglycinemia, non-ketotic	Bupranolol Action Pathway	Nepafenac Action Pathway	Amlodipine Pathway	Gemcitabine Metabolism Pathway	Carteolol Action Pathway	Flurbiprofen Action Pathway	Nifedipine Pathway	Steroid Biosynthesis	Desmosterolosis	Sulfate/Sulfite Metabolism	Acetaminophen  Action Pathway	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Fumarase deficiency	Phenylketonuria	Phenylbutazone Action Pathway	Isradipine Pathway	Mevalonic aciduria	Metoprolol Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Nimodipine Pathway	Phenylacetate Metabolism	Warburg Effect	Diltiazem Pathway	Glutamate Metabolism	Tyrosine Metabolism	Glycolysis	Magnesium salicylate Action Pathway	Leigh Syndrome	Monoamine oxidase-a deficiency (MAO-A)	Citric Acid Cycle	Salicylic Acid Action Pathway	Oxprenolol Pathway	Fructose-1,6-diphosphatase deficiency	Piroxicam Pathway	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Hypercholesterolemia	Sulindac Pathway	Lumiracoxib Action Pathway	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Amiodarone Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	Fenoprofen Action Pathway	Valdecoxib Pathway	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Salsalate Action Pathway	Hyper-IgD syndrome	Tenoxicam Action Pathway	Mexiletine Pathway	Acebutolol Pathway	Sucrase-isomaltase deficiency	Tyrosinemia, transient, of the newborn	Wolman disease	Bevantolol Action Pathway	Acetylsalicylic Acid Pathway	Glutaminolysis and Cancer	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Diflunisal Pathway	Ammonia Recycling	Tocainide Pathway	Fosphenytoin (Antiarrhythmic) Pathway	Bisoprolol Pathway	Glycine and Serine Metabolism	Lornoxicam Action Pathway	Dobutamine Action Pathway	Folate malabsorption, hereditary	Metipranolol Action Pathway
Zinc (II) ion	HMDB_SMPDB	Samples:	63	Pathways:	119	Ureidopropionase deficiency	Olmesartan Action Pathway	Rabeprazole Pathway	Lactic Acidemia	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Beta-Alanine Metabolism	Degradation of Superoxides	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Ketoprofen Pathway	Perindopril Pathway	Homocarnosinosis	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Irbesartan Action Pathway	Disulfiram Pathway	Antipyrine Action Pathway	Fosinopril Pathway	Dimethylglycine Dehydrogenase Deficiency	Spirapril Metabolism Pathway	Gastric Acid Production	Ramipril Pathway	Non Ketotic Hyperglycinemia	Antrafenine Action Pathway	Lornoxicam Action Pathway	Angiotensin Metabolism	Diclofenac Pathway	Hyperglycinemia, non-ketotic	Ibuprofen Pathway	Nepafenac Action Pathway	Moexipril Pathway	Enalapril Metabolism Pathway	Carnosinuria, carnosinemia	Lansoprazole Pathway	Flurbiprofen Action Pathway	Eprosartan Action Pathway	Acetaminophen  Action Pathway	Trandolapril Pathway	3-Phosphoglycerate dehydrogenase deficiency	Quinapril Metabolism Pathway	Metiamide Action Pathway	Candesartan Action Pathway	Bromfenac Pathway	Etodolac Pathway	Losartan Action Pathway	Omeprazole Pathway	Sarcosinemia	Betazole Action Pathway	Roxatidine acetate Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Cilazapril Pathway	Succinic semialdehyde dehydrogenase deficiency	Naproxen Pathway	Pyruvate Carboxylase Deficiency	Pirenzepine Pathway	Captopril Pathway	Glutamate Metabolism	Valsartan Action Pathway	Pyruvate Metabolism	Magnesium salicylate Action Pathway	Leigh Syndrome	Enalapril Pathway	Alanine Metabolism	Primary hyperoxaluria II, PH2	Forasartan Action Pathway	Pantoprazole Pathway	Histidinemia	Telmisartan Action Pathway	Salicylic Acid Action Pathway	Ketorolac Pathway	Ramipril Metabolism Pathway	Trandolapril Metabolism Pathway	Rescinnamine Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Pyruvate kinase deficiency	Cimetidine Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Sulindac Pathway	Lumiracoxib Action Pathway	Spirapril Pathway	Temocapril Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	Fosinopril Metabolism Pathway	Fenoprofen Action Pathway	sarcosine oncometabolite pathway 	Valdecoxib Pathway	Cilazapril Metabolism Pathway	Betaine Metabolism	Meloxicam Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Suprofen Pathway	Salsalate Action Pathway	Primary Hyperoxaluria Type I	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Histidine Metabolism	Moexipril Metabolism Pathway	Lisinopril Pathway	Nizatidine Pathway	Benazepril Pathway	Acetylsalicylic Acid Pathway	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Famotidine Pathway	Diflunisal Pathway	Hyperinsulinism-Hyperammonemia Syndrome	Leukotriene C4 Synthesis Deficiency	Ethanol Degradation	Benazepril Metabolism Pathway	GABA-Transaminase Deficiency	Esomeprazole Pathway	Carprofen Action Pathway	Glycine and Serine Metabolism	Rofecoxib Pathway	Ranitidine Pathway	Nabumetone Pathway	Quinapril Pathway	Phenylbutazone Action Pathway
Manganese	HMDB_SMPDB	Samples:	65	Pathways:	59	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Alanine Metabolism	Congenital lactic acidosis	Lactic Acidemia	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Carbamoyl Phosphate Synthetase Deficiency	Glycogenosis, Type IC	Citric Acid Cycle	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Histidinemia	Phospholipid Biosynthesis	Gluconeogenesis	Fructose-1,6-diphosphatase deficiency	Pyruvate kinase deficiency	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Hyperprolinemia Type II	Pyruvate Dehydrogenase Complex Deficiency	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Malonyl-coa decarboxylase deficiency	The oncogenic action of 2-hydroxyglutarate	Degradation of Superoxides	Citrullinemia Type I	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Primary Hyperoxaluria Type I	2-ketoglutarate dehydrogenase complex deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	The oncogenic action of Fumarate	Histidine Metabolism	Triosephosphate isomerase	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Glycogenosis, Type IB	Urea Cycle	Malonic Aciduria	Argininosuccinic Aciduria	Fumarase deficiency	Glutaminolysis and Cancer	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Transfer of Acetyl Groups into Mitochondria	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Glycogenosis, Type IA. Von gierke disease	Pyruvate dehydrogenase deficiency (E2)	Propanoate Metabolism	L-arginine:glycine amidinotransferase deficiency	Pyruvate Carboxylase Deficiency	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Pyruvate Metabolism	Leigh Syndrome
Glucose 1-phosphate	HMDB_SMPDB	Samples:	16	Pathways:	18	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Glycogenosis, Type IC	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type VI. Hers disease	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Glycogen synthetase deficiency	Mucopolysaccharidosis VI. Sly syndrome	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycolysis
Phosphoric acid	HMDB_SMPDB	Samples:	61	Pathways:	48	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Glycogenosis, Type IC	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Gluconeogenesis	Homocarnosinosis	Fructose-1,6-diphosphatase deficiency	Pyruvate kinase deficiency	2-Hydroxyglutric Aciduria (D And L Form)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Pyruvate Dehydrogenase Complex Deficiency	Hyperprolinemia Type II	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Malonyl-coa decarboxylase deficiency	Citrullinemia Type I	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Triosephosphate isomerase	Glycogenosis, Type IB	Urea Cycle	Malonic Aciduria	Argininosuccinic Aciduria	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Hyperinsulinism-Hyperammonemia Syndrome	Propanoate Metabolism	Ammonia Recycling	L-arginine:glycine amidinotransferase deficiency	Succinic semialdehyde dehydrogenase deficiency	Warburg Effect	Glutamate Metabolism	Selenoamino Acid Metabolism	Pyruvate Metabolism	Glycolysis	Leigh Syndrome
Iron	HMDB_SMPDB	Samples:	58	Pathways:	35	Cerebrotendinous Xanthomatosis (CTX)	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Congenital Bile Acid Synthesis Defect Type III	Familial Hypercholanemia (FHCA)	Disulfiram Action Pathway	27-Hydroxylase Deficiency	Oxidation of Branched Chain Fatty Acids	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Bile Acid Biosynthesis	Refsum Disease	Phenylalanine and Tyrosine Metabolism	Zellweger Syndrome	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Simvastatin Action Pathway	Hyper-IgD syndrome	Congenital Bile Acid Synthesis Defect Type II	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Tyrosinemia, transient, of the newborn	Steroid Biosynthesis	Wolman disease	Desmosterolosis	Phenylketonuria	CHILD Syndrome	Mevalonic aciduria	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Tyrosinemia Type 3 (TYRO3)	Cholesteryl ester storage disease	Hawkinsinuria	Tyrosine Metabolism
Calcium cation	HMDB_SMPDB	Samples:	95	Pathways:	214	Diclofenac Action Pathway	Ureidopropionase deficiency	Levomethadyl Acetate Action Action Pathway	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Alprenolol Action Pathway	Phenindione Action Pathway	Ardeparin Action Pathway	Phospholipid Biosynthesis	Bisoprolol Action Pathway	Gliclazide Action Pathway	Levorphanol Action Pathway	Aprotinin Action Pathway	Ketorolac Action Pathway	Lepirudin Action Pathway	Phenylalanine and Tyrosine Metabolism	Felodipine Action Pathway	Bupivacaine Action Pathway	Isradipine Action Pathway	Ropivacaine Action Pathway	Antrafenine Action Pathway	Buprenorphine Action Pathway	Citrullinemia Type I	Mucopolysaccharidosis VI. Sly syndrome	Enoxaparin Action Pathway	Arbutamine Action Pathway	Heroin Action Pathway	Nisoldipine Action Pathway	Verapamil Action Pathway	Dihydromorphine Action Pathway	Mexiletine Action Pathway	Ketoprofen Action Pathway	Alvimopan Action Pathway	Fentanyl Action Pathway	Methadone Action Pathway	Phenytoin (Antiarrhythmic) Action Pathway	Alteplase Action Pathway	Ximelagatran Action Pathway	Suprofen Action Pathway	Pantothenate and CoA Biosynthesis	Labetalol Action Pathway	Lidocaine (Antiarrhythmic) Action Pathway	Hawkinsinuria	Disopyramide Action Pathway	Nalbuphine Action Pathway	Glibenclamide Action Pathway	Repaglinide Action Pathway	Fluoxetine Action Pathway	Starch and Sucrose Metabolism	Teniposide Metabolism Pathway	Hydrocodone Action Pathway	Tocainide Action Pathway	Procainamide (Antiarrhythmic) Action Pathway	Glycogenosis, Type VI. Hers disease	Bopindolol Action Pathway	Nabumetone Action Pathway	Sotalol Action Pathway	Methadyl Acetate Action Pathway	Anileridine Action Pathway	Salicylate-sodium Action Pathway	Proparacaine Action Pathway	Tolmetin Action Pathway	Sufentanil Action Pathway	Escitalopram Action Pathway	Dopamine beta-hydroxylase deficiency	Androgen and Estrogen Metabolism	Practolol Action Pathway	Dicoumarol Action Pathway	Chloroprocaine Action Pathway	Piroxicam Action Pathway	Pentazocine Action Pathway	Epinephrine Action Pathway	Urokinase Action Pathway	Glycogen synthetase deficiency	Tenecteplase Action Pathway	Valdecoxib Action Pathway	Dimethylthiambutene Action Pathway	Streptokinase Action Pathway	Alpha Linolenic Acid and Linoleic Acid Metabolism	Desipramine Action Pathway	Timolol Action Pathway	Oxprenolol Action Pathway	Trisalicylate-choline Action Pathway	Fondaparinux Action Pathway	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Isoprenaline Action Pathway	Remifentanil Action Pathway	Oxaprozin Action Pathway	Ketobemidone  Action Pathway	Argininosuccinic Aciduria	Ibuprofen Action Pathway	Nateglinide Action Pathway	Esmolol Action Pathway	Penbutolol Action Pathway	Morphine Action Pathway	Nitrendipine Action Pathway	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Acebutolol Action Pathway	Leukotriene C4 Synthesis Deficiency	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	Levobupivacaine Action Pathway	Carprofen Action Pathway	Bivalirudin Action Pathway	Rofecoxib Action Pathway	Diphenoxylate Action Pathway	Etodolac Action Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Cocaine Action Pathway	Ibutilide Action Pathway	Tyrosinemia Type I	Beta-Alanine Metabolism	Ethylmorphine Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Dicumarol Action Pathway	Folate Metabolism	3-Methylthiofentanyl Action Pathway	Aromatase deficiency	Warfarin Action Pathway	Dibucaine Action Pathway	Meloxicam Action Pathway	Levobunolol Action Pathway	Muscle/Heart Contraction	Antipyrine Action Pathway	Mefenamic Acid Action Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Teniposide Action Pathway	Procaine Action Pathway	Benzocaine Action Pathway	Acenocoumarol Action Pathway	Nicotine Action Pathway	Bupranolol Action Pathway	Nepafenac Action Pathway	Etoposide Action Pathway	Carteolol Action Pathway	Carnosinuria, carnosinemia	Propranolol Action Pathway	Flurbiprofen Action Pathway	Mepivacaine Action Pathway	Nifedipine Action Pathway	Acetaminophen  Action Pathway	Urea Cycle	Phenylketonuria	Metoprolol Action Pathway	Diflunisal Action Pathway	Alfentanil Action Pathway	Dezocine Action Pathway	Naloxone Action Pathway	Phenylbutazone Action Pathway	Levallorphan Action Pathway	Pancreas Function	Fosphenytoin (Antiarrhythmic) Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Prilocaine Action Pathway	Tyrosine Metabolism	Magnesium salicylate Action Pathway	Reteplase Action Pathway	Atenolol Action Pathway	Thyroid hormone synthesis	Monoamine oxidase-a deficiency (MAO-A)	Diltiazem Action Pathway	Aminocaproic Acid Action Pathway	Carbamoyl Phosphate Synthetase Deficiency	Hydromorphone Action Pathway	Propoxyphene Action Pathway	Histidinemia	Imipramine Action Pathway	Citalopram Action Pathway	Salicylic Acid Action Pathway	Disulfiram Action Pathway	Betaxolol Action Pathway	Alkaptonuria	Oxycodone Action Pathway	Lumiracoxib Action Pathway	Amiodarone Action Pathway	Argininemia	Carvedilol Action Pathway	Methotrexate Action Pathway	Nebivolol Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Phenprocoumon Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Oxybuprocaine Action Pathway	Clopidogrel Action Pathway	Codeine Action Pathway	Tenoxicam Action Pathway	Tranexamic Acid Action Pathway	Sucrase-isomaltase deficiency	Malate-Aspartate Shuttle	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Naproxen Action Pathway	Bevantolol Action Pathway	Flecainide Action Pathway	Naltrexone Action Pathway	Nimodipine Action Pathway	Tramadol Action Action Pathway	Nadolol Action Pathway	Amlodipine Action Pathway	Quinidine Action Pathway	Anistreplase Action Pathway	Heparin Action Pathway	Argatroban Action Pathway	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Sulindac Action Pathway	Oxymorphone Action Pathway	Pindolol Action Pathway	Carfentanil Action Pathway	Lornoxicam Action Pathway	Dobutamine Action Pathway	Folate malabsorption, hereditary	Metipranolol Action Pathway
D-Glucose 1-phosphate	HMDB_SMPDB	Samples:	16	Pathways:	18	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Glycogenosis, Type IC	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type VI. Hers disease	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Glycogen synthetase deficiency	Mucopolysaccharidosis VI. Sly syndrome	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycolysis
Diphosphate	HMDB_SMPDB	Samples:	68	Pathways:	109	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Lactic Acidemia	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Butyrate Metabolism	Trifunctional protein deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Oxidation of Branched Chain Fatty Acids	Homocarnosinosis	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Smith-Lemli-Opitz Syndrome (SLOS)	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Malonyl-coa decarboxylase deficiency	Glutaric Aciduria Type I	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Carnitine palmitoyl transferase deficiency (I)	Non Ketotic Hyperglycinemia	Citrullinemia Type I	Mucopolysaccharidosis VI. Sly syndrome	Hyperglycinemia, non-ketotic	Ethylmalonic Encephalopathy	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Steroid Biosynthesis	Desmosterolosis	Sulfate/Sulfite Metabolism	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Malonic Aciduria	Phenylketonuria	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	CHILD Syndrome	Mevalonic aciduria	Pantothenate and CoA Biosynthesis	Propanoate Metabolism	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Succinic semialdehyde dehydrogenase deficiency	Pyruvate Carboxylase Deficiency	Sulfite oxidase deficiency	Phenylacetate Metabolism	Glutamate Metabolism	Pyruvate Metabolism	Leigh Syndrome	Cerebrotendinous Xanthomatosis (CTX)	Starch and Sucrose Metabolism	Congenital Bile Acid Synthesis Defect Type III	Alanine Metabolism	Familial Hypercholanemia (FHCA)	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Histidinemia	Glycogenosis, Type VI. Hers disease	Disulfiram Action Pathway	27-Hydroxylase Deficiency	Pyruvate kinase deficiency	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Phytanic Acid Peroxisomal Oxidation	Hypercholesterolemia	Bile Acid Biosynthesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Zellweger Syndrome	Argininemia	Pyruvate Dehydrogenase Complex Deficiency	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Betaine Metabolism	Glycogen synthetase deficiency	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Carnitine palmitoyl transferase deficiency (II)	Primary Hyperoxaluria Type I	Simvastatin Action Pathway	Hyper-IgD syndrome	Ubiquinone Biosynthesis	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Congenital Bile Acid Synthesis Defect Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Prolinemia Type II	Sucrase-isomaltase deficiency	Histidine Metabolism	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Wolman disease	Argininosuccinic Aciduria	Tryptophan Metabolism	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	Ammonia Recycling	Tyrosinemia Type 3 (TYRO3)	Cholesteryl ester storage disease	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Selenoamino Acid Metabolism
Lactose	HMDB_SMPDB	Samples:	33	Pathways:	2	Lactose Degradation	Lactose Intolerance
Magnesium cation	HMDB_SMPDB	Samples:	82	Pathways:	196	Diclofenac Action Pathway	Alprenolol Action Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Butyrate Metabolism	Phospholipid Biosynthesis	Bisoprolol Action Pathway	Oxidation of Branched Chain Fatty Acids	Homocarnosinosis	Ketorolac Action Pathway	Phenylalanine and Tyrosine Metabolism	Felodipine Action Pathway	Carnitine-acylcarnitine translocase deficiency	Glutaric Aciduria Type I	Isradipine Action Pathway	Carnitine palmitoyl transferase deficiency (I)	Antrafenine Action Pathway	Mucopolysaccharidosis VI. Sly syndrome	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	2-ketoglutarate dehydrogenase complex deficiency	Ethylmalonic Encephalopathy	Arbutamine Action Pathway	Nisoldipine Action Pathway	Glycogenosis, Type IB	Verapamil Action Pathway	Mexiletine Action Pathway	Adrenoleukodystrophy, X-linked	Ketoprofen Action Pathway	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Sarcosinemia	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Phenytoin (Antiarrhythmic) Action Pathway	CHILD Syndrome	Pyruvate dehydrogenase deficiency (E2)	Labetalol Action Pathway	Lidocaine (Antiarrhythmic) Action Pathway	Glycogenosis, Type VII. Tarui disease	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Suprofen Action Pathway	Succinic semialdehyde dehydrogenase deficiency	Sulfite oxidase deficiency	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Pyruvate Metabolism	Disopyramide Action Pathway	Starch and Sucrose Metabolism	Teniposide Metabolism Pathway	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Tocainide Action Pathway	Procainamide (Antiarrhythmic) Action Pathway	Gluconeogenesis	Glycogenosis, Type VI. Hers disease	Bopindolol Action Pathway	Nabumetone Action Pathway	Sotalol Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Gemcitabine Action Pathway	Refsum Disease	2-Hydroxyglutric Aciduria (D And L Form)	Dopamine beta-hydroxylase deficiency	Practolol Action Pathway	Piroxicam Action Pathway	Betaine Metabolism	Epinephrine Action Pathway	Glycogen synthetase deficiency	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Valdecoxib Action Pathway	Carnitine palmitoyl transferase deficiency (II)	Timolol Action Pathway	Simvastatin Action Pathway	Trisalicylate-choline Action Pathway	Oxprenolol Action Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Isoprenaline Action Pathway	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Oxaprozin Action Pathway	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Triosephosphate isomerase	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Esmolol Action Pathway	Ibuprofen Action Pathway	Penbutolol Action Pathway	Nitrendipine Action Pathway	Hyperinsulinism-Hyperammonemia Syndrome	Leukotriene C4 Synthesis Deficiency	Acebutolol Action Pathway	Tyrosinemia Type 3 (TYRO3)	Cholesteryl ester storage disease	Carprofen Action Pathway	Rofecoxib Action Pathway	Etodolac Action Pathway	Ibutilide Action Pathway	Tyrosinemia Type I	Congenital lactic acidosis	Etoricoxib Action Pathway	Glycogenosis, Type IC	Tiaprofenic Acid Action Pathway	Trifunctional protein deficiency	Folate Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Smith-Lemli-Opitz Syndrome (SLOS)	Meloxicam Action Pathway	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Levobunolol Action Pathway	Muscle/Heart Contraction	Antipyrine Action Pathway	Mefenamic Acid Action Pathway	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Beta Oxidation of Very Long Chain Fatty Acids	The oncogenic action of 2-hydroxyglutarate	Teniposide Action Pathway	Non Ketotic Hyperglycinemia	Hyperglycinemia, non-ketotic	Bupranolol Action Pathway	Nepafenac Action Pathway	Etoposide Action Pathway	Carteolol Action Pathway	Propranolol Action Pathway	Flurbiprofen Action Pathway	Steroid Biosynthesis	Desmosterolosis	Nifedipine Action Pathway	Sulfate/Sulfite Metabolism	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Acetaminophen  Action Pathway	Fumarase deficiency	Phenylketonuria	Metoprolol Action Pathway	Diflunisal Action Pathway	Phenylbutazone Action Pathway	Fosphenytoin (Antiarrhythmic) Action Pathway	Mevalonic aciduria	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Phenylacetate Metabolism	Warburg Effect	Glutamate Metabolism	Tyrosine Metabolism	Glycolysis	Magnesium salicylate Action Pathway	Leigh Syndrome	Atenolol Action Pathway	Monoamine oxidase-a deficiency (MAO-A)	Diltiazem Action Pathway	Citric Acid Cycle	Salicylic Acid Action Pathway	Disulfiram Action Pathway	Betaxolol Action Pathway	Fructose-1,6-diphosphatase deficiency	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Hypercholesterolemia	Lumiracoxib Action Pathway	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Amiodarone Action Pathway	Carvedilol Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	Methotrexate Action Pathway	Nebivolol Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Hyper-IgD syndrome	Tenoxicam Action Pathway	Sucrase-isomaltase deficiency	Tyrosinemia, transient, of the newborn	Naproxen Action Pathway	Wolman disease	Bevantolol Action Pathway	Flecainide Action Pathway	Nimodipine Action Pathway	Glutaminolysis and Cancer	Nadolol Action Pathway	Amlodipine Action Pathway	Quinidine Action Pathway	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Sulindac Action Pathway	Ammonia Recycling	Pindolol Action Pathway	Glycine and Serine Metabolism	Lornoxicam Action Pathway	Dobutamine Action Pathway	Folate malabsorption, hereditary	Metipranolol Action Pathway
Manganese(2+)	HMDB_SMPDB	Samples:	65	Pathways:	58	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Alanine Metabolism	Congenital lactic acidosis	Lactic Acidemia	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Carbamoyl Phosphate Synthetase Deficiency	Glycogenosis, Type IC	Citric Acid Cycle	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Histidinemia	Phospholipid Biosynthesis	Gluconeogenesis	Fructose-1,6-diphosphatase deficiency	Pyruvate kinase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Hyperprolinemia Type II	Pyruvate Dehydrogenase Complex Deficiency	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Malonyl-coa decarboxylase deficiency	The oncogenic action of 2-hydroxyglutarate	Degradation of Superoxides	Citrullinemia Type I	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Primary Hyperoxaluria Type I	2-ketoglutarate dehydrogenase complex deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	The oncogenic action of Fumarate	Histidine Metabolism	Triosephosphate isomerase	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Glycogenosis, Type IB	Urea Cycle	Malonic Aciduria	Argininosuccinic Aciduria	Fumarase deficiency	Glutaminolysis and Cancer	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Transfer of Acetyl Groups into Mitochondria	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Glycogenosis, Type IA. Von gierke disease	Pyruvate dehydrogenase deficiency (E2)	Propanoate Metabolism	L-arginine:glycine amidinotransferase deficiency	Pyruvate Carboxylase Deficiency	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Pyruvate Metabolism	Leigh Syndrome
UDP	HMDB_SMPDB	Samples:	71	Pathways:	30	Starch and Sucrose Metabolism	Etoposide Action Pathway	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Valproic Acid Metabolism Pathway	Aromatase deficiency	Porphyrin Metabolism	Tramadol Metabolism Pathway	Artemether Metabolism Pathway	Glycogenosis, Type VI. Hers disease	Ibuprofen Action Pathway	Acetaminophen Metabolism Pathway	Tamoxifen Metabolism Pathway	Morphine Action Pathway	Porphyria Variegata (PV)	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Irinotecan Action Pathway	Phenytoin (Antiarrhythmic) Action Pathway	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism	Sorafenib Metabolism Pathway	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Tamoxifen Action Pathway	Acute Intermittent Porphyria	Glycogen synthetase deficiency	Mucopolysaccharidosis VI. Sly syndrome	Nevirapine Metabolism Pathway	Codeine Action Pathway	Hereditary Coproporphyria (HCP)	Nicotine Action Pathway
UDP-glucose	HMDB_SMPDB	Samples:	6	Pathways:	7	Glycogen synthetase deficiency	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Mucopolysaccharidosis VI. Sly syndrome	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Glycogenosis, Type VI. Hers disease
UTP	HMDB_SMPDB	Samples:	6	Pathways:	7	Glycogen synthetase deficiency	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Mucopolysaccharidosis VI. Sly syndrome	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Glycogenosis, Type VI. Hers disease
Zinc cation	HMDB_SMPDB	Samples:	64	Pathways:	109	Diclofenac Action Pathway	Ureidopropionase deficiency	Olmesartan Action Pathway	Lactic Acidemia	Beta-Alanine Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Degradation of Superoxides	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Homocarnosinosis	Ketorolac Action Pathway	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Meloxicam Action Pathway	Irbesartan Action Pathway	Moexipril Action Pathway	Antipyrine Action Pathway	Mefenamic Acid Action Pathway	Dimethylglycine Dehydrogenase Deficiency	Nizatidine Action Pathway	Gastric Acid Production	Non Ketotic Hyperglycinemia	Antrafenine Action Pathway	Angiotensin Metabolism	Hyperglycinemia, non-ketotic	Ranitidine Action Pathway	Nepafenac Action Pathway	Trandolapril Action Pathway	Carnosinuria, carnosinemia	Flurbiprofen Action Pathway	Cilazapril Action Pathway	Eprosartan Action Pathway	Acetaminophen  Action Pathway	3-Phosphoglycerate dehydrogenase deficiency	Captopril Action Pathway	Metiamide Action Pathway	Candesartan Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Perindopril Action Pathway	Losartan Action Pathway	Sarcosinemia	Betazole Action Pathway	Roxatidine acetate Action Pathway	Rescinnamine Action Pathway	Suprofen Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Famotidine Action Pathway	Succinic semialdehyde dehydrogenase deficiency	Pyruvate Carboxylase Deficiency	Glutamate Metabolism	Valsartan Action Pathway	Pyruvate Metabolism	Magnesium salicylate Action Pathway	Leigh Syndrome	Fosinopril Action Pathway	Alanine Metabolism	Primary hyperoxaluria II, PH2	Lansoprazole Action Pathway	Forasartan Action Pathway	Histidinemia	Telmisartan Action Pathway	Salicylic Acid Action Pathway	Disulfiram Action Pathway	Nabumetone Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Pyruvate kinase deficiency	2-Hydroxyglutric Aciduria (D And L Form)	Lumiracoxib Action Pathway	Ramipril Action Pathway	Temocapril Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	Bromfenac Action Pathway	Fenoprofen Action Pathway	Piroxicam Action Pathway	Betaine Metabolism	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Primary Hyperoxaluria Type I	Benazepril Action Pathway	Trisalicylate-choline Action Pathway	Pantoprazole Action Pathway	Tenoxicam Action Pathway	Cimetidine Action Pathway	Oxaprozin Action Pathway	Histidine Metabolism	Naproxen Action Pathway	Ibuprofen Action Pathway	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Pirenzepine Action Pathway	Hyperinsulinism-Hyperammonemia Syndrome	Esomeprazole Action Pathway	Leukotriene C4 Synthesis Deficiency	Sulindac Action Pathway	Ethanol Degradation	Spirapril Action Pathway	Quinapril Action Pathway	GABA-Transaminase Deficiency	Omeprazole Action Pathway	Carprofen Action Pathway	Enalapril Action Pathway	Lisinopril Action Pathway	Rofecoxib Action Pathway	Glycine and Serine Metabolism	Lornoxicam Action Pathway	Etodolac Action Pathway	Rabeprazole Action Pathway	Phenylbutazone Action Pathway
Cortexolone	HMDB_SMPDB	Samples:	31	Pathways:	35	Warfarin Pathway	Aprotinin Pathway	Tenecteplase Pathway	Phenindione Action Pathway	Reteplase Pathway	Ardeparin Pathway	Dicumarol Pathway	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Tranexamic Acid Pathway	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Acenocoumarol Pathway	Steroidogenesis	Bivalirudin Pathway	Alteplase Pathway	Dicoumarol Action Pathway	Phenprocoumon Pathway	Lepirudin Pathway	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Streptokinase Pathway	Urokinase Pathway	Aminocaproic Acid Pathway	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	Heparin Pathway	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Anistreplase Pathway	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Enoxaparin Pathway	Coagulation 	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Ximelagatran Pathway	Fondaparinux Pathway	Argatroban Pathway
Reduced Vitamin K (phylloquinone)	HMDB_SMPDB	Samples:	20	Pathways:	25	Warfarin Pathway	Heparin Pathway	Aprotinin Pathway	Tenecteplase Pathway	Phenindione Action Pathway	Reteplase Pathway	Ardeparin Pathway	Dicumarol Pathway	Anistreplase Pathway	Tranexamic Acid Pathway	Acenocoumarol Pathway	Bivalirudin Pathway	Enoxaparin Pathway	Alteplase Pathway	Coagulation 	Ximelagatran Pathway	Vitamin K Metabolism	Dicoumarol Action Pathway	Phenprocoumon Pathway	Lepirudin Pathway	Fondaparinux Pathway	Argatroban Pathway	Streptokinase Pathway	Urokinase Pathway	Aminocaproic Acid Pathway
Phytonadione	HMDB_SMPDB	Samples:	20	Pathways:	25	Warfarin Pathway	Heparin Pathway	Aprotinin Pathway	Tenecteplase Pathway	Phenindione Action Pathway	Reteplase Pathway	Ardeparin Pathway	Dicumarol Pathway	Anistreplase Pathway	Tranexamic Acid Pathway	Acenocoumarol Pathway	Bivalirudin Pathway	Enoxaparin Pathway	Alteplase Pathway	Coagulation 	Ximelagatran Pathway	Vitamin K Metabolism	Dicoumarol Action Pathway	Phenprocoumon Pathway	Lepirudin Pathway	Fondaparinux Pathway	Argatroban Pathway	Streptokinase Pathway	Urokinase Pathway	Aminocaproic Acid Pathway
7-Dehydrocholesterol	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
Cholesterol	HMDB_SMPDB	Samples:	21	Pathways:	30	Cerebrotendinous Xanthomatosis (CTX)	11-beta-hydroxylase deficiency (CYP11B1)	Congenital Bile Acid Synthesis Defect Type III	Congenital Bile Acid Synthesis Defect Type II	Familial Hypercholanemia (FHCA)	Corticosterone methyl oxidase I deficiency (CMO I)	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Steroid Biosynthesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Desmosterolosis	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Wolman disease	27-Hydroxylase Deficiency	Smith-Lemli-Opitz Syndrome (SLOS)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Hypercholesterolemia	Steroidogenesis	Bile Acid Biosynthesis	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Zellweger Syndrome	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	CHILD Syndrome	Mevalonic aciduria	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Simvastatin Action Pathway	Hyper-IgD syndrome
Formic acid	HMDB_SMPDB	Samples:	52	Pathways:	27	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Steroid Biosynthesis	Wolman disease	Folate Metabolism	Aromatase deficiency	Desmosterolosis	Hyperphenylalaninemia due to dhpr-deficiency	Smith-Lemli-Opitz Syndrome (SLOS)	Methotrexate Pathway	Hypercholesterolemia	Tryptophan Metabolism	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	Sepiapterin reductase deficiency	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism	CHILD Syndrome	Mevalonic aciduria	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Pterine Biosynthesis	Segawa syndrome	Simvastatin Action Pathway	Hyper-IgD syndrome	Folate malabsorption, hereditary
NADP	HMDB_SMPDB	Samples:	72	Pathways:	160	Ureidopropionase deficiency	Lidocaine (Antiarrhythmic) Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Ketoprofen Pathway	Homocarnosinosis	Nicotine Metabolism Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Felbamate Metabolism Pathway	Glutaric Aciduria Type I	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Antrafenine Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Pyridoxine dependency with seizures	21-hydroxylase deficiency (CYP21)	Glucose-Alanine Cycle	Bromfenac Pathway	Doxorubicin Metabolism Pathway	Etodolac Pathway	Transfer of Acetyl Groups into Mitochondria	CHILD Syndrome	Tamoxifen Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Succinic semialdehyde dehydrogenase deficiency	Naproxen Pathway	Hawkinsinuria	Segawa syndrome	Pyruvate Metabolism	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Congenital Bile Acid Synthesis Defect Type III	2-aminoadipic 2-oxoadipic aciduria	Fatty Acid Elongation In Mitochondria	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Ketorolac Pathway	Tolmetin Action Pathway	Methotrexate Pathway	Salicylate-sodium Action Pathway	Desipramine Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Lidocaine (Local Anaesthetic) Pathway	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Zellweger Syndrome	Nicotine Pathway	Dopamine beta-hydroxylase deficiency	Androgen and Estrogen Metabolism	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	17-alpha-hydroxylase deficiency (CYP17)	Saccharopinuria/Hyperlysinemia II	Simvastatin Action Pathway	Trisalicylate-choline Action Pathway	11-beta-hydroxylase deficiency (CYP11B1)	Imipramine Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Phenytoin (Antiarrhythmic) Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	The oncogenic action of Fumarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Tryptophan Metabolism	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Leukotriene C4 Synthesis Deficiency	Ethanol Degradation	Cholesteryl ester storage disease	GABA-Transaminase Deficiency	Carprofen Action Pathway	Nevirapine Metabolism Pathway	Rofecoxib Pathway	Nabumetone Pathway	Carbamazepine Metabolism Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	Beta-Alanine Metabolism	Degradation of Superoxides	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Folate Metabolism	Aromatase deficiency	Smith-Lemli-Opitz Syndrome (SLOS)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Sepiapterin reductase deficiency	Hyperprolinemia Type II	Disulfiram Pathway	Antipyrine Action Pathway	Dopa-responsive dystonia	The oncogenic action of 2-hydroxyglutarate	Celecoxib Metabolism Pathway	Corticosterone methyl oxidase II deficiency - CMO II	Nepafenac Action Pathway	Corticosterone methyl oxidase I deficiency (CMO I)	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Flurbiprofen Action Pathway	Steroid Biosynthesis	Desmosterolosis	Acetaminophen  Action Pathway	Hyperphenylalaninemia due to dhpr-deficiency	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Mevalonic aciduria	Vitamin K Metabolism	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Warburg Effect	Glutamate Metabolism	Tyrosine Metabolism	Magnesium salicylate Action Pathway	Leigh Syndrome	Cerebrotendinous Xanthomatosis (CTX)	Monoamine oxidase-a deficiency (MAO-A)	Familial Hypercholanemia (FHCA)	Histidinemia	Salicylic Acid Action Pathway	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	27-Hydroxylase Deficiency	Piroxicam Pathway	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Bile Acid Biosynthesis	Hypercholesterolemia	Steroidogenesis	Ibuprofen Metabolism Pathway	Lumiracoxib Action Pathway	Sulindac Pathway	Pyruvate Dehydrogenase Complex Deficiency	Fenoprofen Action Pathway	Valdecoxib Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Salsalate Action Pathway	Hyper-IgD syndrome	Tenoxicam Action Pathway	Ubiquinone Biosynthesis	Congenital Bile Acid Synthesis Defect Type II	Prolinemia Type II	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Apparent mineralocorticoid excess syndrome	Wolman disease	Hyperlysinemia I, Familial	Acetylsalicylic Acid Pathway	Glutaminolysis and Cancer	Tamoxifen Metabolism Pathway	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Diflunisal Pathway	L-arginine:glycine amidinotransferase deficiency	Pterine Biosynthesis	Lornoxicam Action Pathway	Folate malabsorption, hereditary	Phenylbutazone Action Pathway
NADPH	HMDB_SMPDB	Samples:	71	Pathways:	186	Diclofenac Action Pathway	Ureidopropionase deficiency	Lidocaine (Antiarrhythmic) Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Ketoprofen Pathway	Homocarnosinosis	Ketorolac Action Pathway	Nicotine Metabolism Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Felbamate Metabolism Pathway	Glutaric Aciduria Type I	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Antrafenine Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Pyridoxine dependency with seizures	21-hydroxylase deficiency (CYP21)	Glucose-Alanine Cycle	Bromfenac Pathway	Doxorubicin Metabolism Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Transfer of Acetyl Groups into Mitochondria	Phenytoin (Antiarrhythmic) Action Pathway	CHILD Syndrome	Tamoxifen Pathway	Suprofen Action Pathway	Lidocaine (Antiarrhythmic) Action Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Succinic semialdehyde dehydrogenase deficiency	Naproxen Pathway	Hawkinsinuria	Segawa syndrome	Pyruvate Metabolism	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Congenital Bile Acid Synthesis Defect Type III	2-aminoadipic 2-oxoadipic aciduria	Fatty Acid Elongation In Mitochondria	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Ketorolac Pathway	Nabumetone Action Pathway	Tolmetin Action Pathway	Methotrexate Pathway	Salicylate-sodium Action Pathway	Desipramine Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Lidocaine (Local Anaesthetic) Pathway	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Zellweger Syndrome	Nicotine Pathway	Dopamine beta-hydroxylase deficiency	Androgen and Estrogen Metabolism	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Piroxicam Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	17-alpha-hydroxylase deficiency (CYP17)	Valdecoxib Action Pathway	Saccharopinuria/Hyperlysinemia II	Desipramine Action Pathway	Simvastatin Action Pathway	Trisalicylate-choline Action Pathway	11-beta-hydroxylase deficiency (CYP11B1)	Imipramine Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Phenytoin (Antiarrhythmic) Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	The oncogenic action of Fumarate	Oxaprozin Action Pathway	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Ibuprofen Action Pathway	Tryptophan Metabolism	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Leukotriene C4 Synthesis Deficiency	Ethanol Degradation	Cholesteryl ester storage disease	GABA-Transaminase Deficiency	Carprofen Action Pathway	Rofecoxib Action Pathway	Nevirapine Metabolism Pathway	Rofecoxib Pathway	Nabumetone Pathway	Etodolac Action Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Carbamazepine Metabolism Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	Beta-Alanine Metabolism	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Folate Metabolism	Aromatase deficiency	Smith-Lemli-Opitz Syndrome (SLOS)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Meloxicam Action Pathway	Sepiapterin reductase deficiency	Hyperprolinemia Type II	Disulfiram Pathway	Antipyrine Action Pathway	Mefenamic Acid Action Pathway	Dopa-responsive dystonia	The oncogenic action of 2-hydroxyglutarate	Celecoxib Metabolism Pathway	Corticosterone methyl oxidase II deficiency - CMO II	Nicotine Action Pathway	Nepafenac Action Pathway	Corticosterone methyl oxidase I deficiency (CMO I)	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Flurbiprofen Action Pathway	Steroid Biosynthesis	Desmosterolosis	Acetaminophen  Action Pathway	Hyperphenylalaninemia due to dhpr-deficiency	Diflunisal Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Mevalonic aciduria	Tamoxifen Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Vitamin K Metabolism	Warburg Effect	Glutamate Metabolism	Tyrosine Metabolism	Magnesium salicylate Action Pathway	Leigh Syndrome	Cerebrotendinous Xanthomatosis (CTX)	Monoamine oxidase-a deficiency (MAO-A)	Familial Hypercholanemia (FHCA)	Histidinemia	Salicylic Acid Action Pathway	Imipramine Action Pathway	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Disulfiram Action Pathway	27-Hydroxylase Deficiency	Piroxicam Pathway	Pyruvate kinase deficiency	Phytanic Acid Peroxisomal Oxidation	Alkaptonuria	Bile Acid Biosynthesis	Hypercholesterolemia	Steroidogenesis	Ibuprofen Metabolism Pathway	Lumiracoxib Action Pathway	Sulindac Pathway	Pyruvate Dehydrogenase Complex Deficiency	Methotrexate Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Valdecoxib Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Hyper-IgD syndrome	Tenoxicam Action Pathway	Ubiquinone Biosynthesis	Congenital Bile Acid Synthesis Defect Type II	Prolinemia Type II	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Naproxen Action Pathway	Apparent mineralocorticoid excess syndrome	Wolman disease	Hyperlysinemia I, Familial	Acetylsalicylic Acid Pathway	Glutaminolysis and Cancer	Tamoxifen Metabolism Pathway	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Diflunisal Pathway	Sulindac Action Pathway	L-arginine:glycine amidinotransferase deficiency	Pterine Biosynthesis	Lornoxicam Action Pathway	Folate malabsorption, hereditary	Phenylbutazone Action Pathway
Mevalonic acid	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
Squalene	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
Vitamin D3	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
Farnesyl pyrophosphate	HMDB_SMPDB	Samples:	2	Pathways:	17	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Steroid Biosynthesis	Wolman disease	Desmosterolosis	Porphyrin Metabolism	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Porphyria Variegata (PV)	CHILD Syndrome	Mevalonic aciduria	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Acute Intermittent Porphyria	Hereditary Coproporphyria (HCP)	Simvastatin Action Pathway	Hyper-IgD syndrome
4,4-Dimethylcholesta-8,14,24-trienol	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
(S)-5-Diphosphomevalonic acid	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
Dimethylallylpyrophosphate	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
Lathosterol	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
(S)-2,3-Epoxysqualene	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
4a-Methylzymosterol	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
Lanosterin	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
Geranyl-PP	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
4,4-Dimethyl-5a-cholesta-8,24-dien-3-b-ol	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
Mevalonic acid-5P	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
Isopentenyl pyrophosphate	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
8-Dehydrocholesterol	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
Desmosterol	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
Heme	HMDB_SMPDB	Samples:	83	Pathways:	168	Diclofenac Action Pathway	Lidocaine (Antiarrhythmic) Pathway	Valproic Acid Metabolism Pathway	Ketoprofen Pathway	Vinorelbine Pathway	Ketorolac Action Pathway	Clopidogrel Pathway	Porphyria Variegata (PV)	Nicotine Metabolism Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Mitochondrial Electron Transport Chain	Felbamate Metabolism Pathway	Teniposide Pathway	Antrafenine Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	21-hydroxylase deficiency (CYP21)	Bromfenac Pathway	Doxorubicin Metabolism Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Irinotecan Action Pathway	Methadone Action Pathway	Phenytoin (Antiarrhythmic) Action Pathway	CHILD Syndrome	Tamoxifen Pathway	Suprofen Action Pathway	Lidocaine (Antiarrhythmic) Action Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Citalopram Pathway	Acute Intermittent Porphyria	Naproxen Pathway	Sulfite oxidase deficiency	Fluoxetine Action Pathway	Congenital Bile Acid Synthesis Defect Type III	Teniposide Metabolism Pathway	Arginine and Proline Metabolism	Tramadol Metabolism Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Desipramine Pathway	Lidocaine (Local Anaesthetic) Pathway	Etoposide Metabolism Pathway	Vinorelbine Action Pathway	Zellweger Syndrome	Nicotine Pathway	Codeine Pathway	Androgen and Estrogen Metabolism	Piroxicam Action Pathway	Vinblastine Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	17-alpha-hydroxylase deficiency (CYP17)	Valdecoxib Action Pathway	Hereditary Coproporphyria (HCP)	Desipramine Action Pathway	Simvastatin Action Pathway	Trisalicylate-choline Action Pathway	11-beta-hydroxylase deficiency (CYP11B1)	Imipramine Pathway	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Phenytoin (Antiarrhythmic) Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Oxaprozin Action Pathway	Ibuprofen Action Pathway	Acetaminophen Metabolism Pathway	Tryptophan Metabolism	Clopidogrel Metabolism Pathway	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Leukotriene C4 Synthesis Deficiency	Ethanol Degradation	Cholesteryl ester storage disease	Carprofen Action Pathway	Rofecoxib Action Pathway	Nevirapine Metabolism Pathway	Methadone Pathway	Rofecoxib Pathway	Nabumetone Pathway	Etodolac Action Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Carbamazepine Metabolism Pathway	Hyperprolinemia Type I	Venlafaxine Metabolism Pathway	Degradation of Superoxides	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Aromatase deficiency	Smith-Lemli-Opitz Syndrome (SLOS)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Fluoxetine Metabolism Pathway	Meloxicam Action Pathway	Hyperprolinemia Type II	Disulfiram Pathway	Sorafenib Metabolism Pathway	Antipyrine Action Pathway	Mefenamic Acid Action Pathway	Teniposide Action Pathway	Celecoxib Metabolism Pathway	Corticosterone methyl oxidase II deficiency - CMO II	Irinotecan Metabolism Pathway	Nicotine Action Pathway	Nepafenac Action Pathway	Vinblastine Action Pathway	Corticosterone methyl oxidase I deficiency (CMO I)	Etoposide Action Pathway	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Flurbiprofen Action Pathway	Steroid Biosynthesis	Desmosterolosis	Sulfate/Sulfite Metabolism	Acetaminophen  Action Pathway	Diflunisal Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Mevalonic aciduria	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Tamoxifen Action Pathway	Magnesium salicylate Action Pathway	Citalopram Metabolism Pathway	Cerebrotendinous Xanthomatosis (CTX)	Thyroid hormone synthesis	Familial Hypercholanemia (FHCA)	Salicylic Acid Action Pathway	Porphyrin Metabolism	Imipramine Action Pathway	Citalopram Action Pathway	Artemether Metabolism Pathway	Disulfiram Action Pathway	27-Hydroxylase Deficiency	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Piroxicam Pathway	Hypercholesterolemia	Steroidogenesis	Bile Acid Biosynthesis	Sulindac Pathway	Ibuprofen Metabolism Pathway	Lumiracoxib Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Clopidogrel Action Pathway	Codeine Metabolism Pathway	Codeine Action Pathway	Hyper-IgD syndrome	Tenoxicam Action Pathway	Congenital Bile Acid Synthesis Defect Type II	Prolinemia Type II	Naproxen Action Pathway	Apparent mineralocorticoid excess syndrome	Wolman disease	Acetylsalicylic Acid Pathway	Tamoxifen Metabolism Pathway	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Diflunisal Pathway	Sulindac Action Pathway	Fluoxetine Pathway	L-arginine:glycine amidinotransferase deficiency	Lornoxicam Action Pathway	Phenylbutazone Action Pathway
7-Dehydrodesmosterol	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
Zymosterol intermediate 2	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
3-Keto-4-methylzymosterol	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
24,25-Dihydrolanosterol	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
4,4-Dimethyl-5a-cholesta-8-en-3b-ol	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
5a-Cholest-8-en-3b-ol	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
5a-Cholesta-7,24-dien-3b-ol	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
4a-Methylzymosterol-4-carboxylic acid	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
Ammonia	HMDB_SMPDB	Samples:	67	Pathways:	79	Tyrosinemia Type I	Hyperprolinemia Type I	Ureidopropionase deficiency	Beta-Alanine Metabolism	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Folate Metabolism	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocarnosinosis	Homocystinuria, cystathionine beta-synthase deficiency	Porphyria Variegata (PV)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Hyperprolinemia Type II	Disulfiram Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	The oncogenic action of 2-hydroxyglutarate	Gemcitabine Pathway	Homocysteine Degradation	Non Ketotic Hyperglycinemia	Citrullinemia Type I	Hyperglycinemia, non-ketotic	Gemcitabine Metabolism Pathway	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Glucose-Alanine Cycle	Phenylketonuria	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Acute Intermittent Porphyria	Citalopram Pathway	Succinic semialdehyde dehydrogenase deficiency	Hawkinsinuria	Warburg Effect	Glutamate Metabolism	Tyrosine Metabolism	Citalopram Metabolism Pathway	Monoamine oxidase-a deficiency (MAO-A)	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Histidinemia	Porphyrin Metabolism	Citalopram Action Pathway	Disulfiram Action Pathway	Methotrexate Pathway	Gemcitabine Action Pathway	Alkaptonuria	2-Hydroxyglutric Aciduria (D And L Form)	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Argininemia	Dopamine beta-hydroxylase deficiency	Methotrexate Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Threonine and 2-Oxobutanoate Degradation	Hereditary Coproporphyria (HCP)	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Histidine Metabolism	Tyrosinemia, transient, of the newborn	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Argininosuccinic Aciduria	Glutaminolysis and Cancer	Gamma-cystathionase deficiency (CTH)	D-Arginine and D-Ornithine Metabolism	Hyperinsulinism-Hyperammonemia Syndrome	Ammonia Recycling	Tyrosinemia Type 3 (TYRO3)	GABA-Transaminase Deficiency	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Selenoamino Acid Metabolism	Folate malabsorption, hereditary
Cytidine triphosphate	HMDB_SMPDB	Samples:	6	Pathways:	1	Pantothenate and CoA Biosynthesis
Fructose 6-phosphate	HMDB_SMPDB	Samples:	55	Pathways:	18	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Glycogenosis, Type IC	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type IB	Homocarnosinosis	Fructose-1,6-diphosphatase deficiency	2-Hydroxyglutric Aciduria (D And L Form)	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Hyperinsulinism-Hyperammonemia Syndrome	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Succinic semialdehyde dehydrogenase deficiency	Warburg Effect	Glutamate Metabolism	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycolysis
Pyruvic acid	HMDB_SMPDB	Samples:	67	Pathways:	57	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Alanine Metabolism	Congenital lactic acidosis	Lactic Acidemia	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Carbamoyl Phosphate Synthetase Deficiency	Glycogenosis, Type IC	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Citric Acid Cycle	Gluconeogenesis	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocarnosinosis	Fructose-1,6-diphosphatase deficiency	Pyruvate kinase deficiency	2-Hydroxyglutric Aciduria (D And L Form)	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Argininemia	Pyruvate Dehydrogenase Complex Deficiency	Dimethylglycine Dehydrogenase Deficiency	The oncogenic action of 2-hydroxyglutarate	Non Ketotic Hyperglycinemia	Citrullinemia Type I	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Hyperglycinemia, non-ketotic	Primary Hyperoxaluria Type I	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Triosephosphate isomerase	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	3-Phosphoglycerate dehydrogenase deficiency	Glycogenosis, Type IB	Urea Cycle	Argininosuccinic Aciduria	Glucose-Alanine Cycle	Fumarase deficiency	Glutaminolysis and Cancer	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Transfer of Acetyl Groups into Mitochondria	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Sarcosinemia	Hyperinsulinism-Hyperammonemia Syndrome	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E2)	Ammonia Recycling	Pyruvate Carboxylase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Glycine and Serine Metabolism	Glutamate Metabolism	Pyruvate Metabolism	Glycolysis	Leigh Syndrome
Phosphoenolpyruvic acid	HMDB_SMPDB	Samples:	58	Pathways:	18	Primary hyperoxaluria II, PH2	Glycogenosis, Type IC	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Pyruvate kinase deficiency	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycogenosis, Type IA. Von gierke disease	Pyruvate Dehydrogenase Complex Deficiency	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Warburg Effect	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Pyruvate Metabolism	Glycolysis	Leigh Syndrome
L-Glutamine	HMDB_SMPDB	Samples:	64	Pathways:	19	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Carbamoyl Phosphate Synthetase Deficiency	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Urea Cycle	Argininosuccinic Aciduria	Homocarnosinosis	Glutaminolysis and Cancer	2-Hydroxyglutric Aciduria (D And L Form)	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Argininemia	Hyperinsulinism-Hyperammonemia Syndrome	Ammonia Recycling	The oncogenic action of 2-hydroxyglutarate	Succinic semialdehyde dehydrogenase deficiency	Phenylacetate Metabolism	Warburg Effect	Glutamate Metabolism	Citrullinemia Type I
D-Fructose	HMDB_SMPDB	Samples:	6	Pathways:	7	Glycogen synthetase deficiency	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Mucopolysaccharidosis VI. Sly syndrome	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Glycogenosis, Type VI. Hers disease
N-Acetyl-D-Glucosamine 6-Phosphate	HMDB_SMPDB	Samples:	2	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
Glucosamine 6-phosphate	HMDB_SMPDB	Samples:	2	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
Chitin	HMDB_SMPDB	Samples:	2	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
Acetate	HMDB_SMPDB	Samples:	60	Pathways:	9	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Ethanol Degradation	Heroin Action Pathway	Disulfiram Action Pathway	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
beta-D-Fructose	HMDB_SMPDB	Samples:	6	Pathways:	7	Glycogen synthetase deficiency	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Mucopolysaccharidosis VI. Sly syndrome	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Glycogenosis, Type VI. Hers disease
CTP	HMDB_SMPDB	Samples:	6	Pathways:	1	Pantothenate and CoA Biosynthesis
D-Fructose 6-phosphate	HMDB_SMPDB	Samples:	55	Pathways:	18	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Glycogenosis, Type IC	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type IB	Homocarnosinosis	Fructose-1,6-diphosphatase deficiency	2-Hydroxyglutric Aciduria (D And L Form)	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Hyperinsulinism-Hyperammonemia Syndrome	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Succinic semialdehyde dehydrogenase deficiency	Warburg Effect	Glutamate Metabolism	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycolysis
D-Glucosamine 6-phosphate	HMDB_SMPDB	Samples:	2	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
N-Acetyl-D-glucosamine 6-phosphate	HMDB_SMPDB	Samples:	2	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
Phosphoenolpyruvate	HMDB_SMPDB	Samples:	58	Pathways:	18	Primary hyperoxaluria II, PH2	Glycogenosis, Type IC	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Pyruvate kinase deficiency	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycogenosis, Type IA. Von gierke disease	Pyruvate Dehydrogenase Complex Deficiency	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Warburg Effect	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Pyruvate Metabolism	Glycolysis	Leigh Syndrome
Pyruvate	HMDB_SMPDB	Samples:	67	Pathways:	56	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Alanine Metabolism	Congenital lactic acidosis	Lactic Acidemia	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Carbamoyl Phosphate Synthetase Deficiency	Glycogenosis, Type IC	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Citric Acid Cycle	Gluconeogenesis	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocarnosinosis	Fructose-1,6-diphosphatase deficiency	Pyruvate kinase deficiency	2-Hydroxyglutric Aciduria (D And L Form)	Argininemia	Pyruvate Dehydrogenase Complex Deficiency	Dimethylglycine Dehydrogenase Deficiency	The oncogenic action of 2-hydroxyglutarate	Non Ketotic Hyperglycinemia	Citrullinemia Type I	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Hyperglycinemia, non-ketotic	Primary Hyperoxaluria Type I	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Triosephosphate isomerase	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	3-Phosphoglycerate dehydrogenase deficiency	Glycogenosis, Type IB	Urea Cycle	Argininosuccinic Aciduria	Glucose-Alanine Cycle	Fumarase deficiency	Glutaminolysis and Cancer	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Transfer of Acetyl Groups into Mitochondria	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Sarcosinemia	Hyperinsulinism-Hyperammonemia Syndrome	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Pyruvate dehydrogenase deficiency (E2)	Ammonia Recycling	Pyruvate Carboxylase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Glycine and Serine Metabolism	Glutamate Metabolism	Pyruvate Metabolism	Glycolysis	Leigh Syndrome
Formaldehyde	HMDB_SMPDB	Samples:	71	Pathways:	38	Fluoxetine Action Pathway	Lidocaine (Antiarrhythmic) Pathway	Venlafaxine Metabolism Pathway	Teniposide Metabolism Pathway	Imipramine Action Pathway	Citalopram Action Pathway	Tramadol Metabolism Pathway	Artemether Metabolism Pathway	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Fluoxetine Metabolism Pathway	Lidocaine (Local Anaesthetic) Pathway	Etoposide Metabolism Pathway	Nicotine Metabolism Pathway	Nicotine Pathway	Codeine Pathway	Dimethylglycine Dehydrogenase Deficiency	Teniposide Pathway	Teniposide Action Pathway	Non Ketotic Hyperglycinemia	Hyperglycinemia, non-ketotic	Codeine Metabolism Pathway	Nicotine Action Pathway	Codeine Action Pathway	Imipramine Pathway	Etoposide Action Pathway	3-Phosphoglycerate dehydrogenase deficiency	Tamoxifen Metabolism Pathway	Sarcosinemia	Methadone Action Pathway	Tamoxifen Pathway	Tamoxifen Action Pathway	Lidocaine (Antiarrhythmic) Action Pathway	Citalopram Pathway	Fluoxetine Pathway	Glycine and Serine Metabolism	Methadone Pathway	Citalopram Metabolism Pathway	Lidocaine (Local Anaesthetic) Action Pathway
Lidocaine	HMDB_SMPDB	Samples:	22	Pathways:	4	Lidocaine (Antiarrhythmic) Action Pathway	Lidocaine (Local Anaesthetic) Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Lidocaine (Antiarrhythmic) Pathway
3-Hydroxylidocaine	HMDB_SMPDB	Samples:	22	Pathways:	4	Lidocaine (Antiarrhythmic) Action Pathway	Lidocaine (Local Anaesthetic) Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Lidocaine (Antiarrhythmic) Pathway
Monoethylglycinexylidide	HMDB_SMPDB	Samples:	22	Pathways:	4	Lidocaine (Antiarrhythmic) Action Pathway	Lidocaine (Local Anaesthetic) Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Lidocaine (Antiarrhythmic) Pathway
2,6-Dimethylaniline	HMDB_SMPDB	Samples:	22	Pathways:	4	Lidocaine (Antiarrhythmic) Action Pathway	Lidocaine (Local Anaesthetic) Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Lidocaine (Antiarrhythmic) Pathway
3-Hydroxymonoethylglycinexylidide	HMDB_SMPDB	Samples:	22	Pathways:	4	Lidocaine (Antiarrhythmic) Action Pathway	Lidocaine (Local Anaesthetic) Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Lidocaine (Antiarrhythmic) Pathway
Glycinexylidide	HMDB_SMPDB	Samples:	22	Pathways:	4	Lidocaine (Antiarrhythmic) Action Pathway	Lidocaine (Local Anaesthetic) Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Lidocaine (Antiarrhythmic) Pathway
2-Amino-3-methylbenzoate	HMDB_SMPDB	Samples:	22	Pathways:	4	Lidocaine (Antiarrhythmic) Action Pathway	Lidocaine (Local Anaesthetic) Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Lidocaine (Antiarrhythmic) Pathway
4-Hydroxy-2,6-dimethylaniline	HMDB_SMPDB	Samples:	22	Pathways:	4	Lidocaine (Antiarrhythmic) Action Pathway	Lidocaine (Local Anaesthetic) Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Lidocaine (Antiarrhythmic) Pathway
L-Carnitine	HMDB_SMPDB	Samples:	59	Pathways:	17	Carnitine Synthesis	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Trifunctional protein deficiency	Fatty acid Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Oxidation of Branched Chain Fatty Acids	Adrenoleukodystrophy, X-linked	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Carnitine-acylcarnitine translocase deficiency	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Beta Oxidation of Very Long Chain Fatty Acids	Glutaric Aciduria Type I	Carnitine palmitoyl transferase deficiency (I)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
L-Acetylcarnitine	HMDB_SMPDB	Samples:	55	Pathways:	4	Adrenoleukodystrophy, X-linked	Oxidation of Branched Chain Fatty Acids	Beta Oxidation of Very Long Chain Fatty Acids	Carnitine-acylcarnitine translocase deficiency
Dodecanoic acid	HMDB_SMPDB	Samples:	51	Pathways:	4	Adrenoleukodystrophy, X-linked	Beta Oxidation of Very Long Chain Fatty Acids	Carnitine-acylcarnitine translocase deficiency	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids
Tetradecanoyl-CoA 	HMDB_SMPDB	Samples:	58	Pathways:	16	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Trifunctional protein deficiency	Fatty acid Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Adrenoleukodystrophy, X-linked	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine-acylcarnitine translocase deficiency	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Beta Oxidation of Very Long Chain Fatty Acids	Glutaric Aciduria Type I	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
Tetracosanoic acid	HMDB_SMPDB	Samples:	46	Pathways:	3	Adrenoleukodystrophy, X-linked	Beta Oxidation of Very Long Chain Fatty Acids	Carnitine-acylcarnitine translocase deficiency
Hexacosanoic acid	HMDB_SMPDB	Samples:	46	Pathways:	3	Adrenoleukodystrophy, X-linked	Beta Oxidation of Very Long Chain Fatty Acids	Carnitine-acylcarnitine translocase deficiency
Lauroyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	17	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Trifunctional protein deficiency	Fatty acid Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Adrenoleukodystrophy, X-linked	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine-acylcarnitine translocase deficiency	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Beta Oxidation of Very Long Chain Fatty Acids	Glutaric Aciduria Type I	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
Hexacosanoyl-CoA 	HMDB_SMPDB	Samples:	46	Pathways:	3	Adrenoleukodystrophy, X-linked	Beta Oxidation of Very Long Chain Fatty Acids	Carnitine-acylcarnitine translocase deficiency
Tetracosanoyl-CoA  	HMDB_SMPDB	Samples:	46	Pathways:	3	Adrenoleukodystrophy, X-linked	Beta Oxidation of Very Long Chain Fatty Acids	Carnitine-acylcarnitine translocase deficiency
O-Acetylcarnitine	HMDB_SMPDB	Samples:	55	Pathways:	4	Adrenoleukodystrophy, X-linked	Oxidation of Branched Chain Fatty Acids	Beta Oxidation of Very Long Chain Fatty Acids	Carnitine-acylcarnitine translocase deficiency
Tetracosanoyl-CoA	HMDB_SMPDB	Samples:	46	Pathways:	3	Adrenoleukodystrophy, X-linked	Beta Oxidation of Very Long Chain Fatty Acids	Carnitine-acylcarnitine translocase deficiency
Tetradecanoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	16	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Trifunctional protein deficiency	Fatty acid Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Adrenoleukodystrophy, X-linked	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Carnitine-acylcarnitine translocase deficiency	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Beta Oxidation of Very Long Chain Fatty Acids	Glutaric Aciduria Type I	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
Bupivacaine	HMDB_SMPDB	Samples:	20	Pathways:	2	Bupivacaine Action Pathway	Bupivacaine Pathway
NADP+	HMDB_SMPDB	Samples:	72	Pathways:	153	Diclofenac Action Pathway	Ureidopropionase deficiency	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Homocarnosinosis	Ketorolac Action Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Felbamate Metabolism Pathway	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Antrafenine Action Pathway	Pyridoxine dependency with seizures	21-hydroxylase deficiency (CYP21)	Doxorubicin Metabolism Pathway	Ketoprofen Action Pathway	Transfer of Acetyl Groups into Mitochondria	Phenytoin (Antiarrhythmic) Action Pathway	CHILD Syndrome	Suprofen Action Pathway	Lidocaine (Antiarrhythmic) Action Pathway	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Succinic semialdehyde dehydrogenase deficiency	Hawkinsinuria	Segawa syndrome	Pyruvate Metabolism	Lysine Degradation	Hyperlysinemia II or Saccharopinuria	Congenital Bile Acid Synthesis Defect Type III	2-aminoadipic 2-oxoadipic aciduria	Fatty Acid Elongation In Mitochondria	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Nabumetone Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Zellweger Syndrome	Dopamine beta-hydroxylase deficiency	Androgen and Estrogen Metabolism	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Piroxicam Action Pathway	17-alpha-hydroxylase deficiency (CYP17)	Valdecoxib Action Pathway	Saccharopinuria/Hyperlysinemia II	Desipramine Action Pathway	Simvastatin Action Pathway	Trisalicylate-choline Action Pathway	11-beta-hydroxylase deficiency (CYP11B1)	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Ornithine Aminotransferase Deficiency (OAT Deficiency)	The oncogenic action of Fumarate	Oxaprozin Action Pathway	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Ibuprofen Action Pathway	Tryptophan Metabolism	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Leukotriene C4 Synthesis Deficiency	Ethanol Degradation	Cholesteryl ester storage disease	GABA-Transaminase Deficiency	Carprofen Action Pathway	Rofecoxib Action Pathway	Nevirapine Metabolism Pathway	Etodolac Action Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Carbamazepine Metabolism Pathway	Tyrosinemia Type I	Hyperprolinemia Type I	Beta-Alanine Metabolism	Degradation of Superoxides	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Folate Metabolism	Aromatase deficiency	Smith-Lemli-Opitz Syndrome (SLOS)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Meloxicam Action Pathway	Sepiapterin reductase deficiency	Hyperprolinemia Type II	Antipyrine Action Pathway	Mefenamic Acid Action Pathway	Dopa-responsive dystonia	The oncogenic action of 2-hydroxyglutarate	Corticosterone methyl oxidase II deficiency - CMO II	Nicotine Action Pathway	Nepafenac Action Pathway	Corticosterone methyl oxidase I deficiency (CMO I)	Carnosinuria, carnosinemia	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Flurbiprofen Action Pathway	Steroid Biosynthesis	Desmosterolosis	Acetaminophen  Action Pathway	Hyperphenylalaninemia due to dhpr-deficiency	Diflunisal Action Pathway	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Mevalonic aciduria	Tamoxifen Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Vitamin K Metabolism	Warburg Effect	Glutamate Metabolism	Tyrosine Metabolism	Magnesium salicylate Action Pathway	Leigh Syndrome	Cerebrotendinous Xanthomatosis (CTX)	Monoamine oxidase-a deficiency (MAO-A)	Familial Hypercholanemia (FHCA)	Histidinemia	Salicylic Acid Action Pathway	Imipramine Action Pathway	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Disulfiram Action Pathway	27-Hydroxylase Deficiency	Pyruvate kinase deficiency	Hypercholesterolemia	Alkaptonuria	Bile Acid Biosynthesis	Steroidogenesis	Lumiracoxib Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	Methotrexate Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Hyper-IgD syndrome	Tenoxicam Action Pathway	Ubiquinone Biosynthesis	Congenital Bile Acid Synthesis Defect Type II	Prolinemia Type II	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Naproxen Action Pathway	Apparent mineralocorticoid excess syndrome	Wolman disease	Hyperlysinemia I, Familial	Glutaminolysis and Cancer	Tamoxifen Metabolism Pathway	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Sulindac Action Pathway	L-arginine:glycine amidinotransferase deficiency	Pterine Biosynthesis	Lornoxicam Action Pathway	Folate malabsorption, hereditary	Phenylbutazone Action Pathway
Sufentanil	HMDB_SMPDB	Samples:	20	Pathways:	2	Sufentanil Pathway	Sufentanil Action Pathway
Inositol 1,4,5-trisphosphate	HMDB_SMPDB	Samples:	15	Pathways:	49	Atenolol Pathway	Lidocaine (Antiarrhythmic) Pathway	Carvedilol Pathway	Felodipine Pathway	Verapamil Pathway	Disopyramide Pathway	Ibutilide Pathway	Oxprenolol Pathway	Bopindolol Action Pathway	Nitrendipine Pathway	Sotalol Action Pathway	Nisoldipine Pathway	Nebivolol Pathway	Amiodarone Action Pathway	Levobunolol Action Pathway	Muscle/Heart Contraction	Quinidine Pathway	Practolol Action Pathway	Propranolol Pathway	Betaxolol Pathway	Epinephrine Action Pathway	Pindolol Pathway	Timolol Action Pathway	Bupranolol Action Pathway	Nadolol Pathway	Amlodipine Pathway	Mexiletine Pathway	Penbutolol Pathway	Acebutolol Pathway	Arbutamine Action Pathway	Carteolol Action Pathway	Isoprenaline Action Pathway	Phenytoin (Antiarrhythmic) Pathway	Esmolol Pathway	Nifedipine Pathway	Bevantolol Action Pathway	Procainamide (Antiarrhythmic) Pathway	Isradipine Pathway	Flecainide Pathway	Metoprolol Pathway	Nimodipine Pathway	Tocainide Pathway	Fosphenytoin (Antiarrhythmic) Pathway	Alprenolol Pathway	Diltiazem Pathway	Bisoprolol Pathway	Labetalol Pathway	Dobutamine Action Pathway	Metipranolol Action Pathway
DG(14:0/14:1(9Z)/0:0)	HMDB_SMPDB	Samples:	15	Pathways:	49	Atenolol Pathway	Lidocaine (Antiarrhythmic) Pathway	Carvedilol Pathway	Felodipine Pathway	Verapamil Pathway	Disopyramide Pathway	Ibutilide Pathway	Oxprenolol Pathway	Bopindolol Action Pathway	Nitrendipine Pathway	Sotalol Action Pathway	Nisoldipine Pathway	Nebivolol Pathway	Amiodarone Action Pathway	Levobunolol Action Pathway	Muscle/Heart Contraction	Quinidine Pathway	Practolol Action Pathway	Propranolol Pathway	Betaxolol Pathway	Epinephrine Action Pathway	Pindolol Pathway	Timolol Action Pathway	Bupranolol Action Pathway	Nadolol Pathway	Amlodipine Pathway	Mexiletine Pathway	Penbutolol Pathway	Acebutolol Pathway	Arbutamine Action Pathway	Carteolol Action Pathway	Isoprenaline Action Pathway	Phenytoin (Antiarrhythmic) Pathway	Esmolol Pathway	Nifedipine Pathway	Bevantolol Action Pathway	Procainamide (Antiarrhythmic) Pathway	Isradipine Pathway	Flecainide Pathway	Metoprolol Pathway	Nimodipine Pathway	Tocainide Pathway	Fosphenytoin (Antiarrhythmic) Pathway	Alprenolol Pathway	Diltiazem Pathway	Bisoprolol Pathway	Labetalol Pathway	Dobutamine Action Pathway	Metipranolol Action Pathway
PIP2(16:0/20:3(8Z,11Z,14Z))	HMDB_SMPDB	Samples:	15	Pathways:	49	Atenolol Pathway	Lidocaine (Antiarrhythmic) Pathway	Carvedilol Pathway	Felodipine Pathway	Verapamil Pathway	Disopyramide Pathway	Ibutilide Pathway	Oxprenolol Pathway	Bopindolol Action Pathway	Nitrendipine Pathway	Sotalol Action Pathway	Nisoldipine Pathway	Nebivolol Pathway	Amiodarone Action Pathway	Levobunolol Action Pathway	Muscle/Heart Contraction	Quinidine Pathway	Practolol Action Pathway	Propranolol Pathway	Betaxolol Pathway	Epinephrine Action Pathway	Pindolol Pathway	Timolol Action Pathway	Bupranolol Action Pathway	Nadolol Pathway	Amlodipine Pathway	Mexiletine Pathway	Penbutolol Pathway	Acebutolol Pathway	Arbutamine Action Pathway	Carteolol Action Pathway	Isoprenaline Action Pathway	Phenytoin (Antiarrhythmic) Pathway	Esmolol Pathway	Nifedipine Pathway	Bevantolol Action Pathway	Procainamide (Antiarrhythmic) Pathway	Isradipine Pathway	Flecainide Pathway	Metoprolol Pathway	Nimodipine Pathway	Tocainide Pathway	Fosphenytoin (Antiarrhythmic) Pathway	Alprenolol Pathway	Diltiazem Pathway	Bisoprolol Pathway	Labetalol Pathway	Dobutamine Action Pathway	Metipranolol Action Pathway
Labetalol	HMDB_SMPDB	Samples:	11	Pathways:	2	Labetalol Action Pathway	Labetalol Pathway
Levorphanol	HMDB_SMPDB	Samples:	20	Pathways:	1	Levorphanol Action Pathway
L-Noradrenaline	HMDB_SMPDB	Samples:	62	Pathways:	63	Nalbuphine Action Pathway	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Levomethadyl Acetate Action Action Pathway	Ethylmorphine Action Pathway	Fluoxetine Action Pathway	Hydrocodone Action Pathway	Hydromorphone Action Pathway	Propoxyphene Action Pathway	Aromatic L-Aminoacid Decarboxylase Deficiency	3-Methylthiofentanyl Action Pathway	Citalopram Action Pathway	Imipramine Action Pathway	Disulfiram Action Pathway	Levorphanol Action Pathway	Methadyl Acetate Action Pathway	Anileridine Action Pathway	Dibucaine Action Pathway	Proparacaine Action Pathway	Alkaptonuria	Sufentanil Action Pathway	Oxycodone Action Pathway	Escitalopram Action Pathway	Dopamine beta-hydroxylase deficiency	Bupivacaine Action Pathway	Chloroprocaine Action Pathway	Pentazocine Action Pathway	Catecholamine Biosynthesis	Procaine Action Pathway	Ropivacaine Action Pathway	Benzocaine Action Pathway	Buprenorphine Action Pathway	Dimethylthiambutene Action Pathway	Oxybuprocaine Action Pathway	Codeine Action Pathway	Nicotine Action Pathway	Desipramine Action Pathway	Tyrosine hydroxylase deficiency	Remifentanil Action Pathway	Tyrosinemia, transient, of the newborn	Heroin Action Pathway	Mepivacaine Action Pathway	Ketobemidone  Action Pathway	Naltrexone Action Pathway	Dihydromorphine Action Pathway	Tramadol Action Action Pathway	Morphine Action Pathway	Alvimopan Action Pathway	Alfentanil Action Pathway	Dezocine Action Pathway	Fentanyl Action Pathway	Naloxone Action Pathway	Levallorphan Action Pathway	Methadone Action Pathway	Prilocaine Action Pathway	Levobupivacaine Action Pathway	Oxymorphone Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Carfentanil Action Pathway	Diphenoxylate Action Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Cocaine Action Pathway
Potassium cation	HMDB_SMPDB	Samples:	73	Pathways:	163	Alprenolol Action Pathway	Levomethadyl Acetate Action Action Pathway	Bisoprolol Action Pathway	Gliclazide Action Pathway	Levorphanol Action Pathway	Lysinuric Protein Intolerance	Felodipine Action Pathway	Triamterene Action Pathway	Furosemide Action Pathway	Bupivacaine Action Pathway	Isradipine Action Pathway	Nizatidine Action Pathway	Ropivacaine Action Pathway	Gastric Acid Production	Buprenorphine Action Pathway	Eplerenone Action Pathway	Arbutamine Action Pathway	Heroin Action Pathway	Nisoldipine Action Pathway	Polythiazide Action Pathway	Verapamil Action Pathway	Dihydromorphine Action Pathway	Metiamide Action Pathway	Mexiletine Action Pathway	Alvimopan Action Pathway	Fentanyl Action Pathway	Methadone Action Pathway	Phenytoin (Antiarrhythmic) Action Pathway	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Methyclothiazide Action Pathway	Labetalol Action Pathway	Lidocaine (Antiarrhythmic) Action Pathway	Iminoglycinuria	Blue diaper syndrome	Ethacrynic Acid Action Pathway	Pyruvate Metabolism	Disopyramide Action Pathway	Nalbuphine Action Pathway	Glibenclamide Action Pathway	Lactose Intolerance	Repaglinide Action Pathway	Fluoxetine Action Pathway	Primary hyperoxaluria II, PH2	Bendroflumethiazide Action Pathway	Hydrocodone Action Pathway	Lansoprazole Action Pathway	Procainamide (Antiarrhythmic) Action Pathway	Tocainide Action Pathway	Spironolactone Action Pathway	Bopindolol Action Pathway	Sotalol Action Pathway	Methadyl Acetate Action Pathway	Anileridine Action Pathway	Proparacaine Action Pathway	Sufentanil Action Pathway	Hydrochlorothiazide Action Pathway	Escitalopram Action Pathway	Practolol Action Pathway	Chloroprocaine Action Pathway	Pentazocine Action Pathway	Betaine Metabolism	Epinephrine Action Pathway	Trichlormethiazide Action Pathway	Dimethylthiambutene Action Pathway	Timolol Action Pathway	Desipramine Action Pathway	Pantoprazole Action Pathway	Oxprenolol Action Pathway	Cimetidine Action Pathway	Isoprenaline Action Pathway	Remifentanil Action Pathway	Chlorthalidone Action Pathway	Ketobemidone  Action Pathway	Esmolol Action Pathway	Nateglinide Action Pathway	Penbutolol Action Pathway	Morphine Action Pathway	Nitrendipine Action Pathway	Acebutolol Action Pathway	Amiloride Action Pathway	Levobupivacaine Action Pathway	Omeprazole Action Pathway	Diphenoxylate Action Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Cocaine Action Pathway	Rabeprazole Action Pathway	Ibutilide Action Pathway	Kidney Function	Ethylmorphine Action Pathway	3-Methylthiofentanyl Action Pathway	Bumetanide Action Pathway	Dibucaine Action Pathway	Levobunolol Action Pathway	Trehalose Degradation	Muscle/Heart Contraction	Procaine Action Pathway	Benzocaine Action Pathway	Quinethazone Action Pathway	Ranitidine Action Pathway	Nicotine Action Pathway	Bupranolol Action Pathway	Glucose Transporter Defect (SGLT2)	Torsemide Action Pathway	Carteolol Action Pathway	Propranolol Action Pathway	Mepivacaine Action Pathway	Nifedipine Action Pathway	Cystinuria	Metoprolol Action Pathway	Lactose Degradation	Alfentanil Action Pathway	Dezocine Action Pathway	Naloxone Action Pathway	Levallorphan Action Pathway	Pancreas Function	Betazole Action Pathway	Roxatidine acetate Action Pathway	Fosphenytoin (Antiarrhythmic) Action Pathway	Hydroflumethiazide Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Prilocaine Action Pathway	Famotidine Action Pathway	Warburg Effect	Glycolysis	Leigh Syndrome	Atenolol Action Pathway	Lysinuric protein intolerance (LPI)	Cyclothiazide Action Pathway	Diltiazem Action Pathway	Hydromorphone Action Pathway	Propoxyphene Action Pathway	Imipramine Action Pathway	Citalopram Action Pathway	Betaxolol Action Pathway	Pyruvate kinase deficiency	Metolazone Action Pathway	Oxycodone Action Pathway	Amiodarone Action Pathway	Carvedilol Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	Nebivolol Action Pathway	Chlorothiazide Action Pathway	Oxybuprocaine Action Pathway	Codeine Action Pathway	Indapamide Action Pathway	Bevantolol Action Pathway	Flecainide Action Pathway	Hartnup Disorder	Naltrexone Action Pathway	Nimodipine Action Pathway	Tramadol Action Action Pathway	Nadolol Action Pathway	Amlodipine Action Pathway	Quinidine Action Pathway	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Pirenzepine Action Pathway	Esomeprazole Action Pathway	Oxymorphone Action Pathway	Pindolol Action Pathway	Carfentanil Action Pathway	Dobutamine Action Pathway	Metipranolol Action Pathway
Sodium cation	HMDB_SMPDB	Samples:	66	Pathways:	135	Alprenolol Action Pathway	Levomethadyl Acetate Action Action Pathway	Capecitabine Action Pathway	Bisoprolol Action Pathway	Levorphanol Action Pathway	Lysinuric Protein Intolerance	Felodipine Action Pathway	Triamterene Action Pathway	Furosemide Action Pathway	Bupivacaine Action Pathway	Isradipine Action Pathway	Ropivacaine Action Pathway	Buprenorphine Action Pathway	Eplerenone Action Pathway	Arbutamine Action Pathway	Heroin Action Pathway	Nisoldipine Action Pathway	Polythiazide Action Pathway	Verapamil Action Pathway	Dihydromorphine Action Pathway	Mexiletine Action Pathway	Alvimopan Action Pathway	Fentanyl Action Pathway	Methadone Action Pathway	Phenytoin (Antiarrhythmic) Action Pathway	Methyclothiazide Action Pathway	Labetalol Action Pathway	Lidocaine (Antiarrhythmic) Action Pathway	Iminoglycinuria	Blue diaper syndrome	Ethacrynic Acid Action Pathway	Disopyramide Action Pathway	Nalbuphine Action Pathway	Fluoxetine Action Pathway	Lactose Intolerance	Hydrocodone Action Pathway	Bendroflumethiazide Action Pathway	Tocainide Action Pathway	Procainamide (Antiarrhythmic) Action Pathway	Spironolactone Action Pathway	Bopindolol Action Pathway	Sotalol Action Pathway	Methadyl Acetate Action Pathway	Anileridine Action Pathway	Proparacaine Action Pathway	Sufentanil Action Pathway	Hydrochlorothiazide Action Pathway	Escitalopram Action Pathway	Practolol Action Pathway	Chloroprocaine Action Pathway	Pentazocine Action Pathway	Epinephrine Action Pathway	Trichlormethiazide Action Pathway	Dimethylthiambutene Action Pathway	Timolol Action Pathway	Desipramine Action Pathway	Oxprenolol Action Pathway	Isoprenaline Action Pathway	Remifentanil Action Pathway	Chlorthalidone Action Pathway	Ketobemidone  Action Pathway	Esmolol Action Pathway	Penbutolol Action Pathway	Morphine Action Pathway	Nitrendipine Action Pathway	Acebutolol Action Pathway	Amiloride Action Pathway	Levobupivacaine Action Pathway	Capecitabine Metabolism Pathway	Diphenoxylate Action Pathway	Lidocaine (Local Anaesthetic) Action Pathway	Cocaine Action Pathway	Ibutilide Action Pathway	Kidney Function	Ethylmorphine Action Pathway	3-Methylthiofentanyl Action Pathway	Bumetanide Action Pathway	Dibucaine Action Pathway	Levobunolol Action Pathway	Trehalose Degradation	Muscle/Heart Contraction	Procaine Action Pathway	Benzocaine Action Pathway	Quinethazone Action Pathway	Nicotine Action Pathway	Bupranolol Action Pathway	Glucose Transporter Defect (SGLT2)	Torsemide Action Pathway	Carteolol Action Pathway	Propranolol Action Pathway	Mepivacaine Action Pathway	Nifedipine Action Pathway	Cystinuria	Metoprolol Action Pathway	Lactose Degradation	Alfentanil Action Pathway	Dezocine Action Pathway	Naloxone Action Pathway	Levallorphan Action Pathway	Fosphenytoin (Antiarrhythmic) Action Pathway	Hydroflumethiazide Action Pathway	Prilocaine Action Pathway	Atenolol Action Pathway	Lysinuric protein intolerance (LPI)	Cyclothiazide Action Pathway	Thyroid hormone synthesis	Diltiazem Action Pathway	Hydromorphone Action Pathway	Propoxyphene Action Pathway	Imipramine Action Pathway	Citalopram Action Pathway	Betaxolol Action Pathway	Metolazone Action Pathway	Oxycodone Action Pathway	Amiodarone Action Pathway	Carvedilol Action Pathway	Nebivolol Action Pathway	Chlorothiazide Action Pathway	Oxybuprocaine Action Pathway	Codeine Action Pathway	Indapamide Action Pathway	Bevantolol Action Pathway	Flecainide Action Pathway	Hartnup Disorder	Naltrexone Action Pathway	Nimodipine Action Pathway	Tramadol Action Action Pathway	Nadolol Action Pathway	Amlodipine Action Pathway	Quinidine Action Pathway	Oxymorphone Action Pathway	Pindolol Action Pathway	Carfentanil Action Pathway	Dobutamine Action Pathway	Metipranolol Action Pathway
Glutathione	HMDB_SMPDB	Samples:	53	Pathways:	69	Diclofenac Action Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Ketoprofen Pathway	Homocarnosinosis	Ketorolac Action Pathway	Meloxicam Action Pathway	Antipyrine Action Pathway	Mefenamic Acid Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Suprofen Action Pathway	Succinic semialdehyde dehydrogenase deficiency	Naproxen Pathway	Glutamate Metabolism	Pyruvate Metabolism	Magnesium salicylate Action Pathway	Leigh Syndrome	Primary hyperoxaluria II, PH2	Salicylic Acid Action Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Pyruvate kinase deficiency	2-Hydroxyglutric Aciduria (D And L Form)	Sulindac Pathway	Lumiracoxib Action Pathway	Pyruvate Dehydrogenase Complex Deficiency	Bromfenac Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Piroxicam Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Ibuprofen Action Pathway	Acetaminophen Metabolism Pathway	Acetylsalicylic Acid Pathway	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Diflunisal Pathway	Hyperinsulinism-Hyperammonemia Syndrome	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Carprofen Action Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Nabumetone Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
Uridine diphosphate glucuronic acid	HMDB_SMPDB	Samples:	76	Pathways:	35	Starch and Sucrose Metabolism	Morphine Metabolism Pathway	Valproic Acid Metabolism Pathway	Aromatase deficiency	Porphyrin Metabolism	Tramadol Metabolism Pathway	Artemether Metabolism Pathway	Glycogenosis, Type VI. Hers disease	Porphyria Variegata (PV)	Etoposide Metabolism Pathway	Nicotine Metabolism Pathway	Ibuprofen Metabolism Pathway	Nicotine Pathway	Codeine Pathway	Androgen and Estrogen Metabolism	Sorafenib Metabolism Pathway	Glycogen synthetase deficiency	Celecoxib Metabolism Pathway	Irinotecan Metabolism Pathway	Mucopolysaccharidosis VI. Sly syndrome	Codeine Metabolism Pathway	Ibuprofen Pathway	Hereditary Coproporphyria (HCP)	Phenytoin (Antiarrhythmic) Pathway	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Acetaminophen Metabolism Pathway	Tamoxifen Metabolism Pathway	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Tamoxifen Pathway	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Acute Intermittent Porphyria	Morphine Pathway	Nevirapine Metabolism Pathway
Arachidonic acid	HMDB_SMPDB	Samples:	15	Pathways:	39	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Oxaprozin Pathway	Salsalate Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Alpha Linolenic Acid and Linoleic Acid Metabolism	Nepafenac Action Pathway	Tenoxicam Action Pathway	Trisalicylate-choline Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Etodolac Pathway	Diflunisal Pathway	Leukotriene C4 Synthesis Deficiency	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Pathway	Magnesium salicylate Action Pathway	Phenylbutazone Action Pathway
Leukotriene B4	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
Prostaglandin F2a	HMDB_SMPDB	Samples:	11	Pathways:	38	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Oxaprozin Pathway	Salsalate Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Etodolac Pathway	Diflunisal Pathway	Leukotriene C4 Synthesis Deficiency	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Pathway	Magnesium salicylate Action Pathway	Phenylbutazone Action Pathway
Leukotriene C4	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
Prostaglandin E2	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
Prostaglandin I2	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
Leukotriene A4	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
Prostaglandin H2	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
Prostaglandin D2	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
Thromboxane A2	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
20-Hydroxy-leukotriene B4	HMDB_SMPDB	Samples:	11	Pathways:	38	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Oxaprozin Pathway	Salsalate Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Etodolac Pathway	Diflunisal Pathway	Leukotriene C4 Synthesis Deficiency	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Pathway	Magnesium salicylate Action Pathway	Phenylbutazone Action Pathway
Ibuprofen	HMDB_SMPDB	Samples:	12	Pathways:	3	Ibuprofen Pathway	Ibuprofen Action Pathway	Ibuprofen Metabolism Pathway
5,6-Epoxy-8,11,14-eicosatrienoic acid	HMDB_SMPDB	Samples:	11	Pathways:	38	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Oxaprozin Pathway	Salsalate Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Etodolac Pathway	Diflunisal Pathway	Leukotriene C4 Synthesis Deficiency	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Pathway	Magnesium salicylate Action Pathway	Phenylbutazone Action Pathway
8,9-Epoxyeicosatrienoic acid	HMDB_SMPDB	Samples:	11	Pathways:	38	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Oxaprozin Pathway	Salsalate Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Etodolac Pathway	Diflunisal Pathway	Leukotriene C4 Synthesis Deficiency	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Pathway	Magnesium salicylate Action Pathway	Phenylbutazone Action Pathway
14,15-DiHETrE	HMDB_SMPDB	Samples:	11	Pathways:	38	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Oxaprozin Pathway	Salsalate Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Etodolac Pathway	Diflunisal Pathway	Leukotriene C4 Synthesis Deficiency	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Pathway	Magnesium salicylate Action Pathway	Phenylbutazone Action Pathway
8,9-DiHETrE	HMDB_SMPDB	Samples:	11	Pathways:	38	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Oxaprozin Pathway	Salsalate Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Etodolac Pathway	Diflunisal Pathway	Leukotriene C4 Synthesis Deficiency	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Pathway	Magnesium salicylate Action Pathway	Phenylbutazone Action Pathway
11,12-DiHETrE	HMDB_SMPDB	Samples:	11	Pathways:	38	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Oxaprozin Pathway	Salsalate Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Etodolac Pathway	Diflunisal Pathway	Leukotriene C4 Synthesis Deficiency	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Pathway	Magnesium salicylate Action Pathway	Phenylbutazone Action Pathway
5,6-DHET	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
Prostaglandin J2	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
Prostaglandin A2	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
Prostaglandin G2	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
Thromboxane B2	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
Oxidized glutathione	HMDB_SMPDB	Samples:	13	Pathways:	44	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Homocarnosinosis	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Salsalate Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Etodolac Pathway	Diflunisal Pathway	Hyperinsulinism-Hyperammonemia Syndrome	Leukotriene C4 Synthesis Deficiency	Nabumetone Pathway	Carprofen Action Pathway	Succinic semialdehyde dehydrogenase deficiency	Naproxen Pathway	Glutamate Metabolism	Rofecoxib Pathway	Lornoxicam Action Pathway	Phenylbutazone Action Pathway
15(S)-HETE	HMDB_SMPDB	Samples:	11	Pathways:	38	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Oxaprozin Pathway	Salsalate Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Etodolac Pathway	Diflunisal Pathway	Leukotriene C4 Synthesis Deficiency	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Pathway	Magnesium salicylate Action Pathway	Phenylbutazone Action Pathway
12-Keto-leukotriene B4	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
Prostaglandin B2	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
Delta-12-Prostaglandin J2	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
6-Ketoprostaglandin E1	HMDB_SMPDB	Samples:	11	Pathways:	38	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Oxaprozin Pathway	Salsalate Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Etodolac Pathway	Diflunisal Pathway	Leukotriene C4 Synthesis Deficiency	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Pathway	Magnesium salicylate Action Pathway	Phenylbutazone Action Pathway
11-Dehydro-thromboxane B2	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
12(S)-HPETE	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
15(S)-HPETE	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
14,15-Epoxy-5,8,11-eicosatrienoic acid	HMDB_SMPDB	Samples:	11	Pathways:	38	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Oxaprozin Pathway	Salsalate Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Etodolac Pathway	Diflunisal Pathway	Leukotriene C4 Synthesis Deficiency	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Pathway	Magnesium salicylate Action Pathway	Phenylbutazone Action Pathway
8-Isoprostane	HMDB_SMPDB	Samples:	11	Pathways:	38	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Oxaprozin Pathway	Salsalate Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Etodolac Pathway	Diflunisal Pathway	Leukotriene C4 Synthesis Deficiency	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Pathway	Magnesium salicylate Action Pathway	Phenylbutazone Action Pathway
11,12-Epoxyeicosatrienoic acid	HMDB_SMPDB	Samples:	11	Pathways:	38	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Oxaprozin Pathway	Salsalate Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Etodolac Pathway	Diflunisal Pathway	Leukotriene C4 Synthesis Deficiency	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Pathway	Magnesium salicylate Action Pathway	Phenylbutazone Action Pathway
8-HETE	HMDB_SMPDB	Samples:	11	Pathways:	38	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Oxaprozin Pathway	Salsalate Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Etodolac Pathway	Diflunisal Pathway	Leukotriene C4 Synthesis Deficiency	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Pathway	Magnesium salicylate Action Pathway	Phenylbutazone Action Pathway
16(R)-HETE	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
11,12,15-THETA	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
12(R)-HPETE	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
11H-14,15-EETA	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
11,14,15-THETA	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
8(S)-HPETE	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
15H-11,12-EETA	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
15-Deoxy-d-12,14-PGJ2	HMDB_SMPDB	Samples:	11	Pathways:	38	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Oxaprozin Pathway	Salsalate Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Etodolac Pathway	Diflunisal Pathway	Leukotriene C4 Synthesis Deficiency	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Pathway	Magnesium salicylate Action Pathway	Phenylbutazone Action Pathway
20-Hydroxyeicosatetraenoic acid	HMDB_SMPDB	Samples:	11	Pathways:	38	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Oxaprozin Pathway	Salsalate Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Etodolac Pathway	Diflunisal Pathway	Leukotriene C4 Synthesis Deficiency	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Pathway	Magnesium salicylate Action Pathway	Phenylbutazone Action Pathway
20-Carboxy-leukotriene B4	HMDB_SMPDB	Samples:	11	Pathways:	38	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Oxaprozin Pathway	Salsalate Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Etodolac Pathway	Diflunisal Pathway	Leukotriene C4 Synthesis Deficiency	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Pathway	Magnesium salicylate Action Pathway	Phenylbutazone Action Pathway
PC(14:0/20:4(5Z,8Z,11Z,14Z))	HMDB_SMPDB	Samples:	11	Pathways:	38	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Oxaprozin Pathway	Salsalate Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Etodolac Pathway	Diflunisal Pathway	Leukotriene C4 Synthesis Deficiency	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Pathway	Magnesium salicylate Action Pathway	Phenylbutazone Action Pathway
5-KETE	HMDB_SMPDB	Samples:	11	Pathways:	38	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Oxaprozin Pathway	Salsalate Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Etodolac Pathway	Diflunisal Pathway	Leukotriene C4 Synthesis Deficiency	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Pathway	Magnesium salicylate Action Pathway	Phenylbutazone Action Pathway
LysoPC(14:0)	HMDB_SMPDB	Samples:	11	Pathways:	38	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Oxaprozin Pathway	Salsalate Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Etodolac Pathway	Diflunisal Pathway	Leukotriene C4 Synthesis Deficiency	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Pathway	Magnesium salicylate Action Pathway	Phenylbutazone Action Pathway
5-HETE	HMDB_SMPDB	Samples:	11	Pathways:	38	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Oxaprozin Pathway	Salsalate Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Etodolac Pathway	Diflunisal Pathway	Leukotriene C4 Synthesis Deficiency	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Pathway	Magnesium salicylate Action Pathway	Phenylbutazone Action Pathway
5-HPETE	HMDB_SMPDB	Samples:	11	Pathways:	38	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Oxaprozin Pathway	Salsalate Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Etodolac Pathway	Diflunisal Pathway	Leukotriene C4 Synthesis Deficiency	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Pathway	Magnesium salicylate Action Pathway	Phenylbutazone Action Pathway
19(S)-HETE	HMDB_SMPDB	Samples:	12	Pathways:	56	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
11-Epi-PGF2a	HMDB_SMPDB	Samples:	11	Pathways:	38	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Oxaprozin Pathway	Salsalate Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Etodolac Pathway	Diflunisal Pathway	Leukotriene C4 Synthesis Deficiency	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Pathway	Magnesium salicylate Action Pathway	Phenylbutazone Action Pathway
Fe3+	HMDB_SMPDB	Samples:	62	Pathways:	78	Diclofenac Action Pathway	Tyrosinemia Type I	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Action Pathway	Meloxicam Action Pathway	Porphyria Variegata (PV)	Phenylalanine and Tyrosine Metabolism	Disulfiram Pathway	Antipyrine Action Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Mefenamic Acid Action Pathway	Gemcitabine Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Gemcitabine Metabolism Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Phenylketonuria	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Suprofen Action Pathway	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Acute Intermittent Porphyria	Naproxen Pathway	Hawkinsinuria	Tyrosine Metabolism	Magnesium salicylate Action Pathway	Monoamine oxidase-a deficiency (MAO-A)	Salicylic Acid Action Pathway	Porphyrin Metabolism	Ketorolac Pathway	Disulfiram Action Pathway	Nabumetone Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Gemcitabine Action Pathway	Alkaptonuria	Sulindac Pathway	Lumiracoxib Action Pathway	Dopamine beta-hydroxylase deficiency	Bromfenac Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Piroxicam Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Hereditary Coproporphyria (HCP)	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Ubiquinone Biosynthesis	Oxaprozin Action Pathway	Tyrosinemia, transient, of the newborn	Naproxen Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Tyrosinemia Type 3 (TYRO3)	Carprofen Action Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Nabumetone Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
12-KETE	HMDB_SMPDB	Samples:	11	Pathways:	38	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Fenoprofen Action Pathway	Valdecoxib Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Oxaprozin Pathway	Salsalate Action Pathway	Diclofenac Pathway	Ibuprofen Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Etodolac Pathway	Diflunisal Pathway	Leukotriene C4 Synthesis Deficiency	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Pathway	Magnesium salicylate Action Pathway	Phenylbutazone Action Pathway
Arachidonate	HMDB_SMPDB	Samples:	16	Pathways:	57	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Ketoprofen Pathway	Ketorolac Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Piroxicam Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Sulindac Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Valdecoxib Pathway	Magnesium salicylate Action Pathway	Meloxicam Pathway	Suprofen Pathway	Mefanamic Acid Pathway	Oxaprozin Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Diclofenac Pathway	Salsalate Action Pathway	Ibuprofen Pathway	Alpha Linolenic Acid and Linoleic Acid Metabolism	Nepafenac Action Pathway	Tenoxicam Action Pathway	Trisalicylate-choline Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Acetylsalicylic Acid Pathway	Bromfenac Pathway	Diflunisal Action Pathway	Etodolac Pathway	Ketoprofen Action Pathway	Diflunisal Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Nabumetone Pathway	Carprofen Action Pathway	Naproxen Pathway	Rofecoxib Action Pathway	Rofecoxib Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
Tramadol	HMDB_SMPDB	Samples:	36	Pathways:	2	Tramadol Metabolism Pathway	Tramadol Action Action Pathway
Tetrahydrobiopterin	HMDB_SMPDB	Samples:	56	Pathways:	37	Tyrosinemia Type I	Hyperprolinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Arginine and Proline Metabolism	Aromatic L-Aminoacid Decarboxylase Deficiency	Disulfiram Action Pathway	Alkaptonuria	Phenylalanine and Tyrosine Metabolism	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Sepiapterin reductase deficiency	Dopamine beta-hydroxylase deficiency	Hyperprolinemia Type II	Disulfiram Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Dopa-responsive dystonia	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Catecholamine Biosynthesis	Tyrosine hydroxylase deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Tyrosinemia, transient, of the newborn	Hyperphenylalaninemia due to dhpr-deficiency	Phenylketonuria	Doxorubicin Metabolism Pathway	Tryptophan Metabolism	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Tyrosinemia Type 3 (TYRO3)	L-arginine:glycine amidinotransferase deficiency	Pterine Biosynthesis	Hawkinsinuria	Segawa syndrome	Tyrosine Metabolism
Adenosine monophosphate	HMDB_SMPDB	Samples:	62	Pathways:	75	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Lactic Acidemia	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Trifunctional protein deficiency	Butyrate Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocarnosinosis	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Disulfiram Pathway	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Malonyl-coa decarboxylase deficiency	Carnitine palmitoyl transferase deficiency (I)	Non Ketotic Hyperglycinemia	Citrullinemia Type I	Hyperglycinemia, non-ketotic	Ethylmalonic Encephalopathy	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Malonic Aciduria	Phenylketonuria	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Pantothenate and CoA Biosynthesis	Propanoate Metabolism	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Pyruvate Carboxylase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Phenylacetate Metabolism	Glutamate Metabolism	Pyruvate Metabolism	Leigh Syndrome	Alanine Metabolism	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Histidinemia	Pyruvate kinase deficiency	2-Hydroxyglutric Aciduria (D And L Form)	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Argininemia	Pyruvate Dehydrogenase Complex Deficiency	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Primary Hyperoxaluria Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Histidine Metabolism	Thiamine Metabolism	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Argininosuccinic Aciduria	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	Ammonia Recycling	Tyrosinemia Type 3 (TYRO3)	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Selenoamino Acid Metabolism
Argininosuccinic acid	HMDB_SMPDB	Samples:	45	Pathways:	18	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Carbamoyl Phosphate Synthetase Deficiency	Urea Cycle	Argininosuccinic Aciduria	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperprolinemia Type II	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	L-arginine:glycine amidinotransferase deficiency	Citrullinemia Type I
Creatine	HMDB_SMPDB	Samples:	50	Pathways:	19	Hyperprolinemia Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Arginine and Proline Metabolism	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperprolinemia Type II	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Dimethylglycine Dehydrogenase Deficiency	L-arginine:glycine amidinotransferase deficiency	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
Glycine	HMDB_SMPDB	Samples:	52	Pathways:	45	Cerebrotendinous Xanthomatosis (CTX)	Hyperprolinemia Type I	Alanine Metabolism	Lactic Acidemia	Congenital Bile Acid Synthesis Defect Type III	Familial Hypercholanemia (FHCA)	Arginine and Proline Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Carnitine Synthesis	Porphyrin Metabolism	27-Hydroxylase Deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocarnosinosis	Porphyria Variegata (PV)	2-Hydroxyglutric Aciduria (D And L Form)	Bile Acid Biosynthesis	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Zellweger Syndrome	Hyperprolinemia Type II	sarcosine oncometabolite pathway 	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Dimethylglycine Dehydrogenase Deficiency	Non Ketotic Hyperglycinemia	Hyperglycinemia, non-ketotic	Primary Hyperoxaluria Type I	Hereditary Coproporphyria (HCP)	Congenital Bile Acid Synthesis Defect Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperinsulinism-Hyperammonemia Syndrome	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Ammonia Recycling	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Acute Intermittent Porphyria	L-arginine:glycine amidinotransferase deficiency	Pyruvate Carboxylase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Glutamate Metabolism	Glycine and Serine Metabolism
Guanidoacetic acid	HMDB_SMPDB	Samples:	50	Pathways:	19	Hyperprolinemia Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Arginine and Proline Metabolism	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperprolinemia Type II	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Dimethylglycine Dehydrogenase Deficiency	L-arginine:glycine amidinotransferase deficiency	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
Fumaric acid	HMDB_SMPDB	Samples:	65	Pathways:	45	Tyrosinemia Type I	Hyperprolinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Congenital lactic acidosis	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Arginine and Proline Metabolism	The oncogenic action of Succinate	Carbamoyl Phosphate Synthetase Deficiency	Citric Acid Cycle	Alkaptonuria	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Argininemia	Mitochondrial Electron Transport Chain	Dopamine beta-hydroxylase deficiency	Hyperprolinemia Type II	Disulfiram Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	The oncogenic action of 2-hydroxyglutarate	Citrullinemia Type I	2-ketoglutarate dehydrogenase complex deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	The oncogenic action of Fumarate	Tyrosinemia, transient, of the newborn	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Urea Cycle	Argininosuccinic Aciduria	Fumarase deficiency	Glutaminolysis and Cancer	Phenylketonuria	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Pyruvate dehydrogenase deficiency (E2)	Tyrosinemia Type 3 (TYRO3)	L-arginine:glycine amidinotransferase deficiency	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Tyrosine Metabolism
L-Proline	HMDB_SMPDB	Samples:	62	Pathways:	14	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	The oncogenic action of Fumarate	The oncogenic action of Succinate	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
L-Aspartic acid	HMDB_SMPDB	Samples:	63	Pathways:	39	Tyrosinemia Type I	Hyperprolinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Beta-Alanine Metabolism	Ureidopropionase deficiency	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Homocarnosinosis	Alkaptonuria	2-Hydroxyglutric Aciduria (D And L Form)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Dopamine beta-hydroxylase deficiency	Hyperprolinemia Type II	Disulfiram Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Citrullinemia Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Tyrosinemia, transient, of the newborn	Carnosinuria, carnosinemia	Malate-Aspartate Shuttle	Urea Cycle	Argininosuccinic Aciduria	Glutaminolysis and Cancer	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperinsulinism-Hyperammonemia Syndrome	Ammonia Recycling	GABA-Transaminase Deficiency	L-arginine:glycine amidinotransferase deficiency	Succinic semialdehyde dehydrogenase deficiency	Hawkinsinuria	Glutamate Metabolism	Tyrosine Metabolism
Ornithine	HMDB_SMPDB	Samples:	49	Pathways:	19	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Carbamoyl Phosphate Synthetase Deficiency	Urea Cycle	Argininosuccinic Aciduria	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperprolinemia Type II	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Citrullinemia Type I
Oxalacetic acid	HMDB_SMPDB	Samples:	65	Pathways:	66	Tyrosinemia Type I	Hyperprolinemia Type I	Lactic Acidemia	Congenital lactic acidosis	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Glycogenosis, Type IC	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Homocarnosinosis	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Hyperprolinemia Type II	Disulfiram Pathway	The oncogenic action of 2-hydroxyglutarate	Citrullinemia Type I	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	2-ketoglutarate dehydrogenase complex deficiency	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Glycogenosis, Type IB	Urea Cycle	Fumarase deficiency	Transfer of Acetyl Groups into Mitochondria	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Glycogenosis, Type IA. Von gierke disease	Pyruvate dehydrogenase deficiency (E2)	Pyruvate Carboxylase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Glutamate Metabolism	Tyrosine Metabolism	Pyruvate Metabolism	Leigh Syndrome	Monoamine oxidase-a deficiency (MAO-A)	Alanine Metabolism	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Carbamoyl Phosphate Synthetase Deficiency	Citric Acid Cycle	Gluconeogenesis	Fructose-1,6-diphosphatase deficiency	Pyruvate kinase deficiency	Alkaptonuria	2-Hydroxyglutric Aciduria (D And L Form)	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Argininemia	Dopamine beta-hydroxylase deficiency	Pyruvate Dehydrogenase Complex Deficiency	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Primary Hyperoxaluria Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	Prolinemia Type II	The oncogenic action of Fumarate	Tyrosinemia, transient, of the newborn	Malate-Aspartate Shuttle	Triosephosphate isomerase	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Argininosuccinic Aciduria	Glutaminolysis and Cancer	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Hyperinsulinism-Hyperammonemia Syndrome	L-arginine:glycine amidinotransferase deficiency
Urea	HMDB_SMPDB	Samples:	59	Pathways:	67	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Kidney Function	Indapamide Pathway	Bumetanide Action Pathway	Lysinuric Protein Intolerance	Cyclothiazide Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Triamterene Action Pathway	Hyperprolinemia Type II	Furosemide Action Pathway	Quinethazone Action Pathway	Citrullinemia Type I	Eplerenone Action Pathway	Glucose Transporter Defect (SGLT2)	Torsemide Action Pathway	Ethacrynic Acid pathway	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Chlorthalidone Pathway	Polythiazide Action Pathway	Urea Cycle	Cystinuria	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hydrochlorothiazide Pathway	Methyclothiazide Action Pathway	Hydroflumethiazide Action Pathway	Methyclothiazide Pathway	Iminoglycinuria	Blue diaper syndrome	Ethacrynic Acid Action Pathway	Amiloride Pathway	Bendroflumethiazide Pathway	Lysinuric protein intolerance (LPI)	Cyclothiazide Action Pathway	Arginine and Proline Metabolism	Bendroflumethiazide Action Pathway	Carbamoyl Phosphate Synthetase Deficiency	Spironolactone Action Pathway	Spironolactone Pathway	Trichlormethiazide Pathway	Hydroflumethiazide Pathway	Metolazone Action Pathway	Hydrochlorothiazide Action Pathway	Argininemia	Polythiazide Pathway	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Bumetanide Pathway	Trichlormethiazide Action Pathway	Chlorothiazide Action Pathway	Chlorothiazide Pathway	Furosemide Pathway	Eplerenone Pathway	Torsemide Pathway	Indapamide Action Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Chlorthalidone Action Pathway	Triamterene Pathway	Hartnup Disorder	Argininosuccinic Aciduria	D-Arginine and D-Ornithine Metabolism	Amiloride Action Pathway	L-arginine:glycine amidinotransferase deficiency	Quinethazone Pathway	Metolazone Pathway
L-Arginine	HMDB_SMPDB	Samples:	50	Pathways:	25	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Argininosuccinic Aciduria	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type II	Prolidase Deficiency (PD)	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Dimethylglycine Dehydrogenase Deficiency	L-arginine:glycine amidinotransferase deficiency	Non Ketotic Hyperglycinemia	Citrullinemia Type I	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
Citrulline	HMDB_SMPDB	Samples:	45	Pathways:	18	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Carbamoyl Phosphate Synthetase Deficiency	Urea Cycle	Argininosuccinic Aciduria	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperprolinemia Type II	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	L-arginine:glycine amidinotransferase deficiency	Citrullinemia Type I
S-Adenosylhomocysteine	HMDB_SMPDB	Samples:	58	Pathways:	39	Tyrosinemia Type I	Hyperprolinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Carnitine Synthesis	Arginine and Proline Metabolism	Aromatic L-Aminoacid Decarboxylase Deficiency	Histidinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Alkaptonuria	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Dopamine beta-hydroxylase deficiency	Hyperprolinemia Type II	Disulfiram Pathway	sarcosine oncometabolite pathway 	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Dimethylglycine Dehydrogenase Deficiency	Betaine Metabolism	Catecholamine Biosynthesis	Non Ketotic Hyperglycinemia	Hyperglycinemia, non-ketotic	Tyrosine hydroxylase deficiency	Ubiquinone Biosynthesis	Phenytoin (Antiarrhythmic) Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Tyrosinemia, transient, of the newborn	Histidine Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Tryptophan Metabolism	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	L-arginine:glycine amidinotransferase deficiency	Hawkinsinuria	Glycine and Serine Metabolism	Tyrosine Metabolism
Carbamoyl phosphate	HMDB_SMPDB	Samples:	45	Pathways:	25	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Prolinemia Type II	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Urea Cycle	Homocarnosinosis	Argininosuccinic Aciduria	2-Hydroxyglutric Aciduria (D And L Form)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperprolinemia Type II	Hyperinsulinism-Hyperammonemia Syndrome	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Ammonia Recycling	L-arginine:glycine amidinotransferase deficiency	Succinic semialdehyde dehydrogenase deficiency	Glutamate Metabolism	Citrullinemia Type I
S-Adenosylmethionine	HMDB_SMPDB	Samples:	58	Pathways:	39	Tyrosinemia Type I	Hyperprolinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Carnitine Synthesis	Arginine and Proline Metabolism	Aromatic L-Aminoacid Decarboxylase Deficiency	Histidinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Alkaptonuria	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Dopamine beta-hydroxylase deficiency	Hyperprolinemia Type II	Disulfiram Pathway	sarcosine oncometabolite pathway 	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Dimethylglycine Dehydrogenase Deficiency	Betaine Metabolism	Catecholamine Biosynthesis	Non Ketotic Hyperglycinemia	Hyperglycinemia, non-ketotic	Tyrosine hydroxylase deficiency	Ubiquinone Biosynthesis	Phenytoin (Antiarrhythmic) Pathway	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Tyrosinemia, transient, of the newborn	Histidine Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Tryptophan Metabolism	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	L-arginine:glycine amidinotransferase deficiency	Hawkinsinuria	Glycine and Serine Metabolism	Tyrosine Metabolism
1-Pyrroline-5-carboxylic acid	HMDB_SMPDB	Samples:	45	Pathways:	18	Hyperprolinemia Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Homocarnosinosis	2-Hydroxyglutric Aciduria (D And L Form)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperprolinemia Type II	Hyperinsulinism-Hyperammonemia Syndrome	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	L-arginine:glycine amidinotransferase deficiency	Succinic semialdehyde dehydrogenase deficiency	Glutamate Metabolism
Pyrroline hydroxycarboxylic acid	HMDB_SMPDB	Samples:	45	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
Phosphocreatine	HMDB_SMPDB	Samples:	45	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
Flavin Mononucleotide	HMDB_SMPDB	Samples:	49	Pathways:	18	Ureidopropionase deficiency	Hyperprolinemia Type I	Beta-Alanine Metabolism	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Carnosinuria, carnosinemia	Doxorubicin Metabolism Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperprolinemia Type II	Pantothenate and CoA Biosynthesis	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	GABA-Transaminase Deficiency	L-arginine:glycine amidinotransferase deficiency
4-Hydroxy-2-oxoglutaric acid	HMDB_SMPDB	Samples:	45	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
L-Glutamic gamma-semialdehyde	HMDB_SMPDB	Samples:	45	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
1-Pyrroline-4-hydroxy-2-carboxylate	HMDB_SMPDB	Samples:	45	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
4-Hydroxy-L-glutamic acid	HMDB_SMPDB	Samples:	45	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
Nitric oxide	HMDB_SMPDB	Samples:	45	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
D-Proline	HMDB_SMPDB	Samples:	45	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
N-(o)-Hydroxyarginine	HMDB_SMPDB	Samples:	45	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
4-Hydroxy-L-proline	HMDB_SMPDB	Samples:	45	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
L-4-Hydroxyglutamate semialdehyde	HMDB_SMPDB	Samples:	45	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
1-Pyrroline-2-carboxylic acid	HMDB_SMPDB	Samples:	47	Pathways:	13	D-Arginine and D-Ornithine Metabolism	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
1-Pyrroline-2-carboxylate	HMDB_SMPDB	Samples:	47	Pathways:	13	D-Arginine and D-Ornithine Metabolism	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
4-Hydroxy-2-oxoglutarate	HMDB_SMPDB	Samples:	45	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
4-Hydroxy-L-glutamate	HMDB_SMPDB	Samples:	45	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
AMP	HMDB_SMPDB	Samples:	62	Pathways:	74	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Lactic Acidemia	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Valproic Acid Metabolism Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Trifunctional protein deficiency	Butyrate Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocarnosinosis	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Hyperprolinemia Type II	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Dimethylglycine Dehydrogenase Deficiency	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Malonyl-coa decarboxylase deficiency	Carnitine palmitoyl transferase deficiency (I)	Non Ketotic Hyperglycinemia	Citrullinemia Type I	Hyperglycinemia, non-ketotic	Ethylmalonic Encephalopathy	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Fatty acid Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Malonic Aciduria	Phenylketonuria	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Pantothenate and CoA Biosynthesis	Propanoate Metabolism	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Pyruvate Carboxylase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Phenylacetate Metabolism	Glutamate Metabolism	Pyruvate Metabolism	Leigh Syndrome	Alanine Metabolism	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Histidinemia	Disulfiram Action Pathway	Pyruvate kinase deficiency	2-Hydroxyglutric Aciduria (D And L Form)	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Argininemia	Pyruvate Dehydrogenase Complex Deficiency	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Carnitine palmitoyl transferase deficiency (II)	Primary Hyperoxaluria Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Histidine Metabolism	Thiamine Metabolism	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Argininosuccinic Aciduria	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Hyperinsulinism-Hyperammonemia Syndrome	Ethanol Degradation	Ammonia Recycling	Tyrosinemia Type 3 (TYRO3)	L-arginine:glycine amidinotransferase deficiency	Glycine and Serine Metabolism	Selenoamino Acid Metabolism
cis-4-Hydroxy-L-proline	HMDB_SMPDB	Samples:	45	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
Delta1-Pyrroline-5-carboxylate	HMDB_SMPDB	Samples:	45	Pathways:	18	Hyperprolinemia Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Homocarnosinosis	2-Hydroxyglutric Aciduria (D And L Form)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperprolinemia Type II	Hyperinsulinism-Hyperammonemia Syndrome	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	L-arginine:glycine amidinotransferase deficiency	Succinic semialdehyde dehydrogenase deficiency	Glutamate Metabolism
FMN	HMDB_SMPDB	Samples:	49	Pathways:	18	Ureidopropionase deficiency	Hyperprolinemia Type I	Beta-Alanine Metabolism	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Carnosinuria, carnosinemia	Doxorubicin Metabolism Pathway	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperprolinemia Type II	Pantothenate and CoA Biosynthesis	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	GABA-Transaminase Deficiency	L-arginine:glycine amidinotransferase deficiency
Fumarate	HMDB_SMPDB	Samples:	65	Pathways:	44	Tyrosinemia Type I	Hyperprolinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Congenital lactic acidosis	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Arginine and Proline Metabolism	The oncogenic action of Succinate	Carbamoyl Phosphate Synthetase Deficiency	Citric Acid Cycle	Disulfiram Action Pathway	Alkaptonuria	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Phenylalanine and Tyrosine Metabolism	Argininemia	Mitochondrial Electron Transport Chain	Dopamine beta-hydroxylase deficiency	Hyperprolinemia Type II	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	The oncogenic action of 2-hydroxyglutarate	Citrullinemia Type I	2-ketoglutarate dehydrogenase complex deficiency	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	The oncogenic action of Fumarate	Tyrosinemia, transient, of the newborn	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Urea Cycle	Argininosuccinic Aciduria	Fumarase deficiency	Glutaminolysis and Cancer	Phenylketonuria	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Pyruvate dehydrogenase deficiency (E2)	Tyrosinemia Type 3 (TYRO3)	L-arginine:glycine amidinotransferase deficiency	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Tyrosine Metabolism
Guanidinoacetate	HMDB_SMPDB	Samples:	50	Pathways:	19	Hyperprolinemia Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Arginine and Proline Metabolism	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperprolinemia Type II	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Dimethylglycine Dehydrogenase Deficiency	L-arginine:glycine amidinotransferase deficiency	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
L-1-Pyrroline-3-hydroxy-5-carboxylate	HMDB_SMPDB	Samples:	45	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
L-Aspartate	HMDB_SMPDB	Samples:	63	Pathways:	39	Tyrosinemia Type I	Hyperprolinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Beta-Alanine Metabolism	Ureidopropionase deficiency	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Arginine and Proline Metabolism	Carbamoyl Phosphate Synthetase Deficiency	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Disulfiram Action Pathway	Homocarnosinosis	Alkaptonuria	2-Hydroxyglutric Aciduria (D And L Form)	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Dopamine beta-hydroxylase deficiency	Hyperprolinemia Type II	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Citrullinemia Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Tyrosinemia, transient, of the newborn	Carnosinuria, carnosinemia	Malate-Aspartate Shuttle	Urea Cycle	Argininosuccinic Aciduria	Glutaminolysis and Cancer	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperinsulinism-Hyperammonemia Syndrome	Ammonia Recycling	GABA-Transaminase Deficiency	L-arginine:glycine amidinotransferase deficiency	Succinic semialdehyde dehydrogenase deficiency	Hawkinsinuria	Glutamate Metabolism	Tyrosine Metabolism
L-Citrulline	HMDB_SMPDB	Samples:	45	Pathways:	18	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Carbamoyl Phosphate Synthetase Deficiency	Urea Cycle	Argininosuccinic Aciduria	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperprolinemia Type II	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	L-arginine:glycine amidinotransferase deficiency	Citrullinemia Type I
L-Glutamate 5-semialdehyde	HMDB_SMPDB	Samples:	45	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
L-Ornithine	HMDB_SMPDB	Samples:	45	Pathways:	18	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Carbamoyl Phosphate Synthetase Deficiency	Urea Cycle	Argininosuccinic Aciduria	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperprolinemia Type II	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	L-arginine:glycine amidinotransferase deficiency	Citrullinemia Type I
N(omega)-Hydroxyarginine	HMDB_SMPDB	Samples:	45	Pathways:	12	Hyperornithinemia with gyrate atrophy (HOGA)	Hyperprolinemia Type I	Hyperprolinemia Type II	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolidase Deficiency (PD)	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Prolinemia Type II	L-arginine:glycine amidinotransferase deficiency	Creatine deficiency, guanidinoacetate methyltransferase deficiency
N-(L-Arginino)succinate	HMDB_SMPDB	Samples:	45	Pathways:	18	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Hyperprolinemia Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Arginine and Proline Metabolism	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Carbamoyl Phosphate Synthetase Deficiency	Urea Cycle	Argininosuccinic Aciduria	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Argininemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Hyperprolinemia Type II	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	L-arginine:glycine amidinotransferase deficiency	Citrullinemia Type I
Oxaloacetate	HMDB_SMPDB	Samples:	65	Pathways:	65	Tyrosinemia Type I	Hyperprolinemia Type I	Lactic Acidemia	Congenital lactic acidosis	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Glycogenosis, Type IC	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Homocarnosinosis	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Hyperprolinemia Type II	The oncogenic action of 2-hydroxyglutarate	Citrullinemia Type I	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	2-ketoglutarate dehydrogenase complex deficiency	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Glycogenosis, Type IB	Urea Cycle	Fumarase deficiency	Transfer of Acetyl Groups into Mitochondria	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Glycogenosis, Type IA. Von gierke disease	Pyruvate dehydrogenase deficiency (E2)	Pyruvate Carboxylase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Hawkinsinuria	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Glutamate Metabolism	Tyrosine Metabolism	Pyruvate Metabolism	Leigh Syndrome	Monoamine oxidase-a deficiency (MAO-A)	Alanine Metabolism	Primary hyperoxaluria II, PH2	Arginine and Proline Metabolism	The oncogenic action of Succinate	Carbamoyl Phosphate Synthetase Deficiency	Citric Acid Cycle	Gluconeogenesis	Disulfiram Action Pathway	Fructose-1,6-diphosphatase deficiency	Pyruvate kinase deficiency	Alkaptonuria	2-Hydroxyglutric Aciduria (D And L Form)	Argininemia	Dopamine beta-hydroxylase deficiency	Pyruvate Dehydrogenase Complex Deficiency	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Primary Hyperoxaluria Type I	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Mitochondrial complex II deficiency	Prolinemia Type II	The oncogenic action of Fumarate	Tyrosinemia, transient, of the newborn	Malate-Aspartate Shuttle	Triosephosphate isomerase	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Argininosuccinic Aciduria	Glutaminolysis and Cancer	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Hyperinsulinism-Hyperammonemia Syndrome	L-arginine:glycine amidinotransferase deficiency
S-Adenosyl-L-homocysteine	HMDB_SMPDB	Samples:	59	Pathways:	38	Tyrosinemia Type I	Hyperprolinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Carnitine Synthesis	Arginine and Proline Metabolism	Aromatic L-Aminoacid Decarboxylase Deficiency	Histidinemia	Disulfiram Action Pathway	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Alkaptonuria	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Dopamine beta-hydroxylase deficiency	Hyperprolinemia Type II	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Dimethylglycine Dehydrogenase Deficiency	Betaine Metabolism	Catecholamine Biosynthesis	Non Ketotic Hyperglycinemia	Hyperglycinemia, non-ketotic	Tyrosine hydroxylase deficiency	Ubiquinone Biosynthesis	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Tyrosinemia, transient, of the newborn	Histidine Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Tryptophan Metabolism	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Phenytoin (Antiarrhythmic) Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	L-arginine:glycine amidinotransferase deficiency	Hawkinsinuria	Glycine and Serine Metabolism	Tyrosine Metabolism
S-Adenosyl-L-methionine	HMDB_SMPDB	Samples:	59	Pathways:	38	Tyrosinemia Type I	Hyperprolinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Carnitine Synthesis	Arginine and Proline Metabolism	Aromatic L-Aminoacid Decarboxylase Deficiency	Histidinemia	Disulfiram Action Pathway	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Alkaptonuria	Creatine deficiency, guanidinoacetate methyltransferase deficiency	Dopamine beta-hydroxylase deficiency	Hyperprolinemia Type II	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	Dimethylglycine Dehydrogenase Deficiency	Betaine Metabolism	Catecholamine Biosynthesis	Non Ketotic Hyperglycinemia	Hyperglycinemia, non-ketotic	Tyrosine hydroxylase deficiency	Ubiquinone Biosynthesis	Ornithine Aminotransferase Deficiency (OAT Deficiency)	Prolinemia Type II	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	Tyrosinemia, transient, of the newborn	Histidine Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Tryptophan Metabolism	Sarcosinemia	Hyperornithinemia with gyrate atrophy (HOGA)	Prolidase Deficiency (PD)	Phenytoin (Antiarrhythmic) Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	L-arginine:glycine amidinotransferase deficiency	Hawkinsinuria	Glycine and Serine Metabolism	Tyrosine Metabolism
12-Hydroxynevirapine	HMDB_SMPDB	Samples:	1	Pathways:	1	Nevirapine Metabolism Pathway
2-Hydroxynevirapine	HMDB_SMPDB	Samples:	1	Pathways:	1	Nevirapine Metabolism Pathway
8-Hydroxynevirapine	HMDB_SMPDB	Samples:	1	Pathways:	1	Nevirapine Metabolism Pathway
3-Hydroxynevirapine	HMDB_SMPDB	Samples:	1	Pathways:	1	Nevirapine Metabolism Pathway
Nevirapine	HMDB_SMPDB	Samples:	1	Pathways:	1	Nevirapine Metabolism Pathway
4-Carboxynevirapine	HMDB_SMPDB	Samples:	1	Pathways:	1	Nevirapine Metabolism Pathway
UDP-glucuronate	HMDB_SMPDB	Samples:	71	Pathways:	30	Starch and Sucrose Metabolism	Etoposide Action Pathway	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Valproic Acid Metabolism Pathway	Aromatase deficiency	Porphyrin Metabolism	Tramadol Metabolism Pathway	Artemether Metabolism Pathway	Glycogenosis, Type VI. Hers disease	Ibuprofen Action Pathway	Acetaminophen Metabolism Pathway	Tamoxifen Metabolism Pathway	Morphine Action Pathway	Porphyria Variegata (PV)	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Irinotecan Action Pathway	Phenytoin (Antiarrhythmic) Action Pathway	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism	Sorafenib Metabolism Pathway	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Tamoxifen Action Pathway	Acute Intermittent Porphyria	Glycogen synthetase deficiency	Mucopolysaccharidosis VI. Sly syndrome	Nevirapine Metabolism Pathway	Codeine Action Pathway	Hereditary Coproporphyria (HCP)	Nicotine Action Pathway
L-Alanine	HMDB_SMPDB	Samples:	61	Pathways:	27	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	Alanine Metabolism	Lactic Acidemia	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Carbamoyl Phosphate Synthetase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Urea Cycle	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocarnosinosis	Argininosuccinic Aciduria	Glucose-Alanine Cycle	Glutaminolysis and Cancer	2-Hydroxyglutric Aciduria (D And L Form)	Tryptophan Metabolism	Selenoamino Acid Metabolism	Argininemia	Sarcosinemia	Hyperinsulinism-Hyperammonemia Syndrome	Dimethylglycine Dehydrogenase Deficiency	Pyruvate Carboxylase Deficiency	Succinic semialdehyde dehydrogenase deficiency	Non Ketotic Hyperglycinemia	Glutamate Metabolism	Citrullinemia Type I	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Primary Hyperoxaluria Type I
Palmitic acid	HMDB_SMPDB	Samples:	58	Pathways:	19	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Familial Hypercholanemia (FHCA)	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Trifunctional protein deficiency	Fatty acid Metabolism	27-Hydroxylase Deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Bile Acid Biosynthesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Zellweger Syndrome	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
L-Palmitoylcarnitine	HMDB_SMPDB	Samples:	58	Pathways:	10	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
Octanoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	14	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
Butyryl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	15	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Trifunctional protein deficiency	Fatty acid Metabolism	Butyrate Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
3-Hydroxybutyryl-CoA	HMDB_SMPDB	Samples:	59	Pathways:	19	2-aminoadipic 2-oxoadipic aciduria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Trifunctional protein deficiency	Butyrate Metabolism	Hyperlysinemia I, Familial	Fatty acid Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Ethylmalonic Encephalopathy	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Carnitine palmitoyl transferase deficiency (I)	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	Lysine Degradation	Pyridoxine dependency with seizures	Hyperlysinemia II or Saccharopinuria
Palmityl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	14	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Phospholipid Biosynthesis	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
Glutaryl-CoA	HMDB_SMPDB	Samples:	59	Pathways:	16	2-aminoadipic 2-oxoadipic aciduria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Trifunctional protein deficiency	Hyperlysinemia I, Familial	Fatty acid Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Ethylmalonic Encephalopathy	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Carnitine palmitoyl transferase deficiency (I)	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	Lysine Degradation	Pyridoxine dependency with seizures	Hyperlysinemia II or Saccharopinuria
Crotonoyl-CoA	HMDB_SMPDB	Samples:	59	Pathways:	19	2-aminoadipic 2-oxoadipic aciduria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Trifunctional protein deficiency	Butyrate Metabolism	Hyperlysinemia I, Familial	Fatty acid Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Ethylmalonic Encephalopathy	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Carnitine palmitoyl transferase deficiency (I)	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	Lysine Degradation	Pyridoxine dependency with seizures	Hyperlysinemia II or Saccharopinuria
(S)-3-Hydroxyhexadecanoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
(S)-3-Hydroxytetradecanoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
3-Oxotetradecanoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
(S)-3-Hydroxydodecanoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
3-Oxododecanoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
(S)-Hydroxydecanoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
3-Oxodecanoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
(S)-Hydroxyoctanoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	14	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
3-Oxooctanoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	14	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
(S)-Hydroxyhexanoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	14	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
3-Oxohexanoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	14	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
trans-2-Hexenoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	15	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
(2E)-Hexadecenoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
(2E)-Tetradecenoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
(2E)-Decenoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
(2E)-Octenoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	14	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
3-Oxohexadecanoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
Decanoyl-CoA (n-C10:0CoA)	HMDB_SMPDB	Samples:	58	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
(R)-3-Hydroxybutanoyl-CoA	HMDB_SMPDB	Samples:	59	Pathways:	19	2-aminoadipic 2-oxoadipic aciduria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Trifunctional protein deficiency	Butyrate Metabolism	Hyperlysinemia I, Familial	Fatty acid Metabolism	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Ethylmalonic Encephalopathy	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Carnitine palmitoyl transferase deficiency (I)	Carnitine palmitoyl transferase deficiency (II)	Saccharopinuria/Hyperlysinemia II	Lysine Degradation	Pyridoxine dependency with seizures	Hyperlysinemia II or Saccharopinuria
(S)-3-Hydroxyoctanoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	12	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
3-Oxopalmitoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
Butanoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	15	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Trifunctional protein deficiency	Fatty acid Metabolism	Butyrate Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
Decanoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	12	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
Hexadecanoic acid	HMDB_SMPDB	Samples:	58	Pathways:	19	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Familial Hypercholanemia (FHCA)	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Trifunctional protein deficiency	Fatty acid Metabolism	27-Hydroxylase Deficiency	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Bile Acid Biosynthesis	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Zellweger Syndrome	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Carnitine palmitoyl transferase deficiency (I)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
Hexanoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	15	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
Palmitoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	14	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Phospholipid Biosynthesis	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
trans-Dec-2-enoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	12	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
trans-Hex-2-enoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	14	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
trans-Hexadec-2-enoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
trans-Oct-2-enoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	12	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
trans-Tetradec-2-enoyl-CoA	HMDB_SMPDB	Samples:	58	Pathways:	13	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	Glutaric Aciduria Type I	Trifunctional protein deficiency	Fatty acid Metabolism	Carnitine palmitoyl transferase deficiency (I)	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Carnitine palmitoyl transferase deficiency (II)	Ethylmalonic Encephalopathy
Etoposide	HMDB_SMPDB	Samples:	6	Pathways:	2	Etoposide Action Pathway	Etoposide Metabolism Pathway
Alfentanil	HMDB_SMPDB	Samples:	20	Pathways:	2	Alfentanil Action Pathway	Alfentanil Pathway
Cyclic AMP	HMDB_SMPDB	Samples:	1	Pathways:	2	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine
Guanosine diphosphate	HMDB_SMPDB	Samples:	65	Pathways:	30	Congenital lactic acidosis	The oncogenic action of Fumarate	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Glycogenosis, Type IC	Mitochondrial complex II deficiency	Citric Acid Cycle	Gluconeogenesis	Triosephosphate isomerase	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Fumarase deficiency	Pyruvate kinase deficiency	Glutaminolysis and Cancer	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycogenosis, Type IA. Von gierke disease	Pyruvate Dehydrogenase Complex Deficiency	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of 2-hydroxyglutarate	Pyruvate dehydrogenase deficiency (E3)	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Warburg Effect	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Pyruvate Metabolism	Leigh Syndrome	2-ketoglutarate dehydrogenase complex deficiency
Guanosine triphosphate	HMDB_SMPDB	Samples:	65	Pathways:	37	Congenital lactic acidosis	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Glycogenosis, Type IC	Citric Acid Cycle	Gluconeogenesis	Fructose-1,6-diphosphatase deficiency	Pyruvate kinase deficiency	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Sepiapterin reductase deficiency	Pyruvate Dehydrogenase Complex Deficiency	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	The oncogenic action of 2-hydroxyglutarate	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Triosephosphate isomerase	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Glycogenosis, Type IB	Hyperphenylalaninemia due to dhpr-deficiency	Fumarase deficiency	Glutaminolysis and Cancer	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycogenosis, Type IA. Von gierke disease	Pyruvate dehydrogenase deficiency (E2)	Pterine Biosynthesis	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Segawa syndrome	Pyruvate Metabolism	Leigh Syndrome
3',5'-Cyclic AMP	HMDB_SMPDB	Samples:	1	Pathways:	2	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine
GDP	HMDB_SMPDB	Samples:	65	Pathways:	29	Congenital lactic acidosis	The oncogenic action of Fumarate	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Glycogenosis, Type IC	Mitochondrial complex II deficiency	Citric Acid Cycle	Gluconeogenesis	Triosephosphate isomerase	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Fumarase deficiency	Pyruvate kinase deficiency	Glutaminolysis and Cancer	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycogenosis, Type IA. Von gierke disease	Pyruvate Dehydrogenase Complex Deficiency	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of 2-hydroxyglutarate	Pyruvate dehydrogenase deficiency (E3)	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Warburg Effect	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Pyruvate Metabolism	Leigh Syndrome	2-ketoglutarate dehydrogenase complex deficiency
GTP	HMDB_SMPDB	Samples:	65	Pathways:	36	Congenital lactic acidosis	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Glycogenosis, Type IC	Citric Acid Cycle	Gluconeogenesis	Fructose-1,6-diphosphatase deficiency	Pyruvate kinase deficiency	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Sepiapterin reductase deficiency	Pyruvate Dehydrogenase Complex Deficiency	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	The oncogenic action of 2-hydroxyglutarate	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	2-ketoglutarate dehydrogenase complex deficiency	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Triosephosphate isomerase	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Glycogenosis, Type IB	Hyperphenylalaninemia due to dhpr-deficiency	Fumarase deficiency	Glutaminolysis and Cancer	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycogenosis, Type IA. Von gierke disease	Pyruvate dehydrogenase deficiency (E2)	Pterine Biosynthesis	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Segawa syndrome	Pyruvate Metabolism	Leigh Syndrome
Beta-D-Glucose	HMDB_SMPDB	Samples:	52	Pathways:	12	Glycogenosis, Type IA. Von gierke disease	Trehalose Degradation	Fanconi-bickel syndrome	Glycogenosis, Type IC	Glycogenosis, Type VII. Tarui disease	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycolysis	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)
Trehalose	HMDB_SMPDB	Samples:	47	Pathways:	1	Trehalose Degradation
Hydrogen	HMDB_SMPDB	Samples:	70	Pathways:	34	Rabeprazole Pathway	Degradation of Superoxides	Carnitine Synthesis	Primary hyperoxaluria II, PH2	Pantoprazole Pathway	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Porphyrin Metabolism	Pyruvate kinase deficiency	Porphyria Variegata (PV)	Mitochondrial Electron Transport Chain	Trehalose Degradation	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	Pyruvate Dehydrogenase Complex Deficiency	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	Malonyl-coa decarboxylase deficiency	Threonine and 2-Oxobutanoate Degradation	Homocysteine Degradation	Catecholamine Biosynthesis	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	Hereditary Coproporphyria (HCP)	Pantoprazole Action Pathway	Malonic Aciduria	Omeprazole Pathway	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Transfer of Acetyl Groups into Mitochondria	Ethanol Degradation	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Propanoate Metabolism	Acute Intermittent Porphyria	Omeprazole Action Pathway	Warburg Effect	Pyruvate Metabolism	Leigh Syndrome	Rabeprazole Action Pathway
Alpha-D-Glucose	HMDB_SMPDB	Samples:	56	Pathways:	19	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Glycogenosis, Type IC	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type VI. Hers disease	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Trehalose Degradation	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Glycogen synthetase deficiency	Mucopolysaccharidosis VI. Sly syndrome	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycolysis
Beta-D-Glucose 6-phosphate	HMDB_SMPDB	Samples:	63	Pathways:	13	Trehalose Degradation	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type IC	Glycogenosis, Type VII. Tarui disease	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type IB	Warburg Effect	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycolysis	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)
alpha,alpha-Trehalose	HMDB_SMPDB	Samples:	47	Pathways:	1	Trehalose Degradation
alpha-D-Glucose	HMDB_SMPDB	Samples:	56	Pathways:	19	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Glycogenosis, Type IC	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type VI. Hers disease	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Trehalose Degradation	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Glycogen synthetase deficiency	Mucopolysaccharidosis VI. Sly syndrome	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycolysis
beta-D-Glucose	HMDB_SMPDB	Samples:	52	Pathways:	12	Glycogenosis, Type IA. Von gierke disease	Trehalose Degradation	Fanconi-bickel syndrome	Glycogenosis, Type IC	Glycogenosis, Type VII. Tarui disease	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycolysis	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)
beta-D-Glucose 6-phosphate	HMDB_SMPDB	Samples:	63	Pathways:	13	Trehalose Degradation	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type IC	Glycogenosis, Type VII. Tarui disease	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type IB	Warburg Effect	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycolysis	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)
Aldosterone	HMDB_SMPDB	Samples:	60	Pathways:	95	Olmesartan Action Pathway	Kidney Function	Indapamide Pathway	Perindopril Pathway	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Bumetanide Action Pathway	Lysinuric Protein Intolerance	Cyclothiazide Pathway	Triamterene Action Pathway	Furosemide Action Pathway	Moexipril Action Pathway	Irbesartan Action Pathway	Fosinopril Pathway	Ramipril Pathway	Corticosterone methyl oxidase II deficiency - CMO II	Quinethazone Action Pathway	Angiotensin Metabolism	Eplerenone Action Pathway	Moexipril Pathway	Corticosterone methyl oxidase I deficiency (CMO I)	Trandolapril Action Pathway	Glucose Transporter Defect (SGLT2)	Torsemide Action Pathway	Ethacrynic Acid pathway	Cilazapril Action Pathway	21-hydroxylase deficiency (CYP21)	Chlorthalidone Pathway	Eprosartan Action Pathway	Trandolapril Pathway	Captopril Action Pathway	Polythiazide Action Pathway	Cystinuria	Candesartan Action Pathway	Perindopril Action Pathway	Losartan Action Pathway	Rescinnamine Action Pathway	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Methyclothiazide Action Pathway	Methyclothiazide Pathway	Hydrochlorothiazide Pathway	Hydroflumethiazide Action Pathway	Iminoglycinuria	Blue diaper syndrome	Cilazapril Pathway	Ethacrynic Acid Action Pathway	Captopril Pathway	Amiloride Pathway	Valsartan Action Pathway	Bendroflumethiazide Pathway	Enalapril Pathway	Fosinopril Action Pathway	Lysinuric protein intolerance (LPI)	Cyclothiazide Action Pathway	Forasartan Action Pathway	Bendroflumethiazide Action Pathway	Spironolactone Action Pathway	Spironolactone Pathway	Telmisartan Action Pathway	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Trichlormethiazide Pathway	Rescinnamine Pathway	Hydroflumethiazide Pathway	Metolazone Action Pathway	Steroidogenesis	Hydrochlorothiazide Action Pathway	Ramipril Action Pathway	Polythiazide Pathway	Spirapril Pathway	Temocapril Action Pathway	Bumetanide Pathway	Trichlormethiazide Action Pathway	Chlorothiazide Action Pathway	17-alpha-hydroxylase deficiency (CYP17)	Chlorothiazide Pathway	Benazepril Action Pathway	Furosemide Pathway	Eplerenone Pathway	11-beta-hydroxylase deficiency (CYP11B1)	Torsemide Pathway	Indapamide Action Pathway	Apparent mineralocorticoid excess syndrome	Chlorthalidone Action Pathway	Triamterene Pathway	Lisinopril Pathway	Hartnup Disorder	Benazepril Pathway	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Amiloride Action Pathway	Spirapril Action Pathway	Quinapril Action Pathway	Enalapril Action Pathway	Lisinopril Action Pathway	Quinethazone Pathway	Metolazone Pathway	Quinapril Pathway
Chloride ion	HMDB_SMPDB	Samples:	68	Pathways:	81	Rabeprazole Pathway	Kidney Function	Olmesartan Action Pathway	Indapamide Pathway	Perindopril Pathway	Lysinuric Protein Intolerance	Cyclothiazide Pathway	Irbesartan Action Pathway	Fosinopril Pathway	Spirapril Metabolism Pathway	Gastric Acid Production	Ramipril Pathway	Angiotensin Metabolism	Mucopolysaccharidosis VI. Sly syndrome	Moexipril Pathway	Enalapril Metabolism Pathway	Glucose Transporter Defect (SGLT2)	Ethacrynic Acid pathway	Lansoprazole Pathway	Eprosartan Action Pathway	Chlorthalidone Pathway	Trandolapril Pathway	Quinapril Metabolism Pathway	Cystinuria	Metiamide Action Pathway	Candesartan Action Pathway	Losartan Action Pathway	Omeprazole Pathway	Betazole Action Pathway	Roxatidine acetate Action Pathway	Hydrochlorothiazide Pathway	Methyclothiazide Pathway	Iminoglycinuria	Blue diaper syndrome	Cilazapril Pathway	Captopril Pathway	Pirenzepine Pathway	Amiloride Pathway	Valsartan Action Pathway	Bendroflumethiazide Pathway	Enalapril Pathway	Lysinuric protein intolerance (LPI)	Starch and Sucrose Metabolism	Forasartan Action Pathway	Pantoprazole Pathway	Spironolactone Pathway	Telmisartan Action Pathway	Glycogenosis, Type VI. Hers disease	Trichlormethiazide Pathway	Ramipril Metabolism Pathway	Trandolapril Metabolism Pathway	Rescinnamine Pathway	Hydroflumethiazide Pathway	Cimetidine Pathway	Spirapril Pathway	Temocapril Action Pathway	Polythiazide Pathway	Fosinopril Metabolism Pathway	Bumetanide Pathway	Cilazapril Metabolism Pathway	Glycogen synthetase deficiency	Chlorothiazide Pathway	Furosemide Pathway	Eplerenone Pathway	Torsemide Pathway	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Triamterene Pathway	Moexipril Metabolism Pathway	Lisinopril Pathway	Hartnup Disorder	Nizatidine Pathway	Benazepril Pathway	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Famotidine Pathway	Benazepril Metabolism Pathway	Esomeprazole Pathway	Quinethazone Pathway	Metolazone Pathway	Ranitidine Pathway	Quinapril Pathway
Angiotensin II	HMDB_SMPDB	Samples:	4	Pathways:	36	Olmesartan Action Pathway	Forasartan Action Pathway	Telmisartan Action Pathway	Rescinnamine Pathway	Perindopril Pathway	Quinapril Pathway	Spirapril Pathway	Ramipril Action Pathway	Temocapril Action Pathway	Irbesartan Action Pathway	Moexipril Action Pathway	Fosinopril Pathway	Ramipril Pathway	Angiotensin Metabolism	Benazepril Action Pathway	Moexipril Pathway	Trandolapril Action Pathway	Cilazapril Action Pathway	Eprosartan Action Pathway	Lisinopril Pathway	Trandolapril Pathway	Captopril Action Pathway	Benazepril Pathway	Candesartan Action Pathway	Perindopril Action Pathway	Losartan Action Pathway	Rescinnamine Action Pathway	Spirapril Action Pathway	Quinapril Action Pathway	Cilazapril Pathway	Enalapril Action Pathway	Lisinopril Action Pathway	Captopril Pathway	Valsartan Action Pathway	Enalapril Pathway	Fosinopril Action Pathway
Vasopressin	HMDB_SMPDB	Samples:	4	Pathways:	36	Olmesartan Action Pathway	Forasartan Action Pathway	Telmisartan Action Pathway	Rescinnamine Pathway	Perindopril Pathway	Quinapril Pathway	Spirapril Pathway	Ramipril Action Pathway	Temocapril Action Pathway	Irbesartan Action Pathway	Moexipril Action Pathway	Fosinopril Pathway	Ramipril Pathway	Angiotensin Metabolism	Benazepril Action Pathway	Moexipril Pathway	Trandolapril Action Pathway	Cilazapril Action Pathway	Eprosartan Action Pathway	Lisinopril Pathway	Trandolapril Pathway	Captopril Action Pathway	Benazepril Pathway	Candesartan Action Pathway	Perindopril Action Pathway	Losartan Action Pathway	Rescinnamine Action Pathway	Spirapril Action Pathway	Quinapril Action Pathway	Cilazapril Pathway	Enalapril Action Pathway	Lisinopril Action Pathway	Captopril Pathway	Valsartan Action Pathway	Enalapril Pathway	Fosinopril Action Pathway
Losartan	HMDB_SMPDB	Samples:	4	Pathways:	1	Losartan Action Pathway
Angiotensin I	HMDB_SMPDB	Samples:	4	Pathways:	23	Olmesartan Action Pathway	Forasartan Action Pathway	Eprosartan Action Pathway	Telmisartan Action Pathway	Lisinopril Pathway	Trandolapril Pathway	Rescinnamine Pathway	Perindopril Pathway	Enalapril Pathway	Benazepril Pathway	Candesartan Action Pathway	Losartan Action Pathway	Quinapril Pathway	Spirapril Pathway	Temocapril Action Pathway	Irbesartan Action Pathway	Fosinopril Pathway	Cilazapril Pathway	Captopril Pathway	Ramipril Pathway	Valsartan Action Pathway	Angiotensin Metabolism	Moexipril Pathway
D-Galactose	HMDB_SMPDB	Samples:	33	Pathways:	2	Lactose Degradation	Lactose Intolerance
Glucose 6-phosphate	HMDB_SMPDB	Samples:	59	Pathways:	19	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Glycogenosis, Type IC	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type VI. Hers disease	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Glycogen synthetase deficiency	Warburg Effect	Mucopolysaccharidosis VI. Sly syndrome	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycolysis
alpha-D-Galactose	HMDB_SMPDB	Samples:	33	Pathways:	2	Lactose Degradation	Lactose Intolerance
D-Glucose 6-phosphate	HMDB_SMPDB	Samples:	59	Pathways:	19	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Glycogenosis, Type IC	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type VI. Hers disease	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Glycogen synthetase deficiency	Warburg Effect	Mucopolysaccharidosis VI. Sly syndrome	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycolysis
2-Ketobutyric acid	HMDB_SMPDB	Samples:	58	Pathways:	13	Sarcosinemia	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Threonine and 2-Oxobutanoate Degradation	Homocysteine Degradation	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Homocystinuria, cystathionine beta-synthase deficiency	Gamma-cystathionase deficiency (CTH)	Hyperglycinemia, non-ketotic	Selenoamino Acid Metabolism
L-Cystathionine	HMDB_SMPDB	Samples:	51	Pathways:	11	Sarcosinemia	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Homocysteine Degradation	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Homocystinuria, cystathionine beta-synthase deficiency	Gamma-cystathionase deficiency (CTH)	Hyperglycinemia, non-ketotic
L-Serine	HMDB_SMPDB	Samples:	51	Pathways:	14	Sarcosinemia	sarcosine oncometabolite pathway 	Ammonia Recycling	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Homocysteine Degradation	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Homocystinuria, cystathionine beta-synthase deficiency	Gamma-cystathionase deficiency (CTH)	Hyperglycinemia, non-ketotic	Selenoamino Acid Metabolism
L-Cysteine	HMDB_SMPDB	Samples:	59	Pathways:	66	Kidney Function	Indapamide Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Homocarnosinosis	Bumetanide Action Pathway	Homocystinuria, cystathionine beta-synthase deficiency	Lysinuric Protein Intolerance	Cyclothiazide Pathway	Triamterene Action Pathway	Furosemide Action Pathway	Dimethylglycine Dehydrogenase Deficiency	Homocysteine Degradation	Non Ketotic Hyperglycinemia	Quinethazone Action Pathway	Hyperglycinemia, non-ketotic	Eplerenone Action Pathway	Glucose Transporter Defect (SGLT2)	Torsemide Action Pathway	Ethacrynic Acid pathway	Chlorthalidone Pathway	3-Phosphoglycerate dehydrogenase deficiency	Polythiazide Action Pathway	Cystinuria	Sarcosinemia	Hydrochlorothiazide Pathway	Methyclothiazide Action Pathway	Hydroflumethiazide Action Pathway	Methyclothiazide Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Iminoglycinuria	Blue diaper syndrome	Pantothenate and CoA Biosynthesis	Ethacrynic Acid Action Pathway	Succinic semialdehyde dehydrogenase deficiency	Amiloride Pathway	Glutamate Metabolism	Bendroflumethiazide Pathway	Lysinuric protein intolerance (LPI)	Cyclothiazide Action Pathway	Bendroflumethiazide Action Pathway	Spironolactone Action Pathway	Spironolactone Pathway	Trichlormethiazide Pathway	Hydroflumethiazide Pathway	Metolazone Action Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Hydrochlorothiazide Action Pathway	Polythiazide Pathway	Bumetanide Pathway	Trichlormethiazide Action Pathway	Chlorothiazide Action Pathway	Chlorothiazide Pathway	Furosemide Pathway	Eplerenone Pathway	Torsemide Pathway	Indapamide Action Pathway	Chlorthalidone Action Pathway	Triamterene Pathway	Hartnup Disorder	Gamma-cystathionase deficiency (CTH)	Hyperinsulinism-Hyperammonemia Syndrome	Amiloride Action Pathway	Quinethazone Pathway	Glycine and Serine Metabolism	Metolazone Pathway
Homocysteine	HMDB_SMPDB	Samples:	52	Pathways:	14	Sarcosinemia	sarcosine oncometabolite pathway 	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Homocysteine Degradation	Betaine Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Catecholamine Biosynthesis	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Homocystinuria, cystathionine beta-synthase deficiency	Gamma-cystathionase deficiency (CTH)	Hyperglycinemia, non-ketotic
2-Oxobutanoate	HMDB_SMPDB	Samples:	59	Pathways:	17	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Malonic Aciduria	Homocystinuria, cystathionine beta-synthase deficiency	Gamma-cystathionase deficiency (CTH)	Sarcosinemia	Propanoate Metabolism	Dimethylglycine Dehydrogenase Deficiency	Malonyl-coa decarboxylase deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Homocysteine Degradation	Threonine and 2-Oxobutanoate Degradation	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Selenoamino Acid Metabolism	Hyperglycinemia, non-ketotic
L-Homocysteine	HMDB_SMPDB	Samples:	51	Pathways:	12	Sarcosinemia	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Homocysteine Degradation	Betaine Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Homocystinuria, cystathionine beta-synthase deficiency	Gamma-cystathionase deficiency (CTH)	Hyperglycinemia, non-ketotic
Alprenolol	HMDB_SMPDB	Samples:	11	Pathways:	1	Alprenolol Pathway
Presqualene diphosphate	HMDB_SMPDB	Samples:	1	Pathways:	1	Steroid Biosynthesis
(R)-5-Diphosphomevalonate	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
(R)-5-Phosphomevalonate	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
(R)-Mevalonate	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
14-Demethyllanosterol	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
4,4-Dimethyl-5alpha-cholesta-8,14,24-trien-3beta-ol	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
4,4-Dimethyl-5alpha-cholesta-8-en-3beta-ol	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
4alpha-Methylzymosterol	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
4alpha-Methylzymosterol-4-carboxylate	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
5alpha-Cholest-8-en-3beta-ol	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
5alpha-Cholesta-7,24-dien-3beta-ol	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
Dimethylallyl diphosphate	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
Formate	HMDB_SMPDB	Samples:	52	Pathways:	27	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Steroid Biosynthesis	Wolman disease	Folate Metabolism	Aromatase deficiency	Desmosterolosis	Hyperphenylalaninemia due to dhpr-deficiency	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Tryptophan Metabolism	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	Sepiapterin reductase deficiency	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism	Methotrexate Action Pathway	CHILD Syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Mevalonic aciduria	Dopa-responsive dystonia	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Pterine Biosynthesis	Segawa syndrome	Simvastatin Action Pathway	Hyper-IgD syndrome	Folate malabsorption, hereditary
Geranyl diphosphate	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
Isopentenyl diphosphate	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
Lanosterol	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
trans,trans-Farnesyl diphosphate	HMDB_SMPDB	Samples:	2	Pathways:	17	Lysosomal Acid Lipase Deficiency (Wolman Disease)	Steroid Biosynthesis	Wolman disease	Desmosterolosis	Porphyrin Metabolism	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Porphyria Variegata (PV)	CHILD Syndrome	Mevalonic aciduria	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Acute Intermittent Porphyria	Hereditary Coproporphyria (HCP)	Simvastatin Action Pathway	Hyper-IgD syndrome
Zymosterol	HMDB_SMPDB	Samples:	1	Pathways:	12	Lysosomal Acid Lipase Deficiency (Wolman Disease)	CHILD Syndrome	Mevalonic aciduria	Steroid Biosynthesis	Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)	Cholesteryl ester storage disease	Desmosterolosis	Wolman disease	Smith-Lemli-Opitz Syndrome (SLOS)	Hypercholesterolemia	Simvastatin Action Pathway	Hyper-IgD syndrome
Gemcitabine	HMDB_SMPDB	Samples:	1	Pathways:	3	Gemcitabine Pathway	Gemcitabine Metabolism Pathway	Gemcitabine Action Pathway
Zinc	HMDB_SMPDB	Samples:	59	Pathways:	27	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Gemcitabine Metabolism Pathway	Tyrosinemia, transient, of the newborn	Porphyrin Metabolism	Hyperphenylalaninemia due to dhpr-deficiency	Porphyria Variegata (PV)	Alkaptonuria	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Felbamate Metabolism Pathway	Sepiapterin reductase deficiency	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Gemcitabine Pathway	Dopa-responsive dystonia	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Acute Intermittent Porphyria	Celecoxib Metabolism Pathway	Pterine Biosynthesis	Hawkinsinuria	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Segawa syndrome	Tyrosine Metabolism	Hereditary Coproporphyria (HCP)
Gemcitabine triphosphate	HMDB_SMPDB	Samples:	1	Pathways:	2	Gemcitabine Pathway	Gemcitabine Metabolism Pathway
Gemcitabine diphosphate	HMDB_SMPDB	Samples:	1	Pathways:	2	Gemcitabine Pathway	Gemcitabine Metabolism Pathway
Lansoprazole	HMDB_SMPDB	Samples:	4	Pathways:	1	Lansoprazole Pathway
Bupranolol	HMDB_SMPDB	Samples:	11	Pathways:	1	Bupranolol Action Pathway
D-myo-Inositol 1,4,5-trisphosphate	HMDB_SMPDB	Samples:	12	Pathways:	49	Alprenolol Action Pathway	Diltiazem Action Pathway	Tocainide Action Pathway	Procainamide (Antiarrhythmic) Action Pathway	Bisoprolol Action Pathway	Betaxolol Action Pathway	Bopindolol Action Pathway	Sotalol Action Pathway	Felodipine Action Pathway	Amiodarone Action Pathway	Levobunolol Action Pathway	Carvedilol Action Pathway	Muscle/Heart Contraction	Nebivolol Action Pathway	Practolol Action Pathway	Isradipine Action Pathway	Epinephrine Action Pathway	Timolol Action Pathway	Bupranolol Action Pathway	Oxprenolol Action Pathway	Arbutamine Action Pathway	Carteolol Action Pathway	Isoprenaline Action Pathway	Propranolol Action Pathway	Bevantolol Action Pathway	Flecainide Action Pathway	Nifedipine Action Pathway	Nisoldipine Action Pathway	Verapamil Action Pathway	Esmolol Action Pathway	Metoprolol Action Pathway	Nadolol Action Pathway	Mexiletine Action Pathway	Amlodipine Action Pathway	Nimodipine Action Pathway	Penbutolol Action Pathway	Quinidine Action Pathway	Ibutilide Action Pathway	Atenolol Action Pathway	Fosphenytoin (Antiarrhythmic) Action Pathway	Nitrendipine Action Pathway	Acebutolol Action Pathway	Phenytoin (Antiarrhythmic) Action Pathway	Labetalol Action Pathway	Lidocaine (Antiarrhythmic) Action Pathway	Pindolol Action Pathway	Dobutamine Action Pathway	Disopyramide Action Pathway	Metipranolol Action Pathway
Betaine	HMDB_SMPDB	Samples:	51	Pathways:	10	Sarcosinemia	sarcosine oncometabolite pathway 	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Betaine Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
Dimethylglycine	HMDB_SMPDB	Samples:	51	Pathways:	10	Sarcosinemia	sarcosine oncometabolite pathway 	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Betaine Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
Glyoxylic acid	HMDB_SMPDB	Samples:	50	Pathways:	11	Sarcosinemia	Alanine Metabolism	Lactic Acidemia	Dimethylglycine Dehydrogenase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Pyruvate Carboxylase Deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Primary Hyperoxaluria Type I
Glyceric acid	HMDB_SMPDB	Samples:	50	Pathways:	7	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Dimethylglycine Dehydrogenase Deficiency
Orotidylic acid	HMDB_SMPDB	Samples:	50	Pathways:	7	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Dimethylglycine Dehydrogenase Deficiency
Sarcosine	HMDB_SMPDB	Samples:	51	Pathways:	9	Sarcosinemia	sarcosine oncometabolite pathway 	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
Phosphoserine	HMDB_SMPDB	Samples:	50	Pathways:	7	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Dimethylglycine Dehydrogenase Deficiency
L-Methionine	HMDB_SMPDB	Samples:	51	Pathways:	10	Sarcosinemia	sarcosine oncometabolite pathway 	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Betaine Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
3-Phosphoglyceric acid	HMDB_SMPDB	Samples:	60	Pathways:	26	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Glycogenosis, Type IC	Sucrase-isomaltase deficiency	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type VI. Hers disease	3-Phosphoglycerate dehydrogenase deficiency	Glycogenosis, Type IB	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Sarcosinemia	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Dimethylglycine Dehydrogenase Deficiency	Glycogen synthetase deficiency	Non Ketotic Hyperglycinemia	Warburg Effect	Glycine and Serine Metabolism	Mucopolysaccharidosis VI. Sly syndrome	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Hyperglycinemia, non-ketotic	Glycolysis
Phosphohydroxypyruvic acid	HMDB_SMPDB	Samples:	50	Pathways:	7	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Dimethylglycine Dehydrogenase Deficiency
5-Aminolevulinic acid	HMDB_SMPDB	Samples:	51	Pathways:	12	Sarcosinemia	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Dimethylglycine Dehydrogenase Deficiency	Acute Intermittent Porphyria	Porphyrin Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Porphyria Variegata (PV)	Hyperglycinemia, non-ketotic	Hereditary Coproporphyria (HCP)
Pyruvaldehyde	HMDB_SMPDB	Samples:	53	Pathways:	13	Sarcosinemia	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Dimethylglycine Dehydrogenase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Pyruvate Metabolism	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Pyruvate kinase deficiency	Hyperglycinemia, non-ketotic	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
Hydroxypyruvic acid	HMDB_SMPDB	Samples:	50	Pathways:	7	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Dimethylglycine Dehydrogenase Deficiency
5,10-Methylene-THF	HMDB_SMPDB	Samples:	51	Pathways:	13	Sarcosinemia	sarcosine oncometabolite pathway 	Ammonia Recycling	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Methotrexate Pathway	Hyperglycinemia, non-ketotic	Folate malabsorption, hereditary
Tetrahydrofolic acid	HMDB_SMPDB	Samples:	51	Pathways:	17	Histidine Metabolism	Histidinemia	Folate Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Methotrexate Pathway	Sarcosinemia	sarcosine oncometabolite pathway 	Ammonia Recycling	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Betaine Metabolism	Non Ketotic Hyperglycinemia	Pterine Biosynthesis	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Folate malabsorption, hereditary
Aminoacetone	HMDB_SMPDB	Samples:	50	Pathways:	7	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Dimethylglycine Dehydrogenase Deficiency
D-Serine	HMDB_SMPDB	Samples:	50	Pathways:	7	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Dimethylglycine Dehydrogenase Deficiency
L-2-Amino-3-oxobutanoic acid	HMDB_SMPDB	Samples:	50	Pathways:	7	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Dimethylglycine Dehydrogenase Deficiency
Dihydrolipoate	HMDB_SMPDB	Samples:	50	Pathways:	8	Sarcosinemia	Ammonia Recycling	Dimethylglycine Dehydrogenase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
8-[(Aminomethyl)sulfanyl]-6-sulfanyloctanoic acid	HMDB_SMPDB	Samples:	50	Pathways:	8	Sarcosinemia	Ammonia Recycling	Dimethylglycine Dehydrogenase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
3-Phosphonooxypyruvate	HMDB_SMPDB	Samples:	50	Pathways:	7	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Dimethylglycine Dehydrogenase Deficiency
5,10-Methylenetetrahydrofolate	HMDB_SMPDB	Samples:	51	Pathways:	12	Sarcosinemia	Methotrexate Action Pathway	Ammonia Recycling	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Folate malabsorption, hereditary
5-Aminolevulinate	HMDB_SMPDB	Samples:	51	Pathways:	12	Sarcosinemia	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Dimethylglycine Dehydrogenase Deficiency	Acute Intermittent Porphyria	Porphyrin Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Porphyria Variegata (PV)	Hyperglycinemia, non-ketotic	Hereditary Coproporphyria (HCP)
D-Glycerate	HMDB_SMPDB	Samples:	50	Pathways:	7	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Dimethylglycine Dehydrogenase Deficiency
Glycerate 3-phosphate	HMDB_SMPDB	Samples:	60	Pathways:	26	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Glycogenosis, Type IC	Sucrase-isomaltase deficiency	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type VI. Hers disease	3-Phosphoglycerate dehydrogenase deficiency	Glycogenosis, Type IB	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Sarcosinemia	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Dimethylglycine Dehydrogenase Deficiency	Glycogen synthetase deficiency	Non Ketotic Hyperglycinemia	Warburg Effect	Glycine and Serine Metabolism	Mucopolysaccharidosis VI. Sly syndrome	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Hyperglycinemia, non-ketotic	Glycolysis
Glyoxylate	HMDB_SMPDB	Samples:	50	Pathways:	11	Sarcosinemia	Alanine Metabolism	Lactic Acidemia	Dimethylglycine Dehydrogenase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Pyruvate Carboxylase Deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Primary Hyperoxaluria Type I
Hydroxypyruvate	HMDB_SMPDB	Samples:	50	Pathways:	7	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Dimethylglycine Dehydrogenase Deficiency
Lipoate	HMDB_SMPDB	Samples:	50	Pathways:	8	Sarcosinemia	Ammonia Recycling	Dimethylglycine Dehydrogenase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
Methylglyoxal	HMDB_SMPDB	Samples:	53	Pathways:	13	Sarcosinemia	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Dimethylglycine Dehydrogenase Deficiency	3-Phosphoglycerate dehydrogenase deficiency	Pyruvate Metabolism	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Pyruvate kinase deficiency	Hyperglycinemia, non-ketotic	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
N,N-Dimethylglycine	HMDB_SMPDB	Samples:	51	Pathways:	9	Sarcosinemia	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Betaine Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic
O-Phospho-L-serine	HMDB_SMPDB	Samples:	50	Pathways:	7	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Dimethylglycine Dehydrogenase Deficiency
Orotidine 5'-phosphate	HMDB_SMPDB	Samples:	50	Pathways:	7	3-Phosphoglycerate dehydrogenase deficiency	Sarcosinemia	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Dimethylglycine Dehydrogenase Deficiency
Tetrahydrofolate	HMDB_SMPDB	Samples:	51	Pathways:	15	Sarcosinemia	Methotrexate Action Pathway	Histidine Metabolism	Ammonia Recycling	Dimethylglycine Dehydrogenase Deficiency	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Histidinemia	Betaine Metabolism	3-Phosphoglycerate dehydrogenase deficiency	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	Non Ketotic Hyperglycinemia	Glycine and Serine Metabolism	Hyperglycinemia, non-ketotic	Folate malabsorption, hereditary
Homogentisic acid	HMDB_SMPDB	Samples:	55	Pathways:	12	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia, transient, of the newborn	Tyrosinemia Type 3 (TYRO3)	Hawkinsinuria	Phenylketonuria	Tyrosine Metabolism	Alkaptonuria	Phenylalanine and Tyrosine Metabolism
L-Tyrosine	HMDB_SMPDB	Samples:	57	Pathways:	17	Tyrosine hydroxylase deficiency	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Thyroid hormone synthesis	Tyrosinemia, transient, of the newborn	Aromatic L-Aminoacid Decarboxylase Deficiency	Disulfiram Action Pathway	Phenylketonuria	Alkaptonuria	Phenylalanine and Tyrosine Metabolism	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia Type 3 (TYRO3)	Catecholamine Biosynthesis	Hawkinsinuria	Tyrosine Metabolism
L-Phenylalanine	HMDB_SMPDB	Samples:	12	Pathways:	4	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia Type 3 (TYRO3)	Phenylketonuria	Phenylalanine and Tyrosine Metabolism
Phenylpyruvic acid	HMDB_SMPDB	Samples:	12	Pathways:	4	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia Type 3 (TYRO3)	Phenylketonuria	Phenylalanine and Tyrosine Metabolism
Fe2+	HMDB_SMPDB	Samples:	64	Pathways:	16	Tyrosine hydroxylase deficiency	The oncogenic action of Fumarate	Carnitine Synthesis	The oncogenic action of Succinate	Aromatic L-Aminoacid Decarboxylase Deficiency	Porphyrin Metabolism	Phenylketonuria	Porphyria Variegata (PV)	Tryptophan Metabolism	Phenylalanine and Tyrosine Metabolism	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Acute Intermittent Porphyria	Tyrosinemia Type 3 (TYRO3)	Catecholamine Biosynthesis	Hereditary Coproporphyria (HCP)
4-Hydroxyphenylpyruvic acid	HMDB_SMPDB	Samples:	55	Pathways:	12	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia, transient, of the newborn	Tyrosinemia Type 3 (TYRO3)	Hawkinsinuria	Phenylketonuria	Tyrosine Metabolism	Alkaptonuria	Phenylalanine and Tyrosine Metabolism
4-Fumarylacetoacetic acid	HMDB_SMPDB	Samples:	55	Pathways:	12	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia, transient, of the newborn	Tyrosinemia Type 3 (TYRO3)	Hawkinsinuria	Phenylketonuria	Tyrosine Metabolism	Alkaptonuria	Phenylalanine and Tyrosine Metabolism
Maleylacetoacetic acid	HMDB_SMPDB	Samples:	55	Pathways:	12	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia, transient, of the newborn	Tyrosinemia Type 3 (TYRO3)	Hawkinsinuria	Phenylketonuria	Tyrosine Metabolism	Alkaptonuria	Phenylalanine and Tyrosine Metabolism
4a-Hydroxytetrahydrobiopterin	HMDB_SMPDB	Samples:	55	Pathways:	14	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia, transient, of the newborn	Tyrosinemia Type 3 (TYRO3)	Disulfiram Action Pathway	Hawkinsinuria	Phenylketonuria	Tyrosine Metabolism	Alkaptonuria	Tryptophan Metabolism	Phenylalanine and Tyrosine Metabolism
L-erythro-tetrahydrobiopterin	HMDB_SMPDB	Samples:	12	Pathways:	4	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia Type 3 (TYRO3)	Phenylketonuria	Phenylalanine and Tyrosine Metabolism
3-(4-Hydroxyphenyl)pyruvate	HMDB_SMPDB	Samples:	55	Pathways:	12	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia, transient, of the newborn	Tyrosinemia Type 3 (TYRO3)	Disulfiram Action Pathway	Hawkinsinuria	Phenylketonuria	Tyrosine Metabolism	Alkaptonuria	Phenylalanine and Tyrosine Metabolism
4-Fumarylacetoacetate	HMDB_SMPDB	Samples:	55	Pathways:	12	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia, transient, of the newborn	Tyrosinemia Type 3 (TYRO3)	Disulfiram Action Pathway	Hawkinsinuria	Phenylketonuria	Tyrosine Metabolism	Alkaptonuria	Phenylalanine and Tyrosine Metabolism
4-Maleylacetoacetate	HMDB_SMPDB	Samples:	55	Pathways:	12	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia, transient, of the newborn	Tyrosinemia Type 3 (TYRO3)	Disulfiram Action Pathway	Hawkinsinuria	Phenylketonuria	Tyrosine Metabolism	Alkaptonuria	Phenylalanine and Tyrosine Metabolism
Homogentisate	HMDB_SMPDB	Samples:	55	Pathways:	12	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia, transient, of the newborn	Tyrosinemia Type 3 (TYRO3)	Disulfiram Action Pathway	Hawkinsinuria	Phenylketonuria	Tyrosine Metabolism	Alkaptonuria	Phenylalanine and Tyrosine Metabolism
Phenylpyruvate	HMDB_SMPDB	Samples:	12	Pathways:	4	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	Tyrosinemia Type 3 (TYRO3)	Phenylketonuria	Phenylalanine and Tyrosine Metabolism
Fructose 1,6-bisphosphate	HMDB_SMPDB	Samples:	55	Pathways:	12	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type IC	Glycogenosis, Type VII. Tarui disease	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type IB	Warburg Effect	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycolysis	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)
D-Glyceraldehyde 3-phosphate	HMDB_SMPDB	Samples:	63	Pathways:	13	Mitochondrial Electron Transport Chain	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type IC	Glycogenosis, Type VII. Tarui disease	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type IB	Warburg Effect	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycolysis	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)
Dihydroxyacetone phosphate	HMDB_SMPDB	Samples:	63	Pathways:	14	Mitochondrial Electron Transport Chain	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type IC	Glycogenosis, Type VII. Tarui disease	Triosephosphate isomerase	Gluconeogenesis	Phospholipid Biosynthesis	Glycogenosis, Type IB	Warburg Effect	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycolysis	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)
D-Fructose 1,6-bisphosphate	HMDB_SMPDB	Samples:	55	Pathways:	12	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type IC	Glycogenosis, Type VII. Tarui disease	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type IB	Warburg Effect	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycolysis	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)
Glyceraldehyde 3-phosphate	HMDB_SMPDB	Samples:	63	Pathways:	13	Mitochondrial Electron Transport Chain	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type IC	Glycogenosis, Type VII. Tarui disease	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type IB	Warburg Effect	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycolysis	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)
Glycerone phosphate	HMDB_SMPDB	Samples:	63	Pathways:	14	Mitochondrial Electron Transport Chain	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type IC	Glycogenosis, Type VII. Tarui disease	Triosephosphate isomerase	Gluconeogenesis	Phospholipid Biosynthesis	Glycogenosis, Type IB	Warburg Effect	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycolysis	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)
Metoprolol	HMDB_SMPDB	Samples:	11	Pathways:	2	Metoprolol Pathway	Metoprolol Action Pathway
Histamine	HMDB_SMPDB	Samples:	13	Pathways:	26	Cimetidine Action Pathway	Rabeprazole Pathway	Ranitidine Pathway	Lansoprazole Action Pathway	Histidine Metabolism	Lansoprazole Pathway	Pantoprazole Pathway	Histidinemia	Rabeprazole Action Pathway	Nizatidine Pathway	Metiamide Action Pathway	Cimetidine Pathway	Omeprazole Pathway	Pirenzepine Action Pathway	Famotidine Pathway	Betazole Action Pathway	Esomeprazole Action Pathway	Roxatidine acetate Action Pathway	Omeprazole Action Pathway	Esomeprazole Pathway	Nizatidine Action Pathway	Famotidine Action Pathway	Gastric Acid Production	Pirenzepine Pathway	Ranitidine Action Pathway	Pantoprazole Action Pathway
Acetylcholine 	HMDB_SMPDB	Samples:	5	Pathways:	15	Betazole Action Pathway	Rabeprazole Pathway	Roxatidine acetate Action Pathway	Lansoprazole Pathway	Pantoprazole Pathway	Phospholipid Biosynthesis	Esomeprazole Pathway	Gastric Acid Production	Pirenzepine Pathway	Nizatidine Pathway	Metiamide Action Pathway	Cimetidine Pathway	Ranitidine Pathway	Omeprazole Pathway	Famotidine Pathway
Cimetidine	HMDB_SMPDB	Samples:	4	Pathways:	2	Cimetidine Action Pathway	Cimetidine Pathway
Histamium	HMDB_SMPDB	Samples:	13	Pathways:	16	Rabeprazole Pathway	Histidine Metabolism	Lansoprazole Pathway	Pantoprazole Pathway	Histidinemia	Nizatidine Pathway	Metiamide Action Pathway	Cimetidine Pathway	Omeprazole Pathway	Famotidine Pathway	Betazole Action Pathway	Roxatidine acetate Action Pathway	Esomeprazole Pathway	Gastric Acid Production	Pirenzepine Pathway	Ranitidine Pathway
Disopyramide	HMDB_SMPDB	Samples:	11	Pathways:	2	Disopyramide Pathway	Disopyramide Action Pathway
Carteolol	HMDB_SMPDB	Samples:	11	Pathways:	1	Carteolol Action Pathway
Beta-Alanine	HMDB_SMPDB	Samples:	58	Pathways:	10	Ureidopropionase deficiency	Beta-Alanine Metabolism	Carnosinuria, carnosinemia	Histidine Metabolism	Propanoate Metabolism	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	GABA-Transaminase Deficiency	Histidinemia	Malonic Aciduria
L-Asparagine	HMDB_SMPDB	Samples:	5	Pathways:	1	Ammonia Recycling
Malonic semialdehyde	HMDB_SMPDB	Samples:	58	Pathways:	8	Ureidopropionase deficiency	Beta-Alanine Metabolism	Carnosinuria, carnosinemia	Propanoate Metabolism	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	GABA-Transaminase Deficiency	Malonic Aciduria
3-Oxopropanoate	HMDB_SMPDB	Samples:	58	Pathways:	8	Ureidopropionase deficiency	Beta-Alanine Metabolism	Carnosinuria, carnosinemia	Propanoate Metabolism	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	GABA-Transaminase Deficiency	Malonic Aciduria
beta-Alanine	HMDB_SMPDB	Samples:	58	Pathways:	10	Ureidopropionase deficiency	Beta-Alanine Metabolism	Carnosinuria, carnosinemia	Histidine Metabolism	Propanoate Metabolism	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	GABA-Transaminase Deficiency	Histidinemia	Malonic Aciduria
cis-Aconitic acid	HMDB_SMPDB	Samples:	64	Pathways:	13	Congenital lactic acidosis	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of Succinate	Citric Acid Cycle	The oncogenic action of 2-hydroxyglutarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Pyruvate dehydrogenase deficiency (E3)	Fumarase deficiency	Glutaminolysis and Cancer	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	2-ketoglutarate dehydrogenase complex deficiency
Citric acid	HMDB_SMPDB	Samples:	64	Pathways:	15	Congenital lactic acidosis	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of Succinate	Citric Acid Cycle	The oncogenic action of 2-hydroxyglutarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Pyruvate dehydrogenase deficiency (E3)	Fumarase deficiency	Glutaminolysis and Cancer	Warburg Effect	Transfer of Acetyl Groups into Mitochondria	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	2-ketoglutarate dehydrogenase complex deficiency
L-Malic acid	HMDB_SMPDB	Samples:	64	Pathways:	21	Congenital lactic acidosis	The oncogenic action of Fumarate	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Mitochondrial complex II deficiency	Citric Acid Cycle	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Fumarase deficiency	Glutaminolysis and Cancer	Pyruvate kinase deficiency	Transfer of Acetyl Groups into Mitochondria	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Pyruvate Dehydrogenase Complex Deficiency	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of 2-hydroxyglutarate	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Pyruvate Metabolism	Leigh Syndrome	2-ketoglutarate dehydrogenase complex deficiency
Isocitric acid	HMDB_SMPDB	Samples:	64	Pathways:	14	Congenital lactic acidosis	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of Succinate	Citric Acid Cycle	The oncogenic action of 2-hydroxyglutarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Pyruvate dehydrogenase deficiency (E3)	Fumarase deficiency	Glutaminolysis and Cancer	Warburg Effect	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	2-ketoglutarate dehydrogenase complex deficiency
D-2-Hydroxyglutaric acid	HMDB_SMPDB	Samples:	63	Pathways:	1	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 
Coenzyme Q10	HMDB_SMPDB	Samples:	64	Pathways:	15	Mitochondrial Electron Transport Chain	Congenital lactic acidosis	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of Succinate	Citric Acid Cycle	The oncogenic action of 2-hydroxyglutarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Pyruvate dehydrogenase deficiency (E3)	Fumarase deficiency	Glutaminolysis and Cancer	Warburg Effect	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	2-ketoglutarate dehydrogenase complex deficiency
FADH	HMDB_SMPDB	Samples:	64	Pathways:	15	Congenital lactic acidosis	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of Succinate	Citric Acid Cycle	The oncogenic action of 2-hydroxyglutarate	Phospholipid Biosynthesis	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Pyruvate dehydrogenase deficiency (E3)	Fumarase deficiency	Glutaminolysis and Cancer	Warburg Effect	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	2-ketoglutarate dehydrogenase complex deficiency
2-Hydroxyglutarate	HMDB_SMPDB	Samples:	64	Pathways:	5	The oncogenic action of Fumarate	The oncogenic action of Succinate	The oncogenic action of 2-hydroxyglutarate	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria
QH(2)	HMDB_SMPDB	Samples:	64	Pathways:	11	Congenital lactic acidosis	Mitochondrial complex II deficiency	Pyruvate dehydrogenase deficiency (E2)	Citric Acid Cycle	The oncogenic action of 2-hydroxyglutarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Pyruvate dehydrogenase deficiency (E3)	Fumarase deficiency	Warburg Effect	The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria 	2-ketoglutarate dehydrogenase complex deficiency
L-Lysine	HMDB_SMPDB	Samples:	58	Pathways:	8	2-aminoadipic 2-oxoadipic aciduria	Carnitine Synthesis	Glutaric Aciduria Type I	Hyperlysinemia I, Familial	Saccharopinuria/Hyperlysinemia II	Lysine Degradation	Pyridoxine dependency with seizures	Hyperlysinemia II or Saccharopinuria
Oxoadipic acid	HMDB_SMPDB	Samples:	58	Pathways:	7	Lysine Degradation	2-aminoadipic 2-oxoadipic aciduria	Saccharopinuria/Hyperlysinemia II	Hyperlysinemia II or Saccharopinuria	Glutaric Aciduria Type I	Pyridoxine dependency with seizures	Hyperlysinemia I, Familial
Saccharopine	HMDB_SMPDB	Samples:	58	Pathways:	7	Lysine Degradation	2-aminoadipic 2-oxoadipic aciduria	Saccharopinuria/Hyperlysinemia II	Hyperlysinemia II or Saccharopinuria	Glutaric Aciduria Type I	Pyridoxine dependency with seizures	Hyperlysinemia I, Familial
Aminoadipic acid	HMDB_SMPDB	Samples:	58	Pathways:	7	Lysine Degradation	2-aminoadipic 2-oxoadipic aciduria	Saccharopinuria/Hyperlysinemia II	Hyperlysinemia II or Saccharopinuria	Glutaric Aciduria Type I	Pyridoxine dependency with seizures	Hyperlysinemia I, Familial
L-Pipecolic acid	HMDB_SMPDB	Samples:	58	Pathways:	7	Lysine Degradation	2-aminoadipic 2-oxoadipic aciduria	Saccharopinuria/Hyperlysinemia II	Hyperlysinemia II or Saccharopinuria	Glutaric Aciduria Type I	Pyridoxine dependency with seizures	Hyperlysinemia I, Familial
Allysine	HMDB_SMPDB	Samples:	58	Pathways:	7	Lysine Degradation	2-aminoadipic 2-oxoadipic aciduria	Saccharopinuria/Hyperlysinemia II	Hyperlysinemia II or Saccharopinuria	Glutaric Aciduria Type I	Pyridoxine dependency with seizures	Hyperlysinemia I, Familial
(S)-2,3,4,5-Tetrahydropiperidine-2-carboxylate	HMDB_SMPDB	Samples:	58	Pathways:	7	Lysine Degradation	2-aminoadipic 2-oxoadipic aciduria	Saccharopinuria/Hyperlysinemia II	Hyperlysinemia II or Saccharopinuria	Glutaric Aciduria Type I	Pyridoxine dependency with seizures	Hyperlysinemia I, Familial
2-Oxoadipate	HMDB_SMPDB	Samples:	56	Pathways:	6	2-aminoadipic 2-oxoadipic aciduria	Saccharopinuria/Hyperlysinemia II	Hyperlysinemia II or Saccharopinuria	Lysine Degradation	Pyridoxine dependency with seizures	Hyperlysinemia I, Familial
L-2-Aminoadipate	HMDB_SMPDB	Samples:	56	Pathways:	6	2-aminoadipic 2-oxoadipic aciduria	Saccharopinuria/Hyperlysinemia II	Hyperlysinemia II or Saccharopinuria	Lysine Degradation	Pyridoxine dependency with seizures	Hyperlysinemia I, Familial
L-Pipecolate	HMDB_SMPDB	Samples:	56	Pathways:	6	2-aminoadipic 2-oxoadipic aciduria	Saccharopinuria/Hyperlysinemia II	Hyperlysinemia II or Saccharopinuria	Lysine Degradation	Pyridoxine dependency with seizures	Hyperlysinemia I, Familial
N6-(L-1,3-Dicarboxypropyl)-L-lysine	HMDB_SMPDB	Samples:	56	Pathways:	6	2-aminoadipic 2-oxoadipic aciduria	Saccharopinuria/Hyperlysinemia II	Hyperlysinemia II or Saccharopinuria	Lysine Degradation	Pyridoxine dependency with seizures	Hyperlysinemia I, Familial
Methadyl Acetate	HMDB_SMPDB	Samples:	20	Pathways:	1	Methadyl Acetate Action Pathway
Adenosine	HMDB_SMPDB	Samples:	34	Pathways:	5	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	Selenoamino Acid Metabolism	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Betaine Metabolism
Phosphoribosyl pyrophosphate	HMDB_SMPDB	Samples:	2	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
10-Formyltetrahydrofolate	HMDB_SMPDB	Samples:	30	Pathways:	5	Methotrexate Action Pathway	Methotrexate Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Folate malabsorption, hereditary
5-Phosphoribosylamine	HMDB_SMPDB	Samples:	2	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
Adenosine diphosphate ribose	HMDB_SMPDB	Samples:	2	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
Guanosine monophosphate	HMDB_SMPDB	Samples:	2	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
D-Ribose 5-phosphate	HMDB_SMPDB	Samples:	52	Pathways:	1	Warburg Effect
Xanthylic acid	HMDB_SMPDB	Samples:	2	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
5-Phospho-alpha-D-ribose 1-diphosphate	HMDB_SMPDB	Samples:	2	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
ADP-ribose	HMDB_SMPDB	Samples:	2	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
GMP	HMDB_SMPDB	Samples:	2	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
Xanthosine 5'-phosphate	HMDB_SMPDB	Samples:	2	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
3',4'-Dihydrodiol	HMDB_SMPDB	Samples:	15	Pathways:	2	Phenytoin (Antiarrhythmic) Pathway	Fosphenytoin (Antiarrhythmic) Pathway
Phenytoin	HMDB_SMPDB	Samples:	16	Pathways:	4	Phenytoin (Antiarrhythmic) Pathway	Fosphenytoin (Antiarrhythmic) Action Pathway	Phenytoin (Antiarrhythmic) Action Pathway	Fosphenytoin (Antiarrhythmic) Pathway
4-Hydroxyphenytoin glucuronide	HMDB_SMPDB	Samples:	6	Pathways:	1	Phenytoin (Antiarrhythmic) Pathway
Adenosine 3',5'-diphosphate	HMDB_SMPDB	Samples:	15	Pathways:	8	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism	Tamoxifen Pathway	Aromatase deficiency	Sulfate/Sulfite Metabolism	Sulfite oxidase deficiency	Acetaminophen Metabolism Pathway	Tamoxifen Metabolism Pathway
Phosphoadenosine phosphosulfate	HMDB_SMPDB	Samples:	15	Pathways:	8	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism	Tamoxifen Pathway	Aromatase deficiency	Sulfate/Sulfite Metabolism	Sulfite oxidase deficiency	Acetaminophen Metabolism Pathway	Tamoxifen Metabolism Pathway
Sulfate	HMDB_SMPDB	Samples:	11	Pathways:	5	Sulfite oxidase deficiency	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism	Aromatase deficiency	Sulfate/Sulfite Metabolism
Phosphorylcholine	HMDB_SMPDB	Samples:	1	Pathways:	1	Phospholipid Biosynthesis
3'-Phosphoadenylyl sulfate	HMDB_SMPDB	Samples:	15	Pathways:	8	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism	Tamoxifen Action Pathway	Aromatase deficiency	Sulfate/Sulfite Metabolism	Sulfite oxidase deficiency	Acetaminophen Metabolism Pathway	Tamoxifen Metabolism Pathway
Adenosine 3',5'-bisphosphate	HMDB_SMPDB	Samples:	15	Pathways:	8	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism	Tamoxifen Action Pathway	Aromatase deficiency	Sulfate/Sulfite Metabolism	Sulfite oxidase deficiency	Acetaminophen Metabolism Pathway	Tamoxifen Metabolism Pathway
Choline phosphate	HMDB_SMPDB	Samples:	1	Pathways:	1	Phospholipid Biosynthesis
Phosphatidylcholine	HMDB_SMPDB	Samples:	12	Pathways:	40	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Phospholipid Biosynthesis	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Alpha Linolenic Acid and Linoleic Acid Metabolism	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Rofecoxib Action Pathway	Magnesium salicylate Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
D-Ribulose 5-phosphate	HMDB_SMPDB	Samples:	52	Pathways:	1	Warburg Effect
Xylulose 5-phosphate	HMDB_SMPDB	Samples:	52	Pathways:	1	Warburg Effect
Acetaldehyde	HMDB_SMPDB	Samples:	57	Pathways:	9	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Disulfiram Pathway	Ethanol Degradation	Disulfiram Action Pathway	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
D-Sedoheptulose 7-phosphate	HMDB_SMPDB	Samples:	52	Pathways:	1	Warburg Effect
6-Phosphogluconic acid	HMDB_SMPDB	Samples:	52	Pathways:	1	Warburg Effect
D-Erythrose 4-phosphate	HMDB_SMPDB	Samples:	52	Pathways:	1	Warburg Effect
6-Phospho-D-gluconate	HMDB_SMPDB	Samples:	52	Pathways:	1	Warburg Effect
D-Xylulose 5-phosphate	HMDB_SMPDB	Samples:	52	Pathways:	1	Warburg Effect
Sucrose	HMDB_SMPDB	Samples:	6	Pathways:	7	Glycogen synthetase deficiency	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Mucopolysaccharidosis VI. Sly syndrome	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Glycogenosis, Type VI. Hers disease
Normorphine	HMDB_SMPDB	Samples:	35	Pathways:	3	Morphine Metabolism Pathway	Morphine Pathway	Morphine Action Pathway
Perindopril	HMDB_SMPDB	Samples:	4	Pathways:	2	Perindopril Pathway	Perindopril Action Pathway
Perindoprilat glucuronide	HMDB_SMPDB	Samples:	4	Pathways:	1	Perindopril Pathway
Dihydrobiopterin	HMDB_SMPDB	Samples:	5	Pathways:	10	Tyrosine hydroxylase deficiency	Sepiapterin reductase deficiency	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Aromatic L-Aminoacid Decarboxylase Deficiency	Dopa-responsive dystonia	Catecholamine Biosynthesis	Hyperphenylalaninemia due to dhpr-deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
Folic acid	HMDB_SMPDB	Samples:	31	Pathways:	5	Pterine Biosynthesis	Methotrexate Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Folate malabsorption, hereditary
Sepiapterin	HMDB_SMPDB	Samples:	2	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
Neopterin	HMDB_SMPDB	Samples:	2	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
Dihydroneopterin triphosphate	HMDB_SMPDB	Samples:	2	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
Dihydrofolic acid	HMDB_SMPDB	Samples:	31	Pathways:	5	Pterine Biosynthesis	Methotrexate Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Folate malabsorption, hereditary
Dyspropterin	HMDB_SMPDB	Samples:	2	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
7,8-Dihydropteroic acid	HMDB_SMPDB	Samples:	1	Pathways:	1	Pterine Biosynthesis
6-Lactoyltetrahydropterin	HMDB_SMPDB	Samples:	2	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
7,8-Dihydroneopterin	HMDB_SMPDB	Samples:	2	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
2,5-Diaminopyrimidine nucleoside triphosphate 	HMDB_SMPDB	Samples:	2	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
Formamidopyrimidine nucleoside triphosphate	HMDB_SMPDB	Samples:	2	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
2,5-Diamino-6-(5'-triphosphoryl-3',4'-trihydroxy-2'-oxopentyl)-amino-4-oxopyrimidine	HMDB_SMPDB	Samples:	2	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
Dihydroneopterin phosphate	HMDB_SMPDB	Samples:	1	Pathways:	1	Pterine Biosynthesis
Tetrahydrofolyl-[Glu](2)	HMDB_SMPDB	Samples:	31	Pathways:	5	Pterine Biosynthesis	Methotrexate Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Folate malabsorption, hereditary
Tetrahydrofolyl-[Glu](n)	HMDB_SMPDB	Samples:	31	Pathways:	5	Pterine Biosynthesis	Methotrexate Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Folate malabsorption, hereditary
PPPi	HMDB_SMPDB	Samples:	2	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
1-hydroxy-2-Oxopropyl tetrahydropterin	HMDB_SMPDB	Samples:	2	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
2,5-Diaminopyrimidine nucleoside triphosphate	HMDB_SMPDB	Samples:	2	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
6-Lactoyl-5,6,7,8-tetrahydropterin	HMDB_SMPDB	Samples:	2	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
6-Pyruvoyltetrahydropterin	HMDB_SMPDB	Samples:	2	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
7,8-Dihydrobiopterin	HMDB_SMPDB	Samples:	5	Pathways:	10	Tyrosine hydroxylase deficiency	Sepiapterin reductase deficiency	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Aromatic L-Aminoacid Decarboxylase Deficiency	Dopa-responsive dystonia	Catecholamine Biosynthesis	Hyperphenylalaninemia due to dhpr-deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
7,8-Dihydroneopterin 3'-triphosphate	HMDB_SMPDB	Samples:	2	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
Polyphosphate	HMDB_SMPDB	Samples:	2	Pathways:	7	Hyperphenylalaninemia due to dhpr-deficiency	Sepiapterin reductase deficiency	Pterine Biosynthesis	Segawa syndrome	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	Dopa-responsive dystonia	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency
Irinotecan	HMDB_SMPDB	Samples:	2	Pathways:	2	Irinotecan Metabolism Pathway	Irinotecan Action Pathway
APC	HMDB_SMPDB	Samples:	2	Pathways:	2	Irinotecan Metabolism Pathway	Irinotecan Action Pathway
Metipranolol	HMDB_SMPDB	Samples:	11	Pathways:	1	Metipranolol Action Pathway
Taurocholic acid	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Glycocholic acid	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Taurine	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3a,7a-Dihydroxycoprostanic acid	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Chenodeoxycholic acid	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Cholic acid	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Deoxycholic acid	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Deoxycholic acid glycine conjugate	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Chenodeoxycholic acid glycine conjugate	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Lithocholic acid glycine conjugate	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Lithocholyltaurine	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Lithocholic acid	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Taurodeoxycholic acid	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Taurochenodesoxycholic acid	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
27-Deoxy-5b-cyprinol	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Choloyl-CoA	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
24-Hydroxycholesterol	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
5-b-Cholestane-3a ,7a ,12a-triol	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7a-Hydroxycholesterol	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7a-Hydroxy-cholestene-3-one	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
27-Hydroxycholesterol	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3a,7a-Dihydroxy-5b-cholestanoyl-CoA	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7a,12a-Dihydroxy-cholestene-3-one	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3a,7a,12a-Trihydroxy-5b-cholestan-26-al	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3'-AMP	HMDB_SMPDB	Samples:	45	Pathways:	8	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Tryptophan Metabolism	Bile Acid Biosynthesis
3a,7a,12a-Trihydroxy-5b-cholestanoic acid	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
25-Hydroxycholesterol	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7-a,25-Dihydroxycholesterol	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7-a,27-Dihydroxycholesterol	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Chenodeoxycholoyl-CoA	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
CE(22:2(13Z,16Z))	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
5b-Cyprinol sulfate	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3a,7a,12a-Trihydroxy-5b-cholest-24-enoyl-CoA	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3a,7a,12a,24-Tetrahydroxy-5b-cholestanoyl-CoA	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3a,7a,12a-Trihydroxy-5b-24-oxocholestanoyl-CoA	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7a-Hydroxy-5b-cholestan-3-one	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3a,7a-Dihydroxy-5b-cholestane	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3a,7a-Dihydroxy-5b-cholestan-26-al	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3a,7a-Dihydroxy-5b-cholest-24-enoyl-CoA	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
(24R)-Cholest-5-ene-3-beta,7-alpha,24-triol  	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3 beta-Hydroxy-5-cholestenoate	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3 beta,7 alpha-Dihydroxy-5-cholestenoate	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3 alpha,7 alpha,26-Trihydroxy-5beta-cholestane	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3 alpha,7 alpha,24-Trihydroxy-5beta-cholestanoyl-CoA	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7 alpha-Hydroxy-3-oxo-4-cholestenoate	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7 alpha,26-Dihydroxy-4-cholesten-3-one	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3alpha,7alpha,12alpha,24-Tetrahydroxy-5beta-cholestanoyl-CoA	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3alpha,7alpha,12alpha,26-Tetrahydroxy-5beta-cholestane	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3alpha,7alpha,12alpha-Trihydroxy-5beta-24-oxocholestanoyl-CoA	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3alpha,7alpha,12alpha-Trihydroxy-5beta-cholest-24-enoyl-CoA	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestan-26-al	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestane	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3alpha,7alpha,12alpha-Trihydroxy-5beta-cholestanoate	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3alpha,7alpha,24-Trihydroxy-5beta-cholestanoyl-CoA	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3alpha,7alpha,26-Trihydroxy-5beta-cholestane	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3alpha,7alpha-Dihydroxy-5beta-cholest-24-enoyl-CoA	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3alpha,7alpha-Dihydroxy-5beta-cholestan-26-al	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3alpha,7alpha-Dihydroxy-5beta-cholestane	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3alpha,7alpha-Dihydroxy-5beta-cholestanoyl-CoA	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3beta,7alpha-Dihydroxy-5-cholestenoate	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
3beta-Hydroxy-5-cholestenoate	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
5beta-Cyprinolsulfate	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7alpha,12alpha-Dihydroxy-5beta-cholestan-3-one	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7alpha,26-Dihydroxy-4-cholesten-3-one	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7alpha,27-Dihydroxycholesterol	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7alpha-Hydroxy-3-oxo-4-cholestenoate	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7alpha-Hydroxy-5beta-cholestan-3-one	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7alpha-Hydroxycholest-4-en-3-one	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
7alpha-Hydroxycholesterol	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Cerebrosterol	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Chenodeoxycholate	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Cholest-5-ene-3beta,7alpha,25-triol	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Cholesterol ester	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Glycochenodeoxycholate	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Glycocholate	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Glycodeoxycholate	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Glycolithocholate	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Taurochenodeoxycholate	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Taurocholate	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Taurodeoxycholate	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Taurolithocholate	HMDB_SMPDB	Samples:	8	Pathways:	7	Cerebrotendinous Xanthomatosis (CTX)	Congenital Bile Acid Synthesis Defect Type II	Congenital Bile Acid Synthesis Defect Type III	Zellweger Syndrome	Familial Hypercholanemia (FHCA)	27-Hydroxylase Deficiency	Bile Acid Biosynthesis
Bumetanide	HMDB_SMPDB	Samples:	58	Pathways:	1	Bumetanide Pathway
Forasartan	HMDB_SMPDB	Samples:	4	Pathways:	1	Forasartan Action Pathway
Choline	HMDB_SMPDB	Samples:	46	Pathways:	4	sarcosine oncometabolite pathway 	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Phospholipid Biosynthesis	Betaine Metabolism
L-Homoserine	HMDB_SMPDB	Samples:	30	Pathways:	1	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)
5-Methylthioribose 1-phosphate	HMDB_SMPDB	Samples:	30	Pathways:	1	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)
S-Adenosylmethioninamine	HMDB_SMPDB	Samples:	30	Pathways:	1	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)
5'-Methylthioadenosine	HMDB_SMPDB	Samples:	30	Pathways:	1	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)
Spermidine	HMDB_SMPDB	Samples:	30	Pathways:	1	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)
5-Methyltetrahydrofolic acid	HMDB_SMPDB	Samples:	46	Pathways:	6	Methotrexate Pathway	sarcosine oncometabolite pathway 	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Folate malabsorption, hereditary	Betaine Metabolism
Putrescine	HMDB_SMPDB	Samples:	30	Pathways:	1	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)
2-Oxo-4-methylthiobutanoic acid	HMDB_SMPDB	Samples:	30	Pathways:	1	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)
Methionine sulfoxide	HMDB_SMPDB	Samples:	30	Pathways:	1	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)
4-Methylthio-2-oxobutanoic acid	HMDB_SMPDB	Samples:	30	Pathways:	1	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)
5-Methyltetrahydrofolate	HMDB_SMPDB	Samples:	31	Pathways:	5	Methotrexate Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Folate malabsorption, hereditary	Betaine Metabolism
S-Methyl-5-thio-D-ribose 1-phosphate	HMDB_SMPDB	Samples:	30	Pathways:	1	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)
Deoxycorticosterone	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
Cortisol	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
Pregnenolone	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
Tetrahydrocorticosterone	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
18-Hydroxycorticosterone	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
17a-Hydroxypregnenolone	HMDB_SMPDB	Samples:	17	Pathways:	14	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Aromatase deficiency	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
17-Hydroxyprogesterone	HMDB_SMPDB	Samples:	17	Pathways:	14	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Aromatase deficiency	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
Tetrahydrocortisone	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
Tetrahydrocortisol	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
4-Methylpentanal	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
Corticosterone	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
Progesterone	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
Cortisone	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
Dihydrocortisol	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
5a-Pregnane-3,20-dione	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
21-Hydroxypregnenolone	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
11-Dehydrocorticosterone	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
21-Deoxycortisol	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
11b-Hydroxyprogesterone	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
22b-Hydroxycholesterol	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
20alpha-Hydroxycholesterol	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
3a,11b,21-Trihydroxy-20-oxo-5b-pregnan-18-al	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
11b,21-Dihydroxy-3,20-oxo-5b-pregnan-18-al	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
3a,21-Dihydroxy-5b-pregnane-11,20-dione	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
21-Hydroxy-5b-pregnane-3,11,20-trione	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
11b,21-Dihydroxy-5b-pregnane-3,20-dione	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
17a,21-Dihydroxy-5b-pregnane-3,11,20-trione	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
3a-Hydroxy-5b-pregnane-20-one	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
11b,17a,21-Trihydroxypreg-nenolone	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
17a,21-Dihydroxypreg-nenolone	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
20a,22b-Dihydroxycholesterol	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
17a,20a-Dihydroxycholesterol	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
11-Deoxycorticosterone	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
11-Deoxycortisol	HMDB_SMPDB	Samples:	31	Pathways:	34	Aminocaproic Acid Action Pathway	Phenindione Action Pathway	Ardeparin Action Pathway	Dicumarol Action Pathway	Warfarin Action Pathway	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Aprotinin Action Pathway	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Steroidogenesis	Lepirudin Action Pathway	Dicoumarol Action Pathway	Phenprocoumon Action Pathway	Urokinase Action Pathway	Tenecteplase Action Pathway	17-alpha-hydroxylase deficiency (CYP17)	Corticosterone methyl oxidase II deficiency - CMO II	Streptokinase Action Pathway	Acenocoumarol Action Pathway	Enoxaparin Action Pathway	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	Tranexamic Acid Action Pathway	Fondaparinux Action Pathway	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Anistreplase Action Pathway	Heparin Action Pathway	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	Argatroban Action Pathway	Alteplase Action Pathway	Ximelagatran Action Pathway	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Bivalirudin Action Pathway	Reteplase Action Pathway
11beta,17alpha,21-Trihydroxy-5beta-pregnane-3,20-dione	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
11beta,17alpha,21-Trihydroxypregnenolone	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
11beta,21-Dihydroxy-3,20-oxo-5beta-pregnan-18-al	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
11beta,21-Dihydroxy-5beta-pregnane-3,20-dione	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
11beta-Hydroxyprogesterone	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
17alpha,20alpha-Dihydroxycholesterol	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
17alpha,21-Dihydroxy-5beta-pregnane-3,11,20-trione	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
17alpha,21-Dihydroxypregnenolone	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
17alpha-Hydroxypregnenolone	HMDB_SMPDB	Samples:	17	Pathways:	14	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Aromatase deficiency	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
17alpha-Hydroxyprogesterone	HMDB_SMPDB	Samples:	17	Pathways:	14	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Aromatase deficiency	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
20alpha,22beta-Dihydroxycholesterol	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
21-Hydroxy-5beta-pregnane-3,11,20-trione	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
22(R)-Hydroxycholesterol	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
3alpha,11beta,21-Trihydroxy-20-oxo-5beta-pregnan-18-al	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
3alpha,21-Dihydroxy-5beta-pregnane-11,20-dione	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
5alpha-Pregnane-3,20-dione	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
Pregnanolone	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
Urocortisol	HMDB_SMPDB	Samples:	14	Pathways:	11	11-beta-hydroxylase deficiency (CYP11B1)	Corticosterone methyl oxidase I deficiency (CMO I)	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	Steroidogenesis	21-hydroxylase deficiency (CYP21)	Apparent mineralocorticoid excess syndrome	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	Corticosterone methyl oxidase II deficiency - CMO II	17-alpha-hydroxylase deficiency (CYP17)	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
Bilirubin	HMDB_SMPDB	Samples:	1	Pathways:	5	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Porphyria Variegata (PV)	Acute Intermittent Porphyria	Porphyrin Metabolism	Hereditary Coproporphyria (HCP)
Protoporphyrin IX	HMDB_SMPDB	Samples:	1	Pathways:	5	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Porphyria Variegata (PV)	Acute Intermittent Porphyria	Porphyrin Metabolism	Hereditary Coproporphyria (HCP)
Porphobilinogen	HMDB_SMPDB	Samples:	1	Pathways:	5	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Porphyria Variegata (PV)	Acute Intermittent Porphyria	Porphyrin Metabolism	Hereditary Coproporphyria (HCP)
Coproporphyrin III	HMDB_SMPDB	Samples:	1	Pathways:	5	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Porphyria Variegata (PV)	Acute Intermittent Porphyria	Porphyrin Metabolism	Hereditary Coproporphyria (HCP)
Coproporphyrin I	HMDB_SMPDB	Samples:	1	Pathways:	5	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Porphyria Variegata (PV)	Acute Intermittent Porphyria	Porphyrin Metabolism	Hereditary Coproporphyria (HCP)
Uroporphyrin III	HMDB_SMPDB	Samples:	1	Pathways:	5	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Porphyria Variegata (PV)	Acute Intermittent Porphyria	Porphyrin Metabolism	Hereditary Coproporphyria (HCP)
Uroporphyrin I	HMDB_SMPDB	Samples:	1	Pathways:	5	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Porphyria Variegata (PV)	Acute Intermittent Porphyria	Porphyrin Metabolism	Hereditary Coproporphyria (HCP)
Biliverdin	HMDB_SMPDB	Samples:	1	Pathways:	5	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Porphyria Variegata (PV)	Acute Intermittent Porphyria	Porphyrin Metabolism	Hereditary Coproporphyria (HCP)
Uroporphyrinogen III	HMDB_SMPDB	Samples:	1	Pathways:	5	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Porphyria Variegata (PV)	Acute Intermittent Porphyria	Porphyrin Metabolism	Hereditary Coproporphyria (HCP)
Protoporphyrinogen IX	HMDB_SMPDB	Samples:	1	Pathways:	5	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Porphyria Variegata (PV)	Acute Intermittent Porphyria	Porphyrin Metabolism	Hereditary Coproporphyria (HCP)
Hydroxymethylbilane	HMDB_SMPDB	Samples:	1	Pathways:	5	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Porphyria Variegata (PV)	Acute Intermittent Porphyria	Porphyrin Metabolism	Hereditary Coproporphyria (HCP)
Heme O	HMDB_SMPDB	Samples:	1	Pathways:	5	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Porphyria Variegata (PV)	Acute Intermittent Porphyria	Porphyrin Metabolism	Hereditary Coproporphyria (HCP)
Coproporphyrinogen III	HMDB_SMPDB	Samples:	1	Pathways:	5	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Porphyria Variegata (PV)	Acute Intermittent Porphyria	Porphyrin Metabolism	Hereditary Coproporphyria (HCP)
Carbon monoxide	HMDB_SMPDB	Samples:	1	Pathways:	5	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Porphyria Variegata (PV)	Acute Intermittent Porphyria	Porphyrin Metabolism	Hereditary Coproporphyria (HCP)
Coproporphyrinogen I	HMDB_SMPDB	Samples:	1	Pathways:	5	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Porphyria Variegata (PV)	Acute Intermittent Porphyria	Porphyrin Metabolism	Hereditary Coproporphyria (HCP)
Uroporphyrinogen I	HMDB_SMPDB	Samples:	1	Pathways:	5	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Porphyria Variegata (PV)	Acute Intermittent Porphyria	Porphyrin Metabolism	Hereditary Coproporphyria (HCP)
Bilirubin diglucuronide	HMDB_SMPDB	Samples:	1	Pathways:	5	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Porphyria Variegata (PV)	Acute Intermittent Porphyria	Porphyrin Metabolism	Hereditary Coproporphyria (HCP)
D-Urobilinogen	HMDB_SMPDB	Samples:	1	Pathways:	5	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Porphyria Variegata (PV)	Acute Intermittent Porphyria	Porphyrin Metabolism	Hereditary Coproporphyria (HCP)
Heme A	HMDB_SMPDB	Samples:	1	Pathways:	5	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Porphyria Variegata (PV)	Acute Intermittent Porphyria	Porphyrin Metabolism	Hereditary Coproporphyria (HCP)
Bilirubin beta-diglucuronide	HMDB_SMPDB	Samples:	1	Pathways:	5	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Porphyria Variegata (PV)	Acute Intermittent Porphyria	Porphyrin Metabolism	Hereditary Coproporphyria (HCP)
CO	HMDB_SMPDB	Samples:	1	Pathways:	5	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Porphyria Variegata (PV)	Acute Intermittent Porphyria	Porphyrin Metabolism	Hereditary Coproporphyria (HCP)
Protoporphyrin	HMDB_SMPDB	Samples:	1	Pathways:	5	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	Porphyria Variegata (PV)	Acute Intermittent Porphyria	Porphyrin Metabolism	Hereditary Coproporphyria (HCP)
Levallorphan	HMDB_SMPDB	Samples:	20	Pathways:	1	Levallorphan Action Pathway
Omeprazole	HMDB_SMPDB	Samples:	4	Pathways:	2	Omeprazole Pathway	Omeprazole Action Pathway
5-Hydroxyomeprazole	HMDB_SMPDB	Samples:	4	Pathways:	1	Omeprazole Pathway
Argatroban	HMDB_SMPDB	Samples:	13	Pathways:	2	Argatroban Pathway	Argatroban Action Pathway
Cytidine monophosphate	HMDB_SMPDB	Samples:	6	Pathways:	1	Pantothenate and CoA Biosynthesis
Pantothenic acid	HMDB_SMPDB	Samples:	41	Pathways:	5	Ureidopropionase deficiency	Beta-Alanine Metabolism	Carnosinuria, carnosinemia	Pantothenate and CoA Biosynthesis	GABA-Transaminase Deficiency
D-4'-Phosphopantothenate	HMDB_SMPDB	Samples:	6	Pathways:	1	Pantothenate and CoA Biosynthesis
4-Phosphopantothenoylcysteine	HMDB_SMPDB	Samples:	6	Pathways:	1	Pantothenate and CoA Biosynthesis
Dephospho-CoA	HMDB_SMPDB	Samples:	6	Pathways:	1	Pantothenate and CoA Biosynthesis
Pantetheine 4'-phosphate	HMDB_SMPDB	Samples:	6	Pathways:	1	Pantothenate and CoA Biosynthesis
Cysteamine	HMDB_SMPDB	Samples:	6	Pathways:	1	Pantothenate and CoA Biosynthesis
Pantetheine	HMDB_SMPDB	Samples:	57	Pathways:	5	Malonic Aciduria	Malonyl-coa decarboxylase deficiency	Pantothenate and CoA Biosynthesis	Propanoate Metabolism	Methylmalonic Aciduria Due to Cobalamin-Related Disorders
Pantothenol	HMDB_SMPDB	Samples:	6	Pathways:	1	Pantothenate and CoA Biosynthesis
D-Pantothenoyl-L-cysteine	HMDB_SMPDB	Samples:	6	Pathways:	1	Pantothenate and CoA Biosynthesis
(R)-4'-Phosphopantothenoyl-L-cysteine	HMDB_SMPDB	Samples:	6	Pathways:	1	Pantothenate and CoA Biosynthesis
CMP	HMDB_SMPDB	Samples:	6	Pathways:	1	Pantothenate and CoA Biosynthesis
N-((R)-Pantothenoyl)-L-cysteine	HMDB_SMPDB	Samples:	6	Pathways:	1	Pantothenate and CoA Biosynthesis
Pantothenate	HMDB_SMPDB	Samples:	41	Pathways:	5	Ureidopropionase deficiency	Beta-Alanine Metabolism	Carnosinuria, carnosinemia	Pantothenate and CoA Biosynthesis	GABA-Transaminase Deficiency
(S)-2-Hydroxyglutarate	HMDB_SMPDB	Samples:	64	Pathways:	1	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria
(S)-Malate	HMDB_SMPDB	Samples:	64	Pathways:	20	Congenital lactic acidosis	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Primary hyperoxaluria II, PH2	The oncogenic action of Succinate	Citric Acid Cycle	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Fumarase deficiency	Glutaminolysis and Cancer	Pyruvate kinase deficiency	Transfer of Acetyl Groups into Mitochondria	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Pyruvate Dehydrogenase Complex Deficiency	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of 2-hydroxyglutarate	Pyruvate dehydrogenase deficiency (E3)	Warburg Effect	Pyruvate Metabolism	Leigh Syndrome	2-ketoglutarate dehydrogenase complex deficiency
cis-Aconitate	HMDB_SMPDB	Samples:	64	Pathways:	12	Congenital lactic acidosis	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of Succinate	Citric Acid Cycle	The oncogenic action of 2-hydroxyglutarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Pyruvate dehydrogenase deficiency (E3)	Fumarase deficiency	Glutaminolysis and Cancer	2-ketoglutarate dehydrogenase complex deficiency
Citrate	HMDB_SMPDB	Samples:	64	Pathways:	14	Congenital lactic acidosis	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of Succinate	Citric Acid Cycle	The oncogenic action of 2-hydroxyglutarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Pyruvate dehydrogenase deficiency (E3)	Fumarase deficiency	Glutaminolysis and Cancer	Warburg Effect	Transfer of Acetyl Groups into Mitochondria	2-ketoglutarate dehydrogenase complex deficiency
FADH2	HMDB_SMPDB	Samples:	64	Pathways:	14	Congenital lactic acidosis	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of Succinate	Citric Acid Cycle	The oncogenic action of 2-hydroxyglutarate	Phospholipid Biosynthesis	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Pyruvate dehydrogenase deficiency (E3)	Fumarase deficiency	Glutaminolysis and Cancer	Warburg Effect	2-ketoglutarate dehydrogenase complex deficiency
Isocitrate	HMDB_SMPDB	Samples:	64	Pathways:	13	Congenital lactic acidosis	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of Succinate	Citric Acid Cycle	The oncogenic action of 2-hydroxyglutarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Pyruvate dehydrogenase deficiency (E3)	Fumarase deficiency	Glutaminolysis and Cancer	Warburg Effect	2-ketoglutarate dehydrogenase complex deficiency
NH4+	HMDB_SMPDB	Samples:	64	Pathways:	2	The oncogenic action of 2-hydroxyglutarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria
Ubiquinone-10	HMDB_SMPDB	Samples:	64	Pathways:	14	Mitochondrial Electron Transport Chain	Congenital lactic acidosis	The oncogenic action of Fumarate	Mitochondrial complex II deficiency	Pyruvate dehydrogenase deficiency (E2)	The oncogenic action of Succinate	Citric Acid Cycle	The oncogenic action of 2-hydroxyglutarate	The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria	Pyruvate dehydrogenase deficiency (E3)	Fumarase deficiency	Glutaminolysis and Cancer	Warburg Effect	2-ketoglutarate dehydrogenase complex deficiency
Tirofiban	HMDB_SMPDB	Samples:	2	Pathways:	2	Tirofiban Action Pathway	Tirofiban Pathway
Glycerol 3-phosphate	HMDB_SMPDB	Samples:	55	Pathways:	2	Mitochondrial Electron Transport Chain	Phospholipid Biosynthesis
PA(16:0/16:0)	HMDB_SMPDB	Samples:	1	Pathways:	1	Phospholipid Biosynthesis
LPA(16:0/0:0)	HMDB_SMPDB	Samples:	1	Pathways:	1	Phospholipid Biosynthesis
Diacylglycerol	HMDB_SMPDB	Samples:	1	Pathways:	1	Phospholipid Biosynthesis
Phosphatidate	HMDB_SMPDB	Samples:	1	Pathways:	1	Phospholipid Biosynthesis
sn-Glycerol 3-phosphate	HMDB_SMPDB	Samples:	55	Pathways:	2	Mitochondrial Electron Transport Chain	Phospholipid Biosynthesis
Diflunisal	HMDB_SMPDB	Samples:	1	Pathways:	2	Diflunisal Pathway	Diflunisal Action Pathway
Dimethylamine	HMDB_SMPDB	Samples:	44	Pathways:	3	Citalopram Pathway	Citalopram Metabolism Pathway	Citalopram Action Pathway
Citalopram	HMDB_SMPDB	Samples:	44	Pathways:	3	Citalopram Pathway	Citalopram Metabolism Pathway	Citalopram Action Pathway
N-Desmethylcitalopram	HMDB_SMPDB	Samples:	44	Pathways:	2	Citalopram Pathway	Citalopram Metabolism Pathway
Dibucaine	HMDB_SMPDB	Samples:	20	Pathways:	2	Dibucaine Pathway	Dibucaine Action Pathway
p-Hydroxyphenylacetic acid	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3-Methoxytyramine	HMDB_SMPDB	Samples:	55	Pathways:	9	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Ascorbic acid	HMDB_SMPDB	Samples:	64	Pathways:	17	Tyrosine hydroxylase deficiency	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	The oncogenic action of Fumarate	Carnitine Synthesis	The oncogenic action of Succinate	Tyrosinemia, transient, of the newborn	Aromatic L-Aminoacid Decarboxylase Deficiency	Oxidation of Branched Chain Fatty Acids	Phytanic Acid Peroxisomal Oxidation	Refsum Disease	Alkaptonuria	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Catecholamine Biosynthesis	Hawkinsinuria	Tyrosine Metabolism
Epinephrine	HMDB_SMPDB	Samples:	60	Pathways:	12	Tyrosine hydroxylase deficiency	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Aromatic L-Aminoacid Decarboxylase Deficiency	Epinephrine Action Pathway	Catecholamine Biosynthesis	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Homovanillic acid	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Methylamine	HMDB_SMPDB	Samples:	55	Pathways:	9	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
L-Dopa	HMDB_SMPDB	Samples:	55	Pathways:	11	Tyrosine hydroxylase deficiency	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Aromatic L-Aminoacid Decarboxylase Deficiency	Catecholamine Biosynthesis	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Vanillylmandelic acid	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Tyramine	HMDB_SMPDB	Samples:	55	Pathways:	9	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3,4-Dihydroxyphenylglycol	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Copper	HMDB_SMPDB	Samples:	56	Pathways:	19	Tyrosine hydroxylase deficiency	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Ureidopropionase deficiency	Beta-Alanine Metabolism	Degradation of Superoxides	Carnosinuria, carnosinemia	Histidine Metabolism	Tyrosinemia, transient, of the newborn	Aromatic L-Aminoacid Decarboxylase Deficiency	Histidinemia	Disulfiram Action Pathway	Alkaptonuria	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	GABA-Transaminase Deficiency	Catecholamine Biosynthesis	Hawkinsinuria	Tyrosine Metabolism
Normetanephrine	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Pyrocatechol	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Dopaquinone	HMDB_SMPDB	Samples:	55	Pathways:	9	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
5,6-Dihydroxyindole-2-carboxylic acid	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Dehydroascorbic acid	HMDB_SMPDB	Samples:	55	Pathways:	11	Tyrosine hydroxylase deficiency	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Aromatic L-Aminoacid Decarboxylase Deficiency	Catecholamine Biosynthesis	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3,4-Dihydroxybenzeneacetic acid	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Guaiacol	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
L-Dopachrome	HMDB_SMPDB	Samples:	55	Pathways:	9	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Vanylglycol	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3,4-Dihydroxymandelic acid	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3,4-Dihydroxyphenylacetaldehyde	HMDB_SMPDB	Samples:	55	Pathways:	9	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
5,6-Dihydroxyindole	HMDB_SMPDB	Samples:	55	Pathways:	9	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3-Methoxy-4-hydroxyphenylglycolaldehyde	HMDB_SMPDB	Samples:	55	Pathways:	9	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Metanephrine	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Leucodopachrome	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Melanin	HMDB_SMPDB	Samples:	55	Pathways:	9	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Homovanillin	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3,4-Dihydroxymandelaldehyde	HMDB_SMPDB	Samples:	55	Pathways:	9	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Indole-5,6-quinone	HMDB_SMPDB	Samples:	55	Pathways:	9	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
2-Hydroxy-3-(4-hydroxyphenyl)propenoic acid	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Topaquinone	HMDB_SMPDB	Samples:	55	Pathways:	14	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Ureidopropionase deficiency	Dopamine beta-hydroxylase deficiency	Beta-Alanine Metabolism	Disulfiram Pathway	Carnosinuria, carnosinemia	Tyrosinemia, transient, of the newborn	Histidine Metabolism	Histidinemia	GABA-Transaminase Deficiency	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Pyrroloquinoline quinone	HMDB_SMPDB	Samples:	55	Pathways:	11	Tyrosine hydroxylase deficiency	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Aromatic L-Aminoacid Decarboxylase Deficiency	Catecholamine Biosynthesis	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Methylammonium	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Disulfiram Pathway	Tyrosinemia, transient, of the newborn	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
2-Carboxy-2,3-dihydro-5,6-dihydroxyindole	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
2-Hydroxy-3-(4-hydroxyphenyl)propenoate	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3,4-Dihydroxy-L-phenylalanine	HMDB_SMPDB	Samples:	55	Pathways:	11	Tyrosine hydroxylase deficiency	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Aromatic L-Aminoacid Decarboxylase Deficiency	Disulfiram Action Pathway	Catecholamine Biosynthesis	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3,4-Dihydroxymandelate	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3,4-Dihydroxyphenylacetate	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3,4-Dihydroxyphenylethyleneglycol	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3-Methoxy-4-hydroxymandelate	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3-Methoxy-4-hydroxyphenylacetaldehyde	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
3-Methoxy-4-hydroxyphenylethyleneglycol	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
4-Hydroxyphenylacetate	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
5,6-Dihydroxyindole-2-carboxylate	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Ascorbate	HMDB_SMPDB	Samples:	64	Pathways:	17	Tyrosine hydroxylase deficiency	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	The oncogenic action of Fumarate	Carnitine Synthesis	The oncogenic action of Succinate	Tyrosinemia, transient, of the newborn	Aromatic L-Aminoacid Decarboxylase Deficiency	Disulfiram Action Pathway	Oxidation of Branched Chain Fatty Acids	Phytanic Acid Peroxisomal Oxidation	Refsum Disease	Alkaptonuria	Dopamine beta-hydroxylase deficiency	Catecholamine Biosynthesis	Hawkinsinuria	Tyrosine Metabolism
Catechol	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Homovanillate	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
L-Adrenaline	HMDB_SMPDB	Samples:	60	Pathways:	12	Tyrosine hydroxylase deficiency	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Aromatic L-Aminoacid Decarboxylase Deficiency	Disulfiram Action Pathway	Epinephrine Action Pathway	Catecholamine Biosynthesis	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
L-Metanephrine	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
L-Normetanephrine	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
o-Methoxyphenol	HMDB_SMPDB	Samples:	55	Pathways:	8	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Disulfiram Action Pathway	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
PQQ	HMDB_SMPDB	Samples:	55	Pathways:	11	Tyrosine hydroxylase deficiency	Tyrosinemia Type I	Monoamine oxidase-a deficiency (MAO-A)	Dopamine beta-hydroxylase deficiency	Tyrosinemia, transient, of the newborn	Aromatic L-Aminoacid Decarboxylase Deficiency	Disulfiram Action Pathway	Catecholamine Biosynthesis	Hawkinsinuria	Tyrosine Metabolism	Alkaptonuria
Codeine	HMDB_SMPDB	Samples:	40	Pathways:	3	Codeine Metabolism Pathway	Codeine Action Pathway	Codeine Pathway
Codeine-6-glucuronide	HMDB_SMPDB	Samples:	40	Pathways:	3	Codeine Metabolism Pathway	Codeine Action Pathway	Codeine Pathway
Norcodeine	HMDB_SMPDB	Samples:	40	Pathways:	3	Codeine Metabolism Pathway	Codeine Action Pathway	Codeine Pathway
4-Hydroxyproline	HMDB_SMPDB	Samples:	62	Pathways:	2	The oncogenic action of Fumarate	The oncogenic action of Succinate
Hydroxyproline	HMDB_SMPDB	Samples:	62	Pathways:	2	The oncogenic action of Fumarate	The oncogenic action of Succinate
Ubiquinol	HMDB_SMPDB	Samples:	63	Pathways:	3	The oncogenic action of Fumarate	Glutaminolysis and Cancer	The oncogenic action of Succinate
Moexipril	HMDB_SMPDB	Samples:	16	Pathways:	3	Moexipril Pathway	Moexipril Metabolism Pathway	Moexipril Action Pathway
Oxycodone	HMDB_SMPDB	Samples:	20	Pathways:	2	Oxycodone Pathway	Oxycodone Action Pathway
Stearic acid	HMDB_SMPDB	Samples:	51	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
Stearoyl-CoA	HMDB_SMPDB	Samples:	51	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
Citicoline	HMDB_SMPDB	Samples:	1	Pathways:	1	Phospholipid Biosynthesis
Octadecanoic acid	HMDB_SMPDB	Samples:	51	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
Procainamide	HMDB_SMPDB	Samples:	11	Pathways:	2	Procainamide (Antiarrhythmic) Action Pathway	Procainamide (Antiarrhythmic) Pathway
Lisinopril	HMDB_SMPDB	Samples:	4	Pathways:	1	Lisinopril Pathway
Gamma-Glutamylcysteine	HMDB_SMPDB	Samples:	2	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
gamma-L-Glutamyl-L-cysteine	HMDB_SMPDB	Samples:	2	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
Glutathione disulfide	HMDB_SMPDB	Samples:	10	Pathways:	44	Diclofenac Action Pathway	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Nabumetone Action Pathway	Homocarnosinosis	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	2-Hydroxyglutric Aciduria (D And L Form)	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Magnesium salicylate Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Hyperinsulinism-Hyperammonemia Syndrome	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Succinic semialdehyde dehydrogenase deficiency	Glutamate Metabolism	Rofecoxib Action Pathway	Lornoxicam Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
Felodipine	HMDB_SMPDB	Samples:	11	Pathways:	1	Felodipine Pathway
Rabeprazole	HMDB_SMPDB	Samples:	4	Pathways:	2	Rabeprazole Pathway	Rabeprazole Action Pathway
L-Lactic acid	HMDB_SMPDB	Samples:	61	Pathways:	16	Primary hyperoxaluria II, PH2	Glycogenosis, Type IC	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glutaminolysis and Cancer	Pyruvate kinase deficiency	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycogenosis, Type IA. Von gierke disease	Pyruvate Dehydrogenase Complex Deficiency	Warburg Effect	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Pyruvate Metabolism	Leigh Syndrome
Malic acid	HMDB_SMPDB	Samples:	63	Pathways:	10	Glycogenosis, Type IA. Von gierke disease	The oncogenic action of Fumarate	Malate-Aspartate Shuttle	Glycogenosis, Type IC	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)
Glyceric acid 1,3-biphosphate	HMDB_SMPDB	Samples:	67	Pathways:	20	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Glycogenosis, Type IC	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type VI. Hers disease	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Mitochondrial Electron Transport Chain	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Glycogen synthetase deficiency	Warburg Effect	Mucopolysaccharidosis VI. Sly syndrome	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycolysis
2,3-Diphosphoglyceric acid	HMDB_SMPDB	Samples:	12	Pathways:	11	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type IC	Glycogenosis, Type VII. Tarui disease	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycolysis	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)
2-Phospho-D-glyceric acid	HMDB_SMPDB	Samples:	55	Pathways:	12	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type IC	Glycogenosis, Type VII. Tarui disease	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type IB	Warburg Effect	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycolysis	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)
(S)-Lactate	HMDB_SMPDB	Samples:	61	Pathways:	16	Primary hyperoxaluria II, PH2	Glycogenosis, Type IC	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glutaminolysis and Cancer	Pyruvate kinase deficiency	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Glycogenosis, Type IA. Von gierke disease	Pyruvate Dehydrogenase Complex Deficiency	Warburg Effect	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Pyruvate Metabolism	Leigh Syndrome
2,3-Bisphospho-D-glycerate	HMDB_SMPDB	Samples:	12	Pathways:	11	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type IC	Glycogenosis, Type VII. Tarui disease	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycolysis	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)
2-Phospho-D-glycerate	HMDB_SMPDB	Samples:	55	Pathways:	12	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type IC	Glycogenosis, Type VII. Tarui disease	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type IB	Warburg Effect	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycolysis	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)
3-Phospho-D-glyceroyl phosphate	HMDB_SMPDB	Samples:	67	Pathways:	20	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Glycogenosis, Type IC	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type VI. Hers disease	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	Mitochondrial Electron Transport Chain	Glycogenosis, Type IA. Von gierke disease	Fanconi-bickel syndrome	Glycogenosis, Type VII. Tarui disease	Glycogen synthetase deficiency	Warburg Effect	Mucopolysaccharidosis VI. Sly syndrome	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Glycolysis
Malate	HMDB_SMPDB	Samples:	63	Pathways:	10	Glycogenosis, Type IA. Von gierke disease	The oncogenic action of Fumarate	Malate-Aspartate Shuttle	Glycogenosis, Type IC	Triosephosphate isomerase	Gluconeogenesis	Glycogenosis, Type IB	Fructose-1,6-diphosphatase deficiency	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)
Nepafenac	HMDB_SMPDB	Samples:	1	Pathways:	1	Nepafenac Action Pathway
(15S)-15-Hydroxy-5,8,11-cis-13-trans-eicosatetraenoate	HMDB_SMPDB	Samples:	8	Pathways:	38	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Rofecoxib Action Pathway	Magnesium salicylate Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
1-Acyl-sn-glycero-3-phosphocholine	HMDB_SMPDB	Samples:	8	Pathways:	39	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Phospholipid Biosynthesis	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Rofecoxib Action Pathway	Magnesium salicylate Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
11,12-DHET	HMDB_SMPDB	Samples:	8	Pathways:	38	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Rofecoxib Action Pathway	Magnesium salicylate Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
11,12-EET	HMDB_SMPDB	Samples:	8	Pathways:	38	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Rofecoxib Action Pathway	Magnesium salicylate Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
11-epi-Prostaglandin F2alpha	HMDB_SMPDB	Samples:	8	Pathways:	38	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Rofecoxib Action Pathway	Magnesium salicylate Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
12-OxoETE	HMDB_SMPDB	Samples:	8	Pathways:	38	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Rofecoxib Action Pathway	Magnesium salicylate Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
14,15-DHET	HMDB_SMPDB	Samples:	8	Pathways:	38	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Rofecoxib Action Pathway	Magnesium salicylate Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
14,15-EET	HMDB_SMPDB	Samples:	8	Pathways:	38	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Rofecoxib Action Pathway	Magnesium salicylate Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
15-Deoxy-Delta12,14-PGJ2	HMDB_SMPDB	Samples:	8	Pathways:	38	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Rofecoxib Action Pathway	Magnesium salicylate Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
20-COOH-Leukotriene B4	HMDB_SMPDB	Samples:	8	Pathways:	38	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Rofecoxib Action Pathway	Magnesium salicylate Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
20-HETE	HMDB_SMPDB	Samples:	8	Pathways:	38	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Rofecoxib Action Pathway	Magnesium salicylate Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
20-OH-Leukotriene B4	HMDB_SMPDB	Samples:	8	Pathways:	38	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Rofecoxib Action Pathway	Magnesium salicylate Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
5(S)-HETE	HMDB_SMPDB	Samples:	8	Pathways:	38	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Rofecoxib Action Pathway	Magnesium salicylate Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
5(S)-HPETE	HMDB_SMPDB	Samples:	8	Pathways:	38	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Rofecoxib Action Pathway	Magnesium salicylate Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
5,6-EET	HMDB_SMPDB	Samples:	8	Pathways:	38	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Rofecoxib Action Pathway	Magnesium salicylate Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
5-OxoETE	HMDB_SMPDB	Samples:	8	Pathways:	38	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Rofecoxib Action Pathway	Magnesium salicylate Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
6-Keto-prostaglandin E1	HMDB_SMPDB	Samples:	8	Pathways:	38	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Rofecoxib Action Pathway	Magnesium salicylate Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
6-Keto-prostaglandin F1alpha	HMDB_SMPDB	Samples:	8	Pathways:	38	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Rofecoxib Action Pathway	Magnesium salicylate Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
8(S)-HETE	HMDB_SMPDB	Samples:	8	Pathways:	38	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Rofecoxib Action Pathway	Magnesium salicylate Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
8,9-DHET	HMDB_SMPDB	Samples:	8	Pathways:	38	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Rofecoxib Action Pathway	Magnesium salicylate Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
8,9-EET	HMDB_SMPDB	Samples:	8	Pathways:	38	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Rofecoxib Action Pathway	Magnesium salicylate Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
9,11,15-Trihydroxy-prosta-5,13-dien-1-oic acid	HMDB_SMPDB	Samples:	8	Pathways:	38	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Rofecoxib Action Pathway	Magnesium salicylate Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
Leukotriene D4	HMDB_SMPDB	Samples:	8	Pathways:	38	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Rofecoxib Action Pathway	Magnesium salicylate Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
Prostaglandin C2	HMDB_SMPDB	Samples:	8	Pathways:	38	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Rofecoxib Action Pathway	Magnesium salicylate Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
Prostaglandin F2alpha	HMDB_SMPDB	Samples:	8	Pathways:	38	Diclofenac Action Pathway	Etoricoxib Action Pathway	Tiaprofenic Acid Action Pathway	Salicylic Acid Action Pathway	Nabumetone Action Pathway	Ketorolac Action Pathway	Tolmetin Action Pathway	Salicylate-sodium Action Pathway	Meloxicam Action Pathway	Lumiracoxib Action Pathway	Antipyrine Action Pathway	Bromfenac Action Pathway	Fenoprofen Action Pathway	Mefenamic Acid Action Pathway	Piroxicam Action Pathway	Lornoxicam Action Pathway	Antrafenine Action Pathway	Valdecoxib Action Pathway	Acetylsalicylic Acid Action Pathway	Salsalate Action Pathway	Nepafenac Action Pathway	Trisalicylate-choline Action Pathway	Tenoxicam Action Pathway	Oxaprozin Action Pathway	Naproxen Action Pathway	Flurbiprofen Action Pathway	Acetaminophen  Action Pathway	Ibuprofen Action Pathway	Diflunisal Action Pathway	Ketoprofen Action Pathway	Sulindac Action Pathway	Leukotriene C4 Synthesis Deficiency	Suprofen Action Pathway	Carprofen Action Pathway	Rofecoxib Action Pathway	Magnesium salicylate Action Pathway	Etodolac Action Pathway	Phenylbutazone Action Pathway
Furosemide	HMDB_SMPDB	Samples:	58	Pathways:	2	Furosemide Pathway	Furosemide Action Pathway
Quinapril	HMDB_SMPDB	Samples:	16	Pathways:	3	Quinapril Metabolism Pathway	Quinapril Action Pathway	Quinapril Pathway
Quinaprilat	HMDB_SMPDB	Samples:	16	Pathways:	2	Quinapril Metabolism Pathway	Quinapril Pathway
Spironolactone	HMDB_SMPDB	Samples:	58	Pathways:	2	Spironolactone Pathway	Spironolactone Action Pathway
Nicotine imine	HMDB_SMPDB	Samples:	35	Pathways:	2	Nicotine Pathway	Nicotine Metabolism Pathway
Cotinine glucuronide	HMDB_SMPDB	Samples:	35	Pathways:	2	Nicotine Pathway	Nicotine Metabolism Pathway
Cotinine	HMDB_SMPDB	Samples:	35	Pathways:	2	Nicotine Pathway	Nicotine Metabolism Pathway
Nornicotine	HMDB_SMPDB	Samples:	35	Pathways:	3	Nicotine Pathway	Nicotine Action Pathway	Nicotine Metabolism Pathway
trans-3-Hydroxycotinine glucuronide	HMDB_SMPDB	Samples:	35	Pathways:	2	Nicotine Pathway	Nicotine Metabolism Pathway
Nicotine glucuronide	HMDB_SMPDB	Samples:	35	Pathways:	2	Nicotine Pathway	Nicotine Metabolism Pathway
Norcotinine	HMDB_SMPDB	Samples:	35	Pathways:	2	Nicotine Pathway	Nicotine Metabolism Pathway
Hydroxycotinine	HMDB_SMPDB	Samples:	35	Pathways:	2	Nicotine Pathway	Nicotine Metabolism Pathway
Cotinine N-oxide	HMDB_SMPDB	Samples:	35	Pathways:	2	Nicotine Pathway	Nicotine Metabolism Pathway
5'-Hydroxycotinine	HMDB_SMPDB	Samples:	35	Pathways:	2	Nicotine Pathway	Nicotine Metabolism Pathway
Nicotine-1'-N-oxide	HMDB_SMPDB	Samples:	35	Pathways:	2	Nicotine Pathway	Nicotine Metabolism Pathway
Nicotine	HMDB_SMPDB	Samples:	35	Pathways:	2	Nicotine Pathway	Nicotine Metabolism Pathway
Methylmalonyl-CoA	HMDB_SMPDB	Samples:	59	Pathways:	1	Valine, Leucine and Isoleucine Degradation
Carnosine	HMDB_SMPDB	Samples:	42	Pathways:	6	Ureidopropionase deficiency	Beta-Alanine Metabolism	Carnosinuria, carnosinemia	Histidine Metabolism	Histidinemia	GABA-Transaminase Deficiency
L-Histidine	HMDB_SMPDB	Samples:	42	Pathways:	7	Ureidopropionase deficiency	Beta-Alanine Metabolism	Carnosinuria, carnosinemia	Histidine Metabolism	Ammonia Recycling	Histidinemia	GABA-Transaminase Deficiency
Urocanic acid	HMDB_SMPDB	Samples:	12	Pathways:	3	Ammonia Recycling	Histidinemia	Histidine Metabolism
3-Methylhistidine	HMDB_SMPDB	Samples:	42	Pathways:	6	Ureidopropionase deficiency	Beta-Alanine Metabolism	Carnosinuria, carnosinemia	Histidine Metabolism	Histidinemia	GABA-Transaminase Deficiency
Formiminoglutamic acid	HMDB_SMPDB	Samples:	9	Pathways:	2	Histidinemia	Histidine Metabolism
1-Methylhistamine	HMDB_SMPDB	Samples:	9	Pathways:	2	Histidinemia	Histidine Metabolism
4-Imidazolone-5-propionic acid	HMDB_SMPDB	Samples:	9	Pathways:	2	Histidinemia	Histidine Metabolism
5-Formiminotetrahydrofolic acid	HMDB_SMPDB	Samples:	33	Pathways:	6	Methotrexate Pathway	Histidine Metabolism	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Histidinemia	Folate Metabolism	Folate malabsorption, hereditary
Imidazoleacetic acid	HMDB_SMPDB	Samples:	9	Pathways:	2	Histidinemia	Histidine Metabolism
Methylimidazoleacetic acid	HMDB_SMPDB	Samples:	9	Pathways:	2	Histidinemia	Histidine Metabolism
Imidazole-4-acetaldehyde	HMDB_SMPDB	Samples:	9	Pathways:	2	Histidinemia	Histidine Metabolism
Methylimidazole acetaldehyde	HMDB_SMPDB	Samples:	9	Pathways:	2	Histidinemia	Histidine Metabolism
4-Imidazolone-5-propanoate	HMDB_SMPDB	Samples:	9	Pathways:	2	Histidinemia	Histidine Metabolism
5-Formiminotetrahydrofolate	HMDB_SMPDB	Samples:	33	Pathways:	6	Methotrexate Action Pathway	Histidine Metabolism	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Histidinemia	Folate Metabolism	Folate malabsorption, hereditary
beta-Alanyl-N(pi)-methyl-L-histidine	HMDB_SMPDB	Samples:	42	Pathways:	6	Ureidopropionase deficiency	Beta-Alanine Metabolism	Carnosinuria, carnosinemia	Histidine Metabolism	Histidinemia	GABA-Transaminase Deficiency
Imidazole-4-acetate	HMDB_SMPDB	Samples:	9	Pathways:	2	Histidinemia	Histidine Metabolism
N(pi)-Methyl-L-histidine	HMDB_SMPDB	Samples:	42	Pathways:	6	Ureidopropionase deficiency	Beta-Alanine Metabolism	Carnosinuria, carnosinemia	Histidine Metabolism	Histidinemia	GABA-Transaminase Deficiency
N-Formimino-L-glutamate	HMDB_SMPDB	Samples:	9	Pathways:	2	Histidinemia	Histidine Metabolism
N-Methylhistamine	HMDB_SMPDB	Samples:	9	Pathways:	2	Histidinemia	Histidine Metabolism
Urocanate	HMDB_SMPDB	Samples:	12	Pathways:	3	Ammonia Recycling	Histidinemia	Histidine Metabolism
Roxatidine acetate	HMDB_SMPDB	Samples:	4	Pathways:	1	Roxatidine acetate Action Pathway
Acetylcholine	HMDB_SMPDB	Samples:	5	Pathways:	15	Cimetidine Action Pathway	Betazole Action Pathway	Esomeprazole Action Pathway	Roxatidine acetate Action Pathway	Lansoprazole Action Pathway	Phospholipid Biosynthesis	Omeprazole Action Pathway	Famotidine Action Pathway	Nizatidine Action Pathway	Rabeprazole Action Pathway	Gastric Acid Production	Metiamide Action Pathway	Ranitidine Action Pathway	Pirenzepine Action Pathway	Pantoprazole Action Pathway
S-Lactoylglutathione	HMDB_SMPDB	Samples:	48	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
Malonyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	10	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Propanoate Metabolism	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	Malonic Aciduria	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
D-Lactic acid	HMDB_SMPDB	Samples:	48	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
Acetylphosphate	HMDB_SMPDB	Samples:	48	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
Propylene glycol	HMDB_SMPDB	Samples:	48	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
D-Lactaldehyde	HMDB_SMPDB	Samples:	48	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
S-Acetyldihydrolipoamide-E	HMDB_SMPDB	Samples:	48	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
Acetyl adenylate	HMDB_SMPDB	Samples:	48	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
(R)-Lactaldehyde	HMDB_SMPDB	Samples:	48	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
(R)-Lactate	HMDB_SMPDB	Samples:	48	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
(R)-S-Lactoylglutathione	HMDB_SMPDB	Samples:	48	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
(S)-Lactaldehyde	HMDB_SMPDB	Samples:	48	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
[Dihydrolipoyllysine-residue acetyltransferase] S-acetyldihydrolipoyllysine	HMDB_SMPDB	Samples:	48	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
Acetyl phosphate	HMDB_SMPDB	Samples:	48	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
Propane-1,2-diol	HMDB_SMPDB	Samples:	48	Pathways:	6	Pyruvate Dehydrogenase Complex Deficiency	Primary hyperoxaluria II, PH2	Pyruvate kinase deficiency	Pyruvate Metabolism	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	Leigh Syndrome
Etoricoxib	HMDB_SMPDB	Samples:	1	Pathways:	1	Etoricoxib Action Pathway
L791456	HMDB_SMPDB	Samples:	1	Pathways:	1	Etoricoxib Action Pathway
Clopidogrel	HMDB_SMPDB	Samples:	1	Pathways:	2	Clopidogrel Pathway	Clopidogrel Metabolism Pathway
2-Oxoclopidogrel	HMDB_SMPDB	Samples:	1	Pathways:	2	Clopidogrel Pathway	Clopidogrel Metabolism Pathway
Ureidopropionic acid	HMDB_SMPDB	Samples:	41	Pathways:	4	Ureidopropionase deficiency	Beta-Alanine Metabolism	GABA-Transaminase Deficiency	Carnosinuria, carnosinemia
Dihydrouracil	HMDB_SMPDB	Samples:	41	Pathways:	4	Ureidopropionase deficiency	Beta-Alanine Metabolism	GABA-Transaminase Deficiency	Carnosinuria, carnosinemia
Uracil	HMDB_SMPDB	Samples:	41	Pathways:	4	Ureidopropionase deficiency	Beta-Alanine Metabolism	GABA-Transaminase Deficiency	Carnosinuria, carnosinemia
3-Ureidopropionate	HMDB_SMPDB	Samples:	41	Pathways:	4	Ureidopropionase deficiency	Beta-Alanine Metabolism	GABA-Transaminase Deficiency	Carnosinuria, carnosinemia
5,6-Dihydrouracil	HMDB_SMPDB	Samples:	41	Pathways:	4	Ureidopropionase deficiency	Beta-Alanine Metabolism	GABA-Transaminase Deficiency	Carnosinuria, carnosinemia
Dihydrofolate	HMDB_SMPDB	Samples:	30	Pathways:	4	Methotrexate Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Folate malabsorption, hereditary
Salicylic acid	HMDB_SMPDB	Samples:	1	Pathways:	1	Salicylic Acid Action Pathway
Salicylate	HMDB_SMPDB	Samples:	1	Pathways:	1	Salicylic Acid Action Pathway
Bromfenac	HMDB_SMPDB	Samples:	1	Pathways:	1	Bromfenac Pathway
Fenoprofen	HMDB_SMPDB	Samples:	1	Pathways:	1	Fenoprofen Action Pathway
Betaxolol	HMDB_SMPDB	Samples:	11	Pathways:	2	Betaxolol Action Pathway	Betaxolol Pathway
Trisalicylate-choline	HMDB_SMPDB	Samples:	1	Pathways:	1	Trisalicylate-choline Action Pathway
4'-Hydroxydiclofenac	HMDB_SMPDB	Samples:	1	Pathways:	1	Diclofenac Pathway
Diclofenac	HMDB_SMPDB	Samples:	1	Pathways:	2	Diclofenac Action Pathway	Diclofenac Pathway
Androstenedione	HMDB_SMPDB	Samples:	10	Pathways:	3	Aromatase deficiency	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism
Dehydroepiandrosterone	HMDB_SMPDB	Samples:	10	Pathways:	3	Aromatase deficiency	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism
Estrone	HMDB_SMPDB	Samples:	11	Pathways:	5	Sulfite oxidase deficiency	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism	Aromatase deficiency	Sulfate/Sulfite Metabolism
Estradiol	HMDB_SMPDB	Samples:	10	Pathways:	3	Aromatase deficiency	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism
Testosterone	HMDB_SMPDB	Samples:	10	Pathways:	3	Aromatase deficiency	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism
Dehydroepiandrosterone sulfate	HMDB_SMPDB	Samples:	10	Pathways:	3	Aromatase deficiency	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism
Estrone sulfate	HMDB_SMPDB	Samples:	11	Pathways:	5	Sulfite oxidase deficiency	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism	Aromatase deficiency	Sulfate/Sulfite Metabolism
Androsterone sulfate	HMDB_SMPDB	Samples:	10	Pathways:	1	Androgen and Estrogen Metabolism
Dihydrotestosterone	HMDB_SMPDB	Samples:	10	Pathways:	3	Aromatase deficiency	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism
Testosterone glucuronide	HMDB_SMPDB	Samples:	10	Pathways:	3	Aromatase deficiency	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism
19-Hydroxyandrost-4-ene-3,17-dione	HMDB_SMPDB	Samples:	10	Pathways:	3	Aromatase deficiency	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism
19-Oxotestosterone	HMDB_SMPDB	Samples:	10	Pathways:	3	Aromatase deficiency	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism
17-beta-Estradiol-3-glucuronide	HMDB_SMPDB	Samples:	10	Pathways:	3	Aromatase deficiency	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism
19-Oxoandrost-4-ene-3,17-dione	HMDB_SMPDB	Samples:	10	Pathways:	3	Aromatase deficiency	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism
19-Hydroxytestosterone	HMDB_SMPDB	Samples:	10	Pathways:	3	Aromatase deficiency	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism
5b-Dihydrotestosterone	HMDB_SMPDB	Samples:	10	Pathways:	3	Aromatase deficiency	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism
5beta-Dihydrotestosterone	HMDB_SMPDB	Samples:	10	Pathways:	3	Aromatase deficiency	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism
Estradiol-17beta	HMDB_SMPDB	Samples:	10	Pathways:	3	Aromatase deficiency	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism
Estradiol-17beta 3-glucuronide	HMDB_SMPDB	Samples:	10	Pathways:	3	Aromatase deficiency	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism
Estrone 3-sulfate	HMDB_SMPDB	Samples:	11	Pathways:	5	Sulfite oxidase deficiency	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	Androgen and Estrogen Metabolism	Aromatase deficiency	Sulfate/Sulfite Metabolism
Olmesartan	HMDB_SMPDB	Samples:	4	Pathways:	1	Olmesartan Action Pathway
Pristanic acid	HMDB_SMPDB	Samples:	54	Pathways:	3	Phytanic Acid Peroxisomal Oxidation	Oxidation of Branched Chain Fatty Acids	Refsum Disease
Phytanic acid	HMDB_SMPDB	Samples:	54	Pathways:	3	Phytanic Acid Peroxisomal Oxidation	Oxidation of Branched Chain Fatty Acids	Refsum Disease
Propionylcarnitine	HMDB_SMPDB	Samples:	54	Pathways:	1	Oxidation of Branched Chain Fatty Acids
2-Hydroxyphytanoyl-CoA	HMDB_SMPDB	Samples:	54	Pathways:	3	Phytanic Acid Peroxisomal Oxidation	Oxidation of Branched Chain Fatty Acids	Refsum Disease
Phytanoyl-CoA	HMDB_SMPDB	Samples:	54	Pathways:	3	Phytanic Acid Peroxisomal Oxidation	Oxidation of Branched Chain Fatty Acids	Refsum Disease
Pristanal	HMDB_SMPDB	Samples:	54	Pathways:	3	Phytanic Acid Peroxisomal Oxidation	Oxidation of Branched Chain Fatty Acids	Refsum Disease
Pristanoyl-CoA	HMDB_SMPDB	Samples:	54	Pathways:	1	Oxidation of Branched Chain Fatty Acids
Formyl-CoA	HMDB_SMPDB	Samples:	54	Pathways:	3	Phytanic Acid Peroxisomal Oxidation	Oxidation of Branched Chain Fatty Acids	Refsum Disease
4,8 Dimethylnonanoyl carnitine	HMDB_SMPDB	Samples:	54	Pathways:	1	Oxidation of Branched Chain Fatty Acids
4,8-Dimethylnonanoyl-CoA	HMDB_SMPDB	Samples:	54	Pathways:	1	Oxidation of Branched Chain Fatty Acids
3-Oxopristanoyl-CoA	HMDB_SMPDB	Samples:	54	Pathways:	1	Oxidation of Branched Chain Fatty Acids
O-Propanoylcarnitine	HMDB_SMPDB	Samples:	54	Pathways:	1	Oxidation of Branched Chain Fatty Acids
Phytanate	HMDB_SMPDB	Samples:	54	Pathways:	3	Phytanic Acid Peroxisomal Oxidation	Oxidation of Branched Chain Fatty Acids	Refsum Disease
Acetaminophen	HMDB_SMPDB	Samples:	3	Pathways:	2	Acetaminophen Metabolism Pathway	Acetaminophen  Action Pathway
Meloxicam	HMDB_SMPDB	Samples:	1	Pathways:	2	Meloxicam Pathway	Meloxicam Action Pathway
Naproxen	HMDB_SMPDB	Samples:	1	Pathways:	2	Naproxen Action Pathway	Naproxen Pathway
O-Desmethylnaproxen	HMDB_SMPDB	Samples:	1	Pathways:	1	Naproxen Pathway
Levomethadyl Acetate	HMDB_SMPDB	Samples:	20	Pathways:	1	Levomethadyl Acetate Action Action Pathway
Levomethadyl acetate	HMDB_SMPDB	Samples:	20	Pathways:	1	Levomethadyl Acetate Action Action Pathway
Propionic acid	HMDB_SMPDB	Samples:	59	Pathways:	5	Propanoate Metabolism	Malonic Aciduria	Malonyl-coa decarboxylase deficiency	Vitamin K Metabolism	Methylmalonic Aciduria Due to Cobalamin-Related Disorders
Hydroxypropionic acid	HMDB_SMPDB	Samples:	57	Pathways:	4	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	Malonic Aciduria	Propanoate Metabolism
Malonyl-CoA semialdehyde	HMDB_SMPDB	Samples:	57	Pathways:	4	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	Malonic Aciduria	Propanoate Metabolism
Acrylyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	4	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	Malonic Aciduria	Propanoate Metabolism
Propinol adenylate	HMDB_SMPDB	Samples:	57	Pathways:	4	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	Malonic Aciduria	Propanoate Metabolism
3-Hydroxypropionyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	4	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	Malonic Aciduria	Propanoate Metabolism
2-Hydroxybutanoic acid	HMDB_SMPDB	Samples:	57	Pathways:	4	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	Malonic Aciduria	Propanoate Metabolism
3-Hydroxypropanoate	HMDB_SMPDB	Samples:	57	Pathways:	4	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	Malonic Aciduria	Propanoate Metabolism
3-Oxopropionyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	4	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	Malonic Aciduria	Propanoate Metabolism
Propanoate	HMDB_SMPDB	Samples:	59	Pathways:	5	Propanoate Metabolism	Malonic Aciduria	Malonyl-coa decarboxylase deficiency	Vitamin K Metabolism	Methylmalonic Aciduria Due to Cobalamin-Related Disorders
Propenoyl-CoA	HMDB_SMPDB	Samples:	57	Pathways:	4	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	Malonic Aciduria	Propanoate Metabolism
Propionyladenylate	HMDB_SMPDB	Samples:	57	Pathways:	4	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	Malonyl-coa decarboxylase deficiency	Malonic Aciduria	Propanoate Metabolism
Mefenamic acid	HMDB_SMPDB	Samples:	1	Pathways:	2	Mefanamic Acid Pathway	Mefenamic Acid Action Pathway
Sulindac	HMDB_SMPDB	Samples:	1	Pathways:	2	Sulindac Pathway	Sulindac Action Pathway
Bendroflumethiazide	HMDB_SMPDB	Samples:	58	Pathways:	2	Bendroflumethiazide Pathway	Bendroflumethiazide Action Pathway
Fosinopril	HMDB_SMPDB	Samples:	16	Pathways:	3	Fosinopril Pathway	Fosinopril Metabolism Pathway	Fosinopril Action Pathway
Amiodarone	HMDB_SMPDB	Samples:	11	Pathways:	1	Amiodarone Action Pathway
Gamma-Aminobutyric acid	HMDB_SMPDB	Samples:	2	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
Nicotinic acid adenine dinucleotide	HMDB_SMPDB	Samples:	2	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
Succinic acid semialdehyde	HMDB_SMPDB	Samples:	2	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
Carbonic acid	HMDB_SMPDB	Samples:	2	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
4-Aminobutanoate	HMDB_SMPDB	Samples:	2	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
Deamino-NAD+	HMDB_SMPDB	Samples:	2	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
Succinate semialdehyde	HMDB_SMPDB	Samples:	2	Pathways:	6	Succinic semialdehyde dehydrogenase deficiency	Hyperinsulinism-Hyperammonemia Syndrome	Homocarnosinosis	Glutamate Metabolism	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	2-Hydroxyglutric Aciduria (D And L Form)
Antrafenine	HMDB_SMPDB	Samples:	1	Pathways:	1	Antrafenine Action Pathway
4-Trimethylammoniobutanoic acid	HMDB_SMPDB	Samples:	2	Pathways:	1	Carnitine Synthesis
N6,N6,N6-Trimethyl-L-lysine	HMDB_SMPDB	Samples:	2	Pathways:	1	Carnitine Synthesis
4-Trimethylammoniobutanal	HMDB_SMPDB	Samples:	2	Pathways:	1	Carnitine Synthesis
3-Hydroxy-N6,N6,N6-trimethyl-L-lysine	HMDB_SMPDB	Samples:	2	Pathways:	1	Carnitine Synthesis
4-Trimethylammoniobutanoate	HMDB_SMPDB	Samples:	2	Pathways:	1	Carnitine Synthesis
Fluorouracil	HMDB_SMPDB	Samples:	2	Pathways:	4	Fluorouracil Pathway	Capecitabine Metabolism Pathway	Fluorouracil Metabolism Pathway	Capecitabine Pathway
Teniposide	HMDB_SMPDB	Samples:	1	Pathways:	3	Teniposide Action Pathway	Teniposide Pathway	Teniposide Metabolism Pathway
Methyclothiazide	HMDB_SMPDB	Samples:	58	Pathways:	2	Methyclothiazide Pathway	Methyclothiazide Action Pathway
Benazepril	HMDB_SMPDB	Samples:	16	Pathways:	3	Benazepril Action Pathway	Benazepril Metabolism Pathway	Benazepril Pathway
Phenylacetic acid	HMDB_SMPDB	Samples:	44	Pathways:	1	Phenylacetate Metabolism
Alpha-N-Phenylacetyl-L-glutamine	HMDB_SMPDB	Samples:	44	Pathways:	1	Phenylacetate Metabolism
Phenylacetyl-CoA	HMDB_SMPDB	Samples:	44	Pathways:	1	Phenylacetate Metabolism
Phenylacetylglutamine	HMDB_SMPDB	Samples:	44	Pathways:	1	Phenylacetate Metabolism
Isradipine	HMDB_SMPDB	Samples:	11	Pathways:	1	Isradipine Pathway
Flurbiprofen	HMDB_SMPDB	Samples:	1	Pathways:	1	Flurbiprofen Action Pathway
Candesartan	HMDB_SMPDB	Samples:	4	Pathways:	1	Candesartan Action Pathway
Oxybuprocaine	HMDB_SMPDB	Samples:	20	Pathways:	1	Oxybuprocaine Pathway
Quinolinic acid	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
Quinolinate	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
Nabumetone	HMDB_SMPDB	Samples:	1	Pathways:	1	Nabumetone Pathway
1,3-Diaminopropane	HMDB_SMPDB	Samples:	41	Pathways:	4	Ureidopropionase deficiency	Beta-Alanine Metabolism	GABA-Transaminase Deficiency	Carnosinuria, carnosinemia
Anserine	HMDB_SMPDB	Samples:	41	Pathways:	4	Ureidopropionase deficiency	Beta-Alanine Metabolism	GABA-Transaminase Deficiency	Carnosinuria, carnosinemia
3-Aminopropionaldehyde	HMDB_SMPDB	Samples:	41	Pathways:	4	Ureidopropionase deficiency	Beta-Alanine Metabolism	GABA-Transaminase Deficiency	Carnosinuria, carnosinemia
3-Aminopropanal	HMDB_SMPDB	Samples:	41	Pathways:	4	Ureidopropionase deficiency	Beta-Alanine Metabolism	GABA-Transaminase Deficiency	Carnosinuria, carnosinemia
Hydrochlorothiazide	HMDB_SMPDB	Samples:	58	Pathways:	2	Hydrochlorothiazide Action Pathway	Hydrochlorothiazide Pathway
L(-)-Nicotine	HMDB_SMPDB	Samples:	29	Pathways:	1	Nicotine Pathway
Bopindolol	HMDB_SMPDB	Samples:	11	Pathways:	1	Bopindolol Action Pathway
Iodotyrosine	HMDB_SMPDB	Samples:	35	Pathways:	2	Tyrosine Metabolism	Thyroid hormone synthesis
Thyroxine	HMDB_SMPDB	Samples:	35	Pathways:	2	Tyrosine Metabolism	Thyroid hormone synthesis
Liothyronine	HMDB_SMPDB	Samples:	35	Pathways:	2	Tyrosine Metabolism	Thyroid hormone synthesis
3,5-Diiodo-L-tyrosine	HMDB_SMPDB	Samples:	35	Pathways:	2	Tyrosine Metabolism	Thyroid hormone synthesis
Caproic acid	HMDB_SMPDB	Samples:	53	Pathways:	3	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Beta Oxidation of Very Long Chain Fatty Acids	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids
Hexanoic acid	HMDB_SMPDB	Samples:	51	Pathways:	2	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids
Aspirin	HMDB_SMPDB	Samples:	1	Pathways:	2	Acetylsalicylic Acid Pathway	Acetylsalicylic Acid Action Pathway
Torasemide	HMDB_SMPDB	Samples:	58	Pathways:	1	Torsemide Pathway
Remifentanil	HMDB_SMPDB	Samples:	20	Pathways:	2	Remifentanil Pathway	Remifentanil Action Pathway
Imipramine	HMDB_SMPDB	Samples:	20	Pathways:	2	Imipramine Pathway	Imipramine Action Pathway
Desipramine	HMDB_SMPDB	Samples:	20	Pathways:	4	Desipramine Pathway	Imipramine Pathway	Desipramine Action Pathway	Imipramine Action Pathway
2-hydroxyimipramine	HMDB_SMPDB	Samples:	20	Pathways:	1	Imipramine Pathway
Caprylic acid	HMDB_SMPDB	Samples:	52	Pathways:	2	Beta Oxidation of Very Long Chain Fatty Acids	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids
Capric acid	HMDB_SMPDB	Samples:	46	Pathways:	1	Beta Oxidation of Very Long Chain Fatty Acids
Ethacrynic acid	HMDB_SMPDB	Samples:	58	Pathways:	1	Ethacrynic Acid pathway
Fluoxetine	HMDB_SMPDB	Samples:	22	Pathways:	2	Fluoxetine Metabolism Pathway	Fluoxetine Pathway
Fluoxetine glucuronide	HMDB_SMPDB	Samples:	22	Pathways:	2	Fluoxetine Metabolism Pathway	Fluoxetine Pathway
Ethanol	HMDB_SMPDB	Samples:	57	Pathways:	3	Disulfiram Action Pathway	Ethanol Degradation	Disulfiram Pathway
Dicumarol	HMDB_SMPDB	Samples:	13	Pathways:	3	Dicoumarol Action Pathway	Dicumarol Action Pathway	Dicumarol Pathway
Reduced Vitamin K	HMDB_SMPDB	Samples:	20	Pathways:	24	Tranexamic Acid Action Pathway	Fondaparinux Action Pathway	Aminocaproic Acid Action Pathway	Phenindione Action Pathway	Ardeparin Action Pathway	Dicumarol Action Pathway	Warfarin Action Pathway	Aprotinin Action Pathway	Anistreplase Action Pathway	Heparin Action Pathway	Lepirudin Action Pathway	Argatroban Action Pathway	Alteplase Action Pathway	Ximelagatran Action Pathway	Vitamin K Metabolism	Dicoumarol Action Pathway	Phenprocoumon Action Pathway	Urokinase Action Pathway	Bivalirudin Action Pathway	Tenecteplase Action Pathway	Streptokinase Action Pathway	Acenocoumarol Action Pathway	Enoxaparin Action Pathway	Reteplase Action Pathway
Vitamin K1 epoxide	HMDB_SMPDB	Samples:	20	Pathways:	24	Tranexamic Acid Action Pathway	Fondaparinux Action Pathway	Aminocaproic Acid Action Pathway	Phenindione Action Pathway	Ardeparin Action Pathway	Dicumarol Action Pathway	Warfarin Action Pathway	Aprotinin Action Pathway	Anistreplase Action Pathway	Heparin Action Pathway	Lepirudin Action Pathway	Argatroban Action Pathway	Alteplase Action Pathway	Ximelagatran Action Pathway	Vitamin K Metabolism	Dicoumarol Action Pathway	Phenprocoumon Action Pathway	Urokinase Action Pathway	Bivalirudin Action Pathway	Tenecteplase Action Pathway	Streptokinase Action Pathway	Acenocoumarol Action Pathway	Enoxaparin Action Pathway	Reteplase Action Pathway
Amlodipine	HMDB_SMPDB	Samples:	11	Pathways:	2	Amlodipine Action Pathway	Amlodipine Pathway
(2E)-Dodecenoyl-CoA	HMDB_SMPDB	Samples:	50	Pathways:	3	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids
Heparin	HMDB_SMPDB	Samples:	18	Pathways:	2	Heparin Action Pathway	Heparin Pathway
DG(16:0/16:0/0:0)	HMDB_SMPDB	Samples:	1	Pathways:	1	Phospholipid Biosynthesis
Ubiquinol 8	HMDB_SMPDB	Samples:	55	Pathways:	1	Mitochondrial Electron Transport Chain
Dezocine	HMDB_SMPDB	Samples:	20	Pathways:	1	Dezocine Action Pathway
Mexiletine	HMDB_SMPDB	Samples:	11	Pathways:	2	Mexiletine Pathway	Mexiletine Action Pathway
Buprenorphine	HMDB_SMPDB	Samples:	20	Pathways:	1	Buprenorphine Action Pathway
2-Aminoacrylic acid	HMDB_SMPDB	Samples:	2	Pathways:	1	Thyroid hormone synthesis
Iodide	HMDB_SMPDB	Samples:	2	Pathways:	1	Thyroid hormone synthesis
3-Iodo-L-tyrosine	HMDB_SMPDB	Samples:	2	Pathways:	1	Thyroid hormone synthesis
Dehydroalanine	HMDB_SMPDB	Samples:	2	Pathways:	1	Thyroid hormone synthesis
Triiodothyronine	HMDB_SMPDB	Samples:	2	Pathways:	1	Thyroid hormone synthesis
Fosphenytoin	HMDB_SMPDB	Samples:	11	Pathways:	2	Fosphenytoin (Antiarrhythmic) Action Pathway	Fosphenytoin (Antiarrhythmic) Pathway
Betaine aldehyde	HMDB_SMPDB	Samples:	44	Pathways:	2	sarcosine oncometabolite pathway 	Betaine Metabolism
Trandolapril	HMDB_SMPDB	Samples:	16	Pathways:	2	Trandolapril Metabolism Pathway	Trandolapril Pathway
N-Desmethyltamoxifen	HMDB_SMPDB	Samples:	1	Pathways:	3	Tamoxifen Action Pathway	Tamoxifen Metabolism Pathway	Tamoxifen Pathway
Tamoxifen	HMDB_SMPDB	Samples:	1	Pathways:	3	Tamoxifen Action Pathway	Tamoxifen Metabolism Pathway	Tamoxifen Pathway
Tamoxifen N-oxide	HMDB_SMPDB	Samples:	1	Pathways:	3	Tamoxifen Action Pathway	Tamoxifen Metabolism Pathway	Tamoxifen Pathway
4-Hydroxytamoxifen	HMDB_SMPDB	Samples:	1	Pathways:	2	Tamoxifen Metabolism Pathway	Tamoxifen Pathway
Norendoxifen	HMDB_SMPDB	Samples:	1	Pathways:	2	Tamoxifen Metabolism Pathway	Tamoxifen Pathway
Tamoxifen-N-glucuronide	HMDB_SMPDB	Samples:	1	Pathways:	2	Tamoxifen Metabolism Pathway	Tamoxifen Pathway
4-Hydroxytamoxifen sulfate	HMDB_SMPDB	Samples:	1	Pathways:	2	Tamoxifen Metabolism Pathway	Tamoxifen Pathway
Endoxifen sulfate	HMDB_SMPDB	Samples:	1	Pathways:	2	Tamoxifen Metabolism Pathway	Tamoxifen Pathway
alpha-Hydroxytamoxifen	HMDB_SMPDB	Samples:	1	Pathways:	2	Tamoxifen Action Pathway	Tamoxifen Metabolism Pathway
Endoxifen	HMDB_SMPDB	Samples:	1	Pathways:	2	Tamoxifen Action Pathway	Tamoxifen Metabolism Pathway
Hydroxytamoxifen	HMDB_SMPDB	Samples:	1	Pathways:	2	Tamoxifen Action Pathway	Tamoxifen Metabolism Pathway
Nisoldipine	HMDB_SMPDB	Samples:	11	Pathways:	2	Nisoldipine Action Pathway	Nisoldipine Pathway
Phenprocoumon	HMDB_SMPDB	Samples:	13	Pathways:	1	Phenprocoumon Pathway
Suprofen	HMDB_SMPDB	Samples:	1	Pathways:	2	Suprofen Pathway	Suprofen Action Pathway
Selenocysteine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Phosphoroselenoic acid 	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Selenomethionine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Adenylylselenate	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Se-Methylselenocysteine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Selenohomocysteine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Selenocystine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Selenocystathionine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Selenophosphate	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Gamma-Glutamyl-Se-methylselenocysteine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
3-Phosphoadenylylselenate	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Hydrogen selenide	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Se-Adenosylselenohomocysteine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Se-Adenosylselenomethionine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Selenite	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
3'-Phosphoadenylylselenate	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
gamma-Glutamyl-Se-methylselenocysteine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
L-Selenocystathionine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
L-Selenocysteine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
L-Selenomethionine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Se-Adenosyl-L-selenohomocysteine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Se-Methyl-L-selenocysteine	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Selenophosphoric acid	HMDB_SMPDB	Samples:	16	Pathways:	1	Selenoamino Acid Metabolism
Butyric acid	HMDB_SMPDB	Samples:	33	Pathways:	1	Butyrate Metabolism
(R)-3-Hydroxybutanoate	HMDB_SMPDB	Samples:	12	Pathways:	2	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Ketone Body Metabolism
Butanoic acid	HMDB_SMPDB	Samples:	33	Pathways:	1	Butyrate Metabolism
Vitamin K1 2,3-epoxide	HMDB_SMPDB	Samples:	2	Pathways:	1	Vitamin K Metabolism
Vitamin K1	HMDB_SMPDB	Samples:	2	Pathways:	1	Vitamin K Metabolism
1,4-Dithiothreitol	HMDB_SMPDB	Samples:	2	Pathways:	1	Vitamin K Metabolism
Oxidized dithiothreitol	HMDB_SMPDB	Samples:	2	Pathways:	1	Vitamin K Metabolism
Dithiothreitol	HMDB_SMPDB	Samples:	2	Pathways:	1	Vitamin K Metabolism
Phylloquinone	HMDB_SMPDB	Samples:	2	Pathways:	1	Vitamin K Metabolism
Penbutolol	HMDB_SMPDB	Samples:	11	Pathways:	2	Penbutolol Pathway	Penbutolol Action Pathway
Lornoxicam	HMDB_SMPDB	Samples:	1	Pathways:	1	Lornoxicam Action Pathway
Valsartan	HMDB_SMPDB	Samples:	4	Pathways:	1	Valsartan Action Pathway
2-hydroxydesipramine	HMDB_SMPDB	Samples:	20	Pathways:	1	Desipramine Pathway
Quinethazone	HMDB_SMPDB	Samples:	58	Pathways:	2	Quinethazone Pathway	Quinethazone Action Pathway
Hydromorphone	HMDB_SMPDB	Samples:	20	Pathways:	2	Hydromorphone Action Pathway	Hydromorphone Pathway
Phenylbutazone	HMDB_SMPDB	Samples:	1	Pathways:	1	Phenylbutazone Action Pathway
Nalbuphine	HMDB_SMPDB	Samples:	20	Pathways:	1	Nalbuphine Action Pathway
Ketorolac	HMDB_SMPDB	Samples:	1	Pathways:	2	Ketorolac Action Pathway	Ketorolac Pathway
Pantoprazole	HMDB_SMPDB	Samples:	4	Pathways:	2	Pantoprazole Pathway	Pantoprazole Action Pathway
Artemether	HMDB_SMPDB	Samples:	8	Pathways:	1	Artemether Metabolism Pathway
Quinidine	HMDB_SMPDB	Samples:	11	Pathways:	2	Quinidine Pathway	Quinidine Action Pathway
Sulfite	HMDB_SMPDB	Samples:	2	Pathways:	2	Sulfite oxidase deficiency	Sulfate/Sulfite Metabolism
Salicylate-sodium	HMDB_SMPDB	Samples:	1	Pathways:	1	Salicylate-sodium Action Pathway
Sodium salicylate	HMDB_SMPDB	Samples:	1	Pathways:	1	Salicylate-sodium Action Pathway
Ramipril	HMDB_SMPDB	Samples:	16	Pathways:	2	Ramipril Metabolism Pathway	Ramipril Pathway
Meprobamate	HMDB_SMPDB	Samples:	1	Pathways:	2	Capecitabine Metabolism Pathway	Capecitabine Pathway
Capecitabine	HMDB_SMPDB	Samples:	1	Pathways:	3	Capecitabine Action Pathway	Capecitabine Metabolism Pathway	Capecitabine Pathway
Indoleacetic acid	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
Tryptamine	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
5-Hydroxy-L-tryptophan	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
L-Kynurenine	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
Kynurenic acid	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
5-Hydroxyindoleacetic acid	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
Xanthurenic acid	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
L-Tryptophan	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
4-(2-Aminophenyl)-2,4-dioxobutanoic acid	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
2-Aminobenzoic acid	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
Indoleacetaldehyde	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
N'-Formylkynurenine	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
N-Acetylserotonin	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
2-Aminomuconic acid semialdehyde	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
2-Amino-3-carboxymuconic acid semialdehyde	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
Melatonin	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
3-Hydroxyanthranilic acid	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
5-Hydroxyindoleacetaldehyde	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
5-Hydroxykynurenamine	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
4,6-Dihydroxyquinoline	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
Cinnavalininate	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
6-Hydroxymelatonin	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
4-(2-Amino-3-hydroxyphenyl)-2,4-dioxobutanoic acid	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
5-Hydroxy-N-formylkynurenine	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
Formylanthranilic acid	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
5-Methoxyindoleacetate	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
Acetyl-N-formyl-5-methoxykynurenamine	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
N-Methylserotonin	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
N-Methyltryptamine	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
L-3-Hydroxykynurenine	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
5-Hydroxykynurenine	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
Formyl-5-hydroxykynurenamine	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
2-Amino-3-carboxymuconate semialdehyde	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
2-Aminomuconate semialdehyde	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
3-Hydroxy-L-kynurenine	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
3-Hydroxyanthranilate	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
4-(2-Amino-3-hydroxyphenyl)-2,4-dioxobutanoate	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
4-(2-Aminophenyl)-2,4-dioxobutanoate	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
4-Hydroxy-2-quinolinecarboxylic acid	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
5-Hydroxyindoleacetate	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
5-Hydroxytryptophan	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
Anthranilate	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
Formyl-N-acetyl-5-methoxykynurenamine	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
Formylanthranilate	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
Indole-3-acetaldehyde	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
Indole-3-acetate	HMDB_SMPDB	Samples:	43	Pathways:	1	Tryptophan Metabolism
D-Glucuronic acid	HMDB_SMPDB	Samples:	6	Pathways:	7	Glycogen synthetase deficiency	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Mucopolysaccharidosis VI. Sly syndrome	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Glycogenosis, Type VI. Hers disease
D-Maltose	HMDB_SMPDB	Samples:	6	Pathways:	7	Glycogen synthetase deficiency	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Mucopolysaccharidosis VI. Sly syndrome	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Glycogenosis, Type VI. Hers disease
Glycogen	HMDB_SMPDB	Samples:	6	Pathways:	7	Glycogen synthetase deficiency	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Mucopolysaccharidosis VI. Sly syndrome	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Glycogenosis, Type VI. Hers disease
Isovalerylglucuronide	HMDB_SMPDB	Samples:	6	Pathways:	7	Glycogen synthetase deficiency	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Mucopolysaccharidosis VI. Sly syndrome	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Glycogenosis, Type VI. Hers disease
Amylose	HMDB_SMPDB	Samples:	6	Pathways:	7	Glycogen synthetase deficiency	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Mucopolysaccharidosis VI. Sly syndrome	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Glycogenosis, Type VI. Hers disease
Alpha-D-Glucose 1,6-bisphosphate	HMDB_SMPDB	Samples:	6	Pathways:	7	Glycogen synthetase deficiency	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Mucopolysaccharidosis VI. Sly syndrome	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Glycogenosis, Type VI. Hers disease
Beta-D-Fructose 6-phosphate	HMDB_SMPDB	Samples:	6	Pathways:	7	Glycogen synthetase deficiency	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Mucopolysaccharidosis VI. Sly syndrome	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Glycogenosis, Type VI. Hers disease
Dextrin	HMDB_SMPDB	Samples:	6	Pathways:	7	Glycogen synthetase deficiency	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Mucopolysaccharidosis VI. Sly syndrome	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Glycogenosis, Type VI. Hers disease
alpha-D-Glucose 1,6-bisphosphate	HMDB_SMPDB	Samples:	6	Pathways:	7	Glycogen synthetase deficiency	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Mucopolysaccharidosis VI. Sly syndrome	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Glycogenosis, Type VI. Hers disease
beta-D-Fructose 6-phosphate	HMDB_SMPDB	Samples:	6	Pathways:	7	Glycogen synthetase deficiency	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Mucopolysaccharidosis VI. Sly syndrome	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Glycogenosis, Type VI. Hers disease
D-Glucuronate	HMDB_SMPDB	Samples:	6	Pathways:	7	Glycogen synthetase deficiency	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Mucopolysaccharidosis VI. Sly syndrome	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Glycogenosis, Type VI. Hers disease
Maltose	HMDB_SMPDB	Samples:	6	Pathways:	7	Glycogen synthetase deficiency	Starch and Sucrose Metabolism	Glycogenosis, Type IV. Amylopectinosis, Anderson disease	Sucrase-isomaltase deficiency	Mucopolysaccharidosis VI. Sly syndrome	Glycogenosis, Type III. Cori disease, Debrancher glycogenosis	Glycogenosis, Type VI. Hers disease
Superoxide	HMDB_SMPDB	Samples:	1	Pathways:	1	Degradation of Superoxides
O2.-	HMDB_SMPDB	Samples:	1	Pathways:	1	Degradation of Superoxides
Proparacaine	HMDB_SMPDB	Samples:	20	Pathways:	2	Proparacaine Pathway	Proparacaine Action Pathway
Eplerenone	HMDB_SMPDB	Samples:	58	Pathways:	2	Eplerenone Pathway	Eplerenone Action Pathway
Erlotinib	HMDB_SMPDB	Samples:	1	Pathways:	1	Erlotinib Pathway
Hydrocodone	HMDB_SMPDB	Samples:	20	Pathways:	2	Hydrocodone Action Pathway	Hydrocodone Pathway
Ranitidine	HMDB_SMPDB	Samples:	4	Pathways:	1	Ranitidine Pathway
Chlorothiazide	HMDB_SMPDB	Samples:	58	Pathways:	2	Chlorothiazide Action Pathway	Chlorothiazide Pathway
Rescinnamine	HMDB_SMPDB	Samples:	4	Pathways:	2	Rescinnamine Pathway	Rescinnamine Action Pathway
Atenolol	HMDB_SMPDB	Samples:	11	Pathways:	1	Atenolol Pathway
Acebutolol	HMDB_SMPDB	Samples:	11	Pathways:	2	Acebutolol Pathway	Acebutolol Action Pathway
Spirapril	HMDB_SMPDB	Samples:	16	Pathways:	2	Spirapril Metabolism Pathway	Spirapril Pathway
Ibutilide	HMDB_SMPDB	Samples:	11	Pathways:	2	Ibutilide Pathway	Ibutilide Action Pathway
Vinblastine	HMDB_SMPDB	Samples:	1	Pathways:	2	Vinblastine Pathway	Vinblastine Action Pathway
Eprosartan	HMDB_SMPDB	Samples:	4	Pathways:	1	Eprosartan Action Pathway
N,N-Didesmethyltramadol	HMDB_SMPDB	Samples:	19	Pathways:	1	Tramadol Metabolism Pathway
N,N,O-Tridesmethyl-tramadol	HMDB_SMPDB	Samples:	19	Pathways:	1	Tramadol Metabolism Pathway
N,O-Didesmethyltramadol	HMDB_SMPDB	Samples:	19	Pathways:	1	Tramadol Metabolism Pathway
L-Threonine	HMDB_SMPDB	Samples:	57	Pathways:	2	Threonine and 2-Oxobutanoate Degradation	Glycine and Serine Metabolism
Warfarin	HMDB_SMPDB	Samples:	13	Pathways:	2	Warfarin Pathway	Warfarin Action Pathway
S-6-Hydroxywarfarin	HMDB_SMPDB	Samples:	13	Pathways:	1	Warfarin Pathway
Nadolol	HMDB_SMPDB	Samples:	11	Pathways:	1	Nadolol Pathway
1-Methylhistidine	HMDB_SMPDB	Samples:	9	Pathways:	1	Histidine Metabolism
Sapropterin	HMDB_SMPDB	Samples:	3	Pathways:	3	Catecholamine Biosynthesis	Aromatic L-Aminoacid Decarboxylase Deficiency	Tyrosine hydroxylase deficiency
7a,12a-Dihydroxy-5b-cholestan-3-one	HMDB_SMPDB	Samples:	8	Pathways:	1	Bile Acid Biosynthesis
7 alpha,24-Dihydroxy-4-cholesten-3-one	HMDB_SMPDB	Samples:	8	Pathways:	1	Bile Acid Biosynthesis
Verapamil	HMDB_SMPDB	Samples:	11	Pathways:	2	Verapamil Action Pathway	Verapamil Pathway
O-Desmethylverapamil (D-702)	HMDB_SMPDB	Samples:	11	Pathways:	1	Verapamil Pathway
Propoxyphene	HMDB_SMPDB	Samples:	20	Pathways:	1	Propoxyphene Action Pathway
Cyclothiazide	HMDB_SMPDB	Samples:	58	Pathways:	2	Cyclothiazide Action Pathway	Cyclothiazide Pathway
Vincristine	HMDB_SMPDB	Samples:	1	Pathways:	2	Vincristine Pathway	Vincristine Action Pathway
Felbamate	HMDB_SMPDB	Samples:	2	Pathways:	1	Felbamate Metabolism Pathway
Atropaldehyde	HMDB_SMPDB	Samples:	2	Pathways:	1	Felbamate Metabolism Pathway
2-Hydroxyfelbamate	HMDB_SMPDB	Samples:	2	Pathways:	1	Felbamate Metabolism Pathway
2-Phenyl-1,3-propanediol monocarbamate	HMDB_SMPDB	Samples:	2	Pathways:	1	Felbamate Metabolism Pathway
3-Carbamoyl-2-phenylpropionaldehyde	HMDB_SMPDB	Samples:	2	Pathways:	1	Felbamate Metabolism Pathway
3-Carbamoyl-2-phenylpropionic acid	HMDB_SMPDB	Samples:	2	Pathways:	1	Felbamate Metabolism Pathway
4-Hydroxy-5-phenyltetrahydro-1,3-oxazin-2-one	HMDB_SMPDB	Samples:	2	Pathways:	1	Felbamate Metabolism Pathway
5-Phenyl-1,3-oxazinane-2,4-dione	HMDB_SMPDB	Samples:	2	Pathways:	1	Felbamate Metabolism Pathway
p-Hydroxyfelbamate	HMDB_SMPDB	Samples:	2	Pathways:	1	Felbamate Metabolism Pathway
Salsalate	HMDB_SMPDB	Samples:	1	Pathways:	1	Salsalate Action Pathway
(R)-3-Hydroxybutyric acid	HMDB_SMPDB	Samples:	12	Pathways:	2	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Ketone Body Metabolism
Acetone	HMDB_SMPDB	Samples:	12	Pathways:	2	Succinyl CoA: 3-ketoacid CoA transferase deficiency	Ketone Body Metabolism
Phenol	HMDB_SMPDB	Samples:	2	Pathways:	2	Sulfite oxidase deficiency	Sulfate/Sulfite Metabolism
Chondroitin	HMDB_SMPDB	Samples:	2	Pathways:	2	Sulfite oxidase deficiency	Sulfate/Sulfite Metabolism
Chondroitin 4-sulfate	HMDB_SMPDB	Samples:	2	Pathways:	2	Sulfite oxidase deficiency	Sulfate/Sulfite Metabolism
Propyl alcohol	HMDB_SMPDB	Samples:	2	Pathways:	2	Sulfite oxidase deficiency	Sulfate/Sulfite Metabolism
Adenosine phosphosulfate	HMDB_SMPDB	Samples:	2	Pathways:	2	Sulfite oxidase deficiency	Sulfate/Sulfite Metabolism
Molybdenum	HMDB_SMPDB	Samples:	2	Pathways:	2	Sulfite oxidase deficiency	Sulfate/Sulfite Metabolism
Phenol sulphate	HMDB_SMPDB	Samples:	2	Pathways:	2	Sulfite oxidase deficiency	Sulfate/Sulfite Metabolism
Adenylyl sulfate	HMDB_SMPDB	Samples:	2	Pathways:	2	Sulfite oxidase deficiency	Sulfate/Sulfite Metabolism
Aryl sulfate	HMDB_SMPDB	Samples:	2	Pathways:	2	Sulfite oxidase deficiency	Sulfate/Sulfite Metabolism
Propane-1-ol	HMDB_SMPDB	Samples:	2	Pathways:	2	Sulfite oxidase deficiency	Sulfate/Sulfite Metabolism
D-1-Piperideine-2-carboxylic acid	HMDB_SMPDB	Samples:	56	Pathways:	1	Lysine Degradation
S-Glutaryldihydrolipoamide	HMDB_SMPDB	Samples:	56	Pathways:	1	Lysine Degradation
Linoleic acid	HMDB_SMPDB	Samples:	4	Pathways:	1	Alpha Linolenic Acid and Linoleic Acid Metabolism
Alpha-Linolenic acid	HMDB_SMPDB	Samples:	4	Pathways:	1	Alpha Linolenic Acid and Linoleic Acid Metabolism
Docosapentaenoic acid (22n-6)	HMDB_SMPDB	Samples:	4	Pathways:	1	Alpha Linolenic Acid and Linoleic Acid Metabolism
Eicosapentaenoic acid	HMDB_SMPDB	Samples:	4	Pathways:	1	Alpha Linolenic Acid and Linoleic Acid Metabolism
Tetracosahexaenoic acid	HMDB_SMPDB	Samples:	4	Pathways:	1	Alpha Linolenic Acid and Linoleic Acid Metabolism
Cis-8,11,14,17-Eicosatetraenoic acid	HMDB_SMPDB	Samples:	4	Pathways:	1	Alpha Linolenic Acid and Linoleic Acid Metabolism
Docosahexaenoic acid	HMDB_SMPDB	Samples:	4	Pathways:	1	Alpha Linolenic Acid and Linoleic Acid Metabolism
Adrenic acid	HMDB_SMPDB	Samples:	4	Pathways:	1	Alpha Linolenic Acid and Linoleic Acid Metabolism
8,11,14-Eicosatrienoic acid	HMDB_SMPDB	Samples:	4	Pathways:	1	Alpha Linolenic Acid and Linoleic Acid Metabolism
Gamma-Linolenic acid	HMDB_SMPDB	Samples:	4	Pathways:	1	Alpha Linolenic Acid and Linoleic Acid Metabolism
Tetracosatetraenoic acid (24:4n-6)	HMDB_SMPDB	Samples:	4	Pathways:	1	Alpha Linolenic Acid and Linoleic Acid Metabolism
Tetracosapentaenoic acid (24:5n-6)	HMDB_SMPDB	Samples:	4	Pathways:	1	Alpha Linolenic Acid and Linoleic Acid Metabolism
Tetracosapentaenoic acid (24:5n-3)	HMDB_SMPDB	Samples:	4	Pathways:	1	Alpha Linolenic Acid and Linoleic Acid Metabolism
Docosapentaenoic acid	HMDB_SMPDB	Samples:	4	Pathways:	1	Alpha Linolenic Acid and Linoleic Acid Metabolism
Stearidonic acid	HMDB_SMPDB	Samples:	4	Pathways:	1	Alpha Linolenic Acid and Linoleic Acid Metabolism
PC(18:3(9Z,12Z,15Z)/18:2(9Z,12Z))	HMDB_SMPDB	Samples:	4	Pathways:	1	Alpha Linolenic Acid and Linoleic Acid Metabolism
(4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoic acid	HMDB_SMPDB	Samples:	4	Pathways:	1	Alpha Linolenic Acid and Linoleic Acid Metabolism
(5Z,8Z,11Z,14Z,17Z)-Icosapentaenoic acid	HMDB_SMPDB	Samples:	4	Pathways:	1	Alpha Linolenic Acid and Linoleic Acid Metabolism
(6Z,9Z,12Z)-Octadecatrienoic acid	HMDB_SMPDB	Samples:	4	Pathways:	1	Alpha Linolenic Acid and Linoleic Acid Metabolism
(7Z,10Z,13Z,16Z,19Z)-Docosa-7,10,13,16,19-pentaenoic acid	HMDB_SMPDB	Samples:	4	Pathways:	1	Alpha Linolenic Acid and Linoleic Acid Metabolism
(8Z,11Z,14Z)-Icosatrienoic acid	HMDB_SMPDB	Samples:	4	Pathways:	1	Alpha Linolenic Acid and Linoleic Acid Metabolism
(9Z,12Z,15Z)-Octadecatrienoic acid	HMDB_SMPDB	Samples:	4	Pathways:	1	Alpha Linolenic Acid and Linoleic Acid Metabolism
7,10,13,16-Docosatetraenoic acid	HMDB_SMPDB	Samples:	4	Pathways:	1	Alpha Linolenic Acid and Linoleic Acid Metabolism
Linoleate	HMDB_SMPDB	Samples:	4	Pathways:	1	Alpha Linolenic Acid and Linoleic Acid Metabolism
Fondaparinux sodium	HMDB_SMPDB	Samples:	18	Pathways:	1	Fondaparinux Pathway
Ketoprofen	HMDB_SMPDB	Samples:	1	Pathways:	2	Ketoprofen Action Pathway	Ketoprofen Pathway
Nitrendipine	HMDB_SMPDB	Samples:	11	Pathways:	2	Nitrendipine Action Pathway	Nitrendipine Pathway
Pentazocine	HMDB_SMPDB	Samples:	20	Pathways:	1	Pentazocine Action Pathway
Triamterene	HMDB_SMPDB	Samples:	58	Pathways:	1	Triamterene Pathway
Tiaprofenic acid	HMDB_SMPDB	Samples:	1	Pathways:	1	Tiaprofenic Acid Action Pathway
5,10-Methenyltetrahydrofolic acid	HMDB_SMPDB	Samples:	30	Pathways:	4	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Methotrexate Pathway	Folate Metabolism	Folate malabsorption, hereditary
Folinic acid	HMDB_SMPDB	Samples:	30	Pathways:	5	Methotrexate Action Pathway	Methotrexate Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Folate malabsorption, hereditary
N-Formyl-L-glutamic acid	HMDB_SMPDB	Samples:	30	Pathways:	4	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Methotrexate Pathway	Folate Metabolism	Folate malabsorption, hereditary
5,10-Methenyltetrahydrofolate	HMDB_SMPDB	Samples:	30	Pathways:	4	Methotrexate Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Folate malabsorption, hereditary
Folate	HMDB_SMPDB	Samples:	30	Pathways:	4	Methotrexate Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Folate malabsorption, hereditary
N-Formyl-L-glutamate	HMDB_SMPDB	Samples:	30	Pathways:	4	Methotrexate Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Folate malabsorption, hereditary
THF-polyglutamate	HMDB_SMPDB	Samples:	30	Pathways:	4	Methotrexate Action Pathway	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	Folate Metabolism	Folate malabsorption, hereditary
PIP2(16:0/16:0)	HMDB_SMPDB	Samples:	1	Pathways:	2	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine
PIP3(16:0/16:0)	HMDB_SMPDB	Samples:	1	Pathways:	2	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine
Lactaldehyde	HMDB_SMPDB	Samples:	48	Pathways:	1	Pyruvate Metabolism
2-(a-Hydroxyethyl)thiamine diphosphate	HMDB_SMPDB	Samples:	48	Pathways:	1	Pyruvate Metabolism
Oxaprozin	HMDB_SMPDB	Samples:	1	Pathways:	2	Oxaprozin Pathway	Oxaprozin Action Pathway
5-Amino-2-oxopentanoic acid	HMDB_SMPDB	Samples:	41	Pathways:	2	D-Arginine and D-Ornithine Metabolism	Fatty Acid Elongation In Mitochondria
2-trans-Dodecenoyl-CoA	HMDB_SMPDB	Samples:	30	Pathways:	2	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	Fatty Acid Elongation In Mitochondria
Oxymorphone	HMDB_SMPDB	Samples:	20	Pathways:	2	Oxymorphone Pathway	Oxymorphone Action Pathway
Celecoxib	HMDB_SMPDB	Samples:	1	Pathways:	1	Celecoxib Metabolism Pathway
Hydroxycelecoxib	HMDB_SMPDB	Samples:	1	Pathways:	1	Celecoxib Metabolism Pathway
Carboxycelecoxib	HMDB_SMPDB	Samples:	1	Pathways:	1	Celecoxib Metabolism Pathway
Naloxone	HMDB_SMPDB	Samples:	20	Pathways:	1	Naloxone Action Pathway
Disulfiram	HMDB_SMPDB	Samples:	55	Pathways:	2	Disulfiram Action Pathway	Disulfiram Pathway
Naltrexone	HMDB_SMPDB	Samples:	20	Pathways:	1	Naltrexone Action Pathway
Gefitinib	HMDB_SMPDB	Samples:	2	Pathways:	1	Gefitinib Pathway
Acenocoumarol	HMDB_SMPDB	Samples:	13	Pathways:	1	Acenocoumarol Pathway
Anileridine	HMDB_SMPDB	Samples:	20	Pathways:	1	Anileridine Action Pathway
Ropivacaine	HMDB_SMPDB	Samples:	20	Pathways:	2	Ropivacaine Action Pathway	Ropivacaine Pathway
Carbamazepine	HMDB_SMPDB	Samples:	2	Pathways:	1	Carbamazepine Metabolism Pathway
Oxcarbazepine	HMDB_SMPDB	Samples:	2	Pathways:	1	Carbamazepine Metabolism Pathway
Carbamazepine-O-quinone	HMDB_SMPDB	Samples:	2	Pathways:	1	Carbamazepine Metabolism Pathway
2-Hydroxycarbamazepine	HMDB_SMPDB	Samples:	2	Pathways:	1	Carbamazepine Metabolism Pathway
2-Hydroxyiminostilbene	HMDB_SMPDB	Samples:	2	Pathways:	1	Carbamazepine Metabolism Pathway
3-Hydroxycarbamazepine	HMDB_SMPDB	Samples:	2	Pathways:	1	Carbamazepine Metabolism Pathway
2,3-Dihydroxycarbamazepine	HMDB_SMPDB	Samples:	2	Pathways:	1	Carbamazepine Metabolism Pathway
Carbamazepine iminoquinone	HMDB_SMPDB	Samples:	2	Pathways:	1	Carbamazepine Metabolism Pathway
10-Hydroxycarbazepine	HMDB_SMPDB	Samples:	2	Pathways:	1	Carbamazepine Metabolism Pathway
2H-Dibenz[b,f]azepin-2-one	HMDB_SMPDB	Samples:	2	Pathways:	1	Carbamazepine Metabolism Pathway
Carbamazepine-10,11-epoxide	HMDB_SMPDB	Samples:	2	Pathways:	1	Carbamazepine Metabolism Pathway
Carbamazepine-o-quinone	HMDB_SMPDB	Samples:	2	Pathways:	1	Carbamazepine Metabolism Pathway
Dihydroxycarbazepine	HMDB_SMPDB	Samples:	2	Pathways:	1	Carbamazepine Metabolism Pathway
(R)-lipoic acid	HMDB_SMPDB	Samples:	49	Pathways:	2	Ammonia Recycling	Glycine and Serine Metabolism
Bevantolol	HMDB_SMPDB	Samples:	11	Pathways:	1	Bevantolol Action Pathway
Ethylmorphine	HMDB_SMPDB	Samples:	20	Pathways:	1	Ethylmorphine Action Pathway
Valproic acid glucuronide	HMDB_SMPDB	Samples:	48	Pathways:	1	Valproic Acid Metabolism Pathway
Valproic acid	HMDB_SMPDB	Samples:	48	Pathways:	1	Valproic Acid Metabolism Pathway
Pentanoyl-CoA	HMDB_SMPDB	Samples:	48	Pathways:	1	Valproic Acid Metabolism Pathway
4-ene-Valproic acid	HMDB_SMPDB	Samples:	48	Pathways:	1	Valproic Acid Metabolism Pathway
5-Hydroxyvalproic acid	HMDB_SMPDB	Samples:	48	Pathways:	1	Valproic Acid Metabolism Pathway
3-Hydroxyvalproic acid	HMDB_SMPDB	Samples:	48	Pathways:	1	Valproic Acid Metabolism Pathway
4-Hydroxyvalproic acid	HMDB_SMPDB	Samples:	48	Pathways:	1	Valproic Acid Metabolism Pathway
2-ene-Valproic acid	HMDB_SMPDB	Samples:	48	Pathways:	1	Valproic Acid Metabolism Pathway
2-Propyl-2,4-pentadienoic acid	HMDB_SMPDB	Samples:	48	Pathways:	1	Valproic Acid Metabolism Pathway
2-n-Propyl-2-pentenoic acid	HMDB_SMPDB	Samples:	48	Pathways:	1	Valproic Acid Metabolism Pathway
2-n-Propyl-4-oxopentanoic acid	HMDB_SMPDB	Samples:	48	Pathways:	1	Valproic Acid Metabolism Pathway
2-n-Propyl-4-pentenoic acid	HMDB_SMPDB	Samples:	48	Pathways:	1	Valproic Acid Metabolism Pathway
2-Propylglutaric acid	HMDB_SMPDB	Samples:	48	Pathways:	1	Valproic Acid Metabolism Pathway
3-Oxovalproic acid	HMDB_SMPDB	Samples:	48	Pathways:	1	Valproic Acid Metabolism Pathway
Levobunolol	HMDB_SMPDB	Samples:	11	Pathways:	1	Levobunolol Action Pathway
Ardeparin	HMDB_SMPDB	Samples:	18	Pathways:	1	Ardeparin Pathway
Enoxaparin	HMDB_SMPDB	Samples:	18	Pathways:	2	Enoxaparin Pathway	Ardeparin Pathway
Esmolol	HMDB_SMPDB	Samples:	11	Pathways:	2	Esmolol Pathway	Esmolol Action Pathway
Vindesine	HMDB_SMPDB	Samples:	1	Pathways:	1	Vindesine Pathway
Irbesartan	HMDB_SMPDB	Samples:	4	Pathways:	1	Irbesartan Action Pathway
Stearoylcarnitine	HMDB_SMPDB	Samples:	51	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
3-Oxooctadecanoyl-CoA	HMDB_SMPDB	Samples:	51	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
trans-Octadec-2-enoyl-CoA	HMDB_SMPDB	Samples:	51	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
(S)-Hydroxyoctadecanoyl-CoA	HMDB_SMPDB	Samples:	51	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
(2E)-Octadecenoyl-CoA	HMDB_SMPDB	Samples:	51	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
3-Oxostearoyl-CoA	HMDB_SMPDB	Samples:	51	Pathways:	1	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids
Isoproterenol	HMDB_SMPDB	Samples:	11	Pathways:	1	Isoprenaline Action Pathway
Sotalol	HMDB_SMPDB	Samples:	11	Pathways:	1	Sotalol Action Pathway
Prilocaine	HMDB_SMPDB	Samples:	20	Pathways:	2	Prilocaine Pathway	Prilocaine Action Pathway
Fentanyl	HMDB_SMPDB	Samples:	20	Pathways:	1	Fentanyl Pathway
Nifedipine	HMDB_SMPDB	Samples:	11	Pathways:	2	Nifedipine Pathway	Nifedipine Action Pathway
Hydroflumethiazide	HMDB_SMPDB	Samples:	58	Pathways:	2	Hydroflumethiazide Action Pathway	Hydroflumethiazide Pathway
Glyburide	HMDB_SMPDB	Samples:	14	Pathways:	2	Glibenclamide Action Pathway	Glibenclamide Pathway
Cilazapril	HMDB_SMPDB	Samples:	16	Pathways:	2	Cilazapril Pathway	Cilazapril Metabolism Pathway
L-Octanoylcarnitine	HMDB_SMPDB	Samples:	50	Pathways:	1	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids
Methadone	HMDB_SMPDB	Samples:	20	Pathways:	2	Methadone Pathway	Methadone Action Pathway
Antipyrine	HMDB_SMPDB	Samples:	1	Pathways:	1	Antipyrine Action Pathway
Enalapril	HMDB_SMPDB	Samples:	16	Pathways:	3	Enalapril Pathway	Enalapril Action Pathway	Enalapril Metabolism Pathway
Chloroprocaine	HMDB_SMPDB	Samples:	20	Pathways:	2	Chloroprocaine Action Pathway	Chloroprocaine Pathway
Sorafenib	HMDB_SMPDB	Samples:	8	Pathways:	1	Sorafenib Metabolism Pathway
Sorafenib beta-D-Glucuronide	HMDB_SMPDB	Samples:	8	Pathways:	1	Sorafenib Metabolism Pathway
Sorafenib N-oxide	HMDB_SMPDB	Samples:	8	Pathways:	1	Sorafenib Metabolism Pathway
Doxorubicin	HMDB_SMPDB	Samples:	9	Pathways:	1	Doxorubicin Metabolism Pathway
Simvastatin	HMDB_SMPDB	Samples:	1	Pathways:	1	Simvastatin Action Pathway
Mepivacaine	HMDB_SMPDB	Samples:	20	Pathways:	2	Mepivacaine Pathway	Mepivacaine Action Pathway
Indapamide	HMDB_SMPDB	Samples:	58	Pathways:	1	Indapamide Pathway
Betazole	HMDB_SMPDB	Samples:	4	Pathways:	1	Betazole Action Pathway
7-Hydroxygliclazide	HMDB_SMPDB	Samples:	14	Pathways:	1	Gliclazide Pathway
Gliclazide	HMDB_SMPDB	Samples:	14	Pathways:	1	Gliclazide Pathway
Methotrexate	HMDB_SMPDB	Samples:	12	Pathways:	2	Methotrexate Pathway	Methotrexate Action Pathway
Propranolol	HMDB_SMPDB	Samples:	11	Pathways:	2	Propranolol Pathway	Propranolol Action Pathway
Phenindione	HMDB_SMPDB	Samples:	13	Pathways:	1	Phenindione Action Pathway
5'-Hydroxypiroxicam	HMDB_SMPDB	Samples:	1	Pathways:	1	Piroxicam Pathway
Piroxicam	HMDB_SMPDB	Samples:	1	Pathways:	2	Piroxicam Action Pathway	Piroxicam Pathway
Lumiracoxib	HMDB_SMPDB	Samples:	1	Pathways:	1	Lumiracoxib Action Pathway
Carprofen	HMDB_SMPDB	Samples:	1	Pathways:	1	Carprofen Action Pathway
6-Phosphonoglucono-D-lactone	HMDB_SMPDB	Samples:	52	Pathways:	1	Warburg Effect
D-Glucono-1,5-lactone 6-phosphate	HMDB_SMPDB	Samples:	52	Pathways:	1	Warburg Effect
Hydroxylansoprazole	HMDB_SMPDB	Samples:	4	Pathways:	1	Lansoprazole Pathway
Bisoprolol	HMDB_SMPDB	Samples:	11	Pathways:	2	Bisoprolol Pathway	Bisoprolol Action Pathway
Chlorthalidone	HMDB_SMPDB	Samples:	58	Pathways:	1	Chlorthalidone Pathway
Nimodipine	HMDB_SMPDB	Samples:	11	Pathways:	2	Nimodipine Pathway	Nimodipine Action Pathway
Metolazone	HMDB_SMPDB	Samples:	58	Pathways:	1	Metolazone Pathway
Tenoxicam	HMDB_SMPDB	Samples:	1	Pathways:	1	Tenoxicam Action Pathway
Valdecoxib	HMDB_SMPDB	Samples:	1	Pathways:	1	Valdecoxib Pathway
Thiamine	HMDB_SMPDB	Samples:	1	Pathways:	1	Thiamine Metabolism
Thiamine triphosphate	HMDB_SMPDB	Samples:	1	Pathways:	1	Thiamine Metabolism
Thiamine monophosphate	HMDB_SMPDB	Samples:	1	Pathways:	1	Thiamine Metabolism
Thiamin monophosphate	HMDB_SMPDB	Samples:	1	Pathways:	1	Thiamine Metabolism
Thiamin triphosphate	HMDB_SMPDB	Samples:	1	Pathways:	1	Thiamine Metabolism
Nebivolol	HMDB_SMPDB	Samples:	11	Pathways:	1	Nebivolol Pathway
Trichlormethiazide	HMDB_SMPDB	Samples:	58	Pathways:	2	Trichlormethiazide Action Pathway	Trichlormethiazide Pathway
Cocaine	HMDB_SMPDB	Samples:	20	Pathways:	2	Cocaine Pathway	Cocaine Action Pathway
Etodolac	HMDB_SMPDB	Samples:	1	Pathways:	2	Etodolac Pathway	Etodolac Action Pathway
Ketobemidone	HMDB_SMPDB	Samples:	20	Pathways:	1	Ketobemidone  Action Pathway
Nizatidine	HMDB_SMPDB	Samples:	4	Pathways:	2	Nizatidine Pathway	Nizatidine Action Pathway
Vinorelbine	HMDB_SMPDB	Samples:	1	Pathways:	1	Vinorelbine Pathway
Escitalopram	HMDB_SMPDB	Samples:	20	Pathways:	1	Escitalopram Pathway
Metiamide	HMDB_SMPDB	Samples:	4	Pathways:	1	Metiamide Action Pathway
Benzocaine	HMDB_SMPDB	Samples:	20	Pathways:	2	Benzocaine Action Pathway	Benzocaine Pathway
Oxprenolol	HMDB_SMPDB	Samples:	11	Pathways:	1	Oxprenolol Pathway
Amiloride	HMDB_SMPDB	Samples:	58	Pathways:	2	Amiloride Pathway	Amiloride Action Pathway
5'-Deoxy-5-fluorouridine	HMDB_SMPDB	Samples:	1	Pathways:	2	Capecitabine Action Pathway	Capecitabine Metabolism Pathway
5-Deoxyribose-1-phosphate	HMDB_SMPDB	Samples:	1	Pathways:	2	Capecitabine Action Pathway	Capecitabine Metabolism Pathway
5-FU	HMDB_SMPDB	Samples:	2	Pathways:	3	Capecitabine Action Pathway	Capecitabine Metabolism Pathway	Fluorouracil Action Pathway
Polythiazide	HMDB_SMPDB	Samples:	58	Pathways:	2	Polythiazide Action Pathway	Polythiazide Pathway
Aminocaproic acid	HMDB_SMPDB	Samples:	13	Pathways:	1	Aminocaproic Acid Pathway
Dobutamine	HMDB_SMPDB	Samples:	11	Pathways:	1	Dobutamine Action Pathway
Practolol	HMDB_SMPDB	Samples:	11	Pathways:	1	Practolol Action Pathway
Tolmetin	HMDB_SMPDB	Samples:	1	Pathways:	1	Tolmetin Action Pathway
Procaine	HMDB_SMPDB	Samples:	20	Pathways:	2	Procaine Action Pathway	Procaine Pathway
Diltiazem	HMDB_SMPDB	Samples:	11	Pathways:	2	Diltiazem Pathway	Diltiazem Action Pathway
Acetaminophen glucuronide	HMDB_SMPDB	Samples:	3	Pathways:	1	Acetaminophen Metabolism Pathway
Paracetamol sulfate	HMDB_SMPDB	Samples:	3	Pathways:	1	Acetaminophen Metabolism Pathway
NAPQI	HMDB_SMPDB	Samples:	3	Pathways:	1	Acetaminophen Metabolism Pathway
Glycerylphosphorylethanolamine	HMDB_SMPDB	Samples:	1	Pathways:	1	Phospholipid Biosynthesis
Ethanolamine	HMDB_SMPDB	Samples:	1	Pathways:	1	Phospholipid Biosynthesis
PC(16:0/16:0)	HMDB_SMPDB	Samples:	1	Pathways:	1	Phospholipid Biosynthesis
PS(16:0/16:0)	HMDB_SMPDB	Samples:	1	Pathways:	1	Phospholipid Biosynthesis
CDP-DG(16:0/16:0)	HMDB_SMPDB	Samples:	1	Pathways:	1	Phospholipid Biosynthesis
PE(16:0/16:0)	HMDB_SMPDB	Samples:	1	Pathways:	1	Phospholipid Biosynthesis
PI(16:0/16:0)	HMDB_SMPDB	Samples:	1	Pathways:	1	Phospholipid Biosynthesis
LysoPC(16:0)	HMDB_SMPDB	Samples:	1	Pathways:	1	Phospholipid Biosynthesis
PG(16:0/16:0)	HMDB_SMPDB	Samples:	1	Pathways:	1	Phospholipid Biosynthesis
LysoPE(16:0/0:0)	HMDB_SMPDB	Samples:	1	Pathways:	1	Phospholipid Biosynthesis
PGP(16:0/16:0)	HMDB_SMPDB	Samples:	1	Pathways:	1	Phospholipid Biosynthesis
CL(16:0/16:0/16:0/16:0)	HMDB_SMPDB	Samples:	1	Pathways:	1	Phospholipid Biosynthesis
CDP-choline	HMDB_SMPDB	Samples:	1	Pathways:	1	Phospholipid Biosynthesis
Phosphatidylethanolamine	HMDB_SMPDB	Samples:	1	Pathways:	1	Phospholipid Biosynthesis
Phosphatidylserine	HMDB_SMPDB	Samples:	1	Pathways:	1	Phospholipid Biosynthesis
sn-Glycero-3-phosphoethanolamine	HMDB_SMPDB	Samples:	1	Pathways:	1	Phospholipid Biosynthesis
Magnesium salicylate	HMDB_SMPDB	Samples:	1	Pathways:	1	Magnesium salicylate Action Pathway
Alvimopan	HMDB_SMPDB	Samples:	20	Pathways:	1	Alvimopan Action Pathway
Nateglinide	HMDB_SMPDB	Samples:	14	Pathways:	2	Nateglinide Pathway	Nateglinide Action Pathway
Tranexamic Acid	HMDB_SMPDB	Samples:	13	Pathways:	1	Tranexamic Acid Pathway
Dihydromorphine	HMDB_SMPDB	Samples:	20	Pathways:	1	Dihydromorphine Action Pathway
Telmisartan	HMDB_SMPDB	Samples:	4	Pathways:	1	Telmisartan Action Pathway
Pindolol	HMDB_SMPDB	Samples:	11	Pathways:	2	Pindolol Action Pathway	Pindolol Pathway
4-Hydroxybenzoic acid	HMDB_SMPDB	Samples:	30	Pathways:	1	Ubiquinone Biosynthesis
3-Hexaprenyl-4-hydroxy-5-methoxybenzoic acid	HMDB_SMPDB	Samples:	30	Pathways:	1	Ubiquinone Biosynthesis
3-Hexaprenyl-4,5-Dihydroxybenzoic acid	HMDB_SMPDB	Samples:	30	Pathways:	1	Ubiquinone Biosynthesis
Ubiquinone-1	HMDB_SMPDB	Samples:	30	Pathways:	1	Ubiquinone Biosynthesis
3-Hexaprenyl-4-hydroxybenzoic acid	HMDB_SMPDB	Samples:	30	Pathways:	1	Ubiquinone Biosynthesis
2-Hexaprenyl-6-methoxyphenol	HMDB_SMPDB	Samples:	30	Pathways:	1	Ubiquinone Biosynthesis
2-Hexaprenyl-6-methoxy-1,4-benzoquinone	HMDB_SMPDB	Samples:	30	Pathways:	1	Ubiquinone Biosynthesis
2-Hexaprenyl-3-methyl-6-methoxy-1,4 benzoquinone	HMDB_SMPDB	Samples:	30	Pathways:	1	Ubiquinone Biosynthesis
2-Hexaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone	HMDB_SMPDB	Samples:	30	Pathways:	1	Ubiquinone Biosynthesis
All-trans-hexaprenyl diphosphate	HMDB_SMPDB	Samples:	30	Pathways:	1	Ubiquinone Biosynthesis
2-Hexaprenyl-3-methyl-6-methoxy-1,4-benzoquinone	HMDB_SMPDB	Samples:	30	Pathways:	1	Ubiquinone Biosynthesis
3-Hexaprenyl-4,5-dihydroxybenzoate	HMDB_SMPDB	Samples:	30	Pathways:	1	Ubiquinone Biosynthesis
3-Hexaprenyl-4-hydroxy-5-methoxybenzoate	HMDB_SMPDB	Samples:	30	Pathways:	1	Ubiquinone Biosynthesis
3-Hexaprenyl-4-hydroxybenzoate	HMDB_SMPDB	Samples:	30	Pathways:	1	Ubiquinone Biosynthesis
4-Hydroxybenzoate	HMDB_SMPDB	Samples:	30	Pathways:	1	Ubiquinone Biosynthesis
all-trans-Hexaprenyl diphosphate	HMDB_SMPDB	Samples:	30	Pathways:	1	Ubiquinone Biosynthesis
Ubiquinone-6	HMDB_SMPDB	Samples:	30	Pathways:	1	Ubiquinone Biosynthesis
Timolol	HMDB_SMPDB	Samples:	11	Pathways:	1	Timolol Action Pathway
8-Hydroxycarvedilol	HMDB_SMPDB	Samples:	11	Pathways:	1	Carvedilol Pathway
Carvedilol	HMDB_SMPDB	Samples:	11	Pathways:	2	Carvedilol Action Pathway	Carvedilol Pathway
Venlafaxine	HMDB_SMPDB	Samples:	2	Pathways:	1	Venlafaxine Metabolism Pathway
N-Desmethylvenlafaxine	HMDB_SMPDB	Samples:	2	Pathways:	1	Venlafaxine Metabolism Pathway
Arbutamine	HMDB_SMPDB	Samples:	11	Pathways:	1	Arbutamine Action Pathway
Flecainide	HMDB_SMPDB	Samples:	11	Pathways:	2	Flecainide Pathway	Flecainide Action Pathway
Pirenzepine	HMDB_SMPDB	Samples:	4	Pathways:	2	Pirenzepine Pathway	Pirenzepine Action Pathway
Captopril	HMDB_SMPDB	Samples:	4	Pathways:	1	Captopril Pathway
Ximelagatran	HMDB_SMPDB	Samples:	13	Pathways:	1	Ximelagatran Pathway
Repaglinide	HMDB_SMPDB	Samples:	14	Pathways:	2	Repaglinide Action Pathway	Repaglinide Pathway
D-Ornithine	HMDB_SMPDB	Samples:	28	Pathways:	1	D-Arginine and D-Ornithine Metabolism
D-Arginine	HMDB_SMPDB	Samples:	28	Pathways:	1	D-Arginine and D-Ornithine Metabolism
2-Oxoarginine	HMDB_SMPDB	Samples:	28	Pathways:	1	D-Arginine and D-Ornithine Metabolism
5-Guanidino-2-oxopentanoate	HMDB_SMPDB	Samples:	28	Pathways:	1	D-Arginine and D-Ornithine Metabolism
Diphenoxylate	HMDB_SMPDB	Samples:	20	Pathways:	1	Diphenoxylate Action Pathway
Famotidine	HMDB_SMPDB	Samples:	4	Pathways:	1	Famotidine Pathway
Tocainide	HMDB_SMPDB	Samples:	11	Pathways:	2	Tocainide Pathway	Tocainide Action Pathway
Enalaprilat	HMDB_SMPDB	Samples:	4	Pathways:	1	Enalapril Action Pathway
NPC	HMDB_SMPDB	Samples:	2	Pathways:	1	Irinotecan Action Pathway
SN-38	HMDB_SMPDB	Samples:	2	Pathways:	1	Irinotecan Action Pathway
6-Aminohexanoate	HMDB_SMPDB	Samples:	13	Pathways:	1	Aminocaproic Acid Action Pathway
Tranexamic acid	HMDB_SMPDB	Samples:	13	Pathways:	1	Tranexamic Acid Action Pathway
Linamarin	HMDB_SMPDB	Samples:	4	Pathways:	1	Lansoprazole Action Pathway
Procaterol hydrochloride	HMDB_SMPDB	Samples:	11	Pathways:	1	Atenolol Action Pathway
L-(-)-1-Butyl-2',6'-pipecoloxylidide	HMDB_SMPDB	Samples:	20	Pathways:	1	Levobupivacaine Action Pathway
Morphine-3-glucuronide	HMDB_SMPDB	Samples:	1	Pathways:	1	Morphine Action Pathway
Morphine-6-glucuronide	HMDB_SMPDB	Samples:	1	Pathways:	1	Morphine Action Pathway
2-Ethyl-5-methyl-3,3-diphenyl-1-pyrroline	HMDB_SMPDB	Samples:	20	Pathways:	1	Methadone Action Pathway
Citalopram aldehyde	HMDB_SMPDB	Samples:	41	Pathways:	1	Citalopram Action Pathway
Citalopram N-oxide	HMDB_SMPDB	Samples:	41	Pathways:	1	Citalopram Action Pathway
Citalopram propionic acid	HMDB_SMPDB	Samples:	41	Pathways:	1	Citalopram Action Pathway
Demethylcitalopram	HMDB_SMPDB	Samples:	41	Pathways:	1	Citalopram Action Pathway
Didemethylcitalopram	HMDB_SMPDB	Samples:	41	Pathways:	1	Citalopram Action Pathway
(R,S)-Nicotine	HMDB_SMPDB	Samples:	29	Pathways:	1	Nicotine Action Pathway
